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Pathogenesis
R2084 Frequent detection by real-time PCR of bacteria from the
Helicobacter and Campylobacter genera in stool samples
from inﬂammatory bowel disease patients
J. Tankovic °, B. Burghoffer, J.C. Petit (Paris, FR)
Objectives: Recent studies have suggested that members of the genus
Helicobacter may play a role in the development of inﬂammatory bowel
disease patients (IBD). The aim of the study was to further investigate
this question and to extend it the closely related Campylobacter genus.
Methods: Bacteria were detected from stools by real-time PCR based on
SYBR-Green ﬂuorescence with an ABI Prism 7000 apparatus (Positivity
threshold: Ct< 30). DNA extraction was performed with the QIAamp
DNA stool minikit. Four sets of oligonucleotides were used: primers
amplifying either a conserved fragment of the 16S rRNA gene from
all known species of Helicobacter or from all known species of
Campylobacter; primers speciﬁc for a fragment of the vacA gene from
Helicobacter pylori; and primers speciﬁc for a fragment of the 16S
rRNA gene from Campylobacter concisus. Stools were also cultured for
10 days on Skirrow-supplemented blood agar plates in a microaerophilic
atmosphere. 30 patients were included, eight with Crohn’s disease (CD),
11 with ulcerative colitis (UC) and 11 symptomatic controls. The
association between the presence of Helicobacter or Campylobacter and
each study group was statistically analysed using the Fisher’s exact test.
Results: 58% (11/19) of IBD patients [64% of UC patients (7/11) and
50% (4/8) of CD patients] and 27% (3/11) of control patients were
Helicobacter-positive (ns, p = 0.17). The H. pylori PCR was always
negative. The Campylobacter PCR was positive for 21% (4/19) of IBD
patients and 9% (1/11) of control patients (ns, p = 0.46). The C. concisus
PCR was positive only for the 4 Campylobacter-positive patients. 3 of
these 4 patients were also Helicobacter-positive. Culture yielded only
two C. concisus strains, from the stools of two of the four patients that
were also C. concisus-positive by PCR.
Conclusion: Although our results are not statistically signiﬁcant, they
suggest that stools from IBD patients are more frequently Helicobacter-
positive (but H. pylori-negative) than those from control patients. Thus
Helicobacteriaceae may have a pathogenic role in the development of
IBD. As C. concisus was only found in stools from IBD patients, it may
also be implicated in IBD.
R2085 Fibronectin binding proteins in Staphylococcus aureus
strains isolated from 6 to 14-year-old nasal carriers
N. Yapar, V. Avkan-Oguz ° (Izmir, TR)
Objective: Staphylococcus aureus is an important pathogen capable of
causing a variety of infections. Nasal carriage rates for S. aureus have
been reported to be between 18% and 50% in different populations and
this carriage represents a risk factor for invasive infections. The aim of
the study presented here was to investigate the presence of ﬁbronectin
binding proteins (FnBPs) mediating adhesion of S. aureus to human
epithelial cells.
Methods: Fifty S. aureus strains isolated from nasal swab specimens of
6−14 years old healthy children were included in the study. Specimens
were inoculated on mannitol salt agar plates and all colonies surrounded
by yellow zones on plates after 24−48 hours of incubation at 37ºC
were selected. The isolates were identiﬁed by biochemical properties
and tube coagulase test. Methicillin susceptibility tests of all strains
were performed by disk diffusion test using 30mcg cefoxitin disks
and by agar dilution method using oxacilline base according to the
recommendations of Clinical and Laboratory Standard Institute (CLSI)
guidelines. Presence of FnBPs was investigated by detection of fnbA and
fnbB genes via conventional PCR method. S. aureus NCTC 8325 was
used to characterise the genes coding FnBP A and B as the reference
strain.
Results: According to cultural properties and positive tube coagulase test
all 50 isolates included in the present study were identiﬁed as S. aureus.
All isolates were found to be susceptible to oxacilline (MIC< 1mg/L).
Of 50 S. aureus strains, 14 (28%) were found to be positive for gene
fnbA and 5 (10%) for gene fnbB.
Conclusion: Presence of FnBPs in our study population was lower
than the other studies performed on nasal carriers published previously.
We concluded that the lower age of study population or geographical
diversities could be resulted in this lower rate. Fibronectin binding
proteins may represent an increased risk factor for subsequent infections
but they are not efﬁcient for adhesion alone.
Animal models including experimental
treatment
R2086 Effectiveness of albendazol against viability of Entamoeba
histolytica in experimental animals
A.M. Al-Mukhtar °, W.J. Barawi (Mosul, IQ)
Objective: Intestinal amebiasis is still an important health problem in
developing countries of the world. One of the most issues for future
biomedical research is the development of antimicrobial resistant, in
order to search for alternative new antiamoebic drugs. A study was
carried out to evaluate the efﬁcacy of albendazol on the viability
of Entamoeba histolytica clinical isolate from human which used for
experimental animals.
Material and Methods: All experimental animal models (mice and
rabbits), divided into 3 groups, each group with either 10 mouse or 10
rabbits, were orally infected with E. histolytica (clinical isolate), then
after 7 days they were given drugs (Metronidazol or Albendazol) daily
according to body weight prepared in advance for 5 days duration and
in addition to the controls without drugs. Stool specimens of each group
were examined microspically for viable trophozoites, and the number
of these trophozoites were counted with haemocytometer chamber, as
compared to untreated and treated groups. Statistical methods used was
student t-test.
Results: The results showed infection of E. histolytica was able
to be intiated in rabbits only. Albendazol and metronidazol were
highly effective(100%) on treatment of infected groups of rabbits
(table I). Trphozoites of E. histolytica was highly sensitive to albendazol
(25% viability), or to metronidazol (22.7% viability) at a dose of
400mg/kg/day and 250mg/kg/day respectively, which was signiﬁcant in
relation to the control 500% viability (table II). However, the differences
were signiﬁcant at the level (p< 0.01).
Conclusions: The presenstudy showed that the newly used albendazol
is very effective anti-amebic drug as metronidazol in rabbits.
R2087 The effect of artesunate on Toxoplasma gondii: in vitro and
in vivo studies
L. El Zawawy ° (Alexandria, EG)
Objectives: In the search for new effective compound with less toxic
effects for treating Toxoplasma infection, this study was conducted to
investigate the effect of AS on Toxoplasma gondii (T. gondii) both in
vitro and in vivo.
S614 19th ECCMID, Abstracts accepted for publication only
Methods: In the in vitro study, tachyzoites of RH strain of T. gondii were
exposed to AS in a concentration of 2mg/ml for 72 hours. The assessment
of the effect of AS was carried out by studying; the viability, infectivity
and ultrastructure changes of the treated tachyzoites by scanning electron
microscope (SEM). In the in vivo study, Swiss albino mice were infected
intraperitoneally with tachyzoites of RH strain of T. gondii then orally
treated with AS in a dose of 200mg/kg for ﬁve successive days. The
effect of AS was evaluated by detecting the mortality rate and the survival
time of the infected treated mice. Parasite burden, viability, infectivity
and ultrastructure changes of tachyzoites harvested from the peritoneal
cavities of infected treated mice, in comparison with that of infected
non-treated control animals, were also studied.
Results: Results of the in vitro study demonstrated a signiﬁcant
reduction in the viability and infectivity of tachyzoites exposed to
AS as compared with the untreated controls. Regarding the in vivo
study, treatment of mice with AS induced a signiﬁcant decrease in
their mortality rate and increase in their survival time. There was also
a signiﬁcant reduction in the parasite burden in the infected treated
mice associated with signiﬁcant reduction in viability and infectivity
of tachyzoites harvested from their peritoneal cavities as compared with
the infected non-treated control. The SEM study demonstrated distortion
in the tachyzoites’ shape, peeling, erosions and discontinuity in areas of
the surface membrane of the treated tachyzoites of both in vitro and in
vivo studies.
Conclusion: The results of the present study suggested that, AS could
provide an effective and promising drug in treating acute toxoplasmosis.
This will open the way to study its effect on cyst forming strains
of T. gondii and to determine its efﬁcacy and safety in treating
toxoplasmosis in humans.
Bioﬁlm
R2088 Effects of extremely low-frequency electromagnetic ﬁelds
on Helicobacter pylori bioﬁlm
L. Cellini °, R. Grande, M. Di Giulio, S. Di Bartolomeo, E. Di Campli
(Chieti, IT)
Objective: Helicobacter pylori is characterised by a dynamic behaviour
in response to environmental stress entering the viable but not culturable
(VBNC) state in which the microorganism modiﬁes its morphology from
spiral to coccoid form with a loss of culturability. This cellular response
is emphasized when bacterial cells organise themselves into microbial
communities forming bioﬁlm.
The aim of this work was to investigate the effect of exposure to
an extremely-low frequency electromagnetic ﬁeld (ELF-EMF), able to
interfere on phenotypic and transcriptional prokaryotic pattern, both in
the formation and in the detachment of the H. pylori bioﬁlm.
Methods: The reference strain H. pylori ATCC43629 was used for this
study. Bacterial cultures grown on polystyrene surfaces were exposed at
50Hz of frequency and 1mT of magnetic ﬁeld within a central area of
a cylindrical solenoid and checked over time. The exposed cultures and
the respective sham-exposed controls were studied for: the cell viability
status; the cell morphological aspects; the biomass measurement; the
analysis of DNA ﬁngerprintings and the expression of genes coding for
hsp60 and amiA involved in the bacillary/coccoid form conversion.
Results: The ELF-EMF effect was studied on 2 day sessile H. pylori
cells and on cultures ﬁrst grown as bioﬁlm and then exposed for 2 days
for a total time of 4 days.
Cultures exposed for 2 days displayed signiﬁcant differences on cell
viability as well as on bacterial morphology with the prevalence of
bacillary forms (58.41%) in respect to the unexposed ones (33.14%).
When comparing the 4 days cultures, signiﬁcant differences were
not found. The measurement of bioﬁlm cell mass displayed, in both
examined experimental condition, a signiﬁcant reduction of adhesion in
exposed cultures at 2 (from 0.0183±0.060 to 0.0067±0.0064 OD492)
and 4 (from 0.2759±0.0678 to 0.1472±0.0394 OD492) days. No
changes on DNA ﬁngerprintings were recorded whereas a modulation
in hsp60 and amiA expression among exposed and unexposed cultures
were expressed.
Conclusion: Our results indicate that the exposure to 50Hz EMF of
H. pylori bioﬁlm induces phenotypical changes on adherent bacteria
and produces a reduction on cell adhesion also suggesting a possible
role in the variability into H. pylori population.
R2089 In vitro comparison of anti-bioﬁlm effects against
carbapenem-resistant A. baumannii: imipenem, colistin,
tigecycline, rifampicin and combined regimens
J.Y. Song °, H.J. Cheong, Y.M. Jo, W.S. Choi, M.J. Kim, J.Y. Heo,
J.Y. Noh, W.J. Kim (Seoul, KR)
Background: Multi-drug resistant (MDR) Acinetobacter baumannii has
emerged as one of the most important nosocomial pathogens. In addition
to the diverse resistance mechanisms, some A. baumannii strains are
known to have bioﬁlm-producing capacity, thereby decreasing antibiotic
effectiveness.
Methods: This study was designed to assess bioﬁlm-producing capacity
of three different MDR A. baumannii strains with diverse resistance
mechanisms (OXA-51, IMP-1 and VIM-2 type b-lactamases), and
intended to compare the effect of each antibiotic regimen (rifampicin,
colistin, imipenem, tigecycline, rifampicin-imipenem and rifampicin-
colistin) on mature A. baumannii bioﬁlms using in vitro polystyrene
plate bioﬁlm assay.
Results: Among three MDR A. baumannii strains, only VIM-2 strain
produced strong bioﬁlm compared to the controls (optical density,
8.04±2.16 vs. 0.49±0.26). Regarding VIM-2 strains, neither imipenem,
colistin, nor rifampicin reduced bioﬁlm formation alone at MIC of
each antibiotic agent (inhibition of bioﬁlm synthesis less than 30%). In
comparison, tigecyclin (0.76±0.23), imipenem-rifampicin (1.07±0.31)
and colistin-rifampicin (1.47±0.54) showed a signiﬁcant inhibition of
bioﬁlm synthesis compared to the positive controls at 48 hours after
incubation (p< 0.01). Tigecycline inhibited bioﬁlm formation even at
the one fourth level of MIC (1.17±0.21). Likewise, both imipenem and
colistin were also effective at the reduced concentrations when those were
combined with rifampicin. Such bioﬁlm-inhibiting effects with those
antibiotic regimens sustained up to 96 hours after incubation.
Conclusions: VIM-2 A. baumannii strain was a strong bioﬁlm producer.
Tigecycline, imipenem-rifampicin and colistin-rifampicin would be
effective against diverse infections by bioﬁlm-producing A. baumannii
strains.
R2090 Comparison of different methods for quantiﬁcation of Can-
dida spp. bioﬁlm grown in different glucose concentration
S. Tobudic °, C. Kratzer, A. Lassnigg, W. Graninger, E. Presterl
(Vienna, AT)
Objectives: Candida species are emerging as important pathogens. In
this study bioﬁlm formation among invasive and non-invasive Candida
isolates using different quantiﬁcation methods as well as different
glucose concentrations was evaluated.
Material and Methods: Two hundred-and-thirty-four Candida isolates
including 160 C. albicans, and 74 non-albicans isolates were recovered
from bloodstream (106), skin swab (40), pharyngeal swab (30), urine
(35), bronchial ﬂuid (11), and medical devices (12). In 96-well microtiter
plates bioﬁlm production was studied using as growth medium (GM)
RPMI 1640 medium containing three different glucose concentrations:
0.2%, 2%, and 8%. Candida bioﬁlms were quantiﬁed using three
different methods: bioﬁlm thickness by the percent transmittance (%
T) method expressed as %Tbloc, metabolic activity by XTT assay
expressed as optical density (OD), and bioﬁlm mass by crystal violet
staining expressed as OD. Using values assessed by % T method bioﬁlm
production was scored as negative, low or high, and compared with
metabolic activity and bioﬁlm mass.
Results: Bioﬁlm production was more frequently observed in GM
containing 2% and 8% glucose (230 of 234 isolates, 98.3%) than in GM
containing 0.2% glucose (212 of 234 isolates, 90.6%). In non invasive
isolates bioﬁlm production was more commonly detected than in invasive
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isolates: 96.9 vs. 82%, p< 0.001 (in GM containing 0.2% glucose), and
99.2% vs. 96.2%, p> 0.05 (in GM containing 2% and 8% glucose).
Correlation between bioﬁlm production assessed by % T method and
bioﬁlm mass assessed by crystal violet staining was noticed: non bioﬁlm
producers (OD 0.1), low bioﬁlm producers (OD 0.1−0.25) and high
bioﬁlm producers (OD 0.25). The OD of bioﬁlm formation assessed
by XTT assay correlated with values assessed by other two assays in all
Candida spp., except for C. tropicalis and C. glabrata, by which OD
decreased in GM containing 2% and 8% glucose.
Conclusion: Our data suggest that RPMI 1640 medium containing
2% and 8% glucose support the highest bioﬁlm production. For the
quantiﬁcation of bioﬁlm formation XTT assay showed some limitation,
particularly in C. glabrata and C. tropicalis.
R2091 Differences between Pseudomonas aeruginosa non-adapted
and adapted to benzalkonium chloride: comparison of
adhesion capacity, and susceptibility of bioﬁlms to removal
and surfactant attack
S.P. Lopes, I. Machado, M.J. Vieira, M.O. Pereira ° (Braga, PT)
Bacteria adhesion, and consequent bioﬁlm formation, in vitro and in
vivo, are phenomena that often occur naturally but are also bacteria’s
strategies to protect themselves from stress factors, playing probably an
important role in virulence. Furthermore, bacteria growing in bioﬁlms
are less susceptible to many antibacterial agents than their suspended
counterparts. These factors emphasize the need of suitable and efﬁcient
surface disinfection procedures in order to reduce the overgrowth
of resistant microorganisms in response to an ineffective course of
antimicrobials. In this study, we examined the effect of adaptation of
P. aeruginosa to a surfactant, benzalkonium chloride (BZK), on the
adherence of bacterial cells to PET, conditioned and non-conditioned
with BZK, and on their ability to resist to removal and BZK aggression.
The assays were carried out in a PPFC. Bacterial adaptation was attained
by exposing P. aeruginosa to gradual increasing concentrations of BZK,
and selected in TSA supplemented with 4.0mM BZK.
The results show that adapted P. aeruginosa adhered in a more extent
than the non-adapted counterpart. For both strains, the pre-conditioning
of the PET surfaces signiﬁcantly favoured bacterial adhesion. The higher
adhesion was observed with the adapted bacteria onto the conditioned
PET coupons. These results highlight that the extent of adhesion is
greater the higher are the stress factors. The strength of adhesion is also
higher in the case of adapted bacteria since detachment only occurs with
P. aeruginosa non-adapted. BZK application did not cause signiﬁcant re-
moval except for P. aeruginosa non-adapted adhered to non-conditioned
PET. Nevertheless, BZK attack causes loss of viability of the cells that
remained adhered to the surfaces, this loss being more notorious in the
case of non adapted cells adhered in the conditioned surfaces.
Based on the results it can be said that the presence of BZK residues
on the adhesion surfaces did not impair the bacterial adhesion capacity
though affects the viability of the adhered cells. It can also be concluded
that resistant bacteria that survived to a simple adaptation step to
a common antimicrobial agent increased its adherence ability and
insusceptibility to removal and antimicrobial treatment. In a disinfection
point of view, these results can represent additional problems for
the eradication of pathogenic bacteria with increased virulence from
equipment and surfaces in the medical arenas.
Antimicrobial pharmacokinetics,
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R2092 Killing kinetics of cefditoren pivoxil against Escherichia
coli clinical isolates
D. Hatzaki °, G. Poulakou, M. Souli, N. Lambri, Z. Chryssouli,
K. Kanellakopoulou, H. Giamarellou (Athens, GR)
Objectives: Cefditoren pivoxil (CFD), an advanced oral cephalosporin
is licensed for urinary tract infections (UTI) only in Japan. In view of
the increasing resistance in community infections, this study aims to
evaluate the in vitro efﬁcacy and killing kinetic proﬁle of CFD against
recently isolated uropathogens from Greece.
Methods: The susceptibility of Escherichia coli isolates recovered
during 2005–2007 from outpatients with UTIs, was tested against 17
antimicrobials with disk diffusion method and for CFD with agar dilution
method (CLSI 2007). In lack of ofﬁcial breakpoints, isolates with
MIC 2mg/L were considered as non-susceptible (NS) according to
recent literature. The killing kinetic proﬁle of CFD was also explored
with killing curves for 18 isolates of E. coli (16 susceptible, 2 non-
susceptible), using concentrations of 1×, 2× and 4×MIC and within
0 h, 2 h, 4 h, 6 h and 24 h of incubation.
Results: The CFD MIC50/90 values of 332 E. coli isolates
were 0.25/0.5mg/L (range 0.06−>32mg/L). Resistance rates among
commonly used antimicrobials and CFD were: ampicillin 31.9%,
amoxicillin/clavulanate 6.6%, ciproﬂoxacin 4.2%, co-trimoxazole 23.8%,
cefuroxime axetil 3.9%, nitrofurantoin 6.3% and CFD 3%. Killing curves
showed that the bactericidal end point (3 log10 reduction) was reached
for 1×MIC concentration within 4 h for 1 isolate and within 6 h for 2 iso-
lates. For 2×MIC, killing was observed within 4 h for 2 isolates, within
6 h for 6 isolates and within 24 h for 5 isolates(1 of them NS) and for
4×MIC within 4 h for 1 isolate, within 6 h for 12 isolates and within 24 h
for 4 isolates (1 of them NS). For 1 NS isolate there was no killing effect.
Conclusion: This study demonstrated the in vitro efﬁcacy and
bactericidal activity of CFD in recently isolated uropathogens from
outpatients, thus indicating a possible future role as an alternative in
UTIs treated in outpatient settings, or for patients receiving sequential
iv/oral treatment.
R2093 Steady-state plasma and tissue concentrations of tigecycline
after intravenous infusion administration to rabbits
K. Zorpas, G. Charkoftaki, E. Vryonis °, A. Dokoumetzidis,
N. Kostomitsopoulos, A. Skoutelis, H. Archontaki, G. Valsami (Athens,
GR; Belfast, IE)
Background: Tigecyclin (T) is the ﬁrst available glycycycline derived
from minocycline. It possesses broad-spectrum activity against aerobic
and anaerobic bacteria including multidrug resistant Gram positive and
Gram negative pathogens.
Trigecyclin was found to exhibit large volume of distribution in healthy
humans, indicating extensive tissue distribution and half-life elimination
of 37 to 67 hours. With a single intravenous (IV) dose of 7 or 14mg/kg
in rabbits the drug concentration in serum can remain above the MIC
for more than 12 hours.
Objectives: To measure T accumulation to body tissues at steady state
in order to construct a full body physiological based PK model and to
describe drug disposition kinetics in rabbits.
Methods: We used New Zealand white rabbits (3.0±0.4 kg). After a
loading IV dose of 75mg T in 15min, animals received 27.5mg of T
during a 2.5 h continuous IV infusion to achieve a 2mg/mL plasma steady
state concentration (SSC). Blood sample measurement at 60, 45, 30 and
15min prior and immediately after the end of the 2.5 h IV infusion were
used to conﬁrm SSC. At the end of the 2.5 h IV infusion all rabbits were
anaesthetized and sacriﬁced. Tissue samples were taken to determine
drug accumulation. Blood samples were centrifuged at 4000 rpm for
15min and plasma samples were frozen at −70ºC until analyzed. Tige-
cycline assay was performed by a HPLC-UV method recently developed
in our laboratory and properly modiﬁed for the needs of this study.
Organ Concentration (mg/g) Organ Concentration (mg/g)
Heart 7.83 (±3.4) Peritoneal fat 1.6 (±0.5)
Spleen 11.3 (±2.2) Orbital fat 4.8 (±2.2)
Liver 38.5 (±16.4) Bone marrow 0.3 (±0.1)
Kidneys 20.9 (±9.0) Brain 0.3 (±0.03)
Gallbladder 70.1 (±21.5) Lung 7.8 (±2.0)
Bile 200.0 (±80.5) Testicular tissue 6.8 (±1.4)
Thigh muscle 10.4 (±4.4) Vitreous ﬂuid 0.4 (±0.1)
Results: The result are presented in the table.
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Conclusion: Results show that in rabbits T accumulates to well perfused
tissues such as kidneys, liver, spleen, muscle and testicular tissue. Due
to its hydrophilic nature tigecycline concentration in fat tissues is low
and is not distributed in the brain.
R2094 Extended studies of piperacillin/tazobactam generic
formulations: variations of branded product lots and
assessment of 38 generic lots
R. Jones °, A. Waters, H. Sader, G. Moet (North Liberty, US)
Objectives: To further assess the potency of piperacillin/tazobactam
(P/T; Zosyn®, Wyeth) branded and generic lots produced for global sale.
P/T is a widely used broad-spectrum b-lactamase inhibitor combination,
and a large number of generic products are available needing careful
evaluation/comparison to the reformulated branded product.
Methods: Updated analysis was performed in three parts; 1.) MIC assay
variations using reference (RLOT) branded lot (B75011; 13 replicates
over 2 years); 2.) other branded lots compared to the RLOT (8 total); and
3.) expanded tests of 38 generic lots (23 reported earlier). Disk diffusion
and MIC assays used 4 organisms (P/T MIC, ranges of 1 to 4mg/L),
with triplicate processing compared to the RLOT potency control. A
total of 24 manufacturers of generic P/T were evaluated from 13 nations.
Assay susceptibility tests employed the CLSI M7-A7 method with 20
incremental dilutions steps between 0.5 and 8mg/L, increasing precision.
Only MIC assays are presented.
Results: Replicate tests (4 organisms × triplicate tests × 13 testing
events) of RLOT showed consistent results only varying ±3% from
averaged MIC results with each assay strain (see ﬁgure). When other
P/T branded lots were tested, the potencies varied from +7 to −19%
(average at −6%). This compares to generic lots (Figure) exhibiting
potency variations of +4 to −27% (average, −13%) in recent testing
and equal to −35% in year 2007 assays. Only 6 of 38 (16%) generic
lots had a potency at least equal to the average of all Zosyn® branded
lots. All values were based on demonstrated antimicrobial activity of
vial contents, where only one generic lot (3%) had activity >RLOT.
Conclusions: The activity of P/T generic products can vary and
signiﬁcant decreases (−15% overall) have been noted by this precise
incremental MIC assay system, RLOT test variations were minor and
the branded lots had greater activity correlations (−6%) when compared
to results from 38 generic lots (Figure). Selection of generic products
should consider the quality of the formulation as measured by in vitro
potency as well as chemical-based analyses.
R2095 Antimicrobial effect of polysaccharide extract of
Ganoderma on some pathogen microorganisms
A. Shariﬁ °, S. Jahedi, M. Naghmachi (Yasuj, IR)
Objective: Antimicrobial activity is the ability of a substance to
inhibit preferably; or to kill microorganisms. Due to emergence of
resistance to antibiotics amongst microorganisms, investigations for
novel antimicrobial agents have always been one of the major pre-
occupations of the medical society. Mushroom is a common name for the
fruiting body of macro fungi particularly to the members of Agaricales,
edible as well as highly poisonous species. Medicinal mushrooms have
been used in folk medicine throughout the world since the ancient times.
The present investigation aims to study the antimicrobial activity of
medicinal mushroom namely Ganoderma Reishi.
Materials and Methods: In this present work, Candida albicans MTCC
1637, Klebsiella pneumonia MTCC 432, and Staphylococcus aureus
HAL 2079, were used as test microorganisms to test polysaccharide
extraction of Ganoderma for the antimicrobial activity with a well assay
method and determination minimum inhibitory concentration by standard
tube agglutination.
Results: The crude polysaccharide extract of Ganoderma Reishi (3a &
3b) was active against Candida albicans (MTCC 1637), Klebsiella
pneumonia (MTCC 432), and Staphylococcus aureus (HAL 2079) while,
Polysaccharide fraction (3a) showed the zone of inhibition 28, 22 &
25mm and MIC 32, 32 and 64 and polysaccharide fraction (3b) showed
zone of inhibition 35, 20, & 27mm and MIC 32, 64 and 64 in cases
of Candida albicans, Klebsiella pneumonia & Staphylococcus aureus
respectively.
The maximum zone of inhibition was found to be 35mm in standard
antibiotics while 34mm was observed in the present study.
Conclusion: This data clearly indicates that the mushroom compounds
show equivalent compatibility with the standard antibiotics. However,
further separation and fraction of polysaccharide fractions need to be
carried out to detective the bioactivity of speciﬁc compounds.
Mechanisms of action and resistance
R2096 Molecular analysis of isoniazid resistance in different
genotypes of Mycobacterium tuberculosis isolates from Iran
A.D. Khosravi °, F. Doustdar, P. Farnia, A. Bahremand (Ahwaz, Tehran,
IR)
Objectives: Signiﬁcant increase of isoniazid-resistance in Iranian
Mycobacterium tuberculosis isolates in the last few years would present
a serious need for rapid detection and effective management of INH-
resistance tuberculosis in Iran. Therefore the aim of present study was
to investigate the prevalence of mutations in the three most commonly
reported loci associated with INH-resistance, katG codon 315, the fabG1-
inhA regulatory region and oxyR-ahpC intergenic region.
Methods: To investigate the mutations associated with isoniazid
resistance, Drug susceptibility test was performed initially and then, parts
of the coding sequence of katG gene and fabG1-inhA and oxyR-ahpC
regulatory regions, were analyzed in a sample of 48 isoniazid-resistant
and 25 isoniazid-sensitive isolates using nucleotide sequencing.
Results: The R463L polymorphism in katG gene was detected with
high frequency in both Isoniazid resistant and sensitive isolates. The
ahpC 46A was the most common mutation in the oxyR-ahpC intergenic
region which was present in 31.2% of resistant and 16.0% of susceptible
isolates. Mutations at katG codon 315 or the fabG1-inhA regulatory
region were identiﬁed in 77.0% of the isoniazid-resistant isolates.
Spoligotyping and IS6110 RFLP patterns revealed that most of the
isolates contained ahpC 46A and katG 463Leu polymorphism belonged
to CAS super family.
Conclusion: mutations at katG codon 315 or the fabG1-inhA regulatory
region were identiﬁed in 77.0% of the isoniazid-resistant isolates and
in none of the isoniazid-sensitive strains and are highly predictive of
isonizid resistance in Iranian isolates.
R2097 The accumulation of resistance mutations in Mycobacterium
tuberculosis in vitro
I.L. Bergval, A.R.J. Schuitema, P. Klatser, R.M. Anthony ° (Amsterdam,
NL)
Objectives: In Mycobacterium tuberculosis (MTB), antibiotic resistance
is almost exclusively established by point mutations. Multidrug-
resistance develops by sequential acquisition of mutations at different
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loci. Although the acquisition of resistance mutations is random, the
genetic routes leading to the development of successful and virulent
(multi)drug-resistant bacteria may be quite constrained (Weinreich DM
et al. Science 2006) and probably inﬂuenced by the genetic background
of the strain in question.
We have studied the acquisition of drug resistance mutations in different
strains and isogenic mutants to better understand the development of
MDR strains.
Methods: Cultures of well-characterised laboratory derived isogenic
mutants and clinical isolates were used. Drug-resistant mutants were
selected in vitro from either a single large liquid culture or a series of
smaller liquid cultures by plating on solid antibiotic-containing medium
and mutant colonies characterised using a multiplex ligation probe assay
(MLPA) and DNA sequencing.
Results: Different clades have a preference for different distributions
of speciﬁc rpoB mutations, this effect was most strongly evident when
individual colonies were selected from a single large broth (frequency).
Less clade speciﬁc variation was seen with multiple cultures(rate). Most
notably we detected a marked increased in the proportion of rpoB
C526T mutations (typically greater than 50%) from strain Mtb72(Group
3 genotype) when selected from a single large broth.
Initial results indicate a possible reduction in the diversity of rpoB
resistance genotypes after selection of strains with pre-existing INH
resistance.
Conclusion: Strain speciﬁc variation in favoured mutations was more
evident when multiple colonies are characterised from a single large
culture. We believe this indicates that the relative ﬁtness of the different
mutations varies based on the strain’s genotype. Our results for the
variation in distribution of spontaneous rpoB mutations between different
clades shows similarity to variations in the distribution of mutations
previously reported from clinical isolates within genotypic groups (Lipin
MY et al. Clin Microbiol 2007). These results suggest the sequence
of mutations leading to a successful MDR strain may indeed be quite
constrained with certain mutations in certain genotypes probably being
signiﬁcantly more likely to become multiply resistant.
R2098 Adhesion and adhesion inhibition properties of
Biﬁdobacterium strains B. longum BB536 and
B. pseudocatenulatum G4 on HT-29 epithelium cell line
A.Q. Sulaiman, F. Azizi Jalilian °, S. Mustafa, Z. Sekawi, H.M. Ghazali,
A.S.M. Hussin, B. Kabeir, A.M. Yazid (Serdang, MY)
Objective: To investigate the adhesion and adhesion inhibition properties
of Biﬁdobacterium strains B. pseudocatenulatum G4 and B. longum
BB536 to the model intestinal epithelium consisting of HT-29 cell-line
under different pH levels at different exposure times.
Methods: Adhesion ability of two Biﬁdobacterium strains B. longum
BB536 and B. pseudocatenulatum G4 was evaluated using HT-29 human
epithelium cell line in vitro. Four different levels of pH were used 5.6,
5.7, 6.6, and 6.8 with two different times 60 and 120min. Adhesion was
quantiﬁed by counting the adhering bacteria after Gram staining. The
evaluation ability of B. longum BB536 and B. pseudocatenulatum G4 to
inhibit adhesion of selective pathogens was done.
Results: The highest adhesion capacity for both Biﬁdobacterium
strains was observed at 120min, the maximum adhesion capacities
for both strains were at pH level 5.7. B. longum BB536 and
B. pseudocatenulatum G4 showed the ability to compete and inhibit
adhesion of pathogens. The ability to inhibit the adhesion or competitive
to adhere pathogens was variable depending on both probiotic and
pathogen tested.
Conclusion: Our results indicate that the ability to adhere and inhibit
adhesion of pathogens can be used for preliminary screening in order
to identify potentially probiotic bacteria suitable for human or animal
consumption.
R2099 High prevalence of mefE gene among macrolide-resistant
Streptococcus pneumoniae isolates in Istanbul
P. Sagiroglu °, B. Aksu, U. Over-Hasdemir (Istanbul, TR)
Objective: Macrolide resistance due to antibiotic efﬂux in Streptococcus
pneumoniae is getting increased in many parts of the world. Macrolide
efﬂux pump encoded by either mefA or mefE genes confers low-level
resistance to 14- and 15-membered macrolides but not to 16-membered
macrolides, lincosamids, or streptogramin B.
We aimed to determine the prevalence of erythromycin resistance and
the role of mef directed efﬂux pump in S. pneumoniae strains isolated
in our university hospital during 2008.
Methods: The prevalence of erythromycine resistance have been
determined by disk diffusion method in 91 S. pneumoniae isolates.
Broth microdilution method was applied in detection of erythromycin
and clindamycin MICs of the pneumococcal strains which were
found to be resistant to erythromycin in disk diffusion test. Two
major macrolide resistance mechanisms regarding efﬂux and target
modiﬁcation were investigated in erythromycin resistant S. pneumoniae
isolates, phenotypically and genotypically. Double disc method was used
to determine the macrolide resistance phenotypes (cMLSB, iMLSB and
M phenotype). The presence of mef genes and ermB genes were analysed
by PCR using primers that distinguish mefA and mefE genes.
Results: Resistance to erythromycin was detected in 28.6% (n:26) of
the isolates. Erythromycin MICs ranged from 2mg/ml to 512mg/mL
and MIC50 of the resistant strains was 512mg/mL. Twenty-four of
erythromycin resistant isolates were in cMLSB phenotype and 2 were in
M phenotype (Table 1).
Table 1. Phenotypic and genotypic test results in erythromycin resistant S. pneumoniae isolates
Resistance phenotype No. of isolates
(%)
MIC range
(mg/mL)*
Resistance genotype no. of isolates
(%)
Erythromycin Clindamycin erm(B) mef (E) erm(B)+mef (E)
cMLSB 24 (92.3) 128−512 512 10 (38) 0 14 (53.8)
M 2 (7.7) 2–4 0.125–0.25 0 2 (8) 0
*Determined by broth microdilution recommended by the CLSI.
In the isolates representing M phenotype, erytromycin MICs remained in
low level (2−4mg/mL) and their clindamycin MICs were in susceptibile
range. Of the 26 erytromycin resistant strains, 14 (53.8%) were found
to harbour mefE and ermB genes together; whereas 2 (7.7%) of them
harboured mefE alone.
Conclusion: This is the ﬁrst report indicating the high prevalence of
mefE gene together with ermB gene in macrolide resistant S. pneumoniae
isolates in Turkey. Although target modiﬁcation (ErmB) was determined
as the mechanism responsible of high level erythromycin resistance in
our strains; the presence of mefE gene either alone or together with
ermB in these isolates signiﬁes a new threat in macrolide resistance of
S. pneumoniae in our region.
R2100 Molecular mechanisms of macrolide resistance in invasive
Streptococcus pneumoniae isolated from Thai patients
T. Chatsuwan °, S. Nilgate, Y. Poovorawan (Bangkok, TH)
Objectives: Macrolide resistance in Streptococcus pneumoniae is an
increasing problem worldwide. Two main mechanisms of macrolide
resistance are active efﬂux, encoded by the mef(A) gene and methylation
of antibiotic target site, encoded by the erm(B) gene. Other mechanisms
of resistance include mutations in 23S rRNA and ribosomal proteins L4
and L22. The aim of this study was to investigate the prevalence and
molecular mechanisms of macrolide resistance in invasive S. pneumoniae
isolated from Thai patients.
Methods: A total of 100 invasive S. pneumoniae isolates were obtained
from patients at King Chulalongkorn Memorial Hospital, Bangkok,
Thailand between February 2001 and March 2006. The minimal
inhibitory concentrations (MICs) of erythromycin, clarithromycin and
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penicillin were examined by agar dilution and Etest. All macrolide-
resistant isolates were investigated for the presence of mef(A) and
erm(B) by PCR. Mutations in the genes encoding domain V of the four
copies of 23S rRNA and ribosomal proteins L4 and L22 were determined
by PCR and DNA sequencing.
Results: Of the 100 invasive S. pneumoniae isolates, 36% were
resistant to erythromycin, 34% to clarithromycin and 16% to penicillin.
Erythromycin resistance was found in 5.7% (3/53) of penicillin-
susceptible isolates, 64.5% (20/31) of penicillin-intermediate isolates and
81.2% (13/16) of penicillin-resistant isolates. Of the 36 erythromycin-
resistant isolates, 12 (33.3%) carried mef(A) and 24 (66.7%) carried
erm(B). Sequencing analysis revealed alteration in ribosomal protein L4
at Ser20 to Asn in 36.1% (13/36). No mutations were detected in the
four copies of the 23S rRNA genes and ribosomal protein L22.
Conclusions: This study demonstrates high prevalence of macrolide
resistance in invasive S. pneumoniae isolated from Thai patients and the
principal resistance mechanism is mediated by a 23S rRNA methylase,
encoded by erm(B).
R2101 Mechanisms of macrolide resistance in Streptococcus
agalactiae isolated at a Tunis hospital (2005–2007)
M. Rachdi, M. Hraoui, M. Saidani, I. Boutiba-Ben Boubaker, S. Ben
Redjeb ° (Tunis, TN)
603 non duplicate clinical Streptococcus agalactiae were collected. 155
(25.7%) were resistant to erythromycin. The isolates were identiﬁed by
conventional methods and speciﬁc agglutination grouping. Antibiotics
susceptibility testing was done using disk diffusion method. A
double disk test using erythromycin and clindamycin was used to
identify the phenotypic macrolide resistance mechanisms. MICs were
determined by E-test for erythromycin, clarithromycin, clindamycin,
azithromycin, quinupristin-dalfopristin and linezolid. ermB, ermTR and
mefA genes conferring resistance to macrolides were identiﬁed by
multiplex PCR. Most erythromycin resistant isolates were recovered
from urines (38.7%) and vaginal specimens (22.5%). 83.8% showed
constitutive MLSB phenotype (MIC50/MIC90: >256/>256mg/mL for
erythromycin and clindamycin), 8.45% inducible MLSB phenotype
(MIC50/MIC90: 192/>256mg/mL for erythromycin and 2/8mg/mL for
clindamycin) and 7.75% M phenotype (MIC50/MIC90: 16/32 mg/mL
for erythromycin and 0.5/0.75mg/mL for clindamycin). Linezolid and
quinupristin-dalfopristin showed excellent activity (MIC90: 0.38 and
0.5mg/mL respectively). Neither resistance to b-lactam nor high level
resistance to aminoglycosides was found. Strains with MLSB phenotype
harboured ermB gene in 82%, ermTR gene in 8.38% and ermB+mefA
genes in 1.87%. All strains categorised as M phenotype carried the mefA
gene in 7.75%.
Erythromycin resistance in S. agalactiae has reached an important
rate in our hospital. MLSB constitutive phenotype conferring cross-
resistance to macrolides, lincosamides and streptogramin B with high
level of resistance was the most prevalent phenotype. Thus, linezolid
and quinupristin-dalfopristin proved to be highly active.
R2102 Susceptibility proﬁles and detection of resistance genes of
carbapenems and 5-nitroimidazole among Bacteroides spp.
in Turkey
O. Dengel Uzunkaya, N. Ulger Toprak °, M. Karavus, G. Soyletir
(Istanbul, TR)
Background: Bacteroides fragilis group (BFG) is the most commonly
encountered bacteria from anaerobic infections and more resistant to
antmicrobial agents than the other anaerobes. However carbapenems
and nitroimidazoles are the most useful antibiotics against Bacteroides,
resistant isolates have been reported. The genes, which may be
responsible for the resistance against carbapenems and metronidazole,
are carbapenems (cﬁA) and 5-nitroimidazole (nim), respectively.
Resistance genes should be activated by upstream insertion sequence
(IS) elements such as IS1169, IS1170, IS1186, and IS1187.
Objective: This study investigated the cﬁA, nim genes and related
IS elements, and determined susceptibility proﬁles of BFG against
carbapenems and metronidazole.
Methods: Different clinical specimens were obtained at Marmara
University Hospital. The specimens were collected, transported, and
processed as outlined in the Wadsworth-KTL Anaerobic Bacteriology
Manual. The strains were identiﬁed by using a combination of
conventional tests and the commercially available biochemical kits.
Antimicrobial susceptibility tests against imipenem, meropenem and
5-nitroimidazole were performed according to recommendations of CLSI
(M 11-A7) agar dilution methods. The resistance genes (cﬁA, nim) and
IS elements were determined by PCR.
Results: Total of 66 BFG strains were isolated and identiﬁed as 48
B. fragilis, 10 B. thetaiotaomicron, 6 B. uniformis/ovatus, 1 B. distasonis
and 1 B. vulgatus. There were no resistant strains against metronidazole.
However non-B. fragilis strains were susceptible to carbapenems,
B. fragilis strains have 8% resistance rates for imipenem and 10% for
meropenem. Metronidazole resistance genes were not detected among
all strains. Only B. fragilis were positive for cﬁA (n:18) gene or IS1187
(n:23) elements. Four strains of B. fragilis which have cﬁA and IS1187
elements together (n:5) were resistant to carbapenems.
Conclusions: Our ﬁndings form a database about resistance genes
of pathogenic BFG in Turkey, where molecular investigation of
antimicrobial resistance of anaerobes has not been performed so far. For
the present, it looks like there was no risk for metronidazole resistance.
Although non-B. fragilis strains are susceptible to carbapenems, nearly
10% of B. fragilis strains are resistant to them. Because of possessing
cﬁA gene and IS elements is more common among B. fragilis, it seems
to be important to monitor B. fragilis for emergence of resistant strains.
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R2103 MRSA in Venezuela, 20 years of history
A. Guzma´n °, A. Merentes, J. Delgado, R. Istu´riz, M. Guzma´n on behalf
of the Venezuelan Program for Surveillance of Bacterial Resistance
to Antimicrobials
Background: MRSA is a worldwide risk for patients in hospitals and,
more recently in community acquired infections.
Venezuela has a national surveillance program for bacterial resistance
since 1988. We present here the historic evolution of S. aureus resistance
in our country.
Methods: All Staphylococcus aureus isolated in 49 laboratories around
the country were tested by disk diffusion using CLSI criteria or Vitek
system. The Whonet software was used for prospective data entry and
reports. For data management the Epi Info 3.4.3 (CDC) and Language
for Statistic Programs R version 2.5.1 (The R Foundation for Statistical
computing) were used.
Results: A total of 262635 S. aureus were identiﬁed during last 20 years,
60% from inpatients and 40% from outpatients.
The MRSA rate was 14% in 1988 in inpatients. This rate remained
stable for years up to 2002 (15%). Since 2003, an important increase in
prevalence of MRSA was observed, climbing up to 45% in year 2006.
The proportion of MRSA from the community, also increased up to 26%
in year 2006.
Conclusion: From 1988 to 2002 Venezuela had a low and stable rate
of MRSA, since then a high increased have seen. The reasons for these
increase are no clear. The presence of Chilean clone has been observed.
R2104 Vascular catheter infection pattern. A temporal surveillance
study of 581 consecutive episodes in a tertiary-care hospital
R. Manfredi °, A. Nanetti (Bologna, IT)
Introduction: A prospective microbiological surveillance program is
ongoing at our tertiary-care Hospital located in Northern Italy.
Patients-Methods: The trend of microbial isolations from patients
admitted during the last calendar year (January to December 2007), with
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a clinically- and microbiologically-conﬁrmed central venous catheter
(CVC) infection, is regularly reported on quarterly basis.
Results: The trend of CVC infections monitored among our inpatients
moderately varied during the observation period (149 cases in January-
March, 169 episodes in April-June, 129 cases in July-September,
and 134 episodes in October-December). Among the most frequent
organisms, Staphylococcus epidermidis accounted for the majority of
isolates (183 cases: 31.5%), followed by Escherichia coli (49: 8.4%),
Staphylococcus aureus (45: 7.7%), Pseudomonas aeruginosa (36: 6.2%),
Enterococcus faecalis (30: 5.2%), Enterococcus faecium (25: 4.3%),
Klebsiella pneumoniae (21: 3.6%), and Enterobacter cloacae (15:
2.6%), while the yeast Candida albicans accounted for a minority of
episodes (17 only: 2.9%). When analysing the available ﬁgures according
to calendar months, only some Gram-negative pathogens showed an
increasing incidence over time: Pseudomonas aeruginosa from 5.4%
in the ﬁrst three months of 2007 up to 7.5% in the last three months of
2007, and Enterobacter cloacae (from 2.0% in January-March 2007, up
to 2.68% in October-December 2007), as well as other environmental
Gram-negative organisms.
Conclusions: A prospective microbiological monitoring may notably
add to the knowledge of local epidemiological ﬁgures and antimicrobial
sensitivity trends of CVC infection (which represent relevant causes of
hospital-related morbidity), and plays a highly signiﬁcant role in the
selection and planning of chemoprophylactic and therapeutic choices, on
both local and regional settings. Although the major causative agents of
CVC-related infection among hospitalised patients remain staphylococci
as a group, however the progressive emerging of Gram-negative
pathogens is appreciable also over a proportionally short (12-month)
observation period, and deserves major attention by Microbiologists and
Clinicians.
R2105 Surveillance of antimicrobial resistance and serotype
epidemiology of Streptococcus pneumoniae in Crete, Greece
S. Maraki °, A. Georgiladakis, Z. Gitti, E. Nioti, G. Samonis
(Heraklion, GR)
Objective: To determine the antimicrobial resistance and seroprevalence
in clinical isolates of Streptococcus pneumoniae collected from patients
at the University Hospital of Heraklion, Crete, Greece, during the years
2000–2007.
Methods: A total of 417 clinical isolates of Streptococcus pneumoniae
collected over a 7-year period, were studied. Antimicrobial susceptibility
testing was performed by the E-test method and the results were inter-
preted following CLSI guidelines. The following antibiotics were tested:
penicillin, cefuroxime, cefotaxime, ceftriaxone, cefepime, imipenem,
meropenem, erythromycin, clarithromycin, azithromycin, roxithromycin,
clindamycin, ciproﬂoxacin, levoﬂoxacin, moxiﬂoxacin, chloramphenicol,
tetracycline, cotrimoxazole and vancomycin. Serotyping was performed
by the capsular swelling method (Quellung reaction) with speciﬁc
antisera available from the Statens Seruminstitute of Copenhagen,
Denmark.
Results: Of the 417 isolates tested, 82 (19.7%) showed intermediate
resistance and 69 (16.5%) high-level resistance to penicillin. Ery-
thromycin, clindamycin, sparﬂoxacin, moxiﬂoxacin, chloramphenicol,
tetracycline, and cotrimoxazole resistance rates were 33.3, 11.5,
0.4, 0.2, 3.8, 27.3, and 30%, respectively. Multiple resistance was
observed in 102 strains. All isolates were susceptible to ciproﬂoxacin,
levoﬂoxacin and vancomycin. Among the serotypeable strains, serotype
19F predominated, followed by serotypes 3, 6B, and 14.
Conclusion: The results of the present study indicate that continuous
surveillance remains important for guiding empirical antibiotic treat-
ment.
R2106 Ten-year survey of co-trimoxazole and quinolone resistance
in Escherichia coli causing urinary tract infections
V. Skandami Epitropaki °, A. Xanthaki, A. Tsiringa, G. Rossos,
D. Sarantopoulos, M. Epitropaki, M. Toutouza (Athens, GR)
Objectives: During the recent years, the treatment of choice for
urinary tract infections in Greece has changed from co-trimoxazole
to quinolones. Aim of this study was to determine the change in
co-trimoxazole and quinolone resistance of Escherichia coli isolated
from urinary tract infections during the last ten years in two groups,
hospitalised patients and community patients.
Methods: Over a ten-year period (1999–2008) a total number of
4969 Escherichia coli clinical strains were isolated in our hospital
laboratory from urine cultures of 3215 hospitalised patients and 1754
community patients with urinary tract infections. Classic microbiological
techniques were performed for the urine cultures and identiﬁcation of
microorganisms. Antibiotic susceptibility was tested by the Kirby-Bauer
method according to CLSI protocols.
Results: The co-trimoxazole resistance ratio increased gradually during
this period from 13.4% and 21% for the community patients and
hospitalised patients respectively in 1999 to 28.8% and 32.1% in 2008.
The quinolone resistance for the community patients and hospitalised
patients respectively, increased highly: from 2.8% and 7.3% in 1999
to 12.7% and 22.4% in 2008 for ciproﬂoxacin (2000: 4.7−7.9%, 2001:
2.8−8.9%, 2002: 3.8−12%, 2003: 6.1−13.4%, 2004: 7.5−15.7%, 2005:
6.2−14.9%, 2006: 4.6−17.6%, 2007: 6.2−19.7%) and from 2.9% and
7.1% in 1999 to 15.9% and 25.9% for norﬂoxacin (2000: 3−7.3%, 2001:
2.8−9.2%, 2002: 3.8−11%, 2003: 6.1−13.9%, 2004: 8.1−15.7%, 2005:
6.8−15.3%, 2006: 4.6−17.3%, 2007: 6.2−22.4%).
Conclusion: The co-trimoxazole and quinolone resistance of Escherichia
coli in urinary tract infections was highly increased during the last ten
years, not only in hospitalised but also in community patients. These
ﬁndings emphasize that antibiotic usage polices, especially empirical
therapies, should be based on antimicrobial resistance surveillance
studies.
R2107 Comparison between hospital cumulative and speciﬁc
antibiograms according to sampling time and type of unit
F. Lamoth °, A. Wenger, G. Prod’hom, Y. Vallet, J. Bille, G. Zanetti
(Lausanne, CH)
Objectives: Empirical antibacterial therapy in hospitals is usually
guided by local epidemiologic features reﬂected by institutional
cumulative antibiograms. This study aimed at investigating the additional
information inferred from speciﬁc antibiograms aggregated by sampling
time, type of unit, or type of sample.
Methods: Antimicrobial susceptibility rates of different pathogens
(Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus,
enterococci) were collected over a four-year period in a tertiary care,
university-afﬁliated hospital. Hospital-wide data were compared with
those selected by type of unit (medical, surgical, paediatric, ICU),
sampling time < or >48 hours after hospital admission (presumably
reﬂecting a community or hospital origin, respectively) and type of
sample (blood vs any other site).
Results: Strains isolated >48 h after hospital admission were signiﬁ-
cantly less susceptible than those presumably arising from the community
(<48 h). The comparison of units revealed signiﬁcant differences among
strains isolated >48 h after admission. When compared to hospital-wide
antibiograms, susceptibility rates were lower in ICU and surgical units for
E. coli with respect to amoxicillin/clavulanate (75 and 70%, respectively,
vs 81%, p< 0.01), and enteroccocci to penicillin (70 vs 86%, p< 0.001)
and in medical units for S. aureus with respect to oxacillin (70 vs 84%,
p< 0.001). Important differences were also observed between units for
P. aeruginosa (Figure). In contrast, few signiﬁcant differences between
units were observed among strains isolated within the ﬁrst 48 h from
admission. Distinction according to the type of sample (blood vs any
other site) also did not show relevant differences.
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Conclusion: Important variations in antibacterial susceptibility were
observed in a same hospital according to the time of sampling
(< or >48 hours from admission) and type of unit. Hospital-wide
antibiograms reﬂect the actual susceptibility pattern for a speciﬁc unit
with respect to presumably community-acquired (<48 h), but not to
hospital-acquired strains (>48 h). Antibiograms speciﬁcally adjusted to
these parameters are easy to obtain and may be useful in guiding the
choice of empirical antibacterial therapy.
Figure: Susceptibility rate of P. aeruginosa strains isolated >48 h after
admission.
R2108 Increasing prevalence of extended spectrum b-lactamases
producers among common uropathogens in a Greek
tertiary-care hospital: a 3-year comparative study
V. Mamali °, G. Altouvas, A. Giannouli, O. Zarkotou, E. Sotiropoulou,
K. Kopsari, K. Digalaki (Athens, GR)
Objectives: Urinary tract infections (UTI) remain the most frequent
infections diagnosed in outpatients as well as in hospitalised patients.
We comparatively evaluated the prevalence of extended spectrum
b-bactamases (ESBL) producing (ESBL+) Escherichia coli, Klebsiella
pneumoniae and Proteus mirabilis among urinary isolates during
the last three years. Resistance rates to ﬂuoroquinolones (FQs)
and trimethoprim/sulfamethoxazole (TMP-SXT), antimicrobial agents
commonly prescribed as per os treatment in patients with UTI, were
also studied.
Methods: A total of 3842 strains isolated from urine cultures were
collected from 2685 hospitalised patients and 1157 outpatients during
a 3-year period (2006–2008). Species identiﬁcation and antimicrobial
susceptibility testing was performed by VITEK 2 Compact automated
system (bioMe´rieux). ESBL-production was screened by double-disc
synergy test (DDST) and conﬁrmed by combined disk test (ceftazidime
and cefotaxime with and without clavulanate), according to CLSI
guidelines.
Results: Among urinary isolates, the prevalence of ESBL-producers was
1.3% in 2006 (17/1300), rising to 2.2% in 2007 (29/1326). A remarkable
increase (7.1%) in ESBL producers was noted in 2008: 86/1216 isolates
carried ESBL. Regarding E. coli, the number of ESBL+ isolates rose
from 12 in 2006 to 22 in 2007. A more than 5-fold increase was
observed in 2008 (69 isolates). The increase of prevalence of ESBL
producers was signiﬁcant but less notable for K. pneumoniae: 5, 7 and
14 were recovered in 2006, 2007 and 2008 respectively. P. mirabilis
ESBL+ was ﬁrst detected in 2008 (3 isolates). The comparative study
of resistance rates revealed that non-ESBL producers expressed low
resistant rates to FQs and TMP-SXT as compared to ESBL producers.
No signiﬁcant differences were observed in resistance rates from 2006
to 2008. Resistance rates are presented in detail in the table.
Conclusion: Increasing spread of ESBL-producers among urinary
isolates along with high resistance rate to ﬂuoroquinolones and
trimethoprim/sulfamethoxazole, either in hospital or community settings,
generate a therapeutic challenge because of limited oral therapeutic
options. Monitoring of ESBL production and antimicrobial susceptibility
testing are necessary to avoid treatment failure in patients with UTI.
% resistance
2006 2007 2008
FQs TMP-SXT FQs TMP-SXT FQs TMP-SXT
ESBL− 12.6 28.9 16.4 21.8 14.4 25.7
ESBL+ 88.2 82.3 86.2 68.9 82.0 66.0
R2109 Inadequate drugs for the treatment of Gram-negative
infections based on the EPICENTER Network data
M. Hoeck, B. Grabein, H.M. Just, I. Schwede, B. Wiedemann ° (Berlin,
Munich, Nuremberg, Frankfurt-Oder, Schaalby, DE)
Objectives: Surveillance data must help to identify drugs, which
are obsolete for the treatment of infections because of resistance
development. We analysed a one year period of the EPICENTER
Network data to categorise drugs.
Methods: At present 4 laboratories participate in the network using
the automated BD PHOENIX system measuring MIC’s. The BD
EPICENTER Data Management System is used for the evaluation of the
data in the laboratory and for the transfer of the data to the concentrator
for evaluation with stratiﬁcation by material, source, medical discipline,
time, patient and others. Copy strains are excluded. Quality control is
mandatory. Antibiotics with more than 35% resistance for a species were
regarded as obsolete for empirical treatment.
Results: We analysed 949 Enterobacter cloacae-, 5500 E. coli-,
613 Klebsiella oxytoca-, 1285 Klebsiella pneumoniae-, 759 Proteus
mirabilis-, and 1459 Pseudomonas aeruginosa strains. Data are presented
in the table. Blank ﬁelds indicate a drug–bug combination which is
regarded as obsolete and was not tested or documented. The isolates were
from all specimen types. Analysing the data by specimen types, urine,
blood, or pulmonary tract isolates the stratiﬁcation is slightly different,
but the general outcome for those drug–bug combinations in question is
similar. According to our data all tested aminoglycosides are still appro-
priate drugs. The same holds true for aztreonam, cefepime, ceftazidime,
meropenem piperacillin/tazobactam, and surprisingly ciproﬂoxacin. The
percentage of resistance to fosfomycin is still low, but it can only be used
in combination with other antibiotics. Amoxicillin should not be used
for empirical therapy for Gram-negative infections. Clavulanic acid in
combination with amoxicillin does not improve the situation signiﬁcantly.
Also Tetracyclin and cotrimoxazole should be used with care.
Antimicrobial Antibiotic resistance of Gram-negative isolates
E. cloacae E. coli K. oxytoca K. pneumoniae P. mirabilis P. aeruginosa
Amikacin 0.10% 0.20% 0.20% 0.20% 0.00% 4.30%
Gentamicin 2.10% 7.20% 1.60% 5.10% 5.40% 14.50%
Tobramycin 2.40% 7.40% 1.50% 5.40% 6.90% 5.80%
Amoxicillin/Clavulanic acid R 39.10% 26.70% 21.00% 14.20% R
Ampicillin R 49.50% R R 31.10% R
Aztreonam 23.20% 6.30% 15.70% 7.50% 10.00% 33.70%
Cefazolin R 11.80% 31.60% 14.00% 9.10% R
Cefepime 2.90% 6.40% 15.80% 7.60% 1.50% 21.00%
Cefotaxime 26.60% 6.00% 15.70% 7.50% 1.10% R
Ceftazidime 25.10% 6.10% 13.90% 7.50% 1.10% 19.50%
Cefuroxime 49.00% 10.00% 22.20% 17.90% 4.80% R
Imipenem 0.70% 0.10% 0.30% 0.10% 39.10% 27.00%
Meropenem 0.40% 0.00% 0.20% 0.20% 0.00% 14.20%
Piperacillin 27.00% 45.40% 21.40% 19.50% 16.70% 21.20%
Piperacillin/Tazobactam 19.60% 4.10% 18.40% 9.30% 4.10% 18.70%
Trimethoprim/sulfamethoxazole 8.90% 31.40% 7.80% 14.30% 56.00% R
Fosfomycin w/G6P 3.70% 0.10% 3.20% 3.20% 0.00% 0.00%
Ciproﬂoxacin 3.20% 19.80% 6.40% 8.80% 12.70% 16.70%
Levoﬂaxacin 3.40% 19.80% 5.20% 8.80% 13.40% 35.50%
Tetracycline 9.70% 38.20% 9.70% 19.60% R R
Conclusion: Based on resistance %ages stored in the EPICENTER Net-
work amoxicillin, amoxicillin/clavulanate, tetracyclin and cotrimoxazole
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should only be used in Germany to treat infections with Gram-negative
bacteria if local or patient speciﬁc data are available that suggest that
therapy will be successful in more than two thirds of the patients.
R2110 Emergence of metallo-b-lactamase-producing Escherichia
coli in a neonatal intensive care unit
M. Papadimitriou °, E. Lebessi, E. Voulgari, E. Koemtzidou,
G. Kourakis, A. Tsakris (Athens, GR)
Objectives: Isolation of metallo-b-lactamase (MBL)-producing Gram-
negative bacteria represents a serious health care problem. Recently,
MBLs have been also sporadically detected among E. coli isolates
causing hospital-acquired infections in the adult population. However,
there are not reports describing MBL-producing E. coli in neonates with
or without prior antimicrobial exposure. We present a case of MBL-
producing E. coli colonisation in a 12-day old neonate, admitted to a
neonatal intensive care unit (NICU).
Methods: The neonate was admitted from home to the NICU with
fever (38.5ºC) and failure to feed properly. The neonate was not
treated with antibiotics and the mother had no exposure to antibiotics
during pregnancy. Surveillance swabs were taken from the rectum
upon admission and cultured in selective medium. The carbapenem-
resistant isolate was identiﬁed with API 20E (Biomerieux, Marcy-
L’Etoile, France) and antimicrobial susceptibility testing was determined
using the disk diffusion method employing CLSI criteria. Imipenem and
meropenem MICs were determined using Etest (AB Biodisk, Solna,
Sweden). The Etest MBL (AB Biodisk) was used for phenotypic
detection of MBL production. PCR and sequencing assays were used
for MBL gene detection.
Results: A strain of E. coli was identiﬁed which exhibited resistance
to all b-lactams and b-lactam/b-lactamase inhibitors, except aztreonam.
The strain was also resistant to aminoglycosides, except gentamicin, and
remained susceptible to ciproﬂoxacin. Imipenem and meropenem MICs
exceeded 32mg/L. Etest-MBL was positive, indicating production of
MBL. PCR revealed production of a VIM-type MBL gene and sequence
analysis identiﬁed blaVIM-1 gene in a class 1 integron structure. The
neonate was discharged two days after the admission in good condition.
Conclusion: MBL-producing E. coli colonisation is described for the
ﬁrst time in the neonatal population. It is noteworthy that a prior exposure
to carbapenems or other antimicrobials was not reported. Such a study
may highlight the need for implementation of microbiological screening
tests and strategies to prevent MBL-producing colonisers from becoming
health care-associated infections in NICUs.
R2111 Emergence of increased mupirocin resistance in Scottish
MRSA isolates
A. Eastaway °, J. Wilson, S. Cairns (Glasgow, UK)
Objectives: An increase in high level mupirocin resistance in meticillin
resistant Staphylococcus aureus (MRSA) bacteraemic isolates has been
observed in Scotland. Mupirocin was introduced into clinical practice in
the United Kingdom in 1985. It is used routinely for the elimination of
nasal carriage of MRSA and as an effective treatment of skin infections.
Resistance to mupirocin was observed worldwide not long after its
introduction however Scotland has recently witnessed a signiﬁcant
increase in the number of mupirocin resistant MRSA strains. This
increase in resistance has signiﬁcant clinical implications for the
treatment of mupirocin resistant MRSA infection and colonisation.
This study will describe trends in mupirocin resistance in bacteraemic
MRSA isolates. The results can be used as a proxy indicator of the
overall MRSA mupirocin resistance for all isolates in Scotland.
Methods: Scotland participates in the European Antimicrobial Resis-
tance Surveillance System (EARSS) and the reporting of Staphylococcus
aureus bacteraemic isolates to this surveillance system is mandatory.
Validated data collected over a two year period will be analysed for the
detection of signiﬁcant changes in mupirocin resistant MRSA isolates.
Results: The graph illustrates the increase in the number of MRSA
isolates resistant to mupirocin within the time period January 2007 to
October 2008.
Initial analysis suggests that the proportion of mupirocin resistance was
signiﬁcantly higher in 2008 as compared to 2007 (OR= 3.48; 95%CI
2.01–6.21; p< 0.00001).
Conclusion: Preliminary analyses suggest that there has been a
statistically signiﬁcant increase in resistance to mupirocin in MRSA
bacteraemic isolates reported to EARSS between January 2007 and
October 2008.
Further work is required to investigate the clinical impact of the
emergence of increased mupirocin resistance. Scotland is currently
conducting pilot studies into the viability of universally screening
patients for the presence of nasal MRSA upon admission. MRSA
resistance to mupirocin would have an impact on the choice of antibiotic
used for MRSA clearance as there are a limited number of antibiotics
licensed for this purpose.
Figure 1. MRSA mupirocin bacteraemic isolates (2007 to 2008).
R2112 Acinetobacter baumannii resistance rates in a tertiary
hospital
F. Panayea °, I. Galani, K. Orlandou, F. Kontopidou, H. Giamarellou
(Athens, GR)
A. baumannii is a well recognized pathogen causing a wide variety
of infections, especially in ICU patients. Colonisation of patients from
resistant strains usually precedes infections that are difﬁcult to control
by antimicrobial agents.
Objectives: To determine A. baumannii antibiotic resistance and
tigecycline MIC distribution
Methods: 1120 A. baumannii strains were recovered in our laboratory
during one year (January to December 2008). Specimens were obtained
from ICU (93.8%), medical wards(2.9%), surgical wards 1.5% and
outpatient clinic(1.8%). Clinical samples were: bronchial secretions
58.3%, rectal swabs 23.5%, wounds and pus 5.9%, catheter tips 3.8%,
urine 3%, BAL 2%, sputum 1.7%, blood 1.4%, pleural and peritoneal
ﬂuid 0.4%. Antimicrobial susceptibility testing was performed for
tazo+piperacillin and meropenem by automated system(Phoenix BD)
and for colistin and tigecycline by E-test according to the manufacturer’s
instructions. CLSI interpretative criteria and guidelines were used.
Results: In 1120 strains resistance rates were: tazo+pip 92.8%
resistant(R), 3.7% intermediate(I), meropenem 49.6% R, 31.7% I,
ciproﬂoxacin 98.3% R, gentamicin 73% R, 2.1% I, trimethoprim-
sulfamethoxazole 94.4% R. ICU isolates were not signiﬁcantly more
resistant than the rest of the isolates. Out of 414 strains 13% were
resistant to colistin(MIC 4mg/L) and MICs of 2, 1 and 0.5mg/L
were detected in 2.4%, 22% and 62.6% of strains respectively. Among
464 strains, MICs to tigecycline 6, 4, 3, 2 and 1mg/L was detected in
25.4%, 50.9%, 17%, 5% and 1.7% respectively. Out of 167 meropenem
resistant strains 22(13.2%) were also resistant to colistin. Sixteen of them
were further tested for tigecycline MIC: 15 of them had MIC= 4mg/L
and one = 3mg/L.
Conclusion: Colistin remains active to the majority of A. baumannii
strains in our hospital. For those strains that were resistant to colistin,
MIC to tigecycline was relatively high. Further studies are needed to
establish the extend to which tigecycline is useful in colistin resistant
strains.
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Surveys of molecular epidemiology of
resistance and resistance genes, strains or
serotypes
R2113 Distribution of integrons and SGI 1 among antibiotic-
resistant human isolates of Salmonella typhimurium phage
types DT104 and U302
V. Majta´n °, T. Majta´n, L. Majta´nova´ (Bratislava, SK)
Objectives: At present, Salmonella Typhimurium is the second most
frequent type of Salmonella isolated from human samples in the
Slovakia. The majority of these isolates correspond to multidrug resistant
phage types DT104 and U302. The aim of this study was to investigate
the presence of the genetic elements, the class 1 integrons as well as of
SGI 1 in the resistant and MDR S. Typhimurium DT104 and U302 strains.
Methods: A total of 90 S. Typhimurium strains (phage type DT104=35,
phage type U302=55) isolated from human sources during year 2007
were included in this study. The strains were tested for susceptibility to
eleven antibiotics by the disk agar diffusion method on Mueller-Hinton
agar plates. PCR for the detection of the class 1 integrons was carried out
using the 5′CS and 3′CS primer pairs and the detection of the left junc-
tion of SGI 1 was carried out with the primer pairs U7–612 and LJ-R1.
Results: From thirty ﬁve DT104 strains the pentaresistant phenotype
(ACSSuT) in 30 strains was found. This same multidrug resistance was
also expressed by the 14 strains of U302 phagetype. The dominant
occurrence of this resistance is closely linked with the presence of
the SGI 1 as well as integrons. Indeed, all isolates of DT104 with
the ACSSuT type resistance harboured the SGI 1, which carriers two
integrons (1.0 kbp and 1.2 kbp) encodes multidrug resistance. Among
14 pentaresistant strains of phage type U302, 13 strains were positive
for the presence of integrons but only 11 of them harboured the SGI
1. Sequencing of the integrons in these isolates identiﬁed aadA2 and
blaPSE gene cassettes. The results showed that the majority of multidrug
resistant U302 strains studied possessed the same antibiotic resistance
genes as well as the SGI 1 as the multidrug resistant DT104 strains.
Conclusion:We analyzed the frequency of antibiotic resistance and con-
tribution of the presence of both integrons and SGI 1 to this resistance.
We tested S. Typhimurium human strains of DT104 and U302 phage
types isolated during a single year from a relatively restricted geographic
area. Nevertheles, the data of molecular analysis suggested a relationship
between these dominant phage types (DT104 and U302) with regard to
multidrug resistance phenotype, integron proﬁle and SGI 1 structure.
This work was supported by Ministry of Health of the Slovak
Republic under the project Molecular analysis of antibiotic resistance
of nontyphoid salmonella serovars.
R2114 Ocurrence of blaCTX-M-15 gene in multidrug-resistant
Citrobacter freundii
S. Ferreira °, A. Paradela, J. Velez, E. Ramalheira, T. Walsh, S. Mendo
(Aveiro, PT; Cardiff, UK)
Objectives: Extended spectrum b-lactamases (ESBL) is one of the
most important resistance mechanisms among Gram-negative bacteria.
ESBL producing strains are emerging worldwide and need a careful
surveillance. We investigated the prevalence of ESBL’s, mainly CTX-M
type, among ESBL positive Citrobacter freundii isolates.
Methods: Six ESBL positive Citrobacter freundii were identiﬁed by the
automatic VITEK 2 system and Advanced Expert System (VITEK 2
AES) (BioMe´rieux, Marcy L’E´toile, France). Resistance proﬁle was also
determined by disc diffusion methods. Presence of ESBL was conﬁrmed
by Etest (AB Biodisk) ESBL with Cefotaxime/Cefotaxime + Clavulanic
acid and Ceftazidime/Ceftazidime + Clavulanic acid strips, according to
manufacturer’s instructions. PCR, nucleotide sequencing and sequence
analysis was employed to detect b-lactamase encoding genes.
Results: Among the isolates studied, CIT1 strain showed a highly resis-
tance proﬁle to b-lactams (ampicillin/sulbactam, cefotaxime ceftazidime,
cefepime, piperacillin and piperacillin/tazobactam), aminoglycosides
(gentamicin and tobramycin) and ﬂuoroquinolones (ciproﬂoxacin and
norﬂoxacin); susceptibility was shown only to carbapenems. Nucleotide
sequence of PCR amplicons revealed the presence of blaCTX-M-15
associated with the insertion sequence ISEcp1 upstream. blaOxa-30 and
TEM-1 were also detected. Plasmid mediated CMY ampC was detected
in all isolates.
Conclusion: The ESBL’s of CTX-M type were the most prevalent.
Different genetic environments associated with ISCR1 and ISEcp1 were
detected.
CTX-M-15 found is plasmid mediated and, therefore, represents a
dissemination problem, as these genes can be easily mobilised between
strains or even species. The presence of a high variety of ESBL’s in a
single isolate highlights the importance of routine detection of ESBL
producers.
R2115 Clones, antibiotypes and virulence genotypes of group C
streptococci from bovine mastitis
M. Rato °, R. Bexiga, S.F. Nunes, L.M. Cavaco, C.L. Vilela,
I. Santos-Sanches (Caparica, Lisbon, PT)
Objectives: To determine the clonality, resistance to macrolides,
lincosamides and tetracycline, and virulence genotypes of Streptococcus
dysgalactiae subsp. dysgalactiae (Group C Streptococcus, GCS), an
important pathogen in bovine mastitis.
Methods: A total of 18 alpha-haemolytic streptococci were recovered
from 304 bovine mastitis milk samples collected at Portuguese herds
during 2002–03. These isolates were selected in blood agar media
and identiﬁed as S. dysgalactiae subsp. dysgalactiae (GCS) using
biochemical tests (API-20 STREP, BioMe´rieux; BBL Crystal Gram-
Positive, Becton Dickinson; Slidex Strepto Kit, BioMe´rieux) and by
sequencing of the 16S rDNA gene. All isolates were typed by pulsed ﬁeld
gel electrophoresis (PFGE) with computer-assisted DNA-band analysis
(BioNumerics v. 4.0 software, Applied Maths). Antimicrobial resistance
against macrolides (erythromycin-E), lincosamides (pirlimycin-PRL) and
tetracycline-T, and the macrolide-lincosamide resistance phenotypes
(M/cMLS/iMLS) were evaluated by disk diffusion. The antimicrobial
resistance genes tet(M), tet(O), tet(W), tet(L), tet(Q), tet(K), tet(S),
mef(A), erm(A) and erm(B) and the virulence phage-encoded genes of
the human pathogen Streptococcus pyogenes (speA, speC, ssa, spd1,
speK, speM, speL, speI and slaA) were searched for by PCR. Induction
of phage lysates was obtained using 2mg/L of mitomycin C (Sigma).
Results: Four PFGE clusters comprised 55.6% of the GCS and only
one was herd speciﬁc. Isolates resistant to both E and T (22%) were
of phenotypes iMLS or cMLS and genotypes erm(B)-tet(O) or erm(A)-
tet(M). Part of the isolates (16.7%) was E susceptible and PRL resistant.
Among all isolates, the following associations of virulence genes were
observed: speC-spd1 (33%); speK-speM (33%); speL-speM (22%).
Phage lysates were obtained from part of the putative lysogenic cultures.
Conclusion: These results suggest an environmental source rather than
contagious origin of bovine GCS causing mastitis in Portuguese farms. A
phenotype of susceptibility to macrolides and resistance to lincosamides-
LSA (previously detected in Streptococcus agalactiae of human origin)
was found in GCS bovine isolates. The ﬁnding of S. pyogenes phage-
encoded virulence genes suggests that S. pyogenes prophages may play
an important role in the transmission of important virulence genes among
animal GCS.
In vitro antibacterial susceptibility and drug
interaction studies
R2116 In vitro antibiotic susceptibility of anginosus group
streptococci strains isolated from oral and respiratory tract
infections
G. Bancescu °, I. Nistor, A. Bancescu, M. Andrei, S. Barbuceanu,
M.A. Topolniski (Bucharest, RO)
Objectives: The streptococci of anginosus group belong to the normal
ﬂora of the oral cavity, upper respiratory tract, gastrointestinal tract
In vitro antibacterial susceptibility and drug interaction studies S623
and urogenital tract. However, these streptococci are often involved in
the aetiology of different pyogenic infections. The aim of the present
study was to investigate the susceptibility of anginosus streptococci
strains (isolated either in pure culture or in association with other
microorganisms, especially anaerobic bacteria) from pus samples
collected from Romanian patients with different oral and respiratory
tract infections (mostly oral abscesses and sinusitis).
Methods: The identiﬁcation of the Streptococcus anginosus group
isolates at the species level was done using the Rapid ID 32
STREP system (Bio-Me´rieux, France) and some additional biochemical
tests. The investigation of the susceptibility of the isolates to:
penicillin G, amoxicillin, erythromycin, clindamycin, chloramphenicol
and tetracycline was performed by the Etest (AB Biodisk, Solna,
Sweden). The phenotype of erythromycin resistance was detected using
the double disk diffusion test.
Results: The anginosus group isolates belonged to: S. anginosus − which
predominated (70% of the strains), S. constellatus and S. intermedius
species. The MICs values varied between: 0.002–0.75mg/l for penicillin
G, 0.016–0.5mg/l for amoxicillin, 0.016–4mg/l for erythromycin,
0.016–0.047mg/l for clindamycin, 0.016–4mg/l for chloramphenicol
and 0.047–256mg/l for tetracycline. Reduced susceptibility to b-lactam
antibiotics was found among the strains belonging to S. constellatus
species. About 10% of the strains were resistant to erythromycin and
only the M phenotype was established. Almost half of the total number
of the isolates were resistant to tetracycline.
Conclusions: The results indicated that the susceptibility of the oral
streptococci isolates of clinical importance should be periodically tested,
mainly to the widely-used antibiotics. Clindamycin was fully active
(as chloramphenicol) and might represent a therapeutical alternative
for patients allergic to b-lactam antibiotics, while tetracycline is not
recommended in infections in which oral streptococci are involved. Due
to their role in human pathology, the anginosus group streptococci merit
to be identiﬁed at species level in clinical laboratory.
R2117 Daptomycin susceptibility in methicillin-resistant Staphy-
lococcus aureus strains isolated from paediatric patients
R. Bandettini °, E. Castagnola (Genoa, IT)
Objective: Daptomycin is a cyclic lipopeptide antibiotic that is rapidly
bactericidal in vitro against a broad spectrum of Gram-positive bacteria.
Its mechanism of action involves calcium-dependent binding to the
bacterial plasma membrane and disruption of membrane function.
Resistance is rare.
The aim of our study is the evaluation of daptomycin susceptibility in
MRSA strains isolated in paediatric patients.
Methods: MRSA strains isolated from 74 paediatric patients, between
2006 and 2008, were studied. Of all this strains 10.8% were isolated from
infected wounds, 10.8% from bacteraemia, 9.5% from blood catheters,
8.1% from burns, 2.7% from conjunctivitis and 48.6% from nasal
carriers. None of this strains were vancomycin and linezolide resistant.
The minimum inhibitory concentration (MIC) of daptomycin were
determined by using E test. Moreover we studied the eventual slime
production using Congo red agar.
Result: All strains of staphylococci were susceptible to daptomycin
and MICs values were between 0.09 and 0.5 microg/ml (susceptible
1microg/ml). None of 74 MRSA strains were slime producers.
Conclusion: The increasing prevalence of Methicillin-Resistant Staphy-
lococcus aureus requires the need to search for more effective agents.
Vancomycin remains the reference standard for the treatment of systemic
infection caused by MRSA. However the need for alternative therapies
has become apparent, as a result of limited tissue distribution, as well
as the emergence of isolates with reduced susceptibility to Vancomycin.
Our study indicates, as data reported in literature, that daptomycin seems
to be effective in vitro against MRSA. However further studies are
needed to asses the pharmacokinetics, pharmacodynamics, safety and
effectiveness of daptomycin in infants and children.
R2118 In vitro activity of tigecycline versus imipenem and
versus vancomycin and linezolid against clinical
isolates of ESBL-producing E. coli, Klebsiella spp. and
methicillin-resistant S. aureus
S. Scheithauer °, H. Haefner, S. Lemmen (Aachen, DE)
Objectives: Multiresistance in bacteria is an increasing problem in
infection control and infectious diseases. Thus new therapeutic options
are urgently needed. The aim of this study was to compare the
local in vitro activity of Tigecycline with Imipenem against ESBL-
producing Enterobacteriaceae and with Vancomycin and Linezolid
against Methicillin resistant S. aureus (MRSA).
Methods: 306 clinical isolates (70 E. coli, ESBL+; 36 Klebsiella
sp., ESBL+; 200 MRSA) were collected consecutively between
7/2005 and 3/2007 at the University Hospital Aachen, Germany. The
Enterobacteriaceae strains were mainly isolated from urine (61%), blood
culture (18%), and respiratory secretions (14%), the MRSA strains
were mainly isolated from wounds (34%), blood culture (29%), and
respiratory secretions (21%), respectively. For identiﬁcation the Phoenix
expert system (BD, Germany) was applied, MIC testing was performed
by e-test. The breakpoints were in accordance with CLSI, USA.
MICs of tigecycline, vancomycin and linezolid against 200 MRSA
strains.
MIC distribution of tigecycline and imipenem against E. coli and
Klebsiella spp., ESBL-positive (n = 106).
Results: The distribution of the MIC values is shown in the ﬁgure. 67/70
(96%) E. coli, 26/36 (72%) Klebsiella sp. and all MRSA isolates were
fully sensitive against Tigecycline. 3/70 (4%) E. coli and 8/36 (22%)
Klebsiella sp. showed intermediate sensitivity against Tigecycilne, 2/36
(6%) Klebsiella sp. isolates were resistant. All ESBL-producing strains
were tested sensitive against Imipenem, all MRSA isolates were tested
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sensitive against Vancomycin and Linezolid. However in 79/200 (40%)
a MIC of 2mg/ml against Vancomycin and in 162/200 (81%) %) MIC
of 2mg/ml against Linezolid was detected.
Conclusion: The in vitro sensitivity of Tigecycline against ESBL-
producing Enterobacteriaceae ranged between 72% for Klebsiella sp and
96% for E. coli. Tigecycline seems to be an effective alternative option
for treatment of infections due to these bacteria, however antimicrobial
resistance testing is recommended before starting therapy.
All MRSA strains were sensitive against the tested antibiotics, thus
Tigecycline can be used for the indications studied and recommended.
R2119 Antimicrobial activity of seven chemotypes of Lippia alba
C.M. Oliveira Nunes, A.P. Delamare, F. Formolo, L. Michelim °,
S. Echeverrigaray (Caxias do Sul, BR)
Objectives: Lippia alba is an American species of the Verbanaceae
family currently used in Brazilian popular medicine with pharmacolog-
ical antimicrobial, analgesic, and spasmolytic. The biological activity of
this plant has been attributed to its essential oil. Several chemotypes of
Lippia alba have been described. These chemotypes are characterised by
high concentration of different mono and sesquiterpenes. Essential oils
are considered natural non-toxic antimicrobial agents, and its efﬁciency
depends on their chemical composition. In the present work we evaluate
the antimicrobial activity of the essential oils of seven chemotypes of
Lippia alba (linalool, limonene, citral, caryophyllene, camphor, carvone,
and 1,8-cineole/camphor) against a panel of nine yeasts and 22 bacterial
species.
Methods: Essential oils were obtained by hydrodistillation and
their composition evaluated by GC and GC-MS. Minimal inhibitory
concentration was determined by a microtiter plate method using serial
oil dilutions (0 to 10ml/L). Bacterial or yeast growth was evaluated in
a microtiter plate reader at 592nm. The effect of oil concentration on
bioﬁlm formation was evaluated using safranine staining of bacterial
cells attached to the polypropylene microtiter plates.
Results: The results obtained showed that the antimicrobial and
bioﬁlm inhibitory activities varied among chemotypes. The most
efﬁcient chemotypes were citral and caryophyllene inhibiting the
highest number of bacterial species at the lowest oil concentration.
The least efﬁciency was obtained with the carvone chemotype. Citral
and caryophyllene oils were particularly efﬁcient against Bacillus
species (B. megaterium, B. subtilis, B. cereus), Listeria monocytogenes,
Enterococcus, Staphylococcus, Aeromonas, and Serratia. In general,
Gram-positive bacteria species were more sensitive than Gram-negative
ones. All the chemotypes reduced bioﬁlm formation, particularly those
characterised by high concentration of oxygenated terpenes (linalool,
citral and 1,8-cineole). Citral, carvone and limonene were the most
efﬁcient oils against yeasts, reducing both growth and bioﬁlm.
Conclusion: These data showed that antimicrobial activity is highly
dependent of essential oil composition, and this fact should be take in
account for the proper therapeutic use of these and other natural products.
R2120 The investigation of the correlations between antibiotics
and host immune effectors on virulence and antibiotic
resistance of some Escherichia coli strains
O. Dracea °, C. Balotescu-Chiﬁriuc, C. Bleotu, C. Iordache,
A. Stanciuc, C. Delcaru-Larion, O. Banu, V. Lazar (Bucharest, RO)
Objectives: The purpose of the present study was to investigate the
inﬂuence of the combined action of antibiotics and different host immune
effectors on the expression of antibiotic resistance and adherence
capacity to the cellular and inert substrata in Escherichia (E.) coli strains.
Methods: This study was performed on two E. coli strains isolated
from cardiovascular infections exhibiting resistance to the 3rd generation
cephalosporins one by the production of the extended spectrum
b-lactamase (ESBL) and the other by membrane impermeability
mechanism, also, on the reference strains E. coli ATTC 25922. The
capacity of adherence to the cellular substratum represented by HeLa
cells (performed by Cravioto’s adapted method) and, also, the adherence
to inert substratum (quantiﬁed by rapid microtiter assay) were performed
in the presence/absence of sub-inhibitory concentrations (SiC) of
cephtazidime (CAZ) and nalidixic acid (NA) as well and/or different
associations of host immune effectors (lyzosyme, complement C4, IgG,
IgG+IgA+IgM) (in similar concentrations with those existing in the
immunocompetent adult host).
Results: The tested strains presented different behaviours in their
interaction with cellular and inert substrata in the presence of antibiotics
and host immune effectors. In the case of E. coli ATCC 25922 strain
the SiC of NA stimulated the capacity of adherence to cellular and
inert substrata, but the SiC of NA and CAZ in association with the
host immune effectors stimulated only the adherence to the cellular
substratum, and inhibited the adherence to the inert substratum. For
the ESBLs producing E. coli strain the SiC of NA, CAZ as well and
the SiC of NA in association with opsonines induced the increase of
adhesins synthesis. The SiC of CAZ in association with the host immune
effectors signiﬁcantly decreased the capacity of adherence to cellular
substratum. The capacity of adherence to the inert substratum was not
inﬂuenced by the SiC of antibiotics as well or in association with the
host immune effectors. For the E. coli strain resistant by a membrane
impermeability mechanism the SiC for both antibiotics stimulated the
capacity of adherence to the cellular and inert substrata.
Conclusion: Our results prove that any immunological imbalance,
characterised by the quantitative decrease or increase of one of the
soluble host immune effectors, may favour, even in the antibiotic
presence, the initiation of an infectious process.
R2121 Antimicrobial resistance of Streptococcus pneumoniae in a
Vilnius university children’s hospital, 2000–2008
I. Narkeviciute °, G. Bernatoniene (Vilnius, LT)
Objectives: Streptococcus pneumoniae (SP) is one of the most frequent
causes of bacterial diseases in children. Local data on antimicrobial
resistance is necessary in the empirical therapy. The aim of the study
was to evaluate antimicrobial resistance of SP in 2000–2008.
Methods: SP strains were isolated from sterile sites (blood and CSF)
and non-sterile sites (sputum, ear swab etc) from hospitalised children.
Susceptibility of SP to penicillin and cefotaxime were performed using
E-test (AB Biodisk, Sweden) and to erythomycin, clindamycin and
vancomycin − using the disk diffusion method according to the CLSI
criteria.
Results: Overall rates of resistance to antimicrobial agents in SP are
given in the Table.
Antimicrobial agent S. pneumoniae resistance (%)
Sterile sites Non-sterile sites
Penicillin 2.4 4.6
Erythromycin 12.5 10.3
Clindamycin 7.3 4.7
Cefotaxime 0 1.9
Vancomycin 0 0.4
Conclusions: Highest rate of resistance has been observed for
erythromycin in SP. Resistance to penicillin is low at present and
resistance range was lowest against isolates from blood and CSF.
SP strains appeared to have stable sensitivities to cefotaxime and
vancomycin.
R2122 Antibiogram proﬁle of potential probiotic Biﬁdobacterium
spp. recovered from faeces sample of human origin
M. Reyed ° (Alexandria, EG)
In the present study, a total of Sixty one strains belonging to potential
probiotic Gram-positive, nonsporeforming, anaerobic biﬁdobacterial
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strains isolated from human faecal samples were evaluated with regard
to the antibiotic resistance. All strains were identiﬁed as B. longum,
B. breve and B. adolescentis.
Spectrum of antibiotics included commonly used medicaments in
human medicine. The antibacterial sensitivity proﬁles were studied
by a microdilution broth method. Probiotic lyophilised stock culture
Biﬁdobacterium biﬁdum 791 “Biﬁdumbacterium” from culture collection
was taken as a control. Most strains of all types resisted 100mg/ml or
more of Kanamycin, Oﬂoxacin, Ciproﬂoxacin, Tetracycline, Gentamycin
and Erythromycin.
8 Biﬁdobcaterial strains with high resistance to antibiotics were selected.
The effect of UV on antibiotic and susceptibility was examined for 3
potent antibiotic resistance strains of biﬁdobacteria.
They were shown that the resistance to Ciproﬂoxacin, Cefazolin and
Amoxicillin. Antibiotics resistant Biﬁdobacteria interact effectively and
adhesive with mucous membrane of mouse in vitro and survive
successfully in gastrointestinal tract of mouse in presence of antibiotics.
These data are discussed in relation to the effect of antimicrobial agents
on biﬁdobacteria in the normal human faecal microbiota, in relation to
the implications.
In mouse oral administration by Ciproﬂoxacin (5mg/kg body weight) are
sufﬁciently high disrupt the micro-ecological balance of the microbiota
in the bowel. The total number of lactobacilli and Biﬁdobacteria were all
reduced in number and Enterobacteria, Enterococci and Staphylococci
reach high numbers.
Resistant Biﬁdobacterial strains can effectively suppress excessive mul-
tiplication of opportunistic microorganisms in mouse intestines, caused
by Ciproﬂoxacin induced dysbacteriosis and reestablish normal level of
lactobacilli and Biﬁdobacteria normal microbiota population of the gut
These results demonstrate that the screening procedures developed in this
study are effective for the selection of resistant Biﬁdobacterium strains,
and developed criteria for in vitro selection of probiotic bacteria that
may reﬂect certain in vivo effects on the host such as modulation of
gastrointestinal tract microbiota.
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R2123 In vitro activity of tigecycline and other broad spectrum
antibiotics against micro-organisms isolated from infected
patients in Colombia
A.L. Leal, G. Buitrago, J.A. Cortes °, M.V. Ovalle, C.A. Alvarez,
J.S. Castillo, J. La Rotta, S. Galo on behalf of the Colombian
Group For Tigecycline Susceptibility Surveillance
Objective: There are usually changes in the susceptibility proﬁles of
antibiotics after their introduction in clinical use. Surveillance studies
are important because they show the magnitude and trend of the change.
A surveillance of tigecycline, two years after its introduction in Colombia
is presented.
Methods: A surveillance study from 13 institutions in 8 different cities in
Colombia was made. Microorganisms isolated from hospitalised patients
with a microbiologically proven diagnosis of infection were sent to a
reference centre. Antimicrobial activity was tested by a microdilution
method for tigecycline (Trek diagnostics, London) and other broad spec-
trum antibiotics (MicroScan, Dade Behring, CA) commonly used. For
interpretation CLSI rules were used and, for tigecycline, FDA approved
breakpoints were used. No Pseudomonas species were collected.
Results: 802 isolates were collected (S. aureus 28%, E. coli 26%, Kleb-
siella spp. 18%, A. baumannii 10%, Enterococcus spp.7%, Enterobacter
spp. 6% and S. marcescens 5%). Isolates were recovered from blood-
stream (33%), skin and soft tissue (17%), surgical site infection (17%),
abdomen (15%), respiratory tract (14%) and bone (4%). Susceptibility
is shown according to the infection site and microorganism in Table 1.
Conclusion: Susceptibility proﬁle of tigecycline is still very high after
2 years of clinical use. A high resistance proﬁle is observed among
collected isolates and limited therapeutic options are available.
Table 1. Susceptibility according to the infection site and microorganism
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Blood 265
Acinetobacter
baumanniib
22 36 31 31 31 31 27 50 0 90 86 100 0.5 1
Enterobacter
spp.
15 86 80 86 66 66 100 100 73 13 100 0.5 1
Escherichia
coli
72 98 79 68 79 79 100 100 87 16.7 41 100 0.25 0.5
Klebsiella spp. 56 87 71 76 71 71 92c 87c 71 32.1 55 100 0.5 1
Serratia
marcescens
13 53 76 100 100 61 100 100 92 0 100 1 1
Staphylococcus
aureus
73 65 100 79 100 0.125 0.25
Enterococcus
spp.
14 93 100 0.125 0.25
Skin and soft
tissue
137
Acinetobacter
baumanniib
9 11 11 11 22 22 11 33 0 100 100 100 0.25 1
Enterobacter
spp.
11 72 81 54 72 63 100 100 81 9 100 0.5 1
Escherichia
coli
22 86 63 54 63 63 100 100 86 31.8 31 100 0.25 1
Klebsiella spp. 15 93 80 73 80 80 93c 93c 60 20 46 100 0.5 1
Serratia
marcescens
11 72 90 90 81 81 100 100 81 9 100 0.5 1
Staphylococcus
aureus
61 62 100 90 100 0.125 0.25
Enterococcus
spp.
8 100 100 0.125 0.25
Abdominal 120
Acinetobacter
baumanniib
10 40 0 0 10 10 0 10 0 90 80 100 0.5 1
Enterobacter
spp.
8 75 62 75 50 50 100 100 50 25 100 0.5 1
Escherichia
coli
58 98 86 70 86 86 100 100 79 10.3 29 100 0.25 0.5
Klebsiella spp. 21 85 66 76 71 71 100 100 42 28.6 42 100 0.5 1
Serratia
marcescens
2 100 100 100 100 100 100 100 100 0 100 0.125 0.5
Staphylococcus
aureus
8 25 100 37 100 0.125 0.25
Enterococcus
spp.
13 100 100 0.125 0.25
Respiratory
tract
111
Acinetobacter
baumanniib
21 33 4 4 9 9 9 9 0 76 100 100 0.5 1
Enterobacter
spp.
5 100 60 80 60 60 100 100 80 40 100 0.5 1
Escherichia
coli
9 100 77 66 77 88 100 100 77 22.2 11 100 0.25 1
Klebsiella spp. 36 97 75 86 69 75 97c 97c 61 25 38 100 0.5 1
Serratia
marcescens
8 100 100 87 100 100 100 100 100 12 100 0.5 2
Staphylococcus
aureus
32 59 100 68 100 0.125 0.25
Enterococcus
spp.
0
Surgical site
infection
136
Acinetobacter
baumanniib
12 66 66 58 75 66 66 75 0 91 83 100 0.25 0.5
Enterobacter
spp.
11 54 36 54 27 36 100 100 36 18 100 0.5 1
Escherichia
coli
43 81 79 69 79 79 100 100 74 14 27 100 0.25 0.5
Klebsiella spp. 12 75 58 50 58 58 100 91c 41 41.7 33 100 0.5 1
Serratia
marcescens
4 75 100 25 75 75 100 100 100 0 100 0.5 1
Staphylococcus
aureus
41 43 100 70 100 0.125 0.25
Enterococcus
spp.
13 100 100 0.125 0.25
Bone 32
Acinetobacter
baumanniib
6 16 16 0 33 33 16 16 0 83 83 100 0.25 1
Enterobacter
spp.
2 50 50 50 50 50 100 100 50 50 100 0.25 1
Escherichia
coli
4 100 100 75 100 100 100 100 100 0 50 100 0.25 1
Klebsiella spp. 3 100 33 66 33 33 100 100 33 66.7 33 100 1 1
Serratia
marcescens
1 100 100 100 100 100 100 100 100 0 100 1 1
Staphylococcus
aureus
13 53 100 84 100 0.125 0.25
Enterococcus
spp.
3 100 100 0.064 0.125
aE-test susceptibility. bEnterobacteriaceae breakpoints for tigecycline. cMolecular conﬁrmation.
OXA, oxacillin; VAN, vancomycin; AMK, amikacin; FEP, cefepime; CIP, ciproﬂoxacin; CAZ, ceftazidime;
CRO, ceftriaxone; ESBL, extended-spectrum beta-lactamase; IMI, imipenem; MEM, meropenem; TZP, piperacillin/
tazobactam; SAM, ampicillin/sulbactam; CSL, cefoperazone/sulbactam; COL, colistin; MIN, minocycline;
TGC, tigecycline; %S, percent susceptibility.
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R2124 Anti-picornaviral activity of novel pirodavir derivatives
R. Timpanaro, A. Garozzo, B. Bisignano °, A. Castro, S. Laconi,
R. Pompei (Catania, Cagliari, IT)
Objectives: The early steps of the Picornavirus replicative cycle seem
to be priviledged targets for some antiviral compounds like Disoxaril
and Pirodavir. These drugs were shown to be strong inhibitors of virus
adsorption in Picornavirus infected HeLa cells. On the basis of drug
sensitivity, the division of Rhinovirus in groups A and B was proposed.
Pirodavir was shown to be effective on both several group A and B strains
of Rhinoviruses. The main weakness of Pirodavir is its cytotoxicity on
cell cultures at relatively low doses. In this work we tested some original
Pirodavir derivatives, in order to ﬁnd less toxic compounds with an
improved protection index (PI).
Methods: Compounds I-002, I-230, I-232, I-273, I-373, I-473; I-501;
I-502, I-602, I-702 were synthesized and purchased from IFI SPA
(Rome). Rhinoviruses HRV14 (group A) and HRV39 (group B) were
grown in HeLa cells (Ohio strain). Poliovirus 1, Echovirus 6, 9, 11,
were propagated in HEp-2 cell culture. Coxsackievirus B1 and A9 were
propagated in RD cell culture. The antiviral activity assay was carried
out by the 50% plaque reduction assay.
Results: The substitution of the oxygen atom in the central chain of
Pirodavir with an amino group resulted in an increased antiviral activity
against Echo and Coxsackie viruses, although a decreased activity
against Rhinoviruses and Poliovirus was observed. Compound I-232 was
about ten times less toxic than Pirodavir, but it was equally active. The
substitution of the oxygen atom in the central chain with a thio group (as
in compounds I-373 and I-501) did not inﬂuence antiviral activity. The
presence of a double oxygen group in the central chain (as in compound
I-602) resulted in a lower cell toxicity and in a higher anti-rhinovirus
activity. In fact, this compound had a PI> 700 against HRV14 while
Pirodavir had a PI=250.
Conclusion: Our results indicate that new derivatives endowed with
lower cytotoxicity and that a higher PI against some Picornaviruses can
be obtained starting from the Pirodavir.
R2125 In vitro resistance development to tobramycin by Pseudo-
monas aeruginosa is minimised by addition of PTZ601
D. Daigle °, J. Hamrick, M. Corrigan, D. Pevear, C. Burns, L. Xerri
(Malvern, US)
Objectives: Evaluate the potential for antagonism between tobramycin
and PTZ601 (previously known as PZ-601 and SMP-601), an injectable
broad-spectrum carbapenem antibiotic with activity against multidrug-
resistant Gram-positive and Gram-negative bacteria, and study the effect
of a tobramycin-PTZ601 combination on the propensity for resistance
development by Pseudomonas.
Methods: Serial passages of the P. aeruginosa strain PAO1, possessing
multiple resistance mechanisms, were performed daily for 20 days in
Mueller-Hinton broth in the presence of sub-inhibitory concentrations
of meropenem, PTZ601, tobramycin and of combinations of each of
the carbapenems with tobramycin (0.5×MIC drug A plus 0.5×MIC
drug B). Resistance mechanisms included inducible AmpC b-lactamase,
resistance-nodulation-cell division efﬂux systems, and OprD down-
regulation. The inoculum for each subsequent passage was taken from
the ﬁrst well demonstrating evident turbidity, according to the CLSI
microdilution method. Checkerboard analyses were performed to deﬁne
a lack of antagonism between PTZ601 and tobramycin.
Results: Following 20 passages of P. aeruginosa PAO1 in sub-
inhibitory concentrations of individual agents (meropenem, PTZ601, and
tobramycin), higher levels were required to achieve inhibition with each
single antibiotic, increasing 128-fold for meropenem (0.5 to 64mcg/mL),
16-fold for PTZ601 (4 to 64mcg/mL), and 64-fold for tobramycin (0.5
to 32mcg/mL).
Conclusions: This study shows that even though PTZ601 is only
marginally active against P. aeruginosa PAO1 on its own (MIC
of 8mcg/mL), when it is combined with tobramycin, resistance
development is minimised. The lack of in vitro antagonism between
PTZ601 and tobramycin indicates that this empirical combination to
provide adequate anti-pseudomonal coverage warrants further study.
Figure: Effect of the combination of two carbapenems with tobramycin
(0.5×MIC plus 0.5×MIC) on the development of resistance in serial
passages of P. aeruginosa PAO1.
R2126 PTZ601: evaluation of the pharmacokinetics following
single intravenous administration with and without
cilastatin to male Sprague-Dawley rats and beagle dogs
A. Parazzoli °, F. Fiorentini, G. Di Gallo, L. Xerri (Nerviano, IT;
Malvern, US)
Objective: PTZ601 (previously known as PZ-601 and SMP-601) is
a novel investigational parenteral 1b-methylcarbapenem active against
a wide range of Gram-positive and Gram-negative bacteria, including
multi-resistant pathogens. The objective of this study was to investigate
the pharmacokinetics of PTZ601 in Sprague-Dawley rats and in beagle
dogs after a single intravenous (IV) administration with or without
cilastatin (a speciﬁc inhibitor of the renal enzyme dehydropeptidase I,
responsible for the hydrolysis of many carbapenems).
Methods: PTZ601 (100mg/kg) alone or in combination with cilastatin
(100mg/kg) was given by 10-minute IV infusion to 3 male rats or to
3 male dogs housed singly in metabolic cages for concomitant urine
collection.
Results: In rats, the systemic clearance (CL) of PTZ601 administered
alone was high (42.8mL/min/kg), accounting for 62% of the hepatic
blood ﬂow (HBF). Renal clearance (CLr), 2.7mL/min/kg, showed
a limited contribution to total CL. Coadministration with cilastatin
increased by 10 times the systemic exposure (AUC0-inf: 401.1 vs
43.3 ugxh/mL without cilastatin), with a concomitant marked reduction
of CL (from 42.8 to 4.3mL/min/kg), but a marginal effect on CLr
(from 2.7 to 1.5mL/min/kg). In dogs, PTZ601 CL without cilastatin
(4.2mL/min/kg) was found to be lower than that observed in rats
and accounted only for about 10% of HBF. The CLr contribution
(0.33mL/min/kg) was proportionally similar to that observed in rats.
In dogs, coadministration with cilastatin caused only a 2-fold increase
of AUC0-inf (from 353 to 833 ugxh/mL) with a limited effect on
both CL (4.2 vs 2.3mL/min/kg) and renal elimination (CLr: 0.33 vs
0.57mL/min/kg).
Conclusion: In rats, the coadministration of PTZ601 with cilastatin
signiﬁcantly reduced total clearance from 42.8 to 4.3mL/min/kg. In
dogs, the effect was much less pronounced. On the basis of these results,
the subsequent nonclinical safety studies in rats, but not in dogs, were
performed with cilastatin to increase exposure of PTZ601.
R2127 Antibacterial activities of cobweb protein
D. Chakraborty °, S. Das (Kolkata, IN)
Objectives: Cobweb production is an essential activity of spiders to
capture their prey and to get nutrients from them. Spider web contains
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various amino acids mainly glycine and alanine along with pyrrolidin,
that retains water and prevents the web from drying up; potassium
hydrogen phosphate and potassium nitrate, which are known to prevent
fungal and bacterial growth on the web. The objective of our experiment
is to study the antibacterial activities of cobweb proteins on different
bacteria.
Methods: Webs of common household spider − Crossopriza lyoni were
collected with a clean glass rod and washed with deionised distilled water
and dried in incubator. The spider silk then dissolved in hydrochloric acid
and acetic acid (50:50 v:v) and neutralised with sodium hydroxide. After
this proteins were separated and a solution of 1mg/mL of the extracted
protein was used for study of its antibacterial activities on international
strains of E. coli, Pseudomonas aeruginosa, Staphylococcus aureus,
Enterococcus faecalis, and many wild strains of bacteria including
MRSA, MBL-positive Gram-negative bacteria. The MIC values were
determined after serial dilution of the protein in liquid MH broth in
micro dilution plates followed by challenge with different microbes and
measuring absorbances at 620 nm in Micronaut system (Germany).
Results: MIC values of all Gram negative organisms including MBL
producing strains were much lower (<10mcg/mL) than that of the Gram
positive organisms (>30mcg/mL).
Conclusion: Cob web protein showed prominent antibacterial activities.
The difference in the activities of spider web proteins between Gram
positive and Gram negative bacteria was well marked. Crude extract of
spider web is included in pharmacopoeia of alternative medicines for
psychological illnesses, thus it has got no toxic effect in human beings.
R2128 Efﬁcacy of carbohydrate-derived fulvic acid against MRSA
and Candida albicans in murine models of sepsis
P.A. Warn °, A. Sharp, S. Howsley (Manchester, UK)
Objectives: Humic acid is a major component of humic substances
which are dark brown constituents of soil organic matter formed by
degradation of plants & animals in the environment. The fraction of
humic acid that is soluble in water at all pH is fulvic acid but due
to its colloidal nature is contaminated by organics and heavy metals.
Carbohydrate Derived Fulvic Acid (CHD-FA) avoids contamination
by production in industrial bioreactors from plant material free of
contaminants. Here we investigated the antimicrobial efﬁcacy of CHD-
FA against MRSA and C. albicans in murine models of sepsis.
Methods: CHD-FA (Fulhold Ltd) naturally exists as a light brown
substance pH 2.1 was buffered with NaOH to pH 5.0 for use. Male CD1
mice 22−25 g were used. In the C. albicans model (ﬂuconazole resistant
strain) mice were compromised with 1 dose of cyclophosphamide. In
both models mice were infected IV with sufﬁcient organisms to cause
100% mortality in untreated mice 5−7 days post infection.
Mice infected with MRSA were treated with 40 or 160mg/kg CHD-FA
BD oral, 80mg/kg oxacillin (OXA) BD, CHD-FA + OXA, 50mg/kg
vancomycin (VAN) BD or vehicle. Treatment started 1 hour post
infection.
Mice infected with C. albicans were treated with 25 or 100mg/kg CHD-
FA BD oral, 10mg/kg ﬂuconazole (FLU) once daily, CHD-FA + FLU,
0.5mg/kg amphotericin (AMB) or vehicle 5 hours post infection. All
animals were euthanised 50 h (MRSA) or 53 h (Candida) post infection.
In both models the kidneys were quantitatively cultured to determine
burden.
Results: CHD-FA at pH 5.0 and given orally was well tolerated. In
the MRSA model vehicle treated mice had high burdens (~106 cfu/gm).
Treatment with CHD-FA or OXA monotherapy had a modest effect
on burden (~105 cfu/gm). In contrast 160mg/kg CHD-FA + 80mg/kg
OXA was highly effective at reducing burden (<103 cfu/gm) p =0.01 and
equivalent to VAN p> 0.05. C. albicans infected, vehicle treated mice
had high burdens (3.7×106 cfu/gm). Monotherapy with CHD-FA had a
modest effect reducing burdens to ~1×106 cfu/gm; FLU monotherapy
reduced the burden to ~4×104 cfu/gm. The combination of CFH-FA
+ FLU was superior to either monotherapy reducing the burden to
~1×104 cfu/gm (p< 0.0001 compared to vehicle) and equivalent to AMB
(p = 0.11)
Conclusions: CHD-FA oral treatment was well tolerated in murine
models of sepsis. Combination treatment of MRSA with CHD-FA +
OXA and C. albicans treated with CHD-FA + FLU were highly effective
at reducing the kidney burden.
R2129 Antibacterial activity of the polymeric guanidines in hygienic
handwash against Escherichia coli K12 NCTC 10538
C. Kratzer °, K. Karaca, N. Kreischitz, W. Graninger, A. Georgopoulos
(Vienna, AT)
Objectives: The cationic biocides Akacid® (Poly-[2-(2-ethoxy)-
ethoxyethyl-guanidinium-chlorid]) and Akacid® Plus, a 3:1-mixture
of Poly-(hexamethylen-guanidinium-chlorid) and Poly-[2-(2-ethoxy)-
ethoxyethyl-guanidinium-chlorid], show broad in vitro activity against
bacteria and fungi. The aim of this pilotstudy was to evaluate the activity
of the novel polymeric guanidines against the non-pathogenic reference
strain Escherichia coli K12 NCTC 10538 in hygienic handwash
according to the test methods of the European Standard EN 1499.
Methods: Akacid® and Akacid® Plus at a concentration of 0.5 and 1%
were tested compared to kalisoap in twelve different healthy volunteers.
For artiﬁcial contamination the proband’s hands were dipped into one
litre of a bacterial suspension of E. coli K12 NCTC 10538 (2×108 to
2×109 cfu/ml) and were air-dried. To test the activity of Akacid® and
Akacid® Plus, the test substances or the reference soap were applied
and were rubbed either once or twice for one minute. The bacterial
prevalues (after contamination) and postvalues (after disinfection and
neutralisation) were determined according to the guidelines of the
reference wash method EN 1499. In each case the reduction factor
between prevalue and postvalue was calculated.
Results: In all test groups the prevalues of the bacterial counts ranged
from 1×106 to 3×107 cfu/ml with a mean value of 1.3×107 cfu/ml. After
single and double application of kalisoap alone mean reductions factors
of 9.8×102 cfu/ml and 5.9×103 cfu/ml were determined. A signiﬁcantly
higher reduction of the microbial count was achieved after treatment with
Akacid® Plus 1% as single and double application (mean reduction value
6.6×103 cfu/ml and 3.7×104 cfu/ml, respectively p< 0.001), whereas
reduction values due to Akacid® Plus 0.5%, Akacid® 1% and Akacid®
0.5% were comparable to kalisoap.
Conclusion: We proved superiority of the new disinfectant solution
Akacid® Plus 1% in reducing colony counts of E. coli K12 on hands
of healthy volunteers compared to the reference substance kalisoap in
hygienic handwash.
R2130 In vitro bactericidal and antibioﬁlm activity of six
antimicrobial peptides against multidrug-resistant
pathogens from patients with cystic ﬁbrosis
G. Di Bonaventura °, A. Pompilio, C. Picciani, M. Scocchi,
M. Benincasa, A. Di Primio, R. Piccolomini, E. Fiscarelli, R. Gennaro
(Chieti, Trieste, Rome, IT)
Respiratory tract infection is the major cause of morbidity and mortality
in cystic ﬁbrosis (CF). Physicians are increasingly faced with infection
with multidrug-resistant isolates due to many prolonged courses of
antimicrobial agents used to slow the rate of decline in pulmonary
function. For this reason, new therapeutic approaches are needed to
improve the management of CF lung disease, including development
of novel agents to treat antibiotic-resistant pathogens.
Objective: To test in vitro the bactericidal activity and the effect
on bioﬁlm formation of six cathelicidin-derived antimicrobial peptides
against eleven Gram-positive and -negative clinical isolates from CF
patients. The peptides included members of the alfa-helical group
(LL-37, SMAP-29, BMAP-27, and BMAP-28), the Trp-rich peptide
indolicidin, and the Pro-rich peptide Bac7(1–35).
Methods: The bactericidal activity of the peptides was tested against
multiply antibiotic-resistant strains of Stenotrophomonas maltophilia
(n = 3), Pseudomonas aeruginosa (n = 4), and Staphylococcus aureus
(n = 4), by using the broth microdilution assay according to the CLSI
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guidelines. The effect of subinhibitory concentrations of peptides on
bioﬁlm formation was analyzed by crystal violet staining in polystyrene
96-well microtiter plates after 24 h of incubation at 37ºC. All assays were
performed at least in duplicated and repeated twice.
Results: SMAP-29 was the most active peptide (MIC range: 2−32
microg/ml; MIC90: 8 microg/ml), followed by BMAP-28 (MIC range:
4−64 microg/ml; MIC90: 16 microg/ml), and BMAP-27 (MIC range:
2−64; MIC90: 64 microg/ml). In contrast, indolicidin, LL-37, and
Bac7(1–35) had no activity against the clinical isolates tested (MIC
64 microg/ml). SMAP-29 and BMAP-27 were particularly active
against P. aeruginosa (MIC range: 2−4 microg/ml) and BMAP-28 against
S. aureus (MIC range: 4−8 microg/ml). These three peptides at 1/2×MIC
signiﬁcantly (P< 0.05) reduced bioﬁlm formation by S. maltophilia and
P. aeruginosa strains (bioﬁlm reduction rate: from 26 to 93%, and from
28 to 83% vs control, respectively). SMAP-29 at 1/2×MIC was the
only peptide that signiﬁcantly (P< 0.05) decreased bioﬁlm formation
by S. aureus (bioﬁlm reduction rate: from 70 to 72% vs control). In
contrast, subinhibitory concentrations of indolicidin, LL-37, and Bac7
had no effect on bioﬁlm formation.
Conclusion: SMAP-29, BMAP-27, and BMAP-28 display potential for
development as therapeutic agents for CF lung disease.
R2131 Outcomes of pan-resistant Acinetobacter baumannii
infections treated with tigecycline
A. Erbay °, A.Y. Tezer Tekce, B. Mert Dinc, H. Cabadak, N. Karabiber,
S. Sen (Ankara, TR)
Objectives: To determine clinical and microbiological outcomes
of patients treated with tigecycline for pan-resistant Acinetobacter
baumannii infections.
Methods: The study was conducted at the Turkiye Yuksek Ihtisas
Education and Research Hospital, a 419 bed, tertiary care hospital. All
adult patients who received tigecycline at least 5 days for treatment
of an infection due to pan-resistant A. baumannii included in the study
and followed up prospectively. Tigecycline susceptibility was determined
using the Etest method. A. baumannii strains were susceptible only
colistin and tigecycline.
Results: Tigecycline therapy was administered to thirteen patients
for pan-resistant A. baumannii infection. Of these, 11 patients who
received tigecycline at least 5 days included in the study. Mean age
of the patients was 64.3±10.6 (range, 40−79) and 8 (72.7%) was
male. All of the patients had comorbidities, 6 (54.6%) had coronary
artery disease, 6 (54.6%) had hypertension, 4 (36.4%) had diabetes
mellitus and 2 (18.2%) had chronic obstructive pulmonary disease. All
of the patients were followed up in ICUs. The mean time between
hospital admission to the development of pan-resistant A. baumannii
infection was 44.3±24.4 days. Ten of the patients had surgical operation.
Seven (63.6%) patients had mechanical ventilation support. Seven
(63.6%) patients had surgical site infection, 2 (18.2%) patients had
ventilator associated pneumonia, one patient had mediastinitis and one
patient had soft tissue infection due to pan-resistant A. baumannii.
The mean duration of the tigecycline treatment was 12.4±5.4 (range
5−21) days. Five patients had additional nosocomial infections. In two
patients imipenem was administered for additional infections further with
tigecycline. Three patients had a fatal outcome and two deaths were
thought to be related to the A. baumannii infection. The mean interval
from the initiation of tigecycline treatment to death was 7.6 days. The
mean APACHE II score was 9.4 in surviving patients and 17.7 for those
who did not survive (p< 0.001). All of the patients with fatal outcome
had surgical site infection. No microbiological failure was observed
during the tigecycline treatment.
Conclusions: Tigecycline has the potential to be an option for pan-
resistant A. baumannii infections including surgical site infection,
ventilator associated pneumonia and mediastinitis.
R2132 In vitro activity of tigecycline alone and in combination
with colistin methanesulfonate against carbapenem
resistant Acinetobacter baumannii isolates
B. Ozbek °, A.A. Gerceker (Istanbul, TR)
Objective: Acinetobacter baumannii is a Gram-negative organism that
has emerged as increasingly important nosocomial pathogens because of
the extent of its antimicrobial resistance and its persistence in the hospital
environment. Since it has an extraordinary ability to acquire antibiotic
resistance, a large number of A. baumannii strains have been recently
reported to be carbapenem resistant in many countries. Tigecycline,
the 9-tert-butyl-glycylamido derivative of minocycline, is the ﬁrst
commercially available member of the glycylcyclines. Tigecycline has
in vitro activity against Acinetobacter spp. and has been suggested as a
therapeutic option in these infections. For these reasons, the aim of the
present study is to determine the in vitro activities of tigecycline alone
and in combination with colistin methanesulfonate against carbapenem
resistant A. baumannii strains.
Methods: 50 clinical isolates were collected and identiﬁed in the Clinical
Microbiology Laboratories of Istanbul University, Istanbul Faculty of
Medicine. Escherichia coli ATCC 25922 was used as a control strain.
Tests for the susceptibility to meropenem and tigecycline were performed
by the broth microdilution method as recommended by CLSI guidelines.
The MICs of colistin methanesulfonate were determined by using a
microbroth dilution assay modiﬁed from the method of the CLSI.
The effects of antibiotics in combination were assessed by using the
microbroth checkerboard technique. With this method, synergy was
deﬁned as an FIC index of 0.5, additivity as an FIC index of 1.0
and antagonism as an FIC index of 2.0.
Results: The MIC values of the three antibiotics were ranked as follows:
meropenem > colistin methanesulfonate > tigecycline. Tigecycline
demonstrated excellent inhibitory activity against A. baumannii with
MIC (90) 0.5mg/l. On the other hand, 32% of the strains were
resistant to meropenem. According to our results, with a FIC index
of 0.5 as a borderline; synergy was detected with tigecycline-colistin
methanesulfonate combination. It should be pointed out that additive
interaction was more frequent. No antagonism was observed.
Conclusion: Tigecycline exhibited potent in vitro antibacterial activity
against clinical A. baumannii strains. The results of combination
studies for the carbapenem resistant A. baumannii provide evidence
that tigecycline used in combination with colistin methanesulfonate will
produce synergy against studied strains.
R2133 In vitro activity of tigecycline against multidrug-resistant
Enterobacteriaceae clinical isolates
S. Maraki °, A. Georgiladakis, A. Christidou, Z. Gitti, G. Samonis
(Heraklion, GR)
Objective: To evaluate the in vitro activity of tigecycline against 108
multidrug-resistant (MDR) strains of Enterobacteriaceae isolated from
ICU and non-ICU patients of our hospital.
Methods: A total of 108 MDR strains of Enterobacteriaceae collected
over a 10-month period, were studied. The minimum inhibitory
concentrations (MICs) for tigecycline and 14 other antimicrobial agents
were determined by the E-test method (AB Biodisk, Sweden). EUCAST
breakpoints were used to interpret tigecycline and colistin MIC results
and CLSI (M100-S18) breakpoints were used to interpret all other agents,
where applicable.
Results: Bacterial species identiﬁed were: K. pneumoniae (77/108),
E. coli (20/108), Proteus mirabilis (7/108), E. cloacae (3/108) and
K. oxytoca (1/108). They were isolated from urine (38/108), blood
(21/108), bronchoalveolar lavage ﬂuid (BAL) (19/108), pus (8/108),
intravenous catheters (6/108), and others (16/108). MIC50 and MIC90
for tigecycline was 1 and 2mg/l, respectively (MIC range: 0.125–4mg/l).
All E. coli isolates tested (MDR, ESBL and MBL producing) were
uniformly sensitive to tigecycline. Resistance to tigecycline was detected
New antimicrobials S629
in 1 of the MDR K. pneumoniae isolate (1.3%), and in all 7 P. mirabilis
isolates tested.
Conclusion: The present data suggest that tigecycline may be
an effective option for treatment of infections caused by MDR
Enterobacteriaceae (with the exception of Proteus mirabilis) in our
setting.
R2134 The challenge of multiresistant Gram-positive cocci: novel,
effective therapeutic options
R. Manfredi ° (Bologna, IT)
Introduction: Multiresistant Gram-positive cocci, including Staphylo-
coccus aureus, the group of coagulase-negative staphylococci, Ente-
rococcus faecalis and Enterococcus faecium, as well as Streptococcus
pneumoniae and other streptococci, represent emerging pathogens in
the community, but especially in the setting of immunocompromised,
hospitalised patients.
Methods-Results: In these last conditions of elevated risk, multiresistant
Gram-positive infections occur in particular when surgery, invasive pro-
cedures, or prosthetic implants are of concern, patients are admitted in in-
tensive care units, or underlying chronic disorders and immunodeﬁciency
are of concern, and broad-spectrum antibiotics are widely used in the
environment. The spectrum of antimicrobial compounds now available
for an effective management and treatment of these relevant infections
is signiﬁcantly threatened by the emerging and spread of methicillin-
resistant and more recently glycopeptide-resistant microbial strains. The
streptogramine association represented by quinupristin/dalfopristin, the
oxazolidinone derivative linezolid, and the recently licensed lipopetide
daptomycin and the glycylcycline tigecycline, together with a number
of novel glycopeptides (including the once-weekly dalbavancin), novel
ﬂuoroquinolones, novel cephalosporins with a spectrum including
also methicillin-resistant staphylococci, and a number of experimental
compounds on the pipeline, represent an effective response to the
majority of these problems, due to their innovative mechanisms of
action, their maintained or enhanced activity against multiresistant
pathogens, their effective pharmacokinetic/pharmacodynamic properties,
their frequent possibility of synergistic activity with other compounds
effective against Gram-positive pathogens, and a diffuse potential for a
safe and easy administration, also in the setting of compromised patients.
Conclusion: The most relevant microbiological, pharmacological, and
therapeutic issues related to the epidemiology of multiresistant Gram-
positive infection, the potential clinical indications of all recently
available compounds compared with the standard of care of treatment of
resistant Gram-positive infections, and an updated overwiew of data on
efﬁcacy and tolerability of all these compounds and those on advanced
investigation, are updated and outlined on the ground of an extensive
review of all available, recent evidences coming from clinical trials
ﬁgures and the international literature.
R2135 A mini-cluster of chronic bone-joint-prosthetic-soft tissue
infection due to multiresistant Acinetobacter baumannii
strains in orthopaedics setting. Effective treatment with
tigecycline plus colistin
R. Manfredi ° (Bologna, IT)
Introduction: Acinetobacter spp is an environmental organism char-
acterised by a proportionally low intrinsic virulence, but a concurrent,
broad-spectrum and high-level resistance to the majority of available
antimicrobials.
Methods and Results: Six unrelated cases of A. baumannii infection
interesting bone, joint, prosthetic devices, and close soft tissue occurred
during Oct 2007-Jun 2008, at a specialised Orthopedics Hospital of
Bologna, Italy. In all cases a concurrent, local polymicrobial infection
including Gram-positive organisms (Staphylococci-Enterococci), and
Gram-negative agents (Escherichia coli, Citrobacter freundii, Enter-
obacter cloacae, Pseudomonas aeruginosa, and Proteus mirabilis),
was diagnosed during the long-term admission (32–112 days). While
concurrent microorganisms were controlled by appropriate chemotherapy
and the implant of antibiotic-impregnated cement, A. baumannii
showed complete resistance to an enlarged panel of antiinfective
compounds, save colistin and tigecyclin (the only agents with MIC
values <0.5mg/mL). As a consequence, both these compounds were
administered at full dosage and by i.v. route, in association with
carbapenems, rifampicin, amikacin, and cotrimoxazole, to exploit the
potential synergistic activity against A. baumannii demonstrated by
in vitro studies. In the meantime, an active, systematic surveillance
program interested the entire Hospital (with special focus on surgery
rooms, intensive care units, and diagnostic-therapeutic devices), but no
apparent foci of environmental colonisation were found. The micro-
cluster of 6 cases of multiresistant A. baumannii infection was cured
after 16−61 days of combined colistin-tigecycline therapy, and neither
relapses nor novel episodes occurred in subsequent 4 months.
Conclusions: Both the oldest and the newest compounds play a crucial
role in the treatment of multiresistant infections caused by challenging
pathogens like A. baumannii. A 60-year-old drug like colistin, with
a new molecule like tigecycline, perfectly traced the target organism,
and successfully resolved long-lasting infections burneded by multiple
morbidity, forced patients’ inability, and extremely prolonged admission
times. The selection of eventual, synergistic agents may be conducted
empirically, or better with the aid of enlarged in vitro susceptibility
assays. A strict co-operation among specialistic surgeons, Infectious
Diseases consultants, Microbiologists, and Pharmacists, is warranted to
contain the impact of these increasing environmental infections.
R2136 Antimicrobial activities of bacteriocins E50−52 and B602
against MRSA and other nosocomial infections
E.A. Svetoch, B.V. Eruslanov, Y.N. Kovalev, E.V. Mitsevich,
I.P. Mitsevich, V.P. Levchuk, N.K. Fursova, V.V. Perelygin,
Y.G. Stepanshin, B.S. Seal, N.J. Stern ° (Obolensk, RU; Athens, US)
Our objective was to determine the antimicrobial activities of previously
published bacteriocins E50−52 and B602 against methicillin resistant
Staphylococcus aureus (MRSA) and other prominent nosocomial
bacterial infections.
Methods: Several Russian hospitals were enlisted into the study from
2003 to 2007 and the hospitals supplied isolates of Acinetobacter
spp. (n = 11), Citrobacter freundii (n = 8), Escherichia coli (n = 9),
Klebsiella pneumoniae (n = 10), Proteus spp. (n = 6), Pseudomonas
aeruginosa (n = 10), and Staphylococcus aureus (n = 10). Susceptibilities
were determined by Kirby-Bauer disc-diffusion assays using 12
antibiotics belonging to different functional groups. Minimal inhibitory
concentrations (MICs) were determined for 19 antibacterials. Extended
spectrum b-lactamase (ESBL) genes were detected using a standardised
polymerase chain reaction (PCR) method.
Results: The amino acid sequences, molecular weights and the
isoelectric points of both bacteriocins E50−52 and B602 were determined
as being consistent with class IIa characteristics, containing 39 and 29
amino acid residues, molecular weights of 3,932 and 3,864Da, and pI
values of 8.5 and 7.2, respectively. ESBL genes were detected in 27 of
the 32 C. freundii, E. coli, K. pneumoniae, Proteus mirabilis isolates and,
were not detected in the Acinetobacter spp., Ps. aeruginosa or S. aureus
isolates. The antibiotic proﬁles of the 64 diverse isolates manifested
substantial resistance, as associated with the poor clinical outcomes of
the infected individuals. The MIC values of the same isolates ranged
from <0.025 to 1.56mg/ml for bacteriocin B602 and 0.05 to 6.25mg/ml
for bacteriocin E50−52.
In conclusion, for the 64 diverse clinical isolates tested, antibiotic
resistance was unfortunately high while the susceptibility to the
bacteriocins tested was remarkably good. The potentials for application
of bacteriocins in clinical settings as therapeutic agents appear quite
promising.
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R2137 In vitro activities of tigecycline and other 22 antimicrobial
agents against Streptococcus pneumoniae strains isolated in
a tertiary care hospital
S. Maraki °, A. Georgiladakis, E. Nioti, G. Samonis (Heraklion, GR)
Objective: Tigecycline is a glycylcycline with promising broad-spectrum
activity, including resistant Gram-positive organisms. We compared
the in vitro activities of tigecycline to those of other antimicrobial
agents against 105 non-duplicate isolates of Streptococcus pneumoniae
recovered from patients treated in the University Hospital of Heraklion,
Crete, Greece in a 27-month period.
Methods: Pneumococci were identiﬁed using standard techniques,
including Gram stain characteristics, colonial morphology, optochin
susceptibility and bile solubility.
MICs of penicillin, cefuroxime, cefotaxime, ceftriaxone, cefepime,
imipenem, meropenem, erythromycin, clarithromycin, azithromycin,
roxithromycin, ciproﬂoxacin, levoﬂoxacin, moxiﬂoxacin, sparﬂoxacin,
tetracycline, chloramphenicol, cotrimoxazole, vancomycin, linezolid,
quinupristin-dalfopristin, vancomycin and tigecycline were determined
by using the E-test method (AB Biodisk, Solna, Sweden). Streptococcus
pneumoniae ATCC 6305 and ATCC 49619 were used as control strains.
Results: Among these isolates, 41.9% were penicillin nonsusceptible,
with 21.9% being penicillin-intermediate (PISP) and 20% being
penicillin-resistant (PRSP). Resistant rates (intermediate and resistant)
among non-b-lactam agents were as follows: macrolides, 30.5%;
clindamycin, 10.5%; tetracycline, 29.5%; chloramphenicol, 0.9%;
and trimethoprim-sulfamethoxazole, 23.8%. Resistance to multiple
antimicrobial agents was observed among 27 (61.4%) PRSP and PISP
strains. No resistance to vancomycin, linezolid, quinupristine/dalfopristin
and tigecycline was observed. MIC50 and MIC90 values of tigecycline
were found to be 0.032 and 0.047mg/l respectively, with a range of
0.016–0.125mg/l.
Conclusion: Tigecycline demonstrated excellent in vitro activity against
both penicillin-sensitive and penicillin-resistant strains. It might thus
represent an alternative treatment for infections caused by multiresistant
Streptococcus pneumoniae.
R2138 Novel antifungal phenolic compound from Parrotia persica
M. Ahanjan °, M. Ragavendera, K. Raveesha (Sari, IR; Mysore, IN)
Aqueous and methanol extracts of Parrotia persica leaves were assayed
for antifungal activity against phytopathogenic Fusarium oxysporum
and human pathogenic Candida albicans by poisoned food technique.
Both the aqueous and methanol extracts demonstrated signiﬁcant
Figure: Structure of the active principle [6-ethoxymethyl)-tetrahydro-2H-
pyran-2,3,4,5-.
antifungal activity. Further fractionation of methanol extract guided by
antifungal activity resulted in the isolation of an active principle which
was identiﬁed as phenolic compound by phytochemical analysis. The
structure of the active principle was elucidated by Mass spectroscopy,
1H NMR and 13C NMR spectroscopy. These results revealed that the
compound is 6-(ethoxymethyl)-tetrahydro-2H-pyran-2, 3, 4, 5-tetraol
compound with 1-isopropyl-4-methoxybenzene. The compound was
found responsible for antifungal activity against both F. oxysporum and
Candida albicans.
Epidemiology of MRSA, VRE and other
Gram-positives
R2139 Prevalence, antimicrobial resistance and clonal features
of drug-resistant Enterococcus faecalis and E. faecium
colonising high-risk patients in a Portuguese hospital
R. Mato °, R. Portela, A.T. Fernandes, T. Ferreira (Oeiras, Lisbon, PT)
Objectives: To establish the prevalence, antimicrobial resistance and
clonal features of Enterococcus faecalis − Eﬂ − and E. faecium − Efm −
resistant to gentamicin-120 (CN120) and glycopeptides (GR) colonising
high-risk patients in a Portuguese hospital during a four months period
(2006–07).
Methods: The VITEK2 system was used for microbial identiﬁcation
and antimicrobial susceptibility testing. The vanA/B and aac(6′)-aph(2′′)
genes were detected by PCR in all GR and CN120 Eﬂ and Efm. The asaI,
cylA, gelE, hyl and esp virulence genes were screened by Multiplex-
PCR. SmaI-PFGE was used for clonal assessment. GR isolates were
tested by multilocus sequence typing (MLST).
Results: A total of 108 haematological malignancy patients were
screened weekly, generating 275 rectal swabs and 212 enterococci mainly
Eﬂ (53.8%), and Efm (35.8%). Close to 50% (39/76) of Efm and 32%
(36/114) of the Eﬂ were multiresistant: (i) Efm resistant to CN120,
ampicillin-Amp, erythromycin-E, clindamycin-Da, ciproﬂoxacin-Cip, 6
of 39 were also resistant to GR with vanA genotype. (ii) Eﬂ resistant to
CN120-E-Da-tetracycline-quinupristine/dalfopristin and 21 of 36 were
resistant to Cip. Two out of 7 Eﬂ PFGE patterns were dominant: PFGE
AO (19/36 isolates) and PFGE A (11/36 isolates). Most of the Eﬂ
PFGE AO (84%, 17/19) carry asaI-cylA-gelE-esp genes, and 88% were
gelatinase producers, while 73% (8/11) of the isolates belonging to
PFGE A had the asaI-cylA-esp proﬁle. The majority of the Efm isolates
(92%, 36/39) belonged to the dominant PFGE c. The esp gene alone
or with hyl gene were detected among 58% (21/36) and 25% (9/36)
respectively of the Efm isolates included PFGE c. All but one Efm-GR
belong to the genetic lineage ST17. ST280 was associated to a single Efm
isolate of PFGE x, that lacks the virulence genes tested. The two Eﬂ and
Efm dominant clones (PFGE AO and PFGE c, respectively) colonising
the patients were also detected among enterococci resistant to CN-120
and/or GR recovered from clinical samples of this same hospital where
became epidemic during 2004–2006.
Conclusions: These data provide further insights on the dynamics of
colonisation by multidrug-resistant enterococci in a particular population
of haematological malignancy patients, who may be used to monitor
enterococcal carriage of epidemic and persistent clones useful for
infection control measures.
R2140 Prevalence of methicillin-resistant Staphylococcus aureus
among students of the Faculty of Veterinary Medicine in
Bari, Italy
M. Corrente °, M. D’Abramo, F. Latronico, M.F. Greco, V. Martella,
D. Buonavoglia (Bari, IT)
Objectives: Recent epidemiological studies have demonstrated that
veterinary students and veterinarians may have higher risks of exposure
to Methicillin resistant Staphylococcus aureus (MRSA) than the general
population. The aim of the study was to analyze the prevalence of MRSA
among students of a Faculty of Veterinary Medicine (Bari, Italy).
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Methods: From November 2007 to January 2008, 200 students of the
Faculty of Veterinary Medicine were randomly selected from the 2nd,
3rd, 4th and 5th year. The students were asked to provide a nasal
swab and to ﬁll a questionnaire inherent the contact with animals
(vet-care associated factors) and exposure to well-known MRSA risk
factors (health-care associated factors). The samples were subjected to
bacteriological analysis and PCR for the mec A gene. The data collected
with the questionnaire were evaluated by statistical analysis (chi square
test for the dichotomous variables and univariate analysis for the risk
factors).
Results: The response rate to the study was 84% (168 out of 200
samples). Twenty-two out of 168 students (13.1%) were found to be
MRSA carriers. Nine out of 22 MRSA carriers had either relatives
working in health-care facilities or subjected recently to hospitalisation.
Fifteen out of 22 carriers attended the 4th and 5th years of the course.
Statistical analysis of the risk factors showed that the ratio of MRSA
carriers increased with having one or more healthcare-workers in the
family (Odds ratio, OR 5.8, 95% Conﬁdence Interval, CI 1.7−20.4) and
with being admitted to the 4th and 5th years of the course (OR 3.9,
95%CI 1.5−10.1), when the students are expected to make practice with
animals.
Conclusion: The high prevalence of MRSA carriers among students
of the Veterinary Faculty of Bari may be linked both to health-care
and vet-care associated factors (chieﬂy making practices with animals).
Molecular characterisation of the MRSA isolates will help elucidate
more accurately the origin and relationships of the strains.
R2141 Spread of epidemic vancomycin-resistant Enterococcus fae-
cium clonal complex 17 in haematological patients in Russia
A. Brilliantova °, G. Kliasova, A. Mironova, G. Novichkova,
V. Bobrynina (Moscow, RU)
Objectives: In this study we investigate molecular background of
selected epidemic vancomycin-resistant (VR) E. faecium isolated from
haematological patients in Russia by Multilocus Sequence Typing
(MLST).
Methods: Genetic relatedness of VR E. faecium collected during 2004–
2007 was examined by Pulsed-ﬁeld Gel Electrophoresis (PFGE) using
SmaI. Predominant epidemic clones A (A1-A30) and F (F1-F8) were
determined. Further MLST analysis was performed on a subset of 16
isolates representing subclones that have spread most widely (A1, A3,
A8, A10, A16, A26, F1, F3). Detection of virulence genes esp, gelE,
cylA, hyl, and agg was performed by PCR.
Results: MLST analysis revealed that all isolates belonged to the
clonal complex 17 (CC17) of hospital adapted, epidemic strains. Strains
grouped into three sequence types (STs): ST202 (n = 11), ST18 (n = 3)
and its single locus variant ST262 (n = 2). ST202 was ﬁrst detected
in 2004. It persisted during 2005–2006 together with ST18. In 2006,
ST262 appeared probably arising from ST18. Relatedness of ST18 and
ST262 is conﬁrmed by the same virulence patterns: strains harboured
two genes esp and hyl simultaneously. All of ST202 isolates also had a
ﬁxed virulence proﬁle. These strains possessed epidemicity marker esp
and a potential virulence gene gelE, which is rarely found in E. faecium.
Conclusion: MLST of VR E. faecium from haematological patients
in Russia revealed the spread of CC17, associated with nosocomial
infections worldwide. Our results demonstrate presence of virulence gene
esp, a marker for epidemicity in different clonal types and its persistence
in time.
R2142 Endocarditis due to vancomycin-resistant enterococci
(E. gallinarum): a case report
G. Ersoz °, M. Uguz, B.N. Aytacoglu, A. Kaya (Mersin, TR)
The ﬁrst described vancomycin resistant enterecocci (VRE) was about
twenty years ago. Recently many clinics reported VRE. However
endocarditis due to VRE is still a rare entity and there are only a few
cases reported in the literature.
Case: We report a 59 year-old male patient with chronic renal failure
who was on haemodialysis. He presented with a sudden onset of fever,
tachycardia and respiratory distress. Echocardiography was performed
and vegetation on the mitral valve was found. As he was diagnosed
to have endocarditis the patient was put on ampicilin and gentamicin
therapy. He underwent an emergent mitral and aortic valve surgery due
to heart failure. While he was still on ampicilin and gentamicin therapy,
E. gallinarum that was resistant to vancomycin (MIC> 32mg/L) was
isolated from the surgical valve specimens and hence his antibiotic
regime was switched to teicoplanin (MIC=0.5mg/L). 28 days after
teicoplanin therapy the patient was discharged with free of symptoms
and any complication.
Conclusion: Endocarditis due to vancomycin resistant enterococci is an
uncommon clinical situation. In review of the literature the commonly
encountered causative agent for endocarditis was found to be E. faecium
especially in patients with comorbid conditions. This patient had no
prior known valvular disease therefore having no cardiac predisposition
but presented with endocarditis caused by E. gallinarum. This patient is
presented as an example for a sudden onset endocarditis with an unusual
type of enterococci.
R2143 Increased rate of methicillin resistance among
Staphylococcus aureus isolates at a major general hospital
located in northern Italy
R. Manfredi °, A. Nanetti (Bologna, IT)
Introduction: The increased rate of methicillin resistance among
Gram-positive cocci is a general concern, especially in the hospital
setting. A prospective microbiological monitoring including a continued
surveillance of antimicrobial susceptibility rates, is ongoing at our
General Hospital, located in Bologna, Italy.
Materials and Methods: The temporal variations of in vitro
antimicrobial sensitivity ﬁgures were examined quarterly for all suitable
Staphylococcus aureus, during the year 2007. The same pathogen
cultured more than once from the same patient within one month, has
been considered one time only.
Results: Among Staphylococcus aureus isolates (357 strains tested on
the whole), both available glycopeptides (vancomycin and teicoplanin),
maintained a full 100% sensitivity proﬁle over time, while the rate of
methicillin resistance showed a signiﬁcant growth from January-March
2007 (40.7% of tested strains), to April-June 2007 (47.5%), to July-
September (42.2%), up to October-December 2007 (56.0% of tested
strains) (p< 0.01). When considering antibiotics other than b-lactam
ones, cotrimoxazole maintained a consistently elevated activity over time
(92.3% to 100% of microbial strains tested during the study period),
followed by choramphenicol (82.7% to 87.8% of tested strains), and
rifampin (67.6% to 73.5% of tested strains), while clindamycin showed
a worse sensitivity proﬁle (48.1% to 57.9% of tested strains), as well as
erythromycin (48.8% to 57.9% of tested strains), and gentamicin (40.4%
to 52.5% of tested strains). Among antimicrobial compounds other than
b-lactam derivatives, no signiﬁcant rates of antibiotic susceptibility rates
were observed during the study period, against Staphylococcus aureus
isolates.
Conclusions: A prospective bacteriological surveillance of antimicrobial
susceptibility rates of a major hospital-associated microorganism like
Staphylococcus aureus is relevant, to establish reliable guidelines of
antibiotic treatment and prophylaxis, on both local and regional basis.
Despite a signiﬁcant increase of methicillin resistance rates, “older”
compounds like cotrimoxazole, chloramphenicol, and rifampin, may still
play a role in selected clinical instances, while the activity of vancomycin
and teicoplanin remains fully preserved until now.
S632 19th ECCMID, Abstracts accepted for publication only
R2144 Microbiological features of Enterococcus faecalis and
Enterococcus faecium assessed according to a hospital-based
prospective surveillance programme: in vitro antimicrobial
susceptibility proﬁle, and temporal trend
R. Manfredi °, A. Nanetti (Bologna, IT)
Introduction: The increased temporal rate of antimicrobial resistance
among Gram-positive cocci (including Enterococci) is a major concern,
especially in hospital-based settings.
Materials and Methods: The temporal trend of the in vitro antibiotic
susceptibility rates was investigated for all Enterococcus faecalis and
Enterococcus faecium strains, isolated at our tertiary-care Hospital
during the year 2007. The same pathogen isolated more than once from
the same patient within one month, has been considered once.
Results: Among Enterococcus faecalis isolates (705 strains tested
on the whole), the greater activity rate was achieved by linezolid
(100% of tested strains), followed by nitrofurantoin (97.4–100% of
strains), teicoplanin (94.8–100%), vancomycin (87.5–100%), ampicillin
(89−92.4%), penicillin (87.9–91.0%), while appreciable, but irregular
variations of sensitivity occurred over time for gentamicin, streptomycin,
and tetracyclines. With regard to Enterococcus faecium strains (175
strains), both linezolid and teicoplanin maintained a 100% in vitro
activity, followed by vancomycin (86.4–100% of strains), streptomycin
(62.5–100%), gentamicin (52.9–63.6%), and tetracyclines (51.8–49.6%),
while negligible efﬁcacy was shown by ampicillin (7.5–18.5% of tested
strains) and penicillin (7.5–18.5%). Eighteen strains of vancomycin-
resistant Enterococcus faecalis strains were detected (12 concentrated
in the July-September period), while vancomycin-resistant Enterococcus
faecium strains were six through the entire observation year. No
signiﬁcant temporal modiﬁcations of antimicrobial sensitivity rates
were observed, as well as no signiﬁcant change in the emergence of
vancomycin-resistant strains.
Conclusions: A prospective surveillance monitoring of in vitro
antimicrobial susceptibility rates of some relevant hospital-associated
organisms like Enterococci represents an useful tool to address antibiotic
treatment and prophylaxis, on local and regional basis. The emerging of
resistance to the reference compounds like glycopeptides may be also
well targeted on these basis, in order to preserve the clinical use of the
majority of molecules which still guarantee effective activity of these
difﬁcult-to-treat Gram-positive cocci.
Antibiotic usage
R2145 Impact of an antimicrobial stewardship programme on
antimicrobial consumption and cost in an Italian hospital
L. Pagani °, M. Falciani, R. Aschbacher, G. Spoladore, C. Larcher,
P. Mian (Bolzano, IT)
Objective: To evaluate the impact of an Antimicrobial Stewardship
Program (ASP) on consumption and cost of antimicrobials.
Methods: from January 2008, an ASP has been carried out in
our 1400-bed referral hospital in the North-Eastern Italy by ID
consultants, pharmacists and microbiologists, who constitute the
Antimicrobial Management Team (AMT). Antimicrobial formulary
restrictions (mainly concerning broad spectrum- and last generation-
antibiotics), microbiologically-driven empirical and targeted therapies,
and regular educational meetings were the most important interventions
implemented. We initially analyzed two surgical and three medical wards
(vascular/thoracic surgery, urology, 2 internal medicine divisions and
pneumology). Deﬁned daily doses (DDD)/100 bed-days consumption
pooled data were analyzed through the ESGAP ABC Calc 3.1b program
for the year 2008. These data were then compared to the same data of
2007, in which the ASP had not yet been implemented.
Results: a remarkable decrease of restricted antimicrobials consumption
has been observed between the two years, whereas a comparable trend
was not detected for freely available drugs. Moreover, drug acquisition
costs strongly decreased. The main results are summarised in the
table, where “*” indicates some of the restricted antimicrobials at our
institution.
Conclusions: although preliminary and concerning a limited number
of wards of our hospital, these data strongly support the need for a
multidisciplinary approach to antimicrobial therapy at institutional level
to decrease antimicrobial pressure and to control expenditures. Through
the regular activity of the AMT, this integrated approach may also
affect the appropriateness of antimicrobial prescription within the whole
hospital.
Antibacterial DDD EUR
2007 2008 2007 2008 2007/2008
Cefuroxime 3,092.3 3,125.0 17,228.73 17,048.64 −180.09
Cefotaxime 3,026.0 2,482.0 14,777.69 7,374.42 −7,403.27
Ceftazidime* 354.8 163.8 6,319.77 2,819.37 −3,500.40
Cefepime* 105.0 8.0 919.25 69.99 −849.26
Meropenem* 410.0 126.8 17,343.49 5,422.43 −11,921.06
Imipenem/enzyme inhibitor 375.8 202.8 16,307.81 8,652.44 −7,655.37
Ciproﬂoxacin 1,655.2 1,702.8 55,725.92 44,533.39 −11,192.53
Levoﬂoxacin 2,758.0 3,479.0 72,583.33 91,820.62 +19,237.29
Vancomycin* 341.3 199.3 2,592.07 1,402.68 −1,189.39
Teicoplanin* 501.0 195.5 18,070.01 7,079.17 −10,990.84
Total 221,868.07 186,223.15 −35,644.92
R2146 Effectiveness of an antimicrobial stewardship program
on broad-spectrum antimicrobials in a Hong Kong
tertiary-care hospital
M. Ip °, T. Marasinghe, J.H.S. You, N. Lee, J. Wong, M. Hui,
C. Cockram, B. Lee, R. Lai (Hong Kong, HK)
Objectives: A multidisciplinary Antimicrobial Stewardship Program
(ASP) with an interventional management team (AMT) was imple-
mented in a 1350-bed teaching hospital in Hong Kong in 2006. Its impact
on the appropriateness of prescription, consumption, resistance and
clinical outcomes in patients of the medical department was examined.
Methods: 635 patients, prescribed one of eight targeted agents,
vancomycin, teicoplanin, carbapenems, linezolid, cefepime, ceftazidime,
cefoperazone/sulbactam and piperacillin/tazobactam during February to
August 2006, were reviewed prospectively. 605 cases prescribed these
agents during March-May 2005 at pre-intervention were reviewed.
Results: Antibiotic prescription of these targeted agents was reduced
from 83 to 63 prescriptions/1000 admissions after ASP implementation.
Inappropriate use/recommendations were made in 19% of cases. An
increase in appropriate prescriptions was obtained during the intervention
period (O.R. 3.15; 95% C.I. 2.07–4.79, p 0.001). The length of hospital
stay in the two groups was not different but a reduction of 3.6% in all
cause mortality was observed in the intervention group. The consumption
of targeted antimicrobials in deﬁned daily doses (DDD)/1000 bed days
occupied (BDO) was reduced by 4.5% overall in 2006. There was
a signiﬁcant reduction in the resistance rates of Escherichia coli to
amoxicillin/clavulanate, 35.28 vs 30.84; p = 0.02 for all specimens, 47.8
vs 29.56; p = 0.006 for blood culture specimens, but no signiﬁcant change
in rates of MRSA or ESBL Gram negative bacteria was observed.
Conclusion: The implementation of ASP in the hospital resulted in
more rational use of antimicrobials, an overall reduced consumption of
antibiotics and improved clinical outcomes.
R2147 Optimisation of systemic antimicrobials usage in
multi-proﬁle hospitals in Russian Federation
S. Ratchina °, R. Kozlov, B. Makushkin, A. Fokin, A. Dekhnich,
R. Pavlukov, V. Mischenko (Smolensk, RU)
Objectives: Insufﬁcient data on systemic antimicrobials (AM) consump-
tion in Russian Federation (RF) appears to be the main barrier for
assessing and optimising AM use in inpatient settings. Hence we aimed
our study to develop an on-line program of systemic AM use monitoring
for hospital wards with intensive AM usage in different regions of RF.
Methods: On-line database development used products and technologies
consisted of operation system (Microsoft Windows Server 2003),
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web framework (ASP.NET 2.0), database (Microsoft SQL Server
2005), development IDE (Microsoft Visual Studio 2008). ATC/DDD
methodology was used as a basis for data presentation and calculation
of AM consumption.
Results: The database consisted of two parts. The ﬁrst part contained
information about AM package numbers and costs based on charges
invoices from hospital pharmacy could be collected on a quarterly basis
at the department level. The AM consumption is expressed as number of
DDD per 100 bed-days. Distribution of AM use according to patients’
proﬁle (ﬁrst, second choice, etc.) on physician judgment could also be
performed. This part of the program allows getting an instantaneous
report on AM consumption and ABC-analysis of AM expenditure
immediately after data entry. The second part of the database is designed
to collect information on any AM prescription with data binding to
the patient’s characteristics. The data about demographic characteristics
of patients (gender, age), diagnosis (main diagnosis, complications,
concomitant diseases), AM trade and generic names, dosing regimen,
route of administration, duration of treatment, reason for AM use
(prophylaxis or therapy with speciﬁcation of diagnosis/procedure) and
AM discontinuation/modiﬁcation, any adverse reactions, length of
hospital stay and treatment outcome could be gathered and analyzed.
Conclusion: On-line registration will facilitate data processing and
afford an opportunity to make a decision on AM administration practice
and/or AM purchases modiﬁcation in time. Detailed analysis of AM
use will allow establishing a correspondence between practice and
existent standards and developing speciﬁc programs aimed at AM use
optimisation and reduction of unreasonable expenses.
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R2148 A molecular diagnostic approach for MRSA hospital
outbreaks providing all necessary data of patients and
contacts within the ﬁrst 24 hours
R.H.T. Nijhuis °, N. van Xanten, G. van der Winden, T. van Zwet (Velp,
NL)
During MRSA hospital outbreaks a rapid and accurate detection of
patients infected or colonised with the outbreaking strain is crucial.
However, the standard culture method for detecting MRSA is time-
consuming, taking several days. Therefore, recently, several MRSA PCR
detection methods are being developed to accelerate the MRSA tracing.
We designed a procedure combining two MRSA PCR detection
methods, to manage all MRSA outbreaks within 24 hours, using the
in house MecA/Martineau PCR developed by Van Hannen, Anthonious
Ziekenhuis, Nieuwegein and the commercially available IDI MRSA PCR
(based on the Huletsky primers).
After an overnight culture incubation step the MecA/Martineau PCR is
used as a ﬁrst step. Positive results are conﬁrmed in the more speciﬁc
Huletsky PCR.
Since the introduction of our “24 hours all-in” procedure we were able
to manage several MRSA outbreaks in three different hospitals. A total
of 396 out of 4086 clinical samples (9.7%) appeared to be positive in
the MecA/Martineau screening PCR and thus needed further processing
with the IDI MRSA PCR.
Of these samples 28.8% (114/396) were also positive in this Huletsky
PCR. In these remaining 114 samples MRSA could be cultured in 89.
In conclusion, this approach combines the advantage of a high
throughput, which is essential in outbreak situations, with a superior
sensitivity and speciﬁcity through the combination of PCR’s targeting
different parts of the genome and is therefore able to give an exact
overview of the spread of MRSA within 24 hours after receiving the
samples.
R2149 Study of vac A genotypes of H. pylori isolated from patients
with upper gastrointestinal diseases by PCR
S.A. Havaei °, R. Salehi, P. Mohajeri, H. Tavakoli, S.A. Fazeli (Isfahan,
IR)
Background and Objectives: Helicobacter pylori is a Gram-negative
curved bacilli which is colonised in the human stomach. It causes
duodental ulcer, gastritis and is associated with adenocarinoma. There
might be a possible relationship between cagA, vacA and ice a genes and
clinical outcomes. The aim of this study was to identify the frequency
od vacA genotypes of H. pylori isolated from the upper gastrointestinal.
Materials and Methods: 100 H. pylori strains were isolated from
patients with different gastrointestinal disease in Azahra hospital. Vac A
alleles were typed using PCR with speciﬁc primers.
Results: There were four Vac A mosaicsms, including 28 for s1a/m1
(28%), 23 for s1b/m1 (23%), 26 for s1a/m2 (26%) and 23 for s1b/m2
(23%), s2 form was not found.
Conclusion: The results showed there is no signiﬁcant relationship
between different genotypes of vacA and the related diseases.
R2150 Comparison of 16S rRNA, 23S rRNA and gyrB genes
sequences in phylogenetic relationships of Shigella isolates
from Iran
Z. Nochi °, N. Sahebekhtiari, B. Noorinayer, H. Dabiri, P. Kharaziha,
M. Chiani, M.R. Zali (Tehran, IR)
Objectives: Shigella is one of the most important agents of acute
diarrhoea and gastrointestinal disorders worldwide that cause bacillary
dysentery which remains a signiﬁcant threat to public health with high
rate of death. Since differentiation of Shigella isolates from each other
is difﬁcult, some reports indicate that application of 16S/23S rRNA and
gyrB genes sequences is a useful method for this purpose. Based on
our knowledge it is the ﬁrst report to differentiate Shigella species in
Iran by these genes. The homology rate of Iranian Shigella strains was
compared with each other in this study.
Methods: Twenty Shigella isolates from diarrhoeal patients were studied.
They were cultured on XLD and MacConkey agar. Biochemical and
serotyping tests were done to distinguish Shigella strains. DNA was
extracted by phenol-chloroform method. Complete gene of 16S rRNA
(1542 bp), 23S rRNA (2904 bp) and partial gene of gyrB (1256 bp) were
ampliﬁed by PCR, and then were sequenced by ABI3130X1. We used
CLUSTAL W software to align nucleotide sequences. A neighbour-
joining analysis was performed to reconstruct phylogenetic tree with
the MEGA 3.1 software.
Results: The homology rate based on both 16S rRNA and gyrB gene
sequences between each 5 isolates of Shigella sonnei and Shigella boydii
were 100% and 99.9% respectively. Based upon gyrB gene sequence,
each 5 isolates of Shigella ﬂexneri and Shigella dysenteriae showed
99.6% and 99.5% similarity, whereas they showed 99.8% and 99.9%
similarity by 16S rRNA gene sequence. The phylogenetic tree based
on 23S rRNA indicates that the homology between each specimens of
S. ﬂexneri, S. boydii, S. dysenteriae and S. sonnei were respectively
99.4%, 99.7% 99.3% and 100%.
Conclusion: Phylogenetic-tree analysis is often used as a method to
classify organisms. Our data indicates that, although the 16S rRNA
sequence method is a highly accurate and rapid method for identifying
most bacteria to the genus level, the gyrB sequence method might be
more useful for identifying bacteria to the species level. In particular,
23S rRNA analysis of bacteria is an effective means to classify closely
related species. Our data were in accordance with the previous studies
reported from other countries, indicating close relationship among
Shigella species isolated from Iran.
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R2151 Genetic heterogeneity of emm12 genotype Streptococcus
pyogenes strains isolated in St. Petersburg, Russia
E. Polyakova °, E. Mnatsakanyan, L. Burova, A. Totolian, A. Dmitriev
(St. Petersburg, RU)
Objectives: Streptococcus pyogenes or group A streptococci (GAS) is a
leading cause of human infections varied from mild pharyngotonsillitis
to severe invasive diseases. GAS being the polylysogenic bacterium can
contain from 2 to 6 different temperate bacteriophages that provides
genetic heterogeneity to this specie. It is supposed that the expression
of the certain toxins encoded by prophage genes correlates with virulent
properties of GAS strains. The aim of the present study was to
characterise the presence of phage-associated genes, including genes for
the toxins and integrases, in GAS strains of emm12 genotype isolated
in Saint-Petersburg.
Methods: The collection of 172 GAS strains isolated in Saint-Petersburg
(Russia) in 2006–2007 was used. The emm genotyping of 64 randomly
selected epidemiologically unrelated strains was done according to
recommendation of the Centre for Disease Control. Chromosomal DNA
of the strains was isolated by the phenol/chloroform extraction. The
presence of 19 phage-associated genes (Table 1) was analyzed by PCR.
Table 1. Distribution of the phage gene proﬁles among the 18
GAS strains of emm12 genotype
Phage gene Encoded protein emm subtype
emm12.0, no. of strains emm12.22
10 2 1 1 1 1 1 1 strain
speA Toxin A − − − − + − + −
speI Toxin I + + + − + + + +
speH Toxin H + + + − + + + +
speL Toxin L − − − − − − − −
sda Streptodornase − − − − − − − −
speCJ Toxin C variant J − − − + + − − −
ssa Superantigen − + − − − + + −
speC Toxin C + + + − + + + −
sla Phospholipase A2 − − − − − − + −
smeZ Toxin Z + + + + + + + +
int1 Integrase 1 − − − − − − + −
int2 Integrase 2 − − − − − − + −
int3 Integrase 3 + + − − + − + −
int4 Integrase 4 − + − − + + + −
int5 Integrase 5 + + + − + + + +
int6 Integrase 6 − − − − − − − −
int7 Integrase 7 − − + + + − + −
int8 Integrase 8 − − − − − − + −
int9 Integrase 9 − − − − − − − −
Symbols “+” and “−” indicate the presence or absence of the
corresponding phage gene in the genome of GAS strain.
Results: Among the 64 GAS strains under study, 18 strains belonged to
emm12 genotype. They were characterised by the emm12.0 (17 strains)
and emm12.22 (1 strain) subtypes. The toxin genes smeZ, speI, speH,
speC were predominant among the strains. They were revealed in 18,
17, 17 and 16 strains, respectively. The genes speL and sda were not
found, and the genes sla and speC/J were present in 1 and 2 strains,
respectively (Table 1). The integrase genes int5 and int3 were found
in 17 and 14 strains, respectively, while the genes int6 and int9 were
absent in the strains under study. Presence of the toxin speI and speH
genes correlated with the presence of int5 gene. Most of the strains
contain 2 or 3 integrase genes, that indicates the presence of 2 or 3
temperate bacteriophages in their genomes (Table 1). At the same time
a single strain contained seven integrase genes, and 2 strains contained
one integrase gene each. A total of 8 different proﬁles of the phage-
associated genes were revealed among the 18 GAS strains of emm12
genotype, including 7 proﬁles among the 17 strains of emm12.0 subtype
(Table 1).
Conclusion: The strains of emm12 genotype isolated in Saint-Petersburg
in 2006–2007 are characterised by signiﬁcant genetic heterogeneity.
Analysis of the prophage gene content is valuable approach for molecular
epidemiology of Streptococcus pyogenes infections.
R2152 Use of the GenXpert system for detection of S. aureus and
MRSA directly in clinical samples
M.C. Ploy, D. Chainier, F. Garnier °, S. Blot, J. Vignaud, C. Duchiron,
B. Franc¸ois, F. Denis (Limoges, FR)
Objectives: Early microbiological documentation is a key point for
adapted antibiotherapy in patients with a septic shock. This is difﬁcult
to achieve using conventional bacteriological methods, requiring at least
36−48 h to obtain ﬁnal results. Real-time PCR could provide an earlier
identiﬁcation of the pathogen with a better sensitivity. Methicillin-
sensible and methicillin-resistant Staphylococcus aureus (MSSA and
MRSA) are frequently involved in severe sepsis of nosocomial origin
community-acquired.
The Xpert® MRSA/SA Blood Culture kit (Cepheid, Instrumentation
Laboratory) used in conjunction with the GeneXpert real-time PCR
platform (Cepheid, Instrumentation Laboratory) has been developped
to allow the rapid detection in 50min of S. aureus and MRSA in
blood cultures. This assay does not require sample preparation time. The
present study evaluated this kit for use directly from clinical samples.
Method: We tested 27 clinical samples (13 respiratory samples, 4
discharge specimen, 1 eschar swab, 5 urines, 3 catheters, 1 serum) from
which S. aureus strains were isolated, 6 MRSA and 19 MSSA. We
performed the assay without any sample preparation and using 50ml of
each sample.
Results: We obtained a complete concordance for 20 samples out of
the 27. For 4 samples (3 respiratory samples and 1 cerebral abcess),
no data were obtained (error system). But a previous treatment of
these 3 respiratory samples which were very viscous with Digest-EUR®
(Eurobio) and a mechanical lysis with the Fast Prep® (MP Biomedicals)
for the cerebral abcess allowed us to obtained a result. Finally, we
obtained discordances for only 4 samples, 1 serum, 1 cutaneous abcess,
2 respiratory samples. For the serum and abcess, the result was negative
for S. aureus and MRSA detection. For the respiratory samples, MRSA
was detected although the strains isolated were susceptible to meticillin.
Conclusion: This preliminary study is very promising. The GeneXpert
Platform with the Xpert SA-MRSA kit could be a very useful tool for
the rapid detection not only of S. aureus but also of MRSA for critical
care patients with severe sepsis. Our results need to be conﬁrmed in a
more large study.
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R2153 Identiﬁcation of hepatitis B virus genotype in patients with
hepatocellular carcinoma in Iran
A. Aghakhani, R. Hamkar, M. Mohraz, N. Zamani, A. Eslamifar,
M. Banifazl, L. Adibi, A. Ramezani ° (Tehran, IR)
Objectives: Hepatitis B virus (HBV) is one of the major causative agents
of hepatocellular carcinoma (HCC) in Iran. The development of HCC
in patients with HBV infection has been associated with speciﬁc HBV
genotypes. The aim of this study was to identify the HBV genotypes in
patients with HCC in Iran.
Methods: This study was performed on parafﬁn-embedded tissue
samples of 40 patients (31 males and 9 females) with HBV-associated
HCC. HBV genotyping was performed by nested PCR-mediated
ampliﬁcation of the target sequence. PCR products were sequenced, and
the genotype of each HBV sequence was determined by comparison with
sequences of known genotypes in the GenBank and Phylogenetic tree
was constructed.
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Results: Phylogenetic analysis revealed that all of the HBV isolates were
clustered in the genotype D.
Conclusion: Our results concurred with other reports from Iran all
showing that genotype D is the only detectable genotype in different
clinical forms of HBV infections in this country.
R2154 New approach for diagnosis of Crimean-Congo
haemorrhagic fever in Bulgaria
N. Kalvatchev °, I. Christova (Soﬁa, BG)
Objectives: Crimean-Congo haemorrhagic fever (CCHF) is a tick-borne
acute viral disease with leading haemorrhagical syndrome and high
fatality rate. The Balkan Peninsula is an endemic region for this disease
and sporadic cases or even outbreaks are being observed every year. Di-
agnosis of CCHF is important for the treatment, outcome of infection and
prevention of its further dissemination. The aim of this study is to present
results from modiﬁcation and adaptation of the conventional RT-PCR,
nested RT-PCR and Real time RT-PCR system for fast and speciﬁc detec-
tion of Crimean-Congo Haemorrhagic Fiver Virus (CCHFV) in Bulgaria.
Materials and Methods: Blood samples from patients, suspective for
CCHF were drawn, transported and kept frozen in the Vector-borne
Infections laboratory at the National Center of Infectious and Parasitic
Diseases in Soﬁa. Also, suspensions with cultivated CCHF virus in
mice brains were stored frozen at −70ºC until the examination or were
directly used for RNA extraction procedure protocol. Different pairs of
oligonucleotide primers, binding to the viral sequence in the region of
the small (S) segment of the CCHFV genome were applied.
Results: A single DNA band corresponding to the well known 536 bp
PCR product was detected by RT-PCR. Two hundred sixty bp amplicon
size was found after the second round of the Nested RT-PCR with
different pairs of praimers. A system for faster detection of CCHFV
by one step Real time RT-PCR was applied. Positive control reaction
was made from the nucleic acid extracted from infected mice brains.
Melting curve analysis was used to demonstrate difference between the
speciﬁc ampliﬁcation products and non-speciﬁc ones.
Conclusion: We introduced various systems of molecular techniques for
rapid detection of CCHFV for ﬁrst time in our country. The combined
use of conventional RT-PCR, nested RT-PCR, Real time RT-PCR and
serology, will allow differential diagnosis of suspecive patients with viral
haemorrhagic fever in the endemic region.
R2155 The prenatal diagnosis for Cytomegalovirus in pregnant
women
G. Evcil, S. Kirdar, A.R. Odabasi, N. Aydin ° (Aydin, TR)
Objective: In this study, we aimed to determine the ratio of CMV
seroconversion and the presence of CMV DNA in amniotic ﬂuids from
pregnant women in the Aydın region of Turkey.
Methods: During the period between March 2006 to December 2008,
CMV-speciﬁc IgG and IgM were determined by EIA in 100 pregnant
women who were performed amniocentesis at 17 to 21 weeks of
gestation. Avidity index was studied by EIA. The pregnant women were
classiﬁed as seropositive or not according to the presence of CMV-IgM
and CMV-IgG and a primary or a recurrent CMV infection according
to avidity index of anti-CMV IgG. CMV DNA was investigated in the
amniotic ﬂuid and blood samples by Real-Time (RT) polymerase chain
reaction (PCR) assay.
Results: The rate of seropositivity was found as 95% and seronegativity
as 5% in pregnant women and the fetal infection rate was found 1%.
The only a pregnant woman was positive for CMV DNA by RT PCR
and high avidity index. The infant whom mother determined CMV DNA
in her amniotic ﬂuid showed high avidity index. The another pregnant
woman was found CMV IgM positive and also high avidity index but
not detected CMV DNA in her amniotic ﬂuid.
Conclusion: We concluded that the fetal CMV infection rate is very low
due to high maternal seroprevalence in our region.
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R2156 Genotypes of Helicobacter pylori isolated from the patients
with hepato-biliary diseases
G.S. Isaeva °, E.R. Abuzarova, J.V. Valeeva, O.K. Pozdeev (Kazan, RU)
Objective: To evaluate the incidence of H. pylori virulence genes in the
liver biopsies and the bile specimens.
Method: 50 patients with chronic cholecystitis and 50 patients with
chronic alcoholic cirrhosis were included in our study. The presence
of genes H. pylori was conﬁrmed by polymerase chain reaction
(PCR) using H. pylori speciﬁc primers for ureC, babA2, cagA, vacA
(“Helicopol”) according to the recommendations of the manufacturer
“Lytech”, Moscow (Russia).
Table. Genotypes of H. pylori isolated from the bile and liver biopsies
H. pylori genes n (%)
Chronic cholecystitis (N = 27) Cirrhosis (N = 36)
vacAs1 15 (55.56±9.56%) 15 (41.67±8.22%)
vacAs2 3 (11.11±6.05%) 7 (19.44±6.6%)
vacAs1/s2 2 (7.4±5.04%) 0
vacAm1 0 4 (11.11±5.24%)
vacAm2 14 (51.85±9.66%) 18 (50±8.33%)
vacA− 7 (25.93±8.43%) 14 (38.89±8.13%)
cagA+ 12 (44.44±9.56%) 0
cagA− 15 (55.56±9.56%) 36 (100%)
babA2+ 8 (29.63±8.79%) 0
babA2− 19 (70.37±8.76%) 36 (100%)
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Results: H. pylori DNA was isolated from the bile and liver biopsies
samples in 54% cases of chronic noncalcular cholecystitis and 72% cases
of cirrhosis. Results of H. pylori genotyping are presented in the table.
Conclusions: The prevalent genotype of H. pylori isolated from the
patients with hepato-biliary disorders is UreC positive VacAs1m2
positive CagA and BabA negative. The received data indicate the
possible role of CagA negative H. pylori in biliary tract and liver
diseases.
R2157 Typing analysis of consecutive C. krusei isolates among
haemato-oncology patients
C. Pina-Vaz °, E. Ricardo, A. Silva, C. Granato, R. Berganti,
T. Gonc¸alves, A. Gonc¸alves Rodrigues (Porto, Coimbra, PT)
Many reports have documented the emergence of non-albicans species of
Candida as important nosocomial pathogens, like C. krusei. The origin of
that colonisation/infection can be exogenous, while the primary reservoir
in the hospital setting is unknown, it is often linked to a prior colonisation
(endogenous). Molecular typing methods, aiming to determine genetic
relatedness help to clarify the origin of the strain as well of its main
routes of transmission.
Objectives: In order to clarify the hypothesis of an outbreak of C. krusei
among haemato-oncology patients, mitochondrial DNA typing was used.
Material and Methods: From three hospitalised patients admitted in
single rooms at the neutropenic unit of Hospital S. Joa˜o, Porto, within
three weeks, C. krusei was isolated from distinct body sites; two of
the patients had been admitted consecutively in the same room. All
patients had received ﬂuconazole-prophylaxis until the ﬁrst C. krusei
isolation. From one of these patients, an additional C. krusei strain,
isolated from the blood two years before, was included, as well as one
C. krusei strain obtained from a distinct patient admitted at another
department. From both rooms, air and surfaces samples were collected.
The identiﬁcation of the yeast isolates was performed using Vitek
2 system (BioMe´rieux, Paris) and susceptibility proﬁle to the main
antifungals assessed accordingly microdilution CLSI protocol M-27 A2.
Total DNA was extracted using a phenol-chlorophorm-isoamilic alcool
protocol and quantiﬁed; 25−30mg of DNA were digested with the
restriction enzyme, Hinf I, at 37ºC, during 9−12 hours. The digestion
reactions were run on 1% agarose gel, for 3−5 h, 120mV and visualised
in UV light. Restriction patterns were compared between strains.
Results: C. krusei were recovered from both room surfaces; the air
samples were found negative. Considering all the studied isolates, only
those recovered from the same patient and its respective room, showed
indistinguishable electrophoretic patterns. Isolates from different patients
were unrelated. Susceptibility proﬁle was similar for all evaluated strains.
Conclusion: The molecular strategy described, showed a good
discriminatory power. It did not support the hypothesis of an outbreak.
Moreover, these ﬁndings highlight the possibility of an endogenous
reservoir, even for long periods of time. This fact should be taken in
account on future antifungal therapeutic protocols.
R2158 Molecular typing of Klebsiella pneumoniae in neonatal
intensive care units using ampliﬁed fragment length
polymorphism analysis
K. Denks, U¨. Parm, K. Huik °, R. Avi, T. Metsvaht, T. Karki, I. Lutsar
(Tartu, EE)
Objectives: The aim of the study was to determine the population
dynamics of Klebsiella pneumoniae in neonatal intensive care units
(NICUs) of two major hospitals in Estonia, using ampliﬁed fragment
length polymorphism (AFLP) analysis.
Methods: From August 2006 until December 2007, repeated perirectal
and nasopharyngeal swabs were collected from all neonates admitted to
two Estonian NICUs with suspected early onset neonatal sepsis. Mucosal
carriage of K. pneumoniae was detected in 51 of 278 eligible patients.
Finally, 47 of 51 patients were analysed: 38 in unit A (including 5 patients
with blood stream infection) and 9 in unit B (plus 1 patient with blood
stream infection but without mucosal colonisation). Depending on the
length of hospitalisation, the per patient isolate number varied from 1 to
7. Alltogether, 88 perirectal, 52 nasopharyngal, 3 tracheal and 5 blood
isolates were used. The AFLP analysis was implemented as described
previously1. After restriction enzyme digestion, the fragments were
selectively ampliﬁed and separated in agarose gel electrophoresis. The
ﬁngerprints on gel were analysed using GeneTools program (Syngene).
In parallel, 10 samples of 5 patients were typed using pulse-ﬁeld gel
electrophoresis (PFGE) technique.
Results: After the reproducibility analysis of AFLP method, isolates
with up to 3-band pattern difference were considered identical. Two
predominant K. pneumoniae clonal groups (type A in 26 patients over
7 months and ﬁve months later, type K in 6 patients over 2 months) were
detected in unit A, while in unit B all colonising K. pneumoniae strains
were different. In all but one subject within individual concordance
between nasopharyngeal and perirectal isolates was observed. All ﬁve
blood stream infections in unit A occurred during the period of
type A K. pneumoniae colonisation. On AFLP and PFGE analysis,
all ﬁve invasive isolates were identical to colonising ones. Ampicillin
and cefotaxime resistance was detected in 41% and 1.4% of isolates,
respectively, but was not reﬂected on AFLP ﬁngerprints.
Conclusion: AFLP method identiﬁed two predominant colonising clonal
groups of K. pneumoniae in NICU setting A, whereas in setting B
all patients had different strain. Vast majority of invasive disease was
caused by only type A K. pneumoniae infection, but it is not known
whether because of possibly higher virulence or as a result of widespread
colonisation.
Reference(s)
[1] Van der Zee et al 2003. J. Clin. Microbiol. 41:798–802
R2159 Ampliﬁed fragment length polymorphism for high-
resolution typing of Listeria monocytogenes from foods and
the environment
A. Parisi °, G. Normanno, A. Susca, A. Miccolupo, L. Latorre, G. La
Salandra, N.C. Quaglia, G. Santagada (Putignano, Bari, Matera,
Foggia, IT)
Objective: Listeria monocytogenes is a Gram-positive food-borne
pathogen that is commonly present in the environment and occurs
naturally in many foods. It is the causative agent of listeriosis, a
severe food-borne disease associated with a high case fatality rate.
The recent association of L. monocytogenes with several large food-
borne disease outbreaks suggests that contaminated foods, including
meat, dairy, vegetable and ﬁsh products, may be the primary source of
the organism. Control of food-borne bacterial pathogens is predicated
upon the identiﬁcation of their sources and routes of transmission.
Source tracking of L. monocytogenes has proved to be difﬁcult as it
is ubiquitous in the environment and also because cases are generally
sporadic and outbreaks are rare. Recently, several molecular methods
such as ribotyping, Pulsed-Field Gel Electrophoresis (PFGE), Ampliﬁed
Fragment Length Polymorphism (AFLP), multilocus sequence typing
have been used to characterise L. monocytogenes isolates. In this study
we compared two AFLP protocols to characterise 162 L. monocytogenes
isolates from foods and environmental sources.
Methods: Four selective primer combinations using the restriction
enzymes, HindIII and HhaI, and a previously published protocol using
EcoRI and MseI, were evaluated for their suitability in genotyping
L. monocytogenes. Based on the number and distribution of the ampliﬁed
bands, a protocol using HindIII and HhaI was selected for further
genotyping of a collection of 162 L. monocytogenes isolates from
different food and environmental sources.
Results: On the whole, 28 different AFLP types were identiﬁed. The
differences in the ﬁngerprinting proﬁles clearly distinguished two genetic
lineages, recognized by serotyping, with a similarity level of 55%. This
provided conﬁrmatory evidence that there is a phylogenetic divergence
between the strains of serotypes 1/2a, 1/2c, 3a, 3c that formed one
cluster and the strains of serotypes 1/2b, 3b, 4b/4e and 4c forming
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another cluster. A different genetic variability was observed among the
serotypes, with the 1/2a and 1/2b strains exhibiting 13 and 8 AFLP
proﬁles, respectively, out of a total of 75 and 23 analyzed strains. By
contrast, all the isolates (n = 30) of the 1/2c serotype were grouped into
a single AFLP type.
Conclusion: AFLP ﬁngerprinting using HindIII and HhaI is suitable
for high resolution genotyping of L. monocytogenes in epidemiological
studies.
R2160 Molecular epidemiological analysis of group A streptococci
with covR expression at different phases of growth
C. Chiang-Ni, P.X. Zeng, H.M. Wu, W.J. Chuang, Y.S. Lin, M.T. Lin,
C.C. Liu, J.J. Wu ° (Tainan, Hualien, TW)
Objectives: emm1 type is one of the most frequently isolated emm
types from invasive and non-invasive Streptococcus pyogenes (group A
streptococcus, GAS) infection worldwide. Our study found that all
analyzed emm1 strains express the global regulator covR in early-
stationary phase and have the better growth activity than strains with
covR expression at exponential phase of growth. However, whether the
strains with covR expression in early-stationary phase of growth related
to speciﬁc clonal cluster is unknown.
Methods: Clinical isolates collected from 1994–2003 were analyzed by
Northern hybridisation for the covR expression pattern. The multi locus
sequence typing and pulsed-ﬁeld gel electrophoresis typing were used
to generate the dendrogram to analyze the clonal relationship of these
strains.
Results: All emm1 strains expressed covR at early-stationary phase
of growth. Multi locus sequence typing analysis showed all emm1
strains have the identical sequence type (ST28). In addition, pulsed ﬁeld
gel electrophoresis analysis showed emm1 clinical isolates have >75%
genetic relatedness. Dendrogram analysis showed only clonal cluster
comprises emm1/ST28 strains were expressing covR at early-stationary
phase of growth.
Conclusion: These results indicate that the speciﬁc covR expression
pattern should be a potential determinant phenotype for pandemic
predominant emm1/ST28 strains.
R2161 Molecular epidemiology of Brucella melitensis in Greece
assessed by multilocus variable-number tandem repeat
markers
G. Vrioni, G. Spanakos, C. Gartzonika, G. Pappas, E. Kalogeropoulou,
N. Charalambaki, A. Kyratsa, A. Kansouzidou, S. Levidiotou °, E. Trikka-
Grafakos, N. Vakalis, A. Tsakris (Athens, Ioannina, Thessaloniki, GR)
Brucellosis remains a common infectious disease in many parts of
the world, notably in Mediterranean countries and the Middle East.
The availability of discriminatory molecular typing tools to inform and
assist conventional epidemiological approaches would be invaluable in
controlling these infections, but efforts have been hampered by the
genetic homogeneity of the genus. Recently, a molecular subtyping
system based on the number of an octameric tandem repeat sequence at
eight loci in the Brucella genome has been developed.
A total of 33 clinical isolates of Brucella melitensis biovar 2
representative of 33 patients residing in Greece (1−8 in Northwest
Greece, 9−13 in North Greece and 14−33 in Central Greece)
were genotyped by 8-locus VNTR system (Hypervariable Octameric
Oligonucleotide Finger-Prints, HOOF-Prints).
The discriminatory power of the technique was readily demonstrated
by the fact that of the 33 genotyping proﬁles determined, 32 were
unique. Only one pair of strains, isolated in the same family (mother and
son), gave identical proﬁles. The most polymorphic markers, as regard
number of alleles and range, were HOOF-Prints 5 and 4, followed by
HOOF-Prints 7 and 1. These results indicate that VNTRs used in the
HOOF technique could discriminate isolates originating from restricted
geographical sources, indicating its potential as an epidemiological
tool. Further combined analysis, using more strains, and comparison
of our results to the proﬁles of the existing isolates from European
and International data banks will elucidate the B. melitensis evolution
within our territory and its transmission mechanisms, and enable the
improvement of brucellosis surveillance and control programs.
R2162 Transverse microbial differences of the human gut evaluated
with terminal restriction fragment length polymorphism
D. Soeltan-Kaersenhout, A. van Bodegraven, P.H.M. Savelkoul °
(Amsterdam, NL)
Objectives: Shifts in microbial composition of the human gut are
thought to play a causal role in the development and sustenance of
intestinal disorders such as inﬂammatory bowel disease (IBD). Since
adherence of microbes is a prerequisite for disease causation, this study
set out to investigate if transverse differences in terminal restriction
fragment length polymorphism (T-RFLP) proﬁles of microbial species
exist. T-RFLP allows for culture-independent, molecular ﬁngerprinting
of complex microbial communities. Transversal differences were studied
between biopsies (the epithelial adherent ﬂora: after removal of the
mucus layer) and colonic luminal space (transient ﬂora: mucus adherent
plus luminal ﬂora).
Methods: Two biopsy samples were taken from each of ﬁve locations in
the colon from a healthy patient. Endoscopy was performed for screening
purposes in light of a positive family history of colorectal cancer. One
biopsy from each location was washed with PBS (leaving the mucus layer
intact) and the other with dithiotreitol (DTT, destroys the mucus layer).
Biopsy samples (PBS and DTT washed) and the associated supernatants
were subjected to T-RFLP analysis by ampliﬁcation of the 16S rRNA
gene with labelled primers 8F-FAM and 926R-NED. Amplimers were
digested with HinP1I and MspI and the labelled terminal restriction
fragments were separated in an ABI 3130XL sequencer. Cladograms
were generated using Pearson correlation and UPGMA clustering in
Bionumerics software.
Results: Five out of ten supernatants were inhibited in PCR and
were excluded from further analysis. The differently washed biopsies
showed a similarity of 89.2%. The PBS supernatants representing
luminal microbes clustered closely with the biopsies (85.4%). The
DTT supernatants representing mucus associated bacteria showed 75.4%
similarity with the biopsies.
Conclusion: In this study, the microbiota of the luminal, mucosal and
biopsy samples within one patient were similar. The small differences
observed seem largely due to differences in bacterial quantity rather than
bacterial composition. This was in agreement with quantitative real-time
PCR analysis of these samples. Treatment of biopsy samples with DTT
does not seem to inﬂuence microbial T-RFLP proﬁles. Future studies
with a larger cohort of healthy patients and inclusion of patients with
IBD should shed more light on this possible equilibrium between gut
lumen and lining and whether or not it is disturbed in intestinal disease.
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R2163 Diagnosis of the pre-patent Schistosoma mansoni infection
by polymerase chain reaction in sera of experimentally
infected mice
L. El Zawawy ° (Alexandria, EG)
Objectives: This work aimed at ascertaining the role of polymerase chain
reaction (PCR) in detection of Schistosoma mansoni (S. mansoni) DNA
during the pre-patent period in sera of experimentally infected mice.
Enzyme linked immuno-sorbent assay (ELISA) was used for detection
of circulating antigen (CA) of S. mansoni as a screening method for the
diagnosis.
Methods: Swiss albino mice were infected with two doses of S. mansoni
(50 and 100 cercariae/mouse). ELlSA and PCR techniques were
performed on serum samples collected from the infected mice on the
ﬁrst, second, third and fourth weeks post infection (PI)
Results: The ELISA test was positive in 99.66% of samples and the
readings were signiﬁcantly increased with each of the dose and the
duration of the infection. PCR technique was positive with all the
examined samples including that was negative by the ELISA test. The
minimal detectable amount of S. mansoni DNA was 1.16 fg. DNA
ampliﬁcation was not achieved with any of the other helminthes used to
evaluate the PCR speciﬁcity including S. haematobium adult worms.
Conclusion: Both assays have proved their validity as diagnostic tools
for S. mansoni infection as early as the ﬁrst week PI However, PCR is
a promising technique due to its higher sensitivity, speciﬁcity and since
it is not affected by the immune status of the hosts. Therefore, PCR
is more reliable and must be used as a conﬁrmatory test for ELISA
negative cases.
R2164 New real-time PCR based molecular assay for the detection
of vanA and vanB genes from rectal swabs
P. Cavallerio °, L. Fossati, C. Parlato, R. Serra (Turin, IT)
Objectives: This study evaluated the Xpert vanA/vanB assay (Cepheid,
Sunnyvale, CA), a fully-automated PCR-based method for rapid
detection of clinically signiﬁcant genotypes of vancomycin-resistant
enterococci (VRE) by rectal swabs, at San Giovanni Battista Hospital
in Turin, Italy.
Methods: 136 patients at two Intensive Care Units (ICUs), two
Haematology and one Bone Marrow Transplant units were screened
using double rectal swabs (Copan, Italy). One swab was used for
the molecular test and the other was used to perform the culture
reference test. Brieﬂy, swab was immersed in Bile Esculine enrichment
Broth (Becton Dickinson, Oxford, UK) and plated on chromID™ VRE
(bioMerieux, Basingstoke, UK). Both the agar and the broth were
incubated at 37ºC for 24 h. Ten microliters of broth was plated on
chromID™ VRE (bioMerieux, Basingstoke, UK). Suspect colonies were
subjected to E-test to conﬁrm resistance to vancomycin and teicoplanin
and to Genotype Enterococcus (Hain LifeScience, Nehren, Germany) to
identify genotypes.
Results: A total of 165 rectal swabs were tested using Xpert vanA/vanB
assay and the culture methods. Hundred and four (63%) specimens were
negative in both methods. Four (2.4%) were positive for both genes
in Xpert vanA/vanB and in the culture methods. Three (1.8%) samples
were positive for vanA gene in both assays. Fifty-four samples were vanB
gene positive in Xpert vanA/vanB Assay (32.7%) while 13 (24.1%) were
positive with culture-based methods.
Conclusion: Xpert vanA/vanB assay offers great attributes for the
detection of VRE. The system is rapid (<1 h) and therefore particularly
useful if testing needs to be performed at any time, day or night. This
is an interesting feature since VRE colonisation can be transient and
cultural methods require at least 48 hours. Some issues have been
highlighted for the vanB gene. If the organism carrying the VanB gene
needs to be known a culture-based methods should be used.
R2165 Evaluation of the GeneXpert GBS assay in determining
group B streptococcus colonisation
J.S. Park, D.H. Cho, I.K. Yeo, J.H. Yang, M.Y. Kim, S.M. Shin, S.I. Joo,
E.K. Ra, S.S. Park, E.C. Kim ° (Seoul, KR)
Objectives: It is recommended that all pregnant women be screened for
group B streptococcus carriage at between 35 and 37 weeks of gestation.
However intrapartum screening test for GBS could reveal more exact
status of GBS colonisation at the time of delivery and would obviate the
need for prenatal screening. One of the latest development in the ﬁeld of
the molecular diagnosis of GBS is a fully automated real-time PCR assay,
the GeneXpert GBS (GXGBS; Cepheid, Sunnyvale, CA, USA), of which
total analysis time is 75min. In this study, we prospectively evaluated the
performance characteristics of GXGBS and in comparison with selective
culture in pregnant women. In addition, this study is designed to provide
data on the rates of maternal carriage of GBS in Korean women and
characteristics of isolated GBS.
Methods: We also performed analytical sensitivity, speciﬁcity and
precision of GXGBS. We compared GXGBS and standard selective
culture with Todd-Hewitt broth in 175 pregnant women at 35−37 week
gestation. Speciﬁc identiﬁcation of colonies was done by Vitek-2 and
Lanceﬁeld grouping. Further serotyping was done using conventional
and molecular methods.
Results: For GXGBS, the 95% detection limit was 1.41×103 CFU/swab
and no cross-reactivity was found. The CVs of within-run, between-run
and total precision were 2.8%, 2.6%, and 3.3%, respectively. Detection
rate of GBS carriers by GXGBS was 11.4% (20/175), compared with
8.6% (15/175) of selective culture method. The sensitivity, speciﬁcity,
positive and negative predictive values of the GXGBS compared with
selective culture were 86.7, 95.6%, 65.0%, and 98.7%, respectively, The
most frequent serotypes were Ia, III, and V (72.2%). All strains were
susceptible to penicillin, but a considerable proportion was resistant to
erythromycin (44.4%) and clindamycin (44.4%).
Conclusion: GXGBS is a highly sensitive and speciﬁc tool for the
detection of GBS. Simple preparation and rapid results are attractive
points of this assay. GXGBS might be substitutive test for the detection
of GBS in antenatal and intrapartum screening test.
R2166 Xylitol and capsular gene expression in Streptococcus
pneumoniae
P. Asumaniemi °, T. Tapiainen, T. Kaijalainen, M. Uhari, A. Saukkoriipi
(Oulu, FI)
Objectives: Xylitol is a sugar alcohol that inhibits the growth
of Streptococcus pneumoniae. Xylitol decreases the occurrence of
acute otitis media in day-care children but does not decrease the
nasopharyngeal carriage of pneumococci. In our previous studies, we
found that xylitol changes the ultrastructure of the polysaccharide
capsule of pneumococci. We hypothesized that xylitol could affect the
expression of pneumococcal capsular genes.
Methods: We investigated capsule gene expression in twenty-four
pneumococcal clinical isolates and one ATCC strain (49619) by using
a two-step real-time RT-PCR method targeted at the second gene of the
pneumococcal capsular locus, the cpsB gene. The pneumococcal isolates
were exposed to 5% glucose, 5% xylitol and control medium (brain
heart infusion medium supplemented with 10% fetal bovine serum) for
two hours. After two hours, bacterial suspensions were treated with
RNA-stabilising solution and subjected to RNA extraction and ﬁrst-
strand cDNA synthesis. CpsB gene expression levels were measured
by a relative quantiﬁcation method where we used the housekeeping-
gene 16SrRNA of S. pneumoniae as a reference gene. The cpsB and
16SrRNA PCRs were performed in separate runs but using the same
cDNA sample. The calibrator normalised gene expression levels were
determined by using the Relative quantitation tool in the LightCycler
software version 4.05. (Roche Diagnostics). Statistical signiﬁcance was
assessed with the analysis of variance for repeated measures.
Molecular biology, including diagnostics − others S639
Results: Exposure to xylitol lowered the cpsB gene expression
levels signiﬁcantly compared to control (P = 0.035) and glucose media
(P = 0.011). Capsular gene expression levels in glucose medium did not
differ signiﬁcantly from those measured in control medium (P = 1.000).
Conclusion: We found that xylitol signiﬁcantly decreased capsular gene
expression levels in S. pneumoniae isolates compared to control medium.
This ﬁnding further explains the good clinical efﬁcacy of xylitol in
preventing otitis media.
R2167 Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae,
herpes simplex virus type 1,2 and papilloma virus in
pregnant women in central Greece
D. Klapsa °, H. Skentou, M. Stavropoulou, A. Damani,
F. Anastassiadou, I. Messinis, E. Petinaki (Larissa, GR)
Objective: To examine the prevalence of genital pathogens including
Chlamydia trachomatis, Neisseria gonorrhoeae, Herpes simplex virus
types 1 and 2 (HSV1, HSV2) and Papilloma virus (HPV) among
asymptomatic pregnant women of Central Greece.
Methods: A total of 269 pregnant women during the ﬁrst trimester of
pregnancy, aged from 18 to 42 years old, presented during 2008 at
the University Hospital were included. Cervical swabs were obtained
and DNA extraction was performed in all specimens. The presence of
C. trachomatis was examined ﬁrstly by direct C. trachomatis antigen
detection (Cypress Diagnostics) and by Real Time PCR (Nanogen
Advanced Diagnostics). DNA of N. gonorrhoeae was detected by a
home-made PCR, while DNA of HSV1 and HSV2 were detected by
Real-Time PCR (Nanogen Advanced Diagnostics). The presence of HPV
DNA and oncogenic potential was assessed using PCR followed by a
restriction method (Maxim).
Results: Four out 269 women (4.8%) were positive by RT-PCR for
C. trachomatis; the direct detection of C. trachomatis antigen was
identiﬁed in only one out the four cases. In addition, two women (2.4%)
were positive for HPV type 16. DNA of N. gonorrhoeae, of HSV1 and
HSV2 were not found in any women.
Conclusions: C. trachomatis and HPV type 16 were identiﬁed in
asymptomatic pregnant women in Central Greece. These results support
a strategy of screening pregnant women for these pathogens (followed
by treatment of infections), which could be integrated into routine
pregnancy care in our area.
R2168 Comparison of two commercial molecular tests for routine
diagnosis of C. difﬁcile
V. Zidaric °, N. Oresic, M. Rupnik (Maribor, SI)
Objectives: C. difﬁcile is currently one of the most important
human pathogens and infection incidence and severity have increased
signiﬁcantly over the last ﬁve years. The rapid and sensitive diagnostic
tests are of crucial importance for correct treatment and for disease
control within the hospital environment. However, currently available
immunological tests detecting toxins A and B have low sensitivity. New
molecular tests could improve sensitivity and enable to detect additional
markers such as binary toxin gene and deletion in tcdC gene, both
indicating the higher possibility of hypervirulent type 027.
Methods: Routine C. difﬁcile diagnosis in our laboratory includes
culture (CLO plates, bioMerieux) and direct toxin test (VIDAS CDAB,
bioMerieux). In this study two molecular tests, BD GeneOhmTMCdiff
Assay (BD Diagnostics, GeneOhm) and Xpert C. difﬁcile Assay
(Cepheid), are additionally performed on all routine samples.
For BD and Cepheid test swab is brieﬂy immersed in the unformed stool
and further processed according to manufacturer instructions. BD test
gives result as Positive, Negative or Unresolved, while Cepheid speciﬁes
Toxigenic C. difﬁcile positive, Toxigenic C. difﬁcile negative and 027-
NAP1-BI presumptive positive or 027-NAP1-BI presumptive negative.
Results: Approximately 23% of our routine samples are culture positive.
CDAB test used for direct detection of toxins is often negative for culture
positive samples (also if containing toxigenic C. difﬁcile strains)
Cepheid assay detected C. difﬁcile in all culture positive samples, but
some culture negative samples had to be retested due to invalid results
and inhibition of PCR reaction. None of the samples was recognized as
presumptive 027, which was conﬁrmed by ribotyping of isolated strains.
BD had somewhat lower sensitivity but no repetition of tests was needed.
None of the molecular tests was positive for C. difﬁcile culture negative
samples.
Conclusion: Both molecular ampliﬁcation assays correlated well with
toxigenic C. difﬁcile culture. Their high speciﬁcity and short run time
until results (from 50−90 minutes) allows quick and correct diagnosis
of C. difﬁcile.
R2169 Multiplex real-time PCR for the detection of intestinal
protozoa indicates unnecessary treatment of Entamoeba
histolytica in Turkish patients with intestinal complaints
Z. Kocak Tufan °, J.J. Verweij, L. van Lieshout, E.A.T. Brienen,
S. Cesur, C. Bulut, S. Kinikli, A.P. Demiroz (Ankara, TR; Leiden, NL)
Objectives: In Turkey the diagnosis of intestinal parasitic diseases is
primarily based on clinical signs and on the epidemiological distribution
of the parasite concerned. Laboratory diagnosis is usually limited to
microscopy of a direct faecal smear, without further differentiation
between the pathogenic Entamoeba histolytica and the non-pathogen
E. dispar. Copro-antigen detection by ELISA is increasingly used, but
is still not generally available, while detection of parasite DNA by
PCR can only be offered by a limited number of university hospitals.
In this pilot study, the diagnostic value of routine microscopy was
assessed by comparing its outcome with real-time PCR for the detection
of intestinal protozoa. The consequences for clinical management of
diarrhoea patients in the region are discussed.
Methods: Seventy-nine stool samples were included in the study.
All patients were suspected to have either amoebiasis or giardiasis
based on clinical signals and referred for stool examination to
the microbiology laboratory of the Ankara Training and Research
Hospital. Microscopy of a direct smear from unpreserved stool samples
was performed immediately after delivery. Aliquots were sent to
the Netherlands for further molecular diagnosis. DNA isolation and
multiplex real-time PCR was performed for the speciﬁc detection of
DNA of E. histolytica, E. dispar, Giardia lamblia, Cryptosporidium
hominis/C. parvum, Enterocytozoon bieneusi and Encephalitozoon spp.
Phocin Herpes Virus 1 (PhHV 1) was added within the isolation lysis
buffer to serve as an internal control to detect inhibition factors.
Results: Based on microscopy, 27 (34%) cases of E. histolytica/E. dispar
and 1 (1.3%) case of G. lamblia were reported. No helminths were
seen. In contrast, real-time PCR detected 2 (2.5%) cases of E. dispar, 9
(11.4%) cases of G. lamblia, and 1 (1.3%) case of E. bieneusi, while no
cases with E. histolytica or C. hominis/C. parvum were found.
Conclusion: Although based on limited numbers, our results clearly
indicate that direct microscopy in this setting had a low speciﬁcity for
amoebiasis and a low sensitivity for giardiasis. Unnecessary treatment
was given to 27 patients based on the detection of E. histolytica/E. dispar
cysts or trophozoites, while 8 of 9 patients with G. lamblia were
left untreated. Improvement of microscopy skills, quality control and
alternative diagnostic procedures with a higher sensitivity and speciﬁcity
are recommended.
R2170 Evaluation of the BD Gene-Ohm™ Clostridium difﬁcile
assay for the diagnosis of C. difﬁcile infection
J. Van Broeck °, C. Hubert, M. Delmee (Brussels, BE)
Introduction: The BD Gene-Ohm™ Cdiff (BD Diagnostics, San Diego,
CA) is a real-time PCR assay targeting the toxin B gene (TcdB)
of Clostridium difﬁcile with a ﬂuorogenic target-speciﬁc hybridisation
probe for the detection of the ampliﬁed DNA. With toxigenic culture
(TC) as gold standard, we evaluated the performances of this new assay
for the diagnosis of C. difﬁcile infections (CDI) on stool specimens
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Materials and Methods: Stools were from inpatients of the St Luc-
UCL University hospital (890 beds), older than 2 years and suffering
from diarrhoea. Cell cytotoxicity (CTA) was performed on MRC5 cells.
Cultures were performed on CCFA. In case of positive culture and
negative CTA, colonies were tested for ‘in vitro’ toxin production
(TC). Some cultures were repeated on CCFA with added taurocholate
(TCCFA).
Real-time PCR was performed according to the manufacturer’s
instructions.
Results: A total of 749 stool specimens collected in 2008 were tested.
Ninety-one samples were shown to contain toxigenic C. difﬁcile by CTA
and/or toxigenic culture (prevalence: 12.2%). The sensitivity, speciﬁcity,
PPV and NPV of BD Gene-Ohm™ Cdiff were respectively: 80.2%,
98.2%, 86.5% and 97.1%. Those of CTA were 60.4%, 100%, 100% and
94.8%. Unresolved result was recorded in 43 instances; PCR tests were
repeated. Only one result remained unresolved and was excluded from
our calculation.
Seventeen false positive cases by PCR were reanalysed by reviewing the
patient’s records and re-inoculating the stool on TCCFA. In ﬁve stools,
colonies of toxigenic C. difﬁcile were isolated. In two other cases the
patient had a history of recent episode of CDI.
Conclusion: The BD Gene-Ohm™ Cdiff demonstrated a very good
sensitivity much superior to that of CTA and a good speciﬁcity. It is
a rapid method allowing result in less than two hours. False positive
result may be observed in case of patient with a history of CDI.
R2171 Preliminary evaluation of the Cobas Taqman real-time
PCR for Mycobacterium tuberculosis detection in clinical
specimens
J. Agu¨ero °, C. Ferna´ndez-Mazarrasa, C. Ruı´z de Alegrı´a,
L. Martı´nez-Martı´nez (Santander, ES)
Objective:We have evaluated the commercially available Cobas Taqman
MTB Test, Roche, which is a new released Real Time PCR test for
qualitative detection of Mycobacterium tuberculosis complex DNA in
human respiratory specimens. Our objective was to evaluate the test in
both pulmonary and extrapulmonary clinical samples, and to compare
the results with those derived from microscopy and our current routine
Real Time PCR assay for M. tuberculosis (RealArt M. tuberculosis TM
PCR, Abbott)
Methods: Using the results from Coletsos culture as gold standard
we evaluated the sensitivities and the predictive values of the three
techniques in 112 samples: 89 respiratory specimens (37 sputum,
28 bronchial aspirates, 14 pleural ﬂuids, 9 bronchial lavages and
one protected specimen brush) and 24 nonrespiratory specimens
(12 cerebrospinal ﬂuids, 7 exudates and 5 tissue specimens)
Results: The overall results of microscopy, RealArt and Cobas Taqman
were: 63%, 85.2% and 81.5% for sensitiviy; 89.5%, 88.5% and 88% for
positive predictive value; and 89.4%, 95.4% and 94.3% for negative
predictive value, respectively. This last value was higher than 95%
for the three techniques in nonrespiratory samples. As described,
sensitivities of molecular techniques were considerably lower for smear
negative specimens (63.6% and 54.5% for RealArt and Cobas Taqman,
respectively)
Conclusions: The Cobas Taqman MTB assay is easy to perform
and provides a valuable diagnostic tool for rapid detection of the
M. tuberculosis directly from clinical samples
R2172 Conventional methods versus PNA FISH for Candida
albicans/Candida glabrata identiﬁcation
J. Skou °, C. Nielsen, T. Bjarnsholt, H. Johansen (Copenhagen, DK)
Objectives: Conventional methods for identiﬁcation of yeast in blood
cultures often take several days. A new peptide nucleic acid ﬂuorescent
in situ hybridisation method (PNA FISH), (AdvanDx, Denmark) for
yeast identiﬁcation has a total response time of 2−3 hours. This could
be an advantage concerning treatment of patients with invasive fungal
infections since they might receive optimal antifungal therapy quicker.
We compared how well PNA FISH identiﬁcation for C. albicans or
C. glabrata performed compared to conventional culture methods.
Methods: Thirty-ﬁve blood cultures were positive for Candida sp. in
our routine laboratory at Rigshospitalet, Denmark during one year from
November 2007 to November 2008. Candida isolates from 29 (83%)
of the positive blood cultures were diagnosed by PNA FISH and also
sent to the Danish Mycology Reference Laboratory at the State Serum
Institute for culture and conﬁrmatory tests. The conventional methods
used were e.g. ChromAgar®, API-strips® and VitekII®.
Results: Thirteen of 29 (45%) of the positive blood cultures were
diagnosed by PNA FISH as C. albicans and 8/29 (28%) as C. glabrata.
8/29 (28%) were PNA FISH negative with growth of other Candida
spp. than C. albicans or C. glabrata. In all C. albicans and C. glabrata
cases the PNA FISH results were identical with the results obtained
by conﬁrmatory tests performed at the Mycology Reference Laboratory
(SSI). The response time for PNA FISH in our routine laboratory
was approximately 4 hours and for the conventional methods 3 days,
respectively.
Conclusion: We have shown that identiﬁcation of C. albicans or
C. glabrata by PNA FISH is in agreement with conventional culture
methods. By implementing the PNA FISH in the laboratory, the
clinical response time for C. albicans and C. glabrata can be reduced
signiﬁcantly. This could lead to improved patient outcomes.
R2173 Detection of mutations of the tcdC gene of Clostridium
difﬁcile in stool specimens using a TaqMan-based real-time
PCR and melt curve analysis
C.R. MacKenzie °, R. Guadarrama, B. Henrich (Dusseldorf, DE)
Objectives: The tcdC gene product has been proposed to regulate toxin
production in C. difﬁcile and thus mutations in the gene leading to
a truncated or altered TcdC protein may play a role in virulence of
the organism. We set out to show that such mutations can be detected
directly in stool specimens using a real-time PCR-based method and thus
facilitate the rapid detection of virulent strains in clinical specimens.
Methods: DNA was extracted from C. difﬁcile strains and clinical
stool specimens and subjected to real-time PCR assays. One assay used
primers spanning the region of the tcdC gene known to contain the 18 bp
deletion. This PCR was designed in such a way that in the subsequent
melt curve analysis of the amplicon the presence of the deletion resulted
in a higher melting temperature. In the second assay a TaqMan PCR was
designed to detect a deletion at position 117 of the tcdC gene, putatively
associated with virulence, so that ampliﬁcation was more than 1000-fold
less efﬁcient in the presence of the deletion.
Results: The tcdC-PCR melt curves for strains without the 18 bp deletion
showed a mean melting point of 76.86ºC (SD 0.31) and for strains
with the 18 bp deletion a mean melting point of 77.26ºC (SD 0.6). The
concentration of bacteria and hence DNA had no inﬂuence on the results.
Using the PCR melt curve analysis we were able to detect the presence
or absence of the 18 bp deletion in the tcdC gene in all the C. difﬁcile
strains tested.
In addition, DNA was extracted from 268 clinical stool specimens and
subjected to the real-time PCR assays. Of the 54 specimens positive for
C. difﬁcile 50 were positive for the PaLoc genes tcdA, tcdB and tcdC,
only one of which was positive for the 18 bp deletion. TaqMan PCR
detecting the 117 deletion was run on 47 clinical stool specimens two of
which were found to contain the deletion. These results were conﬁrmed
using the cultured C. difﬁcile isolates of the same specimens.
Conclusion: We demonstrate here that the detection of mutations in the
PaLoc genes of C. difﬁcile can be detected directly in stool specimens.
This method is well suited to any laboratory equipped for molecular
diagnostics and we envisage development of further applications for
the rapid detection of C. difﬁcile and possible virulence factors thus
facilitating an expedited intensive therapy.
Molecular biology, including diagnostics − others S641
R2174 Role of Toll-like receptors in patients with multiple sclerosis
and Chlamydophila pneumoniae infection
S. Seraceni, L. Badia, A. Grilli, E. Fainardi, C. Contini ° (Ferrara, IT)
Objectives: The possibility that Multiple Sclerosis (MS) is linked to
chronic infection by Chlamydophila pneumoniae (Cpn) has attracted
attention in these last years. Previous studies have demonstrated that
in a subset of MS patients with Relapsing-Remitting (RR) forms, Cpn
could induce a chronic persistent brain infection acting as a cofactor in
the development of the disease. Moreover, mRNA transcript levels of
Cpn 16sRNA and HsP60 genes, have been detected in PBMC and CSF
compared to other neurological disorders (OND) patients found Reverse
Transcriptase (RT) PCR positive for 1 gene only. Literature evidence has
established that there is a high expression of Toll like receptors (TLR)
in various neurodegenerative disorders including SM (active lesions of
microglia and astrocytes). We have evaluated the link between Cpn and
the molecular expression of TLRs by studying clinical specimens from
MS patients infected by Cpn before and after co-culture on Hep-2 cells
speciﬁc for this pathogen.
Methods: Fresh CSF and PBMC specimens were obtained from 20
patients with SM RR and 19 controls with OND previously investigated
for Cpn 16 s rRNA and Hsp60 genes by PCR and RT-PCR. TLR2 and
TLR4 expression was studied by RT-PCR in clinical specimens before
and after inoculation and incubation in CO2 for 144 h, on Hep-2 cells.
Results: An evident expression for either TLR2 or TLR4 receptors (9/10,
90%; 7/10, 70%, respectively) was found in patients with SM RR before
PBMC but not CSF culture inoculation. These patients have shown to
highly express TLR-2 and TLR-4 (6/10; 60%), in contrast with OND
patients who were found to express TLR2 (2/10; 20%) or TLR4 (1/10;
10%7) but not both.
Conclusions: TLRs are transmembrane pattern-recognition receptors
that initiate signals in response to diverse pathogen-associated molecular
patterns. The major expression of TLR-2 and TLR-4 in peripheral blood
and not in CSF from SM patients and particularly those with RR forms,
indicate that their combined activity might be crucial to modulate and
activate cellular-mediated immune response during chronic infections
by Chlamydia. In fact, MS patients show immunological and cytokine
elevations consistent with chronic infections
R2175 Effectiveness of using a new nested PCR tool targeting
glmM for Helicobacter pylori detection
N. Poblet-Mas °, M. Forne´, L.J. Garcia-Gil (Girona, Terrassa, ES)
Introduction: Helicobacter pylori (HP) is a Gram-negative spiral
bacterium that causes gastritis, peptic ulcer disease and seems to be
involved in gastric cancer. The main aim of the present work was to
evaluate the effectiveness of a nested PCR targeting glmM gene by
comparing with two other conventional methods, biopsy urease test
(BUT) and histological examination (HE). The second objective was to
assess the presence of the cytotoxin-associated gene (cagA) in infected
HP patients.
Methods: One hundred frozen gastric biopsies from 100 patients were
thawed prior to extract the DNA of HP. Nested PCR with a new set
of primers targeting the glmM gene was performed, as well as PCR
targeting three different segments of the cagA gene. Moreover, HP
infection was also established by BUT and HE.
Statistical analyses consisted of a Pearson’s chi square test, the
association and the correlation among the four variables studied
(PCR-glmM, PCR-cagA, BUT, and HE) being determined by Kappa’s
concordance and Spearman’s correlation coefﬁcients.
Results: 88.0% cases were positive for HP by PCR-glmM (52.8% being
positives by PCR-cagA), 54.0% by assessing BUT and ﬁnally 56.0%
were positive by HE. All positives by HE and by BUT were also positive
by PCR-glmM.
PCR-glmM was signiﬁcantly associated (k = 0.43, P< 0.05) and
positively correlated (r = 0.53, P< 0.05) with HE and with BUT
(k = 0.58, P< 0.005; r = 0.64, P< 0.005). With regard to PCR-cagA,
both concordance and correlation were also found with HE (k = 0.52,
P< 0.05; r = 0.52, P< 0.05) and with BUT (k = 0.89, P< 0.001; r = 0.90,
P< 0.001).
The number of glmM positives was signiﬁcantly higher than the number
of cagA ones (chi = 5.11, P< 0.05), even though all positives by PCR-
cagA were also positive by PCR-glmM. Thus, this result conﬁrms
the usefulness of nested PCR-glmM and PCR-cagA in detecting,
respectively, all and only virulent strains. Knowing the cagA positive
HP strains will be useful in predicting the chance for complications as
well as for epidemiological and clinical studies of HP infection.
Conclusion: PCR targeting both highly conserved and virulence genes
(as glmM or cagA, respectively) is not only concordant with conventional
techniques (HE and BUT), but the former method seems to be more
sensitive than the latter for detecting HP. For this reason, we suggest
that the nested PCR using the new set of primers targeting the glmM
gene is a suitable tool to detect HP in clinical samples and it might be
included in routine clinical practice.
R2176 A ﬂuorescence in situ hybridisation method using a peptide
nucleic acid probe for the identiﬁcation of Salmonella spp.
in clinical samples
C. Almeida °, N.F. Azevedo, C.W. Keevil, M.J. Vieira (Braga, PT;
Southampton, UK)
Objectives: The diagnostic method currently used for Salmonella
detection relies on time-consuming plating procedures. However, a tool
to assist disease control management and reduce salmonellosis should
detect the microorganism in a rapid and reliable manner. In order to
achieve this, a ﬂuorescence in situ hybridisation (FISH) method for the
rapid detection of Salmonella spp. using a novel peptide nucleic acid
(PNA) probe was developed.
Methods: The new probe for the speciﬁc identiﬁcation of Salmonella
was designed, checked against online sequence databases and tested
on pure cultures of Salmonella and related species. Subsequently, the
PNA-FISH method was adapted not only to the detection in artiﬁcially
contaminated samples, such as blood and powdered infant formula (PIF),
but also to multispecies/natural samples (faeces and water). All samples
were previously enriched in a rich medium (8 hours for PIF and overnight
for the other samples) and analyzed by both PNA-FISH and culture-based
methods.
Results: Speciﬁcity and sensitivity probe matching theoretical estimates
were both 100%. Laboratory testing on representative strains from the
Salmonella genus subspecies and several related species, conﬁrmed the
predicted theoretical values of speciﬁcity and sensitivity. The method
has been successfully adapted to detect this bacterium in blood, faeces,
water and PIF.
Blood and PIF samples artiﬁcially contaminated showed that the method
was able to detect 1 CFU per 10mL of blood and also 1CFU per 10 g
of PIF, by performing a previous enrichment step. The faeces and water
samples enriched according to the corresponding ISO methods, showed
that the PNA FISH method can detect Salmonella immediately after
conducting the ﬁrst enrichment step. Moreover, the probe was able to
discriminate the bacterium in a mixed microbial population by counter-
staining with 4,6-diamidino-2-phenylindole (DAPI).
Conclusions: This new method is applicable to a broad spectrum of
samples, taking less than 20 hours to obtain a diagnosis, except for
PIF samples where the analysis takes less than 12 hours. Results also
showed that this method represents a time saving of at least 48 hours
compared to the culture-based techniques. Moreover, results suggested
that a new universal approach, reducing the enrichment step for 8 hours
as performed for PIF samples, may be developed allowing the use of the
technique in routine diagnosis, for a broad spectrum of clinical samples.
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R2177 Mean neutrophil volume: a new automated haematologic
parameter for acute infection
E. Papakonstantinou, E. Yfantis, S. Chaniotaki, P. Giannopoulou,
I. Grafakos, E. Trikka °, C. Manti (Athens, GR)
Review of peripheral blood smears can yield important diagnostic
information through the identiﬁcation of the morphologic changes
characteristically seen in reactive neutrophils during infection. This
approach, however, is labour-intensive and time-consuming because it
requires manual examination. Furthermore, the results are subjective
because they depend on human interpretation, and only a few hundred
cells can be analyzed for any given sample. The Coulter LH 780
hematology analyzer (Beckman Coulter, Fullerton, CA) has the ability
to measure speciﬁc parameters of neutrophil populations like mean
and standard deviation (SD) of cell volume (MVI, SDVI), conductivity
(MCI, SDCI), and light scatter (MSI, SDSI). These so-called positional
parameters (PP) can detect morphologic changes in neutrophil population
and can be an additional indicator for diagnosing acute infection.
Objectives: To investigate the value of the neutrophil MVI, generated
by VCS technology of the Coulter LH 780 hematology analyzer, as an
additional predictor of acute infection.
Methods: Total white blood cell count, percentage of neutrophils, and
positional parameters data from 289 patients with positive blood cultures
and from 54 age-matched healthy control subjects were prospectively
analyzed. We then studied whether changes in MVI correlated with the
type of microorganism. Positive cultures were subdivided to Gram(+) or
Gram(−) microorganism. The PP was obtained by the Coulter LH 750
hematology analyzer (Beckman Coulter, Fullerton, CA). Comparisons
between means were performed by analysis of variance. Comparison
between 2 means was performed by using the Student t test. A P value
less than 0.05 was considered signiﬁcant.
Results: See the table.
Table
Control Patients P Gram+ Gram− P
N= 54 N= 289 N= 72 N= 128
MVI mean 146.17 163.44 <0.001 162.06 166.1 0.046
MCI mean 145.85 140.99 <0.001 139.46 138.97 0.829
MSI mean 146.06 137.53 <0.001 137.22 138.16 0.711
Conclusion: 1) The MVI increases in acute infection, while MSI
decreases. 2) Using an MVI cutoff of 150, as in bibliography, seems
that MVI is a good predictor of acute infection. 3) The MVI increase
correlated signiﬁcantly both with Gram(+) and Gram(−) microorganisms
but it was greater at Gram(−) microorganisms (P = 0.046). (4) As a
quantitive parameter, the MVI has potential use as an additional indicator
for the diagnosis of acute infection.
R2178 Quantitative determination of neutrophil volume
distribution width as a new automated haematologic
parameter for acute infection
E. Papakonstantinou, E. Yfantis, S. Chaniotaki, P. Giannopoulou,
I. Grafakos, E. Trikka °, C. Manti (Athens, GR)
Review of peripheral blood smears can yield important diagnostic
information through the identiﬁcation of the morphologic changes
characteristically seen in reactive neutrophils during infection. This
approach, however, is labour-intensive and time-consuming because it
requires manual examination. Furthermore, the results are subjective
because they depend on human interpretation, and only a few hundred
cells can be analyzed for any given sample. The Coulter LH 780
hematology analyzer (Beckman Coulter, Fullerton, CA) has the ability
to measure speciﬁc parameters of neutrophil populations like mean
and standard deviation (SD) of cell volume (MVI, SDVI), conductivity
(MCI, SDCI), and light scatter (MSI, SDSI). These so-called positional
parameters (PP) can detect morphologic changes in neutrophil population
and can be an additional indicator for diagnosing acute infection.
Objectives: To investigate the value of the neutrophil SDVI, generated
by VCS technology of the Coulter LH 780 hematology analyzer, as an
additional predictor of acute infection.
Methods: Absolute neutrophils count, and SDVI data from 289 patients
with positive blood cultures and from 54 age-matched healthy control
subjects were prospectively analyzed. We then studied whether changes
in SDVI correlated with patients absolute neutrophil counts (less or
greater than 6600/mL). The PP was obtained by the Coulter LH 750
hematology analyzer. Comparisons between means were performed by
analysis of variance. Comparison between 2 means was performed by
using the Student t test. A P value less than 0.05 was considered
signiﬁcant.
Results: A signiﬁcant increase in the SDVI was observed in the
bacteraemic patients compared with the controls (27.86 vs 20.63,
P< 0.001). Such increase was observed even in patients with absolute
neutrophil counts less than 6600/mL) (25.58 vs 20.63, P< 0.001). The
more dramatic increases were seen in patients with neutrophilia (28.75
vs 20.63, P< 0.001).
Table
Control Patients <6600 >6600 P
N= 54 N= 289 N= 81 N= 208
SDVI mean 20.63 27.86 25.58 28.75 <0.001
Conclusion: 1) The SDVI increases in acute infection. 2) Using an SDVI
cutoff of 23, as in bibliography, seems that SDVI is a good predictor
of acute infection. 3) The SDVI increase correlated signiﬁcantly with
neutrophilia but was observed even in patients with neutrophil counts
less than 6600/mL. 4) As a quantitive parameter, the SDVI has potential
use as an additional indicator for diagnosing acute infection.
R2179 Low blood culture bottle ﬁlling volumes in a tertiary
referral hospital in Oman
H. Schuster, K.S. Hassan ° (Muscat, OM)
Objective: Filling volumes of blood cultures are critical. 30−40mL of
patient blood have previously been found to be the optimal volume range
to rule out low-level bacteraemia. According to recently published sepsis
guidelines 20−30mL of patient blood should be cultured. As part of our
six sigma approach to improving healthcare we conducted a two-month
audit into the blood culture bottle ﬁlling volumes at our institution to
assess compliance with the standard ﬁlling volumes.
Methods: Weights of anaerobic and aerobic blood culture bottles were
recorded in a spreadsheet against the bottle barcode number before
circulating them to all wards. On receipt in the laboratory the weight
difference for each individual bottle was recorded and expressed as
collected blood volume. Laboratory episodes, culture result and patient
details were recorded.
Results: 298 paired blood culture bottles contained a mean blood volume
of 4.9mL per each pair.
In total blood cultures for 283 episodes of clinically suspected
bacteraemia were obtained with a mean volume of 5.3mLs blood per
episode. 43 sets (14.4%) and 38 (13.3%) episode cultures were culture
positive. 18 (6%) blood culture sets and 19 (6.7%) episode cultures
represented true bacteraemias.
278 (98.2%) of all episode cultures did not attain the recommended
target blood culture volume of 20mLs. 2 episode cultures attaining the
target volume were culture positive compared with 36 episode cultures
that did attain smaller volumes.
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Conclusions: Our audit revealed high level of non-compliance with the
local and international blood culture ﬁlling volume standards. The level
of non-compliance was so high that the audit was terminated prematurely
in order to take corrective action. In our institution nurses collect blood
samples including blood cultures. Before re-auditing the blood culture
volumes we will implement an intensive educational program for staff
carrying out phlebotomy duties.
In our audit we were unable to compare positivity rates for low ﬁlling
volumes with those culture volumes for which the target volume for the
standard had been attained. This audit proved that it is feasible to carry
out audits into blood culture volumes using individually weighed bottles.
Future work will focus on the comparison of optimally ﬁlled bottles with
underﬁlled bottles with regards to culture positivity rates.
Statistics for total paired blood culture bottles and blood cultures obtained for each septic episode
Total paired
blood culture
bottles
(N = 298)
Septic episodes
(N= 283)
<20mL blood obtained per episode (%) N/A 278 (98.23)
Paired bottle underﬁlled below bottle ranges i.e. <6mL blood (%) 224 (75.17) N/A
Paired bottle underﬁlled below optimal bottle ranges i.e. <16mL blood (%) 290 (97.44) N/A
Positive cultures 43 38
Positive cultures amongst suboptimal ﬁlling volumes 43 36
Positive cultures for blood cultures with >20mL blood obtained 0 2
Catheter-related bloodstream infections 6 3
Blood culture contamination 19 16
True bacteraemias 18 19
Positivity rate
Overall blood culture positivity rate, % 14.43 13.43
True bacteraemia rate, % 6.04 6.71
R2180 Determination of the accuracy and optimal cut-off point
for ELISA test in the diagnosis of brucellosis in Iran
M. Hasibi °, H. Mortazavi, A. Soudbakhsh, G. Esmaeeli Djavid,
M. Hajiabdolbaghi, S. Jafari, H. Emadi, M. Abouzari (Tehran, IR)
Objectives: Brucellosis is a prevalent infectious disease in Iran and
ﬁnding a reliable diagnostic method is the most challengeable problem.
In this study we opted to determine an optimal diagnostic cut-off point
for Elisa test in Iranian brucellosis patients.
Methods: We collected 56 conﬁrmed cases of brucellosis (based on
results of blood culture and standard agglutination test) from Department
of Infectious Diseases, Imam Hospital, Tehran University of Medical
Sciences. Furthermore, blood samples from 126 controls including 73
healthy controls and 53 non-brucellosis febrile patients were collected.
In all of the cases and controls ELISA IgG and ELISA IgM levels were
measured and compared with each other by the means of box plot graph
and receiver operating characteristic (ROC) curve. The sensitivity and
speciﬁcity ELISA IgG and IgM were ﬁxed in different cut-off values and
IgG and IgM levels yielding maximal sensitivity plus speciﬁcity were
selected for determination of optimal cut-off point.
Results: Nineteen patients had positive blood culture for Brucella
melitensis. The standard agglutination test results were 1:160 or more in
54 patients. The box plot graph indicated the high degree of dispersion
for IgG and IgM data in brucellosis patients compared with non-
brucellosis febrile patients and healthy controls. We observed partially
overlapping for IgM but not for IgG levels between cases and controls.
The area under ROC curve for discrimination between cases and healthy
controls were 0.978 and 0.854 for ELISA IgG and IgM, respectively
which were signiﬁcantly different from 0.5 (P< 0.001). In this manner,
the area under ROC curve for discrimination between cases and non-
brucellosis febrile patients were 0.975 and 0.931 for ELISA IgG and
IgM, respectively which again were signiﬁcantly different from 0.5
(P< 0.001). After calculation of sensitivity and speciﬁcity of ELISA
IgG and IgM in different cut-off values, maximal sensitivity (75%) plus
speciﬁcity (100%) for ELISA IgG while maximal sensitivity of 95.7%
plus speciﬁcity of 83.3% for ELISA IgM were observed by cut-off of
50 IU/ml.
Conclusion: The results of present study showed that ELISA IgG is
a more accurate test than ELISA IgM in the diagnosis of brucellosis.
Using a cut-off of 50 IU/ml could be optimal amount for discrimination
patients from controls.
R2181 Predictive model of anaerobic bacteraemias
J.M. Ruiz-Giardin °, A. Noguerado, A. Barrios, J.V. San Martin,
N. Cabello, J. Hinojosa, R. Carrillo, C. Jimenez, J. Ortiz (Madrid, ES)
Objective: To develop and validate a model for the prediction and
diagnosis anaerobic bacteraemias.
Methods: The developing model was created in a urban tertiary care
hospital, and the validating model in a urban secondary care hospital.
It’s a prospective cohort study with derivation and validation set. The
derivation set was collected in the tertiary care hospital during 1986, and
1996 (984 episodes of bacteraemia), and the validation set was collected
in the secondary care hospital in 2005–2006 (320 bacteraemias).
Results: The derivation set was studied analysing 938 true aerobic
bacteraemias in front of 46 true anaerobic bacteraemias. Independent
multivariate predictors of true anaerobic bacteraemia were used to
develop a model stratifying patients with puntuations of 0 to 11 points,
and they were: unknown bacteraemia focus OR 1.13 (IC 1.13–10.54)
3 points (p); abdominal, and skin focus OR 14.85 (IC 6.37–34.62)
6p; hypotension OR 1.99 (IC 0.98–4.04) 2p; absence of vascular
manipulations OR 2.62 (IC 1.04–6.60) 2p; age between 40−60 years
OR 1.60 (IC 0.51–5.04) 1p; and age over 60 years OR 3.21 (IC 1.19–
8.67) 3p. In the derivation set’s group with 6 or more points there
are 331 aerobic bacteraemias and 40 (12%) of them are by anaerobic
bacteraemias. These 40 bacteraemias are the 87% of all the anaerobic
bacteraemias diagnosticated in the derivation set group. The positive
predictive value with more than six points is of 13%, with a sensibility
(S) of 80.4%.
The validation set was studied analysing 320 bacteraemias. The 83.6%
(IC95% 71.19%-92.23%) of anaerobic bacteraemias have more than 7
points, and 72.7% have more than 9 points. S:83.6%, E: 73.6%.
The 26.4% (IC95% 21.2%-32.15%) of aerobic and facultative anaerobic
bacteraemias have more than 7 points, and only the 11.7% have 9 or
more points. The difference of anaerobic bacteraemias with more than
7 points and the aerobic and aerobic and facultative anaerobic ones has
a signiﬁcance <0.05.
Conclusion: Abdominal, and skin focus OR 14.85; hypotension
OR 1.99; absence of vascular manipulations OR 2.62; age between
40−60 years OR 1.60 and age over 60 years let us to make a predictive
clinical model of probability of anaerobic bacteraemia with a high
sensibility and especiﬁcity.
R2182 Isolation and identiﬁcation of Ureaplasma urealyticum and
Mycoplasma hominis: comparison of two methods
S. Baka °, I. Karanikolas, E. Logothetis, E. Kouskouni (Athens, GR)
Objectives: Ureaplasma urealyticum (U. urealyticum) and Mycoplasma
hominis (M. hominis) have been associated with a plethora of clinical
manifestations on the genital system of women. The purpose of our study
was to compare two methods of isolation of these two mycoplasmas from
the vaginal secretions of symptomatic women.
Methods: Vaginal samples from symptomatic women presenting to the
Outpatient Clinic of Aretaieion Hospital were studied. We included in
the present study 168 samples from an equal number of women positive
for U. urealyticum and M. hominis which were isolated by two different
methods. One was the commercial kit Mycoplasma IST2 (BioMerieux,
France) and the other Mycoplasma HUF (Bioprepare G. Papanikolaou
S. Sofou, Gerakas, Attika, Greece). After inoculation onto the respective
nutrient medium the samples were incubated at 36–370C in aerobic
conditions and checked at 24 h and 48 h.
Results: Out of the 168 samples, at 24 h 122 (72.6%) U. urealyticum
were identiﬁed by Mycoplasma IST2 with 54 (32.1%) of them being
in a concentration of >104 CFU/ml while 124 (73.8%) U. urealyticum
were positive by Mycoplasma HUF and 48 (28.6%) of these were in a
concentration of >104 CFU/ml. At 48 h 138 (82.1%) U. urealyticum were
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identiﬁed by Mycoplasma IST2 and 136 (81.0%) were in a concentration
of >104 CFU/ml while 138 (82.1%) U. urealyticum were identiﬁed
by Mycoplasma HUF and 120 (71.4%) were in a concentration of
>104 CFU/ml. On the other hand, at 24 h with both methods were
identiﬁed 24 (14.3%) M. hominis. Four (2.4%) of these were isolated in
a concentration of >104 CFU/ml by Mycoplasma IST2 and 18 (10.7%)
with Mycoplasma HUF. At 48 h by both methods were isolated 30
(17.9%) M. hominis out of which 18 (10.7%) were in a concentration
of >104 CFU/ml by Mycoplasma IST2 and 26 (15.5%) by Mycoplasma
HUF.
Conclusions: Both methods proved to be sensitive in the isolation
and identiﬁcation of U. urealyticum and M. hominis. However, taking
into consideration the quantitative detection more U. urealyticum were
isolated using the Mycoplasma IST2 method and, on the contrary, more
M. hominis with the aid of Mycoplasma HUF.
R2183 Performance characteristics of an anti-Typhi Vi IgG ELISA
J. Harley °, R. Budd, D.J. Taylor, S. Starling, A.R. Bradwell
(Birmingham, UK)
Objective: To investigate performance characteristics of the Vacc-
ZymeTM anti-Typhi Vi IgG EIA with respect to reproducibility, linearity
and normal incidence.
Background: Salmonella typhi is a Gram-negative bacterium which
causes the systemic febrile illness typhoid fever. The disease can be fatal
if untreated killing around 10% of the people infected. Vaccination with
the puriﬁed Vi capsular polysaccharide can protect adults and children
>18 months against typhoid fever. A patient’s speciﬁc antibody response
to the vaccine may be evaluated by the serological determination of their
IgG anti-Typhi Vi antibody levels pre- and post-vaccination. Patients
with suspected immunodeﬁciency may be investigated by assessing their
ability to respond to speciﬁc polysaccharide antigens like those present
in the Typhi Vi vaccine.
Method: Anti-Typhi Vi antibodies were determined using the
VaccZymeTM Anti-Typhi Vi IgG EIA kit (The Binding Site, UK). The
incidence of antibody was assessed in 200 normal UK blood donors
of unknown immune status. Intra-assay reproducibility was determined
on eight samples (20 replicates) and inter-assay precision was tested
on eight samples in duplicate, on six separate occasions. Linearity was
demonstrated on three high titre sera.
Results: The incidence of anti-Typhi Vi IgG antibody in 200 normal
blood donors was shown to not follow a normal distribution (Shapiro-
Wilk p< 0.0001) with a 95% conﬁdence interval of 34.4–60.3U/ml.
Performance characteristic Anti-Typhi Vi IgG
Intra-assay reproducibility (%CV) 3.2–6.3
Inter-assay reproducibility (%CV) 6.1–12.6
Linearity R2 >0.999
Linearity % recovery 90
Conclusion: The distribution of IgG antibodies to Typhi Vi in the
samples tested is illustrative of a population where the disease is not
endemic and vaccination is given to targeted individuals only. The
VaccZymeTM anti-Typhi Vi IgG assay demonstrates excellent linearity
and reproducibility. By testing pre and post-immunisation paired sera
the assay will be of value to aid diagnosis of individuals suspected of
immunodeﬁciency.
R2184 Evaluation of different immunoassays on Liaison®
M. Piqueur °, I. Opdenbergh, D. Baetens (Antwerp, BE)
Objectives: Our aim was to evaluate different serological assays
on the Liaison® (DiaSorin), a fully automated analyser based on
chemiluminescence technology, by comparing them with our routinely
used methods for antibody detection against cytomegalovirus (CMV),
Epstein-Barr virus (EBV), herpes simplex virus (HSV), varicella
zoster virus (VZV) and Borrelia burgdorferi (ELISA on BEP 2000
Advance®, Siemens); rubella virus and Toxoplasma gondii (Access®,
Beckman Coulter) and Treponema pallidum (INNO-LIA™ syphilis kit,
Innogenetics).
Methods: DiaSorin controls were used to determine within-run
imprecision (CV%). Samples classiﬁed as positive by routinely used
methods mentioned above, were used: CMV (31 IgM; 28 IgG), EBV
(28 IgM; 27 IgG), HSV (51 IgG), VZV (24 IgG), B. burgdorferi (10
IgM; 37 IgG), rubella virus (49 IgM; 38 IgG), T. gondii (17 IgM; 12 IgG)
and T. pallidum (total Ig 56). Also a number of negative routine samples
were analysed. Discordant results were retested with both methods and/or
compared with a third method (VIDAS®, bioMerieux or Western blot).
Results: CV’s were acceptable and comparable to those claimed by
DiaSorin ranging from 5.6%-20.6%.
For CMV, EBV, HSV, VZV, rubella virus and T. gondii IgG assays
agreement ranged from 90 to 100%. B. burgdorferi IgG agreement was
86%; 5 samples were found negative on Liaison® while earlier positive
in ELISA. For T. pallidum total Ig, all 56 INNO-LIA™ positive samples
were detected by Liaison®. The 10 ELISA positive CMV IgM’s negative
on Liaison® were conﬁrmed as negative by VIDAS®. All ELISA positive
samples for EBV IgM screened positive on Liaison®. Out of 20 EBV
IgM negative samples, 3 were equivocal on Liaison®. All B. burgdorferi
IgM ELISA positives were positive on Liaison®; out of 37 IgM negative
samples 6 were positive or equivocal on Liaison®. Out of 17 T. gondii
IgM positives 6 were negative on Liaison® and also on VIDAS®. Out
of 49 rubella virus IgM samples tested positive by Access®, 34 yielded
a negative result on Liaison® of which only 5 were conﬁrmed positive
by VIDAS®.
Conclusion: Most of the evaluated IgG assays on Liaison® showed a
good concordance with our routine methods. Further analyses will be
done to draw a conclusion on sensitivity and speciﬁcity for IgM assays.
In our opinion, the Liaison® offers a reliable and easy method for the
evaluated serological assays with a high grade of automation, short turn
around times and the ability to run up to 15 different immunoassays at
a time.
R2185 Evaluation of the IMMULITE 2000 Syphilis Screen Assay in
comparison with Treponema pallidum particle agglutination
F. Vlaspolder °, P. Singer (Alkmaar, NL)
Objectives: In this study we compared the IMMULITE 2000 Syphilis
screen assay with the Treponema pallidum particle agglutination (TPPA).
Methods: Totally 322 sera, in which, 150 sera derived from women
who were in their third month of pregnancy, 48 sera with a known
reactive TPPA (Fujirebio®) result and 124 ad random sera asked for
syphilis serology testing. IMMULITE 2000 Syphilis screen assay is a
solid phase, one-step chemoluminescent enzyme immunoassay. The solid
phase (beads) is coated with puriﬁed recombinant Treponema pallidum
(Tp 17) antigen. The assays were performed on the IMMULITE 2000
instrument (Siemens®)
Results: The agreement between the two test methods was 98%
(315/322). The sensitivity, speciﬁcity, negative (NPV) and positive
predictive values (PPV) were 94%, 100%, 98%, and 98%, respectively.
The resolved results using FTA-abs to conﬁrm TPPA are given in table
1. The sensitivity, speciﬁcity NPV and PPV were all 100%.
IMMULITE 2000 Treponema pallidum particle agglutination (TPPA)
Positive Indeterminate Negative Total
Positive 44 1* 0 45
Indeterminate 1* 0 0 1
Negative 3** 3** 270 276
Total 48 4 270 322
*FTA-abs: positive; **FTA-abs: negative.
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Conclusion: The agreement, sensitivity, speciﬁcity, negative and positive
predictive values are comparable with the TPPA.
The conﬁrmed reactive results in both screening methods showed less
false positives in the IMMULITE 2000 Syphilis screen assay.
The mostly manually performed TPPA can be replaced by a fully
automated system.
R2186 Evaluation of the new Bio-Rad Platelia™ Toxo kits for the
detection of toxoplasmic IgM, IgG and IgG avidity
J. Jung °, O. Villard, M. Kirschving, M. Gehres, T. Steinmetz,
E. Candolﬁ (Strasbourg, FR)
Bio-Rad has revisited his current offer for Toxoplasmosis in order to
improve the practicability and performance to current assays. The new
Platelia™ Toxoplasmosis assays (IgG, IgM and IgG avidity assays) is
offering full-automation with cancellation of pre-wash step, new sample
dilution, ready to use TMB substrate, standardised washing solution,
improvement of conjugate preparation and stability.
Objectives: The aim of this study was to compare the results obtained
with these new versions of Platelia TM TOXO kits versus the former
one for the detection of anti-Toxoplasma gondii IgM or IgG and the
determination of IgG avidity, in a retrospective study in the routine
conditions of our laboratory.
Methods: Previous and new versions of the kits were used strictly
following manufacturer’s recommendations on EVOLIS™ automated
system.
Material: 2 to 3 successive samples from 49 acute toxoplasmosis (AT)
(100 samples); 100 cases from chronic toxoplasmosis (CT). CT samples
were divided into one group with both IgM and IgG positive (CT-Mpos)
and one group with IgG positive and IgM negative (CT-Mneg).
Results: In all groups, IgG were 100% concordant, and IgM 95.4%.
Among the ten IgM discordant cases, 6 belonged to 3 AT patients and
allowed earlier detection of seroconversion. The 4 other sera were from
CT-Mneg group and the detected IgM were considered as long-lasting
toxoplasmic IgM. IgG avidity was concordant in 95.7%. Among the 8
discordant cases, 3 of them belonged to CT-Mneg group which shifted
from high to intermediate avidity, they were immunocompromised
patients. The 5 remaining discordant cases belonged to AT (avidity
stepped from low to intermediate) and CT-Mpos groups (avidity stepped
from high to intermediate). One of them, the second sample of the
AT case, was considered as an already subacute toxoplasmosis, and
the two others discordant sera from CT-Mpos were considered as still
subacute toxoplasmosis, 6−12 months post-primary infection; ﬁnally, the
2 remaining discordant cases were determined as at least 2 years old CT.
Conclusions: The new Platelia™ TOXO kits are user-friendly; IgM
detection is greatly improved; IgG avidity determination is generally
more accurate and brings to indeterminate section, patients with
subacute toxoplasmosis or uncertain toxoplasmic status such as
immunocompromised patients.
R2187 Comparative analysis of simulated candidaemia by using
2 different blood culture systems and rapid identiﬁcation
of Candida albicans
M.K. Lee °, B.R. Park, T.H. Kim (Seoul, KR)
Objectives: To determine the time to detection of Candida species
isolated from the 2 most common automated blood culture systems
and to evaluate rapid and widely available methods for presumptive
identiﬁcation of Candida albicans (C. albicans).
Methods: Simulated candidaemia models of 8 commonly detected
Candida species were prepared by ATCC standards. The time to
detection was evaluated with BACTEC 9240 (Becton Dickinson) and
BacT/Alert 3D (bioMerieux). The presence of pseudohyphae clusters
by Gram stain and wet preparation was examined. The germ tube test
was performed directly from the blood culture bottles. All samples were
cultured on blood agar plates and macroscopically examined for the
presence of an irregular margin (spiking).
Results: Most Candida species (6/8) except C. glabrata and C. krusei
grew more rapidly, which were detected in aerobic bottles than in
anaerobic bottles. The clusters of pseudohyphae were observed in
cultures of C. albicans and C. tropicalis. All culture bottles that
detected C. albicans showed positive results for germ tube tests and
macroscopically showed a “spiking”.
Conclusion: Aerobic and anaerobic blood culture systems can effectively
detect candidaemia. In addition, the direct germ tube test may be the most
useful morphological presumptive identiﬁcation method for C. albicans.
R2188 Assessment of sputum Gram stain and culture for
S. pneumoniae and Haemophilus spp. in the aetiologic
diagnosis of lower respiratory tract infections in the
European GRACE study
M. Ieven °, C. Lammens, K. Loens, T. Verheij, P. Little, H. Goossens
on behalf of the GRACE Study Team
Objectives: To evaluate the usefulness and yield of sputum Gram stain
and culture when applied routinely in the aetiologic diagnosis of Lower
Respiratory Tract Infections (LRTI) in the European GRACE study.
Methods: From October 2007 through May 2008, a total of 711 adult
patients with LRTI in the community were included during the ﬁrst
winter period in a 3 year prospective study in 11 primary care networks
in 8 European countries. Among other respiratory samples, sputum
specimens were collected before possible antibiotic therapy was started
for the aetiologic diagnosis. Specimens were sent to the local laboratory
and processed immediately. Specimens were scored according to the
number of leucocytes (WBC) and squamous epithelial cells: specimens
with ratios of WBC/epithelial cells >1 were deﬁned as good quality
sputa, ratios =1 were considered microscopically valid. Gram Stain and
culture were performed according to a standardised protocol. Culture
was considered diagnostic when S. pneumoniae or Haemophilus spp
were isolated as a predominant microorganism.
Results: Of the 711 patients included, 538 (75.7%) of patients were able
to produce a sputum sample: 254 (47.2%) of these were of good quality.
139 (25.8%) of sputa were microscopically valid with equal numbers
of WBC and epithelial cells; 27% of sputa contained more epithelial
cells than WBC and were considered salivary contamination. A total of
117/538 (21.7%) of sputa were culture positive for S. pneumoniae and
Haemophilus spp. In good quality sputa, culture positivity increased
to 84/254 (33.0%): 80 (14.9%) of sputa were culture positive for
Haemophilus spp, 37 (6.9%) were positive for S. pneumoniae. Analysing
the results in correlation with quality showed that 59/80 (73.8%)
of Haemophilus spp and 25/37 (67.6%) all S. pneumoniae positives
were from good quality sputa respectively; another 12/80 (15.0%) and
6/37 (16.2%) were isolated, respectively, from sputa with a ratio of
WBC/epithelial cells =1.
A predominant morphotype in Gram stain was observed in 53/80 of
Haemophilus spp and in 33/37 of S. pneumoniae positive sputa resulting
in sensitivities of 66.3% and 89.2% respectively.
Conclusion: In this primary care setting a good quality sputum sample
can be obtained from a considerable number of patients who present
with LRTI and culture of these specimens had a good diagnostic yield.
Gram stain is more sensitive for the detection of pneumococcal LRTI
compared to the detection of Haemophilus spp.
R2189 Usefulness of chromoID VRE agar for the detection of
vancomycin-resistant enterococci in faecal specimen
J.D. Chae °, K.D. Lee, H.S. Lee, S.S. Oh (Seoul, KR)
Objectives: Rapid and accurate screening methods are required to
effectively control spread of vancomycin-resistant enterococci (VRE)
and for the successful management of colonised or infected patients.
However, conventional culture methods take long time for detection
of VRE. We compared the performance of chromoID VRE agar
(bioMe´rieux, Marcy-l’Etoile, France) designed to recover and identify
S646 19th ECCMID, Abstracts accepted for publication only
VRE from clinical specimens with conventional blood agar plate (BAP)
based culture.
Methods: From 1, December, 2007 to 31, January, 2008, rectal swab
specimens were received for the detection of VRE and they were
inoculated blood agar plate and suspicious VRE isolates subcultured
and conﬁrmed by Vitek 2 (bioMe´rieux, Marcy-l’Etoile, France). From
1, February 2008 to 30 April 2008, surveillance VRE screening cultures
performed directly chromoID VRE agar (bioMe´rieux, Marcy-l’Etoile,
France) admitted new patients in intensive care unit (ICU). No suspicious
growths of chromoID VRE agar plate reported No-VRE. Suspicious
growths of chromoID VRE agar plate conﬁrmed by Vitek 2.
Results: 127 specimens from 31 patients were conﬁrmed VRE by
conventional blood agar methods. 153 specimens from 31 patients
were conﬁrmed VRE by chromoID VRE agar methods. 202 specimens
from 202 patients were conﬁrmed non-VRE by chromoID VRE agar
methods. The average time for reporting VRE positive specimen was
5days 23hours 50minutes by conventional methods. The average time for
reporting VRE positive specimen was 3days 6minutes by chromoID VRE
agar methods. The average time for reporting VRE negative specimen
was 1days 7hours 28minutes by chromoID VRE agar methods.
Conclusions: ChromoID VRE agar methods revealed the shortest time
for reporting VRE and non-VRE. ChromoID VRE agar proved to be
a sensitive, speciﬁc and rapid method of detection VRE for VRE
surveillance.
R2190 Evaluation of Robobact system for isolation of Salmonella
sp. in faecal samples
R. Pavo´n, M.D. Martı´n, A. Sa´nchez, L. Molina, C. Campelo, I. Buhigas,
A. Delgado-Iribarren ° (Madrid, ES)
Objective: To validate a Robobact System for isolation of Salmonella
sp in faecal samples compare to conventional methods.
Introduction: The development of new methods to improve the
automation of the Microbiology laboratory seems necessary considering
the present low disponibility of qualiﬁed human resources.
Methods: 630 samples of liquid or semi liquid faeces have been
studied and compared in our unit both by 1. conventional methods,
agar Salmonella–Shigella − SS − and Hektoen direct culture and
subculture of selenite broth after 24 hours of incubation, and 2.
Robobact system with SS and Hektoen media following manufacturer’s
protocol. Robobact system is an automatic sewing method after a
6 hour pre-incubation of the sample in selenite broth at 37ºC. The
preliminary identiﬁcation of colonies Salmonella-compatibles was done
using enterotube (Becton Dickinson) or the agglutination of antiserum
(Oxoid) with ﬁnal identiﬁcation and sensibility study using MicroScan
Walkaway (Siemens).
Results: 613 cases have been evaluable (including the results of both
methods) recovering a total of 54 isolates (8.8%), 51 (8.3%) using
Robobact, and 49 (8.0%) using the conventional method, obtaining an
excellent correlation between both methods (Kappa coefﬁcient 0.913).
The performance of the culture media of Robobact was of 47 (7.7%)
isolated cases detected in the SS agar and 42 (6.9%) in Hektoen agar. In
17.6% of the samples processed by Robobact in SS and in a 15.3% in
Hektoen agar no growth was detected, not isolating Salmonella by the
conventional method.
Conclusion: We have obtained the best sensibility using two culture
media (SS and Hecktoen). Robobact system may simplify the
observation of cultures due to the pre-incubation time before sowing,
taking into account that more than a 15% of the samples didn’t
show any growth without detecting Salmonella sp by the conventional
method. Furthermore, Robobact has decreased working and response
time. All together these results show that Robobact is a valid method for
Salmonella sp isolation in our microbiology laboratory.
R2191 Efﬁcient antibody panel for the correct diagnosis of
Epstein-Barr virus
D. Marchetti ° (Bologna, IT)
Objectives: Epstein-Barr virus (EBV) is responsible for infective
mononucleosis, a disease which affects only 5% of young adults in
Western countries, as the majority of the population is immune having
contracted an asymptomatic EBV infection in early childhood. The aim
of this study was to evaluate the most useful diagnostic parameters to
conﬁrm or exclude EBV infection in immunocompetent patients with
highly suspicious symptoms for the disease
Methods: Between January and June 2008, we received 1336 requests
for serodiagnosis of EBV infection by determination of anti-VCA IgG
and anti-EBV IgM antibodies; some samples required also determination
of anti-EBNA IgG antibodies. The samples came from subjects of
all ages, but particularly from young adults. The antibodies were
detected using the Liaison® EBV IgM, VCA IgG and EBNA IgG
chemiluminescent assays in accordance with the instructions provided
by the manufacturer (DiaSorin, Saluggia − Italy).
Results: EBV IgM antibodies were found in 19.4% of the samples,
whereas 74.8% were negative; VCA IgG antibodies were positive in
80.9% of the samples and negative in only 19.1%. Of the 167 samples in
which anti-EBNA IgG antibodies were determined, 62.9% were positive
and 32.3% negative.
Conclusion: The results show the importance of determining anti-EBNA
IgG antibodies in the serodiagnosis of EBV infection as the detection
of anti-EBV IgM antibodies, alone, may not be sufﬁcient to conﬁrm or
exclude it. In our experience, the determination of anti-EBNA antibodies
has proved to be very useful tool in discriminating the different phases
of EBV infection, allowing us to offer clinicians an extremely efﬁcient
parameter to diagnose acute or previous infection.
R2192 Can the nucleic acid ampliﬁcation test be an alternative to
the serologic tests? A prospective study − results of 18,200
blood donors from Turkish Red Crescent
E. Kosan, B. Kocazeybek, H. Altunay, M. Aymelek, E. Alan,
S. Saribas °, M. Aslan, O.S. Yenen, P. Yuksel, I. Birinci, K. Kirali,
A. Aksoy (Istanbul, Ankara, TR)
Aim: Serologic tests having high sensitivity and speciﬁcity are used
in order to prevent contamination with infectious agents from blood
and blood products for transfusion safety.. Present serologic tests have
problems like having low sensitivity and weak detection capacity of
infectious agents in “window period”. We aimed to test the use of NAT
(Nucleic Acid Ampliﬁcation Test) in routine blood screening in Blood
Banking.
Method: We used Procleix ultrio (Chiron, USA) test kit based TMA
(Transcription Mediated Ampliﬁcation) for NAT study in serum samples
of 18200 donors who were applied to the Turkish Redcrescent between
February 2007-September 2008. The NAT positive samples were studied
twice. The discrimination of HIV, HCV and HBV of NAT positive
samples were performed by Procleix Discrimination (Chiron, USA) test.
Otherwise Micro ELISA were used parallely for routine serological
screening of Anti-HIV, Anti-HCV and HBsAg with Vironoste HIV Uni-
form, AG/Ab innotest HCV Ab and Hepanostica ultra HBsAg test kits.
Results: The results of serum samples with serology(+) and NAT(+)
(13/18200 and 0.05%) for Anti-HIV, Anti-HCV and HBsAg were
detected higher than other NAT studies and we also detected that a
transfusion risk can be occurred in every 1400 transfusions.
Table 1. Serologic tests and NAT results
Patterns Anti HIV/1–2 Anti-HCV HBsAg
Serology(+) NAT(−) 19 59 17
Sero1ogy(−) NAT(+) − 2 11
Serology(+) NAT(+) 3 9 297
Diagnostic/laboratory methods (other than molecular) S647
Conclusion: We suggest that the reason for this higher positive
NAT results can be due to donating status of blood donors. Blood
donors(almost 100%) of our study were donating the ﬁrst time. On the
other hand, the cost of NAT test are very higher compared with other
serologic tests. As a result of we suggest that it is not necessary to apply
NAT tests to the all of the blood donors because of the NAT tests are
not being cost-effective. We can also advice to apply the NAT tests to
the blood donors who will donate the ﬁrst time.
R2193 Periodontal pathogenic bacteria diagnostic methods for
halitosis patients in Latvia
D. Rostoka °, J. Kroica, A. Reinis, V. Kuznecova (Riga, LV)
Objectives: Bad breath is a frequent problem in Latvia and thus for many
patients may cause signiﬁcant patients distress. Oral bacteria hydrolyze
proteins and further degrade amino acids, which leads to halitosis.
Gram-negative oral anaerobes, such as Porphyromonas, Tannerella,
Prevotella, Treponema spp., produce volatile sulphur compounds (VCS)
from sulphur-containing amino acids. In advanced cases, signiﬁcant
amounts of the malodorous components produce high levels of volatile
sulfhur compounds (VSC), especially hydrogen sulphide and methyl
mercaptan, dimethyl sulphide disulphide cysteine, cysteine, methionine,
indole, lactic acid and other compounds, which are mostly derived from
the affected sites. Preliminary investigation data show that the reason
of bad breath or halitosis often is periodontal diseases and periodontal
pathogens.
Methods: The study began in 2001 and included 358 untreated halitosis
patients (45.4 year, 201 females, 157 males). The periodontal pocket
and dorsal part of tongue microﬂora was analysed by quantitative PRC
(micro-IDent®, Hain Lifescience, Germany) for amounts of periodontal
pathogenic bacteria: Actinobacillus actinomycetemcomitans, Porphy-
romonas gingivalis, Tannerella forsythietensis, Treponema denticola, and
Prevotella intermedia. Periodontal pathogens were analysed before and
after periodontal treatment. ANOVA, t-test, and chi-square were used
to detect statistically signiﬁcant differences. Bad breath was conﬁrmed
by measurements made by a portable sulphide monitor or halimeter
(Interscan Corporation, Model RH-17E USA).
Results: Halimeter measurements of 358 patients showed increased
levels of VSC (380 ppb compared with the control group 40−70 ppb).
Before periodontal treatment high level of ﬁve periodontal pathogens
was both in periodontal pockets and dorsal part of tongue. After planed
treatment increased level of periodontal pathogenic bacteria was 71.5%
(p< 0.0001) patients in dorsal part of tongue microﬂora.
Conclusion: Halitosis can be diagnosed and monitored using different
methods, among which halimetric examination is particularly useful.
Since there is present protein degradation in the oral cavity and increased
amount of VSC we can conclude that there are changes in oral microﬂora
with a large prevalence of oral anaerobes. That explains the frequent
incidence of periodontal diseases in Latvia. Data show that halitosis,
increased amount of VSC correlate with increased level of periodontal
pathogenic bacteria.
R2194 Diagnostic value of procalcitonin in the early detection of
the infection and prognostic and evolutive value in sepsis.
Comparison with C-reactive protein and leukocyte count
A. Galar °, M. Espinosa, N. Varo, F. Guille´n-Grima, J.R. Yuste, J. Leiva
(Pamplona, ES)
Objectives: Procalcitonin (PCT) is a precursor of the hormone calcitonin
and is produced by the C-cells of the thyroid gland.
Our purpose is to study the utility of the PCT as an acute-phase reactant
in the diagnosis of infections of different aetiology in comparison with
C-Reactive Protein (CRP) and leukocyte count; and his prognostic and
evolutive value in sepsis.
Methods: Clinical and laboratory data of 522 patients (mean age,
65 years) were analyzed. Determinations of serum PCT were performed
with a semiquantitative immunochromatograﬁc test (BRAHMS PCT-Q).
Test values were <0.5 ng/mL, 0.5−2 ng/mL, 2−10 ng/mL and >10 ng/mL.
CRP was determined by an immunoturbidimetric method (CRPLX
Tina-quant. Roche) and leukocyte count by an impedance spectroscopy
technique (Pentra 120. ABX Diagnostics). The presence of bacterial,
viral, parasitic or fungal infections was obtained from routine
microbiological analyses. ROC curves were employed to calculate the
sensitivity, speciﬁcity and cut-off values to predict all kind of infections.
Results: Studying globally all the infectious diseases, we observe that for
concentrations higher than 10, the PCT presents a major diagnostic value
of bacterial infections with regard to viral, fungal and parasitic infections.
These differences are not observed in CRP and leukocyte count values.
Analysing our results we verify that inside the bacterial infections,
the PCT only would have diagnostic value besides sepsis [AUC:0.82
(0.78–0.87)], in abdominal infections [AUC:0.67 (0.59–0.75)]. We found
signiﬁcantly more cases of mortality in the ﬁrst 15 days for patients with
PCT’s values >0.5 (OR= 2.810). We observe a signiﬁcant decrease of
PCT’s values in patients treated with antibiotics adapted to their type
of infection, which suggests that infection is under control and a good
prediction. For PCT’s values of 2−10 in the cases of sepsis, a signiﬁcantly
major number of Gram negative bacteria was isolated opposite to Gram
positive. Nevertheless, we do not ﬁnd signiﬁcant differences between a
range of PCT’s values and the detection of a certain microbial species.
With regard to the risk of mortality we do not observe statistically
signiﬁcant differences between bacteria Gram positive or negative.
Conclusions: The measurement of PCT in serum is better to identify
patients with bacterial sepsis than CRP and leukocyte count. PCT value
is an useful marker for monitoring the antibiotic treatment.
R2195 Impact of rapid identiﬁcation of Staphylococcus aureus
directly from blood cultures using PNA FISH technology
P. Della-Latta °, S. Whittier, F. Wu (New York, US)
Objectives: This study compared the performance of the new Rapid
peptide nucleic acid ﬂuorescent in situ hybridisation (PNA FISH) assay
(AdvanDx) to that of the Standard PNA FISH for identiﬁcation of
S. aureus from blood culture bottles positive for Gram-positive cocci in
clusters. The rapid assay shortens time to pathogen detection from 3 hrs
using the Standard PNA FISH to 2 hrs, expediting prudent therapeutic
and infection control decisions.
Methods: Two smears from 33 blood culture bottles newly positive
for Gram-positive cocci in clusters were prepared and assayed by
both the Standard and the Rapid PNA FISH (AdvanDx, Woburn MA)
methods, following manufacturer’s instructions. This assay uses colour
labeled ﬂuorescent PNA probes targeting speciﬁc rRNA sequences;
slides are examined with a ﬂuorescent microscope. Smears positive for
S. aureus appear as bright green cells. Routine culture identiﬁcation
of staphylococci was performed from blood culture media using
Staphaurex (Remel, Lenexa KS) and MicroScan (Siemens Healthcare,
Tarrytown, NY).
Results: Of the 10 S. aureus isolates recovered from the positive blood
cultures, 8 were methicillin-susceptible and 2 were methicillin-resistant.
The remaining 23 staphylococci were coagulase-negative (CoNS), 48%
were Staphylococcus epidermidis. The sensitivity, speciﬁcity, positive
and negative predictive values of both the Rapid and Standard PNA FISH
assays for S. aureus identiﬁcation were 100% when compared to routine
identiﬁcation methods. The correlation of the Rapid with the Standard
PNA FISH assays was 100%. No false-positive or false-negative results
were found.
Conclusions: The Rapid PNA FISH correlates 100% with the Standard
assay and can be utilised to rapidly and accurately identify S. aureus
and differentiate this pathogen from CoNS directly from newly positive
blood cultures using inexpensive ﬂuorescent microscopy. This assay is
a cost-effective and user friendly alternative to molecular methods for
detection of staphylococcal bacteraemia in real-time.
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R2196 Correlation between serum levels of ceruloplasmin and
acute phase proteins and oxidative stress markers in
patients with sepsis
M. Lupse °, S. Suciu, D. Daicoviciu, M. Flonta, C. Cismaru,
M. Munteanu, V. Zanc, N. Todor (Cluj-Napoca, RO)
Background: Acute phase proteins (APP) are elevated in systemic
inﬂammation such as sepsis. Most studied acute phase proteins were:
C Reactive Protein (CRP), ﬁbrinogen, Procalcitonin (PCT), Alfa 2
macroglobulin, haptoglobin and alfa 1 acidic glycoprotein. In many
inﬂammatory conditions the markers of oxidative stress are also elevated.
Ceruloplasmin is considered both an acute phase and an antioxidant
protein.
Objective: this preliminary prospective study compares serum levels
of ceruloplasmin to acute phase protein (CRP, ﬁbrinogen, PCT) and
oxidative stress markers, such as malonaldehyde (MDA) in patients with
sepsis.
Materials and Methods: All patients admitted in Teaching Hospital
of Infectious Diseases Cluj-Napoca, Romania, between Jan-June 2008,
diagnosed with sepsis according to ACCP/SCCM, were tested in the
ﬁrst day for serum concentration of acute phase proteins and oxidative
stress markers. PCR was measured by turbidimetric method, ﬁbrinogen
by Claus method, PCT by the semiquantitative immunochromatographic
BRAHMS Diagnostica method, CRP by Ravin method and MDA by
spectroﬂuorimetry, using thiobarbituric acid. As statistic analysis we
performed ANOVA score and correlation coefﬁcient Pearson.
Results: Twenty patients (13 males), mean age 51.9 years (median
50.5 years). We found high levels of CRP (mean 12.2mg/dl, CI
8.9−15.5mg/dl), ﬁbrinogen (mean 679.2mg/dl, CI 551–807mg/dl) and
PCT (90% of the values were above 0.5 ng/ml). By the contrary,
ceruloplasmin levels were lower than normal (mean 22.1, CI 19.7–
24.5mg/dl). MDA levels were high (mean 3.9 nmol/ml, CI 3.3−4.5
nmol/ml). We found a positive correlation between ceruloplasmin and
both ﬁbrinogen (r = 0.7, p< 0.01) and MDA serum concentrations
(r = 0.61, p< 0.01) and no correlation with the other acute phase proteins.
Conclusions: 1. Acute phase proteins and oxidative stress markers are
increased in sepsis. 2. We view ceruloplasmin as being an oxidative
stress marker rather than an acute phase protein in patients with sepsis.
Methods for antibacterial susceptibility
testing
R2197 Direct susceptibility testing of respiratory samples in the
guiding of antimicrobial treatment in ventilator-associated
pneumonia
F. Kontopidou °, I. Galani, I. Karadani, F. Panayea, H. Giamarellou
(Athens, GR)
Background: The purpose of this study was to evaluate a direct
antimicrobial susceptibility method by E-test, disk diffusion and
antibiotic containing media for guiding adequate and rapid antimicrobial
therapy in ventilator-associated pneumonia (VAP), compared to standard
microbiological procedures (MIC determinations).
Methods: The study was performed in a 21-bed ICU of a University
General Hospital in Athens. In a four month period once weekly,
bronchial aspirates (BA) were obtained from each hospitalised patient
and were streaked directly on MacConkey agar plates containing
each of the antibiotics: Ciproﬂoxacin 2mg/L, Meropenem 4mg/L,
Piperacilline/Tazobactam 32/4mg/L, Colistin 4mg/L and Vancomycin
(VAN) 6mg/L and in two Muller-Hinton agar(MHA) plates. In the MHA
plates E-test strips and disks of the above antibiotics and Tigecycline
were immediately placed. After 24 hours of incubation, antibiotic
susceptibility was determined according to CLSI breakpoints. All
samples were also pocessed by standard microbiological methodology.
Results: Among 198 BA that were performed, 166 were positive
resulting in 298 isolates (A. baumannii 38%, P. aeruginosa 24%,
K. pneumoniae 7.5%, S. aureus 5.2%, other Gram(−) 20%). Resistance
rates of Gram(−) to carbapenems and colistin were 64% and 16.5%
respectively. In total 34% were polymicrobial specimens (80 BA with
2 isolates and 10 BA with 3 isolates) and 62% with quantitative
cultures of 10(4). The use of E-test, Disk Diffusion and Antibiotic
Containing Media results would have been administrated in the
appropriate therapeutic regiment in 76%, 82% and 53% respectively.
The sensitivity of Etest and Disk Diffusion method was increased in
BA with quantitative cultures of 10(4) independently the number of
the isolates. Most discrepancies resulting in inappropriate therapeutic
regiment were due to A. baumannii and P. aeruginosa susceptibility to
Colistin and subsequently Meronem and Piperacilline/Tazobactam.
Conclusions: The described tests could serve an early diagnostic tool
providing guidance for the initial appropriate therapy in VAP, helping to
decrease the overuse of broad spectrum antimicrobial agents.
Public health and community-acquired
infections
R2198 High incidence of Listeria monocytogenes meningitis in a
north-eastern Italian area
M. Libanore °, M.R. Rossi, R. Bicocchi, P. Antonioli, A. Leclercq,
F. Ghinelli (Ferrara, IT; Paris, FR)
Background: Listeria monocytogenes (LM) is a Gram positive rod agent
of meningoencephalitis, expecially in immunoompromised patients. Host
factors that increase the risk of listeria infection are: pregnancy, acuired
immunosuppression, haematological malignancies, diabetes mellitus,
renal failure and chronic alcoholism. In northeastern Italy the incidence
of listeria infection with cerebral involvement is unknown since it’s
unsuspected.
Objective: to study the incidence, epidemiologcal and clinical features
of meningitis due to LM in a NorthEastern Italian area.
Methods: we have analyzed by means of computed database all the
cases of acute meningitis in HIV negative patients admitted to our
department of Infectious Diseases between January 1989 and December
2008. Demographic data, predisposing conditions, underlying diseases,
CSF cell count, CSF chemical data, CSF bacterial antigens, CSF and
blood coltures, clinical therapeutic and outcomes were investigated with
an accurate ﬂow-chart. he diagnosis of listeriosis was conﬁrmed by the
Centre de Refe´rences des Listeria of Pasteur Institute in Paris.
Results: during the study period, 183 cases of meningitis have
been observed: 91 with purulent CSF and 92 with clear CSF; ratio
males/females 1.4; median age 53.5 years patients with purulent CSF
and 46.5 years patients with clear CSF (range 16−88). The study was
divided infour compaired periods: 1988–1993, 1994–1998, 1999–2003,
2004–2008. The incidence of listeria infection has been increased: from
no cases in the ﬁrst period, 4.4% in the second, 6.7% in the third
and 19% in the last period. The incidence for 100,000 persons in
the same periods was respectively: none, 0.28, 0.57 and 1.14. Risk
factors of the 7 observed cases were: chronic alcoholism, haematological
malignancies and advanced age. Symptomatology: fever, confusional
state, rigor nucalis, indisposition. In 6/7 cases LCF was purulent with cell
count between 700 and 2500/mmc. The last 3 observed cases presented
in vitro resistance to ampicillin, so was employed levoﬂxacin i.v. in
association with ceftriaxone. Two patients developped hydrocephalus.
Conclusions: LM is increased in our area and it’s related to the global
consumption of food. This is an important fact in order to high percentual
of isolation (17.4%) in cheese, vegetables and chicken. On th high
observed incidence it’s indispensable that empirical therapy of acute
mininitis contemplate the employ of an active chemioterapic against LM.
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R2199 Transmission of Tannerella forsythia in man and domestic
cats
W.A. van der Reijden °, C.J. Bosch-Tijhof, W.E.A.J. de Wit,
H.E. Booij-Vrieling, A.J. van Winkelhoff (Amsterdam, Utrecht, NL)
Background: The periodontal pathogen Tannerella forsythia (Tf) is
strongly associated with periodontal bone loss. Carriership in periodontal
healthy subjects reaches levels of almost 48% in the Netherlands. The
genetic variation of this pathogen is, however, unknown and there
are only few data upon associations between clinical status and Tf-
genotypes.
Objectives: To obtain more insight in the clonality and transmission of
Tf, we developed an ampliﬁed fragment length polymorphism technique-
analysis (AFLP) and applied them on isolates from related inhibitants
(spouses and/or siblings of spouses) of a tea estate on Western Java,
Indonesia. In addition, transmission between domestic cats of various
age and their owners were studied in a Dutch population.
Methods: AFLP analysis based on restriction enzymes MseI and PstI
was developed to observe whole-genome variation of Tf. The AFLP
method was optimised to observe sufﬁcient variation and validated
on isolates from twenty-seven individual non-linked subjects with
periodontitis. In addition, intra- and interexperimental variation was
determined. 178 Tf isolates from 72 subjects (one to four isolates
per subject) according to 39 married couples were used to determine
transmission of the pathogen between couples and/or siblings. These
couples were clustered into 17 family trees.
Results: The intra-isolate homology was >96% when a single strain
was processed ﬁve times in a single experiment. This intra-isolate
homology between independent experiments was 78%. Taking this into
account, we found that in only 6 out of 72 subjects two AFLP-genotypes
were observed. One of the subjects was carrying two genotypes.
Each genotype was identical in two separate non-related subjects.
Transmission of Tf between spouses or siblings was not observed. Only
one subject carried two genotypes that could be recovered in two different
unrelated subjects.
From a simulteneous study in the Netherlands it was found that in 50
couples of young domestic cats (<2 yr old) and their owners no identical
strains were found. However, in a group of 7 couples of older cats (>5 yrs
old) and their owners, one identical strain in a couple was isolated.
Conclusions: In a closed Indonesian population, only 8.3% of the
subjects carried more than one Tf-genotype. Transmission between
spouses was not found. Identical strains between cats and their owners
suggest an environmental source of Tf that might explain the existence
of large numbers of genotypes.
R2200 Failure of antirabic postexposure prophylaxis
C.M. Dorobat °, L. Ghibu, D. Dumitrache, E. Miftode, G. Dorobat
(Iasi, RO)
Despite of all progresses made in diagnosis and treatment of rabies,
prophylaxis remain the most reliable posibilityof salvation of the infected
patients. In humans, rabies results almost always in death, the exceptions
being known worldwide. The risk of rabies in untreated patients is
50−80% for head and neck region’15–40% for wounds in upper members
and 30−40% for legs wounds. Prophylaxis implies several measures
speciﬁc and nonspeciﬁc pre-exposure (reducing the natural reservoir
of infection, pre-exposure vaccination) and post-exposure (for rabid
animal, for the wounds, post-exposure prophylaxis with vaccine and
rabies immune globulin in cases at risk).
Methods: We describe a case of fatal rabies despite of use of Verorab
vaccine and equine immunoglobuline. A 40-years old man with history
of diabetus mellitus type 2 and alcoholism was admitted in our clinic
with fever (39ºC), headache, muscular fasciculations in left arm, fallowed
by paresis, left palpebral ptosis (simptomatology started 4 days before
admittance). The patient (who worked as a forester) had been attacked
by a rabid wolf, 30 days before addmittance.
The attack was violent and resulted in many wounds in left shoulder,
neck region, scalp and both legs. Wound cleansing and tetanus toxoid
administration were done at a nearby hospital. Because of high risk of
bleeding some of the wounds had to be sutured. Post-exposure profylaxis
was started in 3 hours after attack, with equine immunoglobulins (Favirab
40UI/kg) and Verorab (puriﬁed rabies vaccine cultured on Vero-cells).
Verorab has been administrated on days 0, 3, 7, 14, 21 after exposure,
in deltoid region. After the last administration he became feverish and
he was admitted in our clinic with described simptomatology.
After admittance patient rapidly deteriorated with dysautonomia, confu-
sion and coma. Although the diagnosis of rabies was obvious, variants of
Guillain–Barre´ syndrome and acute disseminate encephalomyelitis were
also considered in view of supervised vaccination proﬁle. The patient
died despite mechanical ventilation in 12 days after admittance. Autopsy
was positive for rabies antigen.
Conclusions: Failure of rabies post-exposure prophylaxis is extremely
rare in our country. A short incubation period, immunodepresion induced
by diabetus melitus, failure to inﬁltrate maximum Favirab locally due
to anatomic nonfeasibility and suturing the wounds could have been
contributory in our case.
R2201 Inﬂuence of probiotics application on occurrence of
common colds and ﬂu: results from the Epidemiology of
Allergic Disorders in Poland (ECAP) study
K. Wajda °, A. Lusawa, J. Gutowska-Slesik, A. Walkiewicz, E. Krzych-
Falta, L. Trzpil, P. Samel-Kowalik, A. Tomaszewska, J. Marszalkowska,
F. Raciborski, N. Jakubik, B. Piekarska, B. Samolinski (Warsaw, PL)
Aims: The inﬂuence of probiotics application on occurrence of common
colds and ﬂu.
Materials and Methods: The ECRHS II and ISAAC questionnaires
were conducted on 2132 persons − 576 in age group 6−7 y.o., 561
in age group 13−14 y.o. and 995 in age group 20−44 y.o. Sample
selection: a randomised study based on the PESEL operat, stratiﬁed and
representative of particular age groups and the two sexes. Respondents
are asked about probiotics application and occurrence of common colds,
ﬂu and their signs and symptoms for last 6 months.
Results: In age group 6−7 y.o. 88.0% people with common colds or
ﬂu applied probiotics and 11.4% did not; 83.3% respondents without
common colds or ﬂu applied probiotics and 13.1% did not; OR= 1.215
(95%CI: 0.607–2.438) and p = 0.041. In age group 13−14 y.o. there were
respectively 79.5% vs. 19.2% for respondents with common colds or
ﬂu and 76.1% vs. 18.6% for without common colds or ﬂu; OR= 1.011
(95%CI: 0.594–1.721) and p = 0.033. In age group 20−44 y.o. there were
respectively 56.1% vs. 40.4% for respondents with common colds or ﬂu
and 54.7% vs. 41.2% for without common colds or ﬂu; OR= 1.046
(95%CI: 0.73–1.498) and p = 0.926.
Conclusions: Application of probiotics is slightly associated with
increased risk of common colds or ﬂu for children, but not for adults.
In the case of adolescent p value means signiﬁcance, but OR is almost
equal 1. These results require more studies in order to ascertain, whether
increased risk among children is associated with activity of probiotics.
R2202 Adult vaccination rates in Greece
V. Papastamopoulos °, E. Kakalou, T. Panagiotopoulos, J. Baraboutis,
E. Vryonis, A. Skoutelis (Athens, GR)
Objectives: Our study sought to describe vaccination coverage in Greece
among the adult population.
Methods: We conducted a random-sampling, telephone based house-
hold survey among adult individuals in Greece. For this purpose a
sample of 1104 adults representative of the basic demographic, social
and geographical characteristics of the overall population of Greece
according to the latest national survey, was used. Two target groups
were determined for analysis: persons >65 years of age and persons
with chronic conditions such as respiratory and heart conditions (other
than hypertension), diabetes mellitus and other conditions.
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Results: Among adults 25.4% report having been vaccinated after the
age of 18. Among the ones that have been vaccinated in adult life,
31% report inﬂuenza vaccination, 30% anti-tetanus, 21.9% hepatitis-B
vaccination and less than 10% a number of other vaccinations including
anti-pneumococcal vaccine.
88% among persons with chronic conditions report having had any type
of contact with the National Health System or a private physician within
the last three years. Among them, only 20.1% had been recommended to
get vaccinated. Vaccination was recommended only to 22.8% of people
over 65 years of age and 11% of the overall adult population. Only 3% of
persons with respiratory illness, 6.5% of persons with diabetes mellitus,
10% of persons with heart conditions and 7.3% of persons over 55 years
of age in respect, were recommended the pneumococcal vaccine by a
physician.
Conclusions: Available data show unacceptably low levels of vaccination
coverage among vulnerable groups such as the population over 65 years
of age and people living with chronic illness. Inﬂuenza vaccination
is the most common vaccination among all different groups and the
main vaccine recommemded by physicians. Other important vaccines
recommended to either the general adult population such as the anti-
tetanus vaccination or high risk groups such as the pneumococcal vaccine
are actually not being recommended by physicians. Focused efforts are
required in order to increase recommendation of vaccination by medical
services and acceptance by patients in order to succeed in enhancing
vaccination coverage speciﬁcally among vulnerable groups such as the
elderly and people living with chronic illness.
R2203 Brucellosis: a retrospective evaluation of clinical, laboratory
and therapeutic features of 101 cases
A. Inan °, D. Ozturk, P. Goktas, N. Ceran, S.C. Ozyurek, S. Senbayrak,
I. Erdem (Istanbul, Tekirdag, TR)
Objectives: The aim of this study was to evaluate the clinical and
laboratory ﬁndings, complications and treatment outcomes of patients
with brucellosis.
Methods: One hundred one cases, followed-up in our clinic between
the period of January 2001-August 2008, were assessed retrospectively.
The diagnosis of brucellosis was established by one of the following
criteria; isolation of Brucella species in blood or other body ﬂuids or
tissue samples, a compatible clinical picture supported by the detection of
speciﬁc antibodies by standart tube agglutination test (STA) or enzyme-
immunoassay.
Results: The patients’ mean age was 43.47 years(14–77). Forty-
nine patients were male and 52 patients were female. Of them,
44.5% were diagnosed as acute, 47.5% as subacute and 7.9% as
chronic brucellosis. Overall, 61.3% of the cases had a history of
ingestion of unpasteurised milk and diary products. The most common
complaints were fever(72.2%), sweating(57.4%), arthralgia(51.4%)
and malaise(50.5%). Lymphadenopathy(17.8%), splenomegaly(34.6%),
hepatomegaly(27.7%) were also detected. Leukopenia was determined
in 34.6%, thrombocytopenia in 11.8%, anaemia in 47.5%, elevated
erytrocyte sedimentation rate in 72.2%, C-reactive protein positivity in
62.3%, and anaemia in 51.7% of them. Blood cultures were performed
from 75 of the patients, and 39 (52%) of them yielded Brucella spp. The
bacterial growth was also detected in a soft tissue abscess and hip joint
ﬂuid samples. STA test was found negative in 1.9% of patients who were
culture positive. The osteoarticuler involvement was observed in eighteen
patients (17.8%). neurobrucellosis in eight cases (7.9%), epididymo-
orchitis in two cases (1.9%), endocarditis in two cases (1.9%), hepatitis
in two cases (1.9%); and splenic abscess, multiple soft tissue abscesses,
mesenteric lymphadenopathies (mimicking acute abdomen syndrom) and
arthritis were present in one each. Doxycycline and rifampin combination
during six weeks was the most preferred antibiotic regimen. Relapse and
unresponsiveness to the therapy were detected in 5.9% and 0.9% of the
cases, respectively.
Conclusion: Brucellosis displays diagnostic and therapeutic difﬁculties
because of the various clinical presentations and lead to labour loss and
rarely mortality due to serious complications. It should be considered
in patients with unexplained signs and symptoms associated with any
organ system involvement, especially in endemic areas.
R2204 Investigation of Toxoplasma gondii in shellﬁsh from
Adriatic Sea, Italy
S. Seraceni, C. Macchia, R. Cultrera, S. Rubini, C. Contini ° (Ferrara, IT)
Objectives: Toxoplasma gondii infections have been reported in a
number of marine molluscal bivalve shellﬁsh. How these animals acquire
T. gondii from their aquatic environment is not known. Some authors
have shown that the Eastern oysters (Crassostrea virginica) from North
America can remove T. gondii oocysts from surrounding seawater and
retain their infectivity. In order to investigate if T. gondii can be acquired
from aquatic environment; we searched T. gondii by a sensitive PCR in
a selected shellﬁsh’s set (Mytilus galloprovincialis, Tapes philippinarum,
Chamaelea gallina, Crassostrea gigas), collected from a restricted tract
of Adriatic sea coast (26 km2) at intensive breeding, to evaluate the
possibility that these marine bivalves can assume T. gondii oocysts in
same way.
Methods: T. gondii DNA was investigated by nested PCR on 140
shellﬁsh and seawater specimens. After homogenising, DNA was
extracted according to standard protocols and T. gondii B1 gene
was ampliﬁed. All samples also underwent rigorous bacteriological
assays, including the search of biotoxins and harmful algae (Dinophysis
spp., Alexandrium ostenfeldii, Protoceratium reticulatum, Lingulodinium
polyedrum) according to European legislation (2004; Reg. EU 853/854).
Results: No sample did detect T. gondii DNA. However, bacteriological
investigation showed Salmonella spp., and E. coli in 8 (5.7%) and
11 (7.8%) specimens, respectively, whereas marine biotoxins (7 of
Yessotoxin, 13 of Acid Okadaic) were found in 20 specimen (14.3%).
No harmful algae were detected.
Conclusions: Although the high rates of either bacteria or marine
biotoxins found but not designed for human consumption, the results
show that the shellﬁsh are not able to acquire T. gondii or retain
infectivity for prolonged periods. Consequently, they should not be a
possible source of contamination for humans with possible public health
implication.
R2205 Comparison of multiple and single liver abscess
J.H. Lee ° (Iksan, KR)
Background: The aim of this study was to compare the difference
between multiple and single liver abscess for clinical feature.
Methods: We retrospectively analysed the medical records of 201
patients with a discharge diagnosis of pyogenic liver abscess between
January 2004 and July 2006 at a Wonkwang medical centre.
Results: Of the 201 patients, 34 were classiﬁed in the multiple liver
abscess groups and 167 were classiﬁed into the single liver abscess
groups. The frequency of underlying biliary disease and multi-septated
abscess were higher in the multiple liver abscess group than in the
single liver abscess group (p< 0.05)). Klebsiella pneumonia was most
common pathogen (95/138) and Escherichia coli was 2nd common
pathogen(21/138), but there was no difference between the both groups.
The presenting symptom/sign and laboratory ﬁnding, underlying disease
(except biliary disease) were similar on the both groups. The drainage
procedure or medical management alone were used similarly on the both
groups. The death rate were no signiﬁcantly difference between the two
groups [3(8.8%) vs. 8(4.8%)].
Conclusion: Our study suggests that underlying biliary disease and
multi-septated abscess were associated with multiple liver abscess.
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R2206 Asymptomatic bacteriouria in women with diabetes
mellitus in our area
T. Exiara °, L. Papazoglou, A. Kalpaka, G. Metallidis, L. Mporgi,
S. Bousios, G. Hasan, A. Kostantis, S. Papanastasiou (Komotini, GR)
Objectives: Diabetes Mellitus (DM) is a metabolic disorder which
is responsible for several abnormalities of the host defence system.
Infections and especially urinary tract infections (UTI) are more frequent
in patients with DM than the rest population. The aim of this study was to
determine the prevalence of asymptomatic bacteriouria (ASB) in women
with DM type 2 in our area and to asses the microorganisms isolated of
these patients and the antimicrobial sensitivity.
Methods: 287 women with DM type 2 and mean age of 56±17 years
were included in this study, as out-patients, during a 18-month period.
Patients with symptomatic UTI, hospitalisation or surgery in the last
4 months and use antibiotics for any reason in the last two weeks,
were excluded. Demographical data, medical history and duration of
diabetes of patients were registered. All patients underwent laboratory
examinations (serum creatinin, glycosylated haemoglobin A1c, fasting
blood glucose, blood urea nitrogen and urine samples for urianalysis,
microscopy and culture). Urine samples were obtained by clean voided
mid-stream technique. The criterion used for deﬁning ASB was the
presence of at least 105 CFU/ml in 1 culture conﬁrmed by a second
culture. Mann-Whitney U test, t test, chi squared and Fisher exact test
were used for statistical analysis of data.
Results: 42 (14.6%) women with DM type 2 had two positive
cultures with the same microorganism. The uropathogens isolated
were: E. coli in 23(54.8%) cases, Streptococcus spp. in 7(16.7%),
Staphylococcus coagulase negative in 6(14.3%), Proteus spp. in 3(7.1%)
and Pseudomonas spp. in 3(7.1%) cases. The sensitivity of E. coli,
Streptococcus spp., Staphylococcus coagulase negative, Proteus spp.
and Pseudomonas spp. to antibiotics was: 69.6%, 85.7%, 100%, 100%
and 33.3% to amikacin, 86.9%%, 71.4%, 83.3%, 66.7% and 33.3% to
ciproﬂoxacin, 78.2%, 71.4%, 83.3%, 66.7% and 33.3% to cotrimoxazole,
69.5%, 85.7%, 66.7%, 66.7% and 33.3% to ampicillin, respectively.
Duration of DM, level of HbA1c and the presence of albuminuria
were not correlated with ASB in our study (p = 0.1, p = 0.45 and p = 0.1
respectively). The age of woman and the presence of glucosuria were
signiﬁcant correlated with ASB (p< 0.001 and p< 0.03, respectively).
Conclusions: The presence of ASB is quite high in women with DM
in our area such as in previous studies. Periodically urine analysis
and cultures as a routine examination in diabetes women may help to
recognize ASB episodes.
R2207 The effectiveness of different window mesh sizes in the
prevention of mosquito–human contact
O.A. Idowu °, M. Adeleke, Q.O. Junaid, O.J. Funmilayo (Abeokuta, NG)
Introduction: The use of Insecticide Treated Bednets (ITN) for
prevention of mosquito borne diseases has not been fully embraced in
Nigeria.
Objective:This study was carried out to assess the efﬁcacy of the two
different window mesh sizes as commonly used in Abeokuta, Nigeria.
A high proportion of the human residence sampled in the preliminary a
survey use only window nets as screen against mosquitoes.
Methods: Newly hatched mosquitoes were kept in specially designed
experimental cages for 7 days using window nets of different mesh sizes
as screen.
Results: The species of mosquitoes that hatched from larvae collected
from different locations in Abeokuta were Culex quiquefasciatus,
Aedes aegypti, Anopheles gambiae and Mansonia africanus with
various anthropometric measurements ranging from head diameter of
0.25mm-0.50mm, thoracic width of 0.30mm-1.05mm, and abdominal
width of 0.30mm-0.60mm. None of the mosquitoes was able to pass
through any of the two mesh sizes assessed indicating their effectiveness
as barrier against mosquitoes of different species. However, 70% of
the window nets in the household survey were observed to record
various degrees of perforations and damages through deliberate and/or
indeliberate activities. Frequency of opening and closing of doors may
also contribute additional entry route for mosquitoes.
Conclusions: This study emphasizes the fact that the use of window nets
solely may not be sufﬁcient for prevention of mosquito borne infections.
There is the need to further encourage the use of ITN in Nigeria.
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R2208 Multiple cranial nerves involvement caused by Brucella
melitensis
E. Sahin, A. Yilmaz, G. Ersoz °, M. Uguz, A. Kaya (Mersin, TR)
Objective: Neurobrucellosis is a rare complication of brucellosis and
cranial nerve involvement is rarely observed during the course of
neurobrucellosis. We report a case of neurobrucellosis complicated by
optic, abducens and vestibulocochlear nerve palsies.
Case report: A 23-year-old woman was referred to our centre for
headache starting 20 days ago and gradually exacerbating in severity,
nausea and vomiting for the past two weeks and double vision and
disturbed balance for the past one week. On admission, the patient had
a moderate general wellbeing and was conscious and cooperative. Blood
leukocyte count was 3500/mL, erythrocyte sedimentation rate (ESR)
was 22mm/hour and C-reactive protein (CRP) was 0.3mg/L. Other
laboratory investigations revealed normal results. Vital signs were stable.
On physical examination, she had neck stiffness, restricted abduction of
the left eye (indicative of the left abducens nerve palsy) and bilateral
papillary stasis. Other systems of the body were normal.
Lumbar puncture was performed and cerebrospinal ﬂuid (CSF) pressure
was 30 cmH2O (normal range:10–18 cmH2O). Microscopic examination
of CSF showed 10 lymphocytes/mm3. Gram and acid fast staining of CSF
did not demonstrate any microorganisms. CSF specimens were cultured.
CSF glucose was 14mg/dL (simultaneously measured blood glucose was
90mg/dL) and CSF protein was 135.8mg/dL (normal; 15−45mg/dL).
Brucella melitensis was isolated in cerebrospinal ﬂuid. The diagnosis
of brucellosis was conﬁrmed by serological tests, cerebrospinal ﬂuid
biochemistry and serology. The case was diagnosed with retrobulbar-
neuritis. Despite medical treatment, the patient developed optic atrophy.
Abducens and vestibulocochlear nerve palsies were relieved. It has been
reported in the literature that n. abducens and vestibulocochlear nerve
involvement frequently occurs, but that that optic nerve involvement is
not frequent. It has been noted that optic nerve involvement is frequently
accompanied by optic neuritis.
Conclusion: In addition, multiple cranial nerve involvement has not
been reported. In conclusion, it should be kept in mind especially in
regions where brucellosis is endemic that several cranial nerves may be
involved in cases of brucellosis and that differential diagnosis should
include brucellosis in patients presenting with blurred vision and double
vision.
R2209 Fournier gangrene caused by Gardnerella vaginalis: a brief
report
S. Gu¨ndes ° (Kocaeli, TR)
Objectives: Fournier’s gangrene is a life-threatening necrotising
infection of the perineal and genital regions. If urgent surgery is delayed,
the disease will soon result in septic shock, multiorgan failure, and death.
Gardnerella vaginalis is an infrequent cause of soft tissue infections,
bacteraemia and is typically associated with immunocompromised states.
Case: The case presented here refers to an diabetic 61-year-old women,
admitted in emergency to our department with clinical signs and
symptoms of sepsis related to gangrene of the perineum. The lesion had
developed 10 days previously from a carbuncle, which she attempted to
treat by way of an over-the-counter products. Lab results were normal
apart from the leucocytosis (13700/I) and CRP (6mg/dl). She was
diabetic for the last 11 years. An early wide surgical debridment was
performed and empirical intravenous therapy with ampisillin-sulbactam
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and ciproﬂoxacin was initiated. Two days later, results from perioperative
swab culture revealed growth of G. vaginalis. The patient was released
21 days postoperatively with a clean wound, and no complications.
Conclusion: An examination of the literature revealed no reports of
G. vaginalis in soft tissue infections such as Fournier gangrene. There
are very few reports of infections caused by this pathogen in diabetic
patients. As a result, although it is uncommon and the mechanism of
infection is unclear, G. vaginalis should be included in the causative
pathogens in Fournier gangrene.
R2210 The epidemiological, clinical and laboratory evaluation of
Crimean-Congo haemorrhagic fever cases in a tertiary-care
hospital in Turkey, 2008
C. Ataman Hatipoglu °, C. Bulut, M.A. Yetkin, M.C. Karakoyun,
F.S. Erdinc, G. Tuncer Ertem, B. Oral, S. Kinikli, A.P. Demiroz
(Ankara, TR)
Objective: Crimean-Congo haemorrhagic fever (CCHF) is a serious
disease caused by the CCHF virus and has been reported in our country
since 2002. In this study we present the epidemiological features, clinical
and laboratory ﬁndings, treatment, and outcome of cases with CCHF
followed in Ankara Training and Research Hospital in 2008.
Methods: Eighty-six patients suspected to have CCHF were included
in the study. Serum samples were analyzed with speciﬁc ELISA for
detecting antibodies (IgM and IgG) against CCHF, and also with RT-
PCR to investigate the genome of the virus. Those with positive IgM
antibodies and/or PCR for CCHF virus in blood evaluated as conﬁrmed
case, and those with negative results as suspected cases.
Results: Among 86 patients, 71 were diagnosed as conﬁrmed cases. Of
all the patients, 51 (59.3%) were female; mean age was 48.8±18.2 years
(15−83 years). Seventy-four patients (86%) were living in the rural
area. Tick bite history was detected in 57 patients (66.3%) and
haemorrhage history in 22 (25.6%). Epistaxis and petechia/purpura
were the mostly declared haemorrhagic complaints. Mean time from
tick bite to admission to the hospital was 8.6±7.2 days (1−35 days).
The most common symptoms were fever, fatigue, nausea, myalgia and
headache (84.9%, 82.6%, 67.4%, 64.0% and 41.9%, respectively). The
mean hospital stay of the patients was 7.3±2.9 days (1−17 days).
Median level and minimum and maximum values of some of the
laboratory ﬁndings were as follows; 2200/mm3 (500–29000) for white
blood cells, 57500/mm3 (7000–361000) for platelets, 126U/L (10–
1155) for aspartate aminotransferase, 77U/L (14–800) for alanine
aminotransferase, 216U/L (19–4564) for creatinine phosphokinase,
10.7 seconds (7.0–109.0) for protrombin time and 37.0 seconds (20.4–
105.0) for partial thromboplastin time. Ribavirin and steroid therapies
were given to 17 (19.8%) and 22 (25.6%) of the patients, respectively.
Among the patients, 44.2% received platelet (random/aferesis), 24.4%
fresh frozen plasma and 11.6% erythrocyte infusions. Although
supportive therapy was administered, four cases (4.7%) were died
because of massive hemorrhage.
Conclusion: In CCHF patients, serum platelet counts, haemoglobin
values and protrombin and partial thromboplastin times should be closely
monitored. In case who had a deterioration of the related ﬁndings, the
physicians should consider to adjust supportive therapy.
R2211 Nocardiosis: an emerging disease?
R. Gu¨erri °, F. Sa´nchez, M. Trenchs, I. Rodrı´guez, G. Vallecillo,
C. Segura, M. Salvado´ (Barcelona, ES)
Introduction and Objective: although Nocardia spp. is an unusual
pathogen in our settings, its incidence shows a rising trend related
to the increase of immunosuppressive factors. The aim of this study
is to analyze the clinical and epidemiological characteristics of those
cases diagnosed in a 455-bed, University-afﬁliated hospital in Barcelona,
Spain.
Methods: Retrospective analysis (2002–2008) of all patients with
nocardiosis consistently documented: isolation from extrapulmonary
samples, pulmonary-invasive BAL, or at least two positive-consecutive
sputum samples.
Results: During the study period 32 patients (29 men), mean age
73, were included for analysis: 3 in 2002, 4 in 2003, 9 in 2004, 4
in 2005, 4 in 2006, 5 in 2007 and 3 in 2008. The average score
on the Charlson comorbidity index was 3.53 (range 1−7). The most
frequent underlying disease was COPD (26 patients, 14 of them receiving
continuous therapy with steroids), and the main reason for being visited
were general, non speciﬁc respiratory symptoms. In 14 patients (44%)
chest radiography showed lung inﬁltrates involving alveolar spaces,
which improved (or resolved) after antimicrobial therapy. Molecular
identiﬁcation was successfully done in 23 strains: N. asteroides 13;
N. cyriacigeorgica 6; N. paucivorans 1, N. brasiliensis 1, N. abscessus 1;
N. ﬂavorosea 1. All were sensitive to sulphonamides, aminoglycosides
and carbapenems. The empirical therapy most commonly used was
cotrimoxazole (21 patients). Nocardia asteroides was considered to be
the direct cause of death in 8 patients (25%), all with a very severe
COPD (FEV1< 30%), and receiving continous steroid therapy.
Conclusions: The incidence of nocardiosis has slightly increased in our
patients, being N. asteroides the ultimately fatal lung infection in the
most severe COPD cases.
R2212 A case of Crimean-Congo haemorrhagic fever with normal
laboratory ﬁndings
T. Sari, C. Ataman Hatipoglu °, F.S. Erdinc, M.A. Yetkin,
M.C. Karakoyun, G. Tuncer Ertem, B. Oral (Ankara, TR)
Objectives: Crimean-Congo Haemorrhagic Fever (CCHF) is a tickborn
disease caused by a Nairovirus of the Bunyaviridae family. Infection
is transmitted to humans by Hyalomma ticks or by direct contact
with the blood or tissues of infected humans or viraemic livestock.
Clinical features usually include a rapid progression characterised
by haemorrhage, myalgia and fever, with a mortality rate of up to
30%. Thrombocytopenia, leukopenia, elevated alanine aminotransferase
(ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH)
and creatinine phosphokinase (CK) levels are common. In this report,
we present a conﬁrmed CCHF case without laboratory abnormality.
Case: A 36-year-old woman admitted to our clinic with the complaints
of fever, chills, myalgia and vomiting. She had a history of anaemia
for six years. She was living in an endemic region for CCHF and
had a history of tick bite ten days ago. Her complaints were started
ﬁve days after the tick bite and bleeding of the nose and vagen
were added subsequently. On the initial examination, body temperature
was 37.6ºC, pulse 88 beats/min. No any abnormality was noted on
systemic examination except vaginal haemorrhage. The epidemiological
and clinical features of the patient were typical for CCHF but the
laboratory investigation was normal except anaemia. The leukocyte
count was 7300/mm3, haemoglobin 11.9 g/dL, platelets 293000/mm3,
AST 23U/L, ALT 14U/L, ALP 30U/L, GGT 11U/L, LDH 139U/L,
CK 39U/L, INR 0.8 and APTT 26.2 seconds. Vaginal haemorrhage
stopped in the third day of the hospitalisation, and haemorrhage from
nose one day after. Laboratory values were closely followed-up and no
any abnormality was detected. Her symptoms regressed gradually. She
had discharged from the hospital on sixth day of the hospitalisation; all
the clinical and laboratory ﬁndings were normal except anaemia. The
diagnosis of CCHF was conﬁrmed with the PCR positivity.
Conclusion: We suggest that patients who were coming from endemic
region and who had typical epidemiological and clinical ﬁndings should
evaluate as a possible case for CCHF even if the laboratory ﬁndings
were not compatible.
R2213 A case of infective endocarditis caused by Gemella sanguinis
R. Almaghrabi °, M. Halim, B. Fadel, A. Alsheikh, M. Kherallah
(Riyadh, SA)
Introduction: Infective Endocarditis (IE) is one of the most commonly
recognized infections associated with Gemella spp. Approximately 42
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cases of IE associated with Gemella spp. have been reported in the
literature. Gemella sanguinis has been reported only in two cases as a
cause IE.
Case summary: A 23-year-old male with history of repaired ventricular
septal defect and regurgitated aortic valve and history of Behcet’s
disease who was admitted with the diagnosis of infective arotic valve
endocarditis based on a clinical presentation of fever, right ﬂank
pain, a new diastolic murmur, mild anaemia, leukocytosis and an
elevated erythrocyte sedimentation rate, supported with a positive blood
culture for Gemella sanguinis and echocardiogram ﬁndings of aortic
regurgitation with large mass (17×9mm) that is attached to the right
coronary cuspid of aortic valve. An embolisation to the right kidney
was conﬁrmed with a computed tomography of the abdomen revealing
a wedge shaped infarction. The patient was treated with ceftriaxone and
gentamicin and had a good clinical response with resolution of fever,
negativity of follow up blood culture and decreased sedimentation rate.
The patient had eventually died with intracranial bleed as a complication
of anticoagulation that was started for hypercoagulable state associated
with Behcet’s disease..
Discussion: To the best of our knowledge, this is only the third report
of endocarditis caused by G. sanguinis. Our patient had a predisposing
cardiac disease and in the absence of other predisposing dental or
periodontal diseases; we believe that his oral ulcers related to his
Behcet’s disease served as the entry port of the organism to the blood
stream. The vegetation size is relatively lage and associated with visceral
embolisation, none of the case reports that described this organism have
commented on the vegetations size.
Conclusion: This case represents the ﬁrst case of Gemella IE in the
kingdom and the third in the literature.
R2214 Actinobaculum schaalii: a new cause of mastitis
S. Agudo °, D. Domingo, J.L. Navarro, N. Arenal, M. Lo´pez-Brea
(Madrid, ES)
Objective: Actinobaculum sp. is a Gram-positive rod closely related to
the genus Actinomyces. A new species, Actinobaculum schaalii was ﬁrst
discovered in 1997 and has been related to urinary tract infections. We
report one case of A. schaalii isolate found in a breast abscess.
Methods: The drainage obtained was immediately sent to the
Microbiological Department. The specimen was cultured in Columbia
agar with 5% sheep blood, chocolate agar and Brucella blood agar
incubated in aerobic, microaerophilic and anaerobic environments,
respectively. The strain was characterised by using the Rapid ID32A
systems (bioMe´rieux, France) in according to manufacter’s instructions.
For deﬁnite conﬁrmation, isolate was referred to a reference laboratory
for PCR of the bacterial 16S RNA gene sequencing. Minimum in-
hibitory concentrations (MICs) to penicillin, amoxycillin and clavulanic,
clyndamycin, erythromycin and linezolid, were determined by E-test on
Mueller Hinton sheep blood agar in anaerobic conditions.
Results: A 32 year-old woman presented inﬂammation in the right
breast. An initial diagnosis of a breast abscess was made and needle
aspiration was attempted. Four months later, she developed a new abscess
in the same place. The abscess was drained and the pus was sent for
bacteriological culture. The sample was processed by standard protocols,
but bacteriological investigations were negative. The patient was treated
with ceftidoren. After two months, a breast magnetic resonance imaging
was performed to control the evolution and the abscess was observed
one more time. It was required other drainage procedure, the sample
was immediately sent to the Microbiological Department. After 48 h
anaerobic incubation, colonies <1mm in diameter, grey, convex and
weakly-haemolytic were obtained. The Api Rapid ID32 identiﬁed the
microorganism as Actinomyces meyeri with the code 0521473705.
The result of the deﬁnite conﬁrmation by PCR was A. schaalii.
According to the Clinical and Laboratory Standards Institute criteria for
Streptococcus spp., the isolate was susceptible to all antibiotics tested.
Conclusion: This is the ﬁrst case of A. schaalii isolate found in a breast
abscess. These organisms could be missed in routine cultures due to the
anaerobic and slow growth. It is recommended that the identiﬁcation of
A. schaalii be done by performing Rapid ID32A test system and 16S
rRNA gene sequencing, at least until the manufacters’ databases have
been updated.
R2215 Clinical and epidemiological aspects of invasive
Streptococcus pyogenes during one year
M.J. Unzaga, Y. Martin, M.D. Suarez, C. Ezpeleta, J.A. Alava,
R. Cisterna ° (Bilbao, ES)
Objective: The aim of this study was to improve understanding of the
epidemiology of invasive group A streptococcal (GAS) disease.
Material and Methods: We realised a retrospective study of GAS
isolates recovered from hospitalised patients with invasive disease. The
isolates were sent to Carlos III Institute to typing procedures.
Results: There were 21 patients: 11 males (52.4%). The median and the
mean age of patients were 40 years (range 0 to 77) and 38.47 years,
respectively, with no important differences between male (40.27 mean)
and females (36.5). The incidence was increased with low age range:
<20 y. (33.3%), 20−50 y. (33.3%), 50−70 (9.6%) and >70 (23.8%).
The majority of isolates were recovered from blood (52.4%); skin, soft
tissue infections (33.3%) and arthritis joint (4.8%) and other normal
sterile sites. Skin and soft infections accounted for 52.4% of the cases
(n = 11), arthritis (4.8%) (n = 1) and primary bacteraemia with no focal
symptoms (28, 6%) (n = 6). 16 patients have at least one risk factor of
which neoplasia accounted in n = 5, diabetes n = 3, previous traumatism
n = 3, and previous surgery in n = 1. The mean case fatality rate was only
a case 4.8% a woman 73 years old. Were admitted to intensive care 2
(9.5%) patients and underwent surgical intervention 3 (14.3%) patients
as a part of the treatment.
Type distribution of GAS A broad range of emm types was recorded with
the most common types being types, 1 (26.3%), 22 (10.5%), 3(10.5%),
and 89 (10.5%). All emm 1 isolates (5) were T1, the emm 3 (2) were
T3 type the emm 89 (2) T B3262 and the emm 6 (1) were T 6.
Skin and soft tissue infections were caused by emm 1, and emm 89 (20%)
and 11, 22, 3, 5, 50, 6 (10%). Septicaemia isolates evenly distributed
emm 1, 3, 4, 6, 77 and 87 (10%).
The cluster genes A/B/F/G/J/Z and B/C/F/G were detected in 21.1% and
15.8% of the isolates. Skin and soft infections were associated in 30%
with the cluster B/C/F/G. Among the 21 strains 71.4%, (5) were speA
positive and speC negative and 71.4% (10) were speC positive and speA
negative. Positive speA and speC were 28.6% (2).
The rate of erythromycin-clindamycin resistance was 5%. This strain
was emm 11, T11 and the B/C/F/G/H cluster gene.
Conclusions: The incidence of GAS was in the group of age <50 years
and a smaller peak >70 years. Skin and soft tissue infections accounted
52.4%. A low level of macrolide resistance has been detected in this
group. emm type 1 and 89 accounted for the highest percentage of
invasive disease.
S654 19th ECCMID, Abstracts accepted for publication only
R2216 Changes in the activated T-lymphocytes in patients with
Mediterranean spotted fever and Lyme borreliosis aged
60+ years
M. Gospodinova °, M. Nenova, S. Mileva (Varna, BG)
Introduction: Multiple clinical observations lead to the conclusion
that old age is the most widely distributed type of immunodeﬁciency.
Immunocompetence decreases with the ageing, i.e. the immune system
starts to lose some of its functions in the process of growth and becomes
unable for fast and effective response to stimulation. Age dependent
changes in the immune system are observed at all levels − chemical
changes in the cells, differences in the types of the surface cell proteins,
changes in the organs.
Objectives: To specify the changes in the activated T-lymphocytes in
patients with Mediterranean spotted fever (MSF) and Lyme borreliosis
in the age 60+.
Methods: We investigated the cell immunity of 30 patients of age over
60 years using immunoﬂuocytometry – 20 of them with MSF and 10
with Lyme borreliosis. The control group consisted of 10 young patients
and 10 healthy individuals over the age of sixty.
Results: Increased number of the activated cytotoxic T-lymphocytes
(CD3+/HLA-DR+) was found in the patients over 60 years of age
with MSF and also in patients under 60 years with MSF. In the
elderly patients with Lyme borreliosis and in the healthy 60+ controls
activated T-lymphocytes are two times less. There is statistically
reliable difference between activated T-lymphocytes in patients with
Mediterranean spotted fever (MSF) over sixty and the control group
of healthy elderly individuals, p< 0.01. Straight correlative dependence
exists between activated T-lymphocytes (CD3+/HLA-DR+) and age in
healthy individuals and patients of 60+ with MSF. In patients over
60 years with Lyme borreliosis and in patients under 60 years with MSF
this dependence is reverse. There is a moderate straight dependence
between the activated T-lymphocytes and the severity of the disease in
patients under 60 years of age with MSF.
Conclusions:
• Activated T-lymphocytes increase their number in all patients with
Mediterranean spotted fever. This is related with the increased activity
against the infected endothelial cells and macrophages. Those activity
probably is crucial for the healing process.
• The observed differences between the activated T-lymphocytes in
elderly patients with Mediterranean spotted fever and elderly healthy
individuals are statistically reliable.
R2217 Prospective evaluation of rickettsioses in the Trakya region
of Turkey, 2008
F. Kuloglu °, Z. Yulugkural, A. Dogan-Celik, F. Akata (Edirne, TR)
Objectives: Prospective surveillance, serologic and molecular diagnosis
of rickettsioses in the Trakya Region of Turkey has been conducted by
Trakya University and Universite´ de la Mediterrane´e, Marseille, France
since 2003. For three years, we have started to use molecular methods
for the diagnosis of spotted fever group(SFG) rickettsioses in the Trakya
University Hospital, a tertiary-care hospital in Edirne, Turkey.
Materials and Methods: From May to September 2008, 28
patients with Mediterranean spotted fever (MSF) were admitted to
the Trakya University Hospital. SFG rickettsioses were diagnosed
clinically. Before treatment, punch biopsy from skin lesions (eschar or
maculopapular rash) was performed. Serum specimens were tested by
microimmunoﬂuorescence assay MIF) using a commercially available
antigen (R. conorii IFA IgG; Focus Technologies, USA). DNA was
extracted from skin biopsies using the High Pure PCR Template
Preparation Kit (Roche Diagnostics, Germany). Standard PCR was
performed with primers suitable for hybridisation within the conserved
region of genes coding for outer membrane protein A (ompA) and citrate
synthase (gltA).
Results: The average age of 28 patients (12 male and 16 female)
was 57±17. All the patients had high fever and maculopapular rash
(including the palms or soles of the feet). Twenty three patients (82%)
had eschar. Twenty patients (71.4%) had clinical scores 25. One patient
presented with meningoencephalitis. Twenty one patients (75%)had
signiﬁcant antibody titers against Spotted Fever Group Rickettsiae.
Twenty three patients (82%)accepted skin biopsy. PCR experiments were
positive in 18(78%) out of 23 biopsy samples.
A 28 years old man with possible tick contact presented with high fever,
headache, nausea and a few macular rash on his arms without eschar;
leukopenia, thrombocytopenia, elevated ALT, AST, LDH, CPK levels,
low level of CRP were determined. RT-PCR test for Crimean-Congo
haemorrhagic fever virus RNA was negative but antibody titers against
Spotted Fever Group Rickettsiae increased more than four folds.
Conclusion: Trakya Region is an endemic area for rickettsioses with
a population of one million. Since 2001, 124 patients were diagnosed
as SFG rickettsioses. Differential diagnosis of tick-born diseases is
important in Turkey, as Crimean-Congo haemorrhagic fever is also
reported since 2003.
This study was supported by TU¨BI˙TAK SBAG-K-78 (104S290).
R2219 Risk of Crimean-Congo haemorrhagic fever among
healthcare workers
C. Bulut, G.R. Yilmaz, E. Karakoc¸, U. O¨nde, Z. Koc¸ak Tufan,
A.P. Demiro¨z ° (Ankara, TR)
Objectives: Crimean-Congo haemorrhagic fever (CCHF) is a potentially
fatal disease. The disease caused by a virus belonging to Bunyaviridae
family. CCHF has been reported from more than 30 countries in Africa,
Asia, south-eastern Europe, and the Middle East. The disease has been
seen since 2002 in middle and east of Turkey. The number of patients
is getting increase by years. The main transmission routes of the virus
are tick-bite and contact with tissues, body ﬂuids and blood of infected
animals. Contact with a patient’s blood or excretion is another route of
transmission. The aim of this study was to investigate seroprevalence of
CCHF in health care worker (HCW) of three hospitals which in CCHF
patients were hospitalised and followed up.
Methods: This study was executed in Ankara Training and Research
Hospital, Kastamonu State Hospital and Corum State Hospital. The
sera of the HCWs’ who are working in infectious diseases and
clinical microbiology, emergency and laboratory departments of these
hospitals were tested. A questionnaire was fulﬁlled for each HCW.
Presence of CCHF IgG was investigated in the sera samples by ELISA
(Vectocrimean-CHF-IgG, Bectop, Russia).
Results: Totally 90 HCWs were included in the study. Thirty-eight
(43.2%), 31 (35.2%) and 21 (23.9%) HCWs were from Corum State
Hospital, Kastamonu State Hospital and Ankara Training and Research
Hospital, respectively. Distribution of the profession of the HCW’s was as
follow: 41(46.5%), nurses 18 (20.5%) physicians, 11 (12.5%) laboratory
technician and 18 (20.5%) other. Forty-seven (52%) HCWs were from
Infectious and Clinical Microbiology Department, 34 (38%) were from
emergency department, 9 (10%) were from laboratory. Needle-stick
injury was detected in two HCWs, both of them had received ribavirin
prophylaxis. They were negative for CCHF IgG. One sera sample was
found as positive for CCHF IgG. This HCW was working in blood-draw
department and he had a history of contact with blood and needle-stick
injury. He had no symptoms or clinical ﬁndings of CCHF.
Conclusion: In the literature, CCHF outbreaks by nosocomial transmis-
sion have been reported. In Turkey, there have been eight reported cases
between 2002 and June 2008. One of them was died. We found a low
rate of seropositivity in HCWs (1%) in endemic regions. This might be
related to compliance with application of standard control measures.
R2220 Evidence for tick-borne encephalitis virus infections in
Bulgaria
I. Trifonova °, E. Tasseva, T. Gladnishka, V. Nikolaeva, R. Refaat,
E. Mohareb, I. Christova (Soﬁa, BG; Cairo, EG)
Objectives: Ofﬁcially, there are no reported cases of tick-borne
encephalitis virus (TBEV) infections in Bulgaria. Nevertheless, clinically
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compatible disorders have been described but have not been laboratory
conﬁrmed.
Materials and Methods: Two hundred and seven serum samples
from 120 patients with febrile syndromes were evaluated for IgM
and IgG antibodies against TBEV by a commercial enzyme-linked
immunosorbent assay (ELISA) kit.
Results: Seroconversion of TBEV IgM antibodies was detected in 20
(16.7%) of 120 patients and seroconversion of both classes, IgM and IgG,
antibodies was conﬁrmed in other 22 (18.3%) of the patients. TBEV IgG
antibodies with no dynamics in the paired serum samples were found
in 26 (21.6%) of the patients. Clinical manifestations in seroreactive
patients were compatible mostly with viral meningitis and Mediterranean
spotted fever.
Conclusions: Our results suggest the presence and wide distribution of
human TBEV infections in Bulgaria.
Infection control
R2221 Information technology and infection control: a project for
an active computer-assisted microbiology surveillance
P. Lanzafame °, P. Caciagli, I. Caola, G. Miceli, A. Sabatini (Trento,
Bologna, IT)
Objectives: The correct management of data represents one of the
most relevant factors in the processes of risk-management and control
of hospital infections(HAI). Informatised laboratories, a privileged
observatory for HAI surveillance, have contributed to optimise the
processes of data collection and elaboration. A project aiming at
transforming passive laboratory surveillance into an active “virtual”
process started in the hospitals of Trentino.
Methods: A dedicated software was developed which, once integrated
with the databases of the laboratories, can carry out a systematic and real-
time research of the possible epidemic events, of the warning/alert events
and integrated clinical data. At the same time, it can periodically control
antibiotic-resistance and infection prevalence. This software is made up
of three components: 1)Import, which imports data in real time through
a connection to the data-base of the laboratory; 2)Elaboration, which
ﬁlters the alarms on the basis of the established rules; 3)Report, which
produces the report according to the queries deﬁned by the user. These
data are sent to the ward in electronic format using the visualisation
system of the laboratory reports and, at the same time, a notiﬁcation
ﬁle is produced for the infection control unit. In the second phase of the
process, the wards give the notiﬁcation with the clinical information back
to the laboratory and it is ﬁled in a normalised and standardised data
structure for a real-time monitoring which also constitutes a historical
database for longer periods.
Results: In the ﬁrst three months the surveillance system has highlighted
its considerable potentialities. 4 outbreaks have been precociously
detected, as well as numerous microorganisms and alert events followed
by the immediate activation of processes and precautions aiming at
circumscribing and limiting their diffusion. A major sensitivity of
health-workers to HAI and bacterial resistance problems and a better
integration between laboratories, wards and infection control personnel
were highlighted as well.
Conclusions: The described system has proved able to increase the
monitoring, control, treatment and prevention power against hospital
infections. Such system integrates the surveillance programs which are
already active with a tool able to detect outbreaks precociously and to
provide a rapid alert system for the ward, which can thus precociously
activate the necessary precautions to limit infectious events.
R2222 Value of procalcitonin, C-reactive protein and leukocyte
cell count for the diagnosis and antibiotic management of
intensive care unit-acquired infections
A. Georgouli °, E. Chinou, Z. Chiolou, G. Mataras, E. Skouteli (Athens,
GR)
Objectives: The patients in Intensive Care Units (ICU) are subjected to
various inﬂammatory factors, a fact that makes the diagnosis of infection
difﬁcult. The aim of this prospective study was to compare the value of
Procalcitonin (PCT) to that of C-Reactive Protein (CRP) and White Cell
Count (WBC) for the diagnosis of ICU-acquired infections.
Patients and Methods: 104 patients who stayed for more than 72 hours
in the ICU and had no infection at admission were included in the study.
Serum CRP and PCT measurement and WBC counts were performed
in parallel every three days. Blood cultures were taken as clinically
indicated.
Results:
– Normal CRP levels and WBC counts were accompanied by normal
PCT levels.
– Out of 63 positive blood cultures, PCT was normal in only 7 cases,
in each of which the CRP level was <5mg/dl and WBC counts
were normal. It was considered that these cultures were probably
contaminated.
– The infection-free patients had normal or slightly raised average
PCT values but signiﬁcantly elevated CRP levels and WBC count
throughout their stay in the ICU.
– The infected patients had signiﬁcantly elevated PCT values during
the infection, which decreased quickly after effective treatment and
was completely normalised on discharge from the ICU. Among these
patients’ population, average CRP levels were in the pathological
range even on discharge from the ICU.
Conclusion: PCT measurement is a more speciﬁc marker in the
diagnosis of infection in ICU than CRP and WBC count, allowing better
selection of patients who should receive antibiotic therapy.
R2223 Nosocomial pneumonia on general medical ward in a
tertiary-care hospital
A. Zacharof ° (Athens, GR)
Objective: To describe the demographic, clinical, and microbiologic
characteristics of patients who develop nosocomial pneumonia on
general medical ward of a tertiary-care hospital.
Methods: We study retrospectively, the ﬁles of our patients hospitalised
in our Department for nosocomial pneumonia, using a standard case
deﬁnition.
Results: During these years (1986–2006) we identify 1056 nosocomial
pneumonias in our patients. The mean age of these patients was 63±12
year (53% were males). Bacteraemia was identiﬁed in 467 patients
(44%) of 612 episodes, and 238 (51%) grew potential pathogens from
respiratory specimens. Eighty eight patients (37%) required transfer
to the intensive-care unit (ICU), and 20 (22%) received mechanical
ventilation. By multivariate analysis, patients with Staphylococcus aureus
isolated from respiratory secretions were more likely to require ICU
admission. The overall mortality rate was 20% (19/88), with a directly
associated mortality of 14% (17/88). Patients who died were older,
more frequently resided longer on a medical ward, and had a greater
mean number of co-morbidities. These patients often were treated no
aggressively and were not considered candidates for ICU admission due
to advanced age and poor underlying clinical status.
Conclusion: Although the morbidity of nosocomial pneumonia in this
population was high, as evidenced by high rates of transfer to ICU,
the directly associated mortality was relatively low. Admission to ICU
requires further study for those patients to identify preventive measures
that could decrease the morbidity in this group. Interventions to prevent
pneumonia or to improve prognosis may not be feasible for the majority
of these old patients who die from nosocomial pneumonia
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R2224 Impact of economic modelling and infection prevention
protocol compliance on blood culture contamination rates
A. Guleri °, G. Hardy, B. Lunt, S. Ellershaw, J. Patterson, E. Trautt,
R. Palmer (Blackpool, UK)
Objective: Contaminated blood cultures result in delay in optimal
clinical management and associated healthcare costs. An economic
modelling was undertaken to gather an impression of associated wastage
of resources and coupled to a 3-year surveillance of all blood cultures
processed in the microbiology laboratory.
Methods: Data on all blood cultures processed over 3-years [1.10.05–
31.10.08] was collected from laboratory database. A working deﬁnition
of contaminants was used to compare all positive blood cultures. Rates
of blood culture collectionstions, trends in key pathogens, contamination
rates and effect of infection prevention interventions were analysed.
Results: A total of 25325 blood cultures were processed over the 37
month period. Of these, 5507 (21.75%) were positive for signiﬁcant
bacterial growth. Contaminants were identiﬁed 2896 blood cultures
(52.59% of positive blood cultures, 11.4% of all blood cultures taken).
The monthly rates of contamination are displayed in the graph below,
along with the linear regression. The results show a signiﬁcant downward
trend in the results from the 3 year period (r = −0.42). However we
were unable to demonstrate a further increase in the downward trend
following introduction of the aseptic policy. Rates of MRSA appeared
to have decreased in the study period. Rates of blood cultures positive for
MRSA (as a percentage of total positive cultures) has decreased from
an average of 3.58% in 05−06, 3.15% in 06−07, to 2.14% in 07−08
(r = −0.44). Rates of pseudomonal bacteraemia appear to have increased
in the study period when plotted graphically, however no statistically
signiﬁcant increase was identiﬁed. Rates of candidal septicaemia do not
show a signiﬁcant increase or decrease (mean 2.41% of all positive blood
cultures).
Discussion: The overall downward trend of blood culture contaminants
is encouraging, however this conclusion must be treated with caution. We
were unable to demonstrate a signiﬁcant improvement in rates following
the introduction of the new policy; however the study may have been
undertaken too soon after the policy change to detect any affect.
Figure: Monthly contamination rates.
R2225 Control charts with days between episodes in surveillance
of nosocomial bacteraemia in intensive care units: a way
to intervene
A.L. Skovby °, U.S. Jensen, T. Slotsbjerg, B. Lundgren, J.D. Knudsen
(Hvidovre, Copenhagen, DK)
Background: Nosocomial infections are often seen after invasive
procedures in hospitals; especially in intensive care units (ICU) were
patients frequently are given intravenous lines, catheters, drainages,
etc., besides having surgery performed recently. Surveying nosocomial
bacteraemia draws attention to the problem, and makes it possible to
study the effect of various interventions. Creating control-charts for
nosocomial bacteraemia in intensive care units enables the staff to follow
the rate of infection (almost in real-time) and intervene if an increased
incidence is observed.
Materials and Methods: Bacteraemia is deﬁned as a clinical episode
with one or more positive blood cultures, given signiﬁcance by a clinical
microbiologist and the attending physicians, and nosocomial bacteraemia
is deﬁned as bacteraemia from an the infection which was not present
or incubating at admission to the hospital. As part of a collaborative
network between three departments of clinical microbiology, a semi
national database of bacteraemia with numerous clinical and paraclinical
information has been established, making this special surveillance
possible. In this study, data from 2006–2008 (2008; three quarters)
is presented for two ICU’s. In the autumn of 2007, the antimicrobial
treatment was changed for patients undergoing abdominal-surgery.
Results: The mean incidence (bacteraemic episodes/1000 bed days) for
the two departments, Bbh-ICU and Hvh-ICU, were: Bbh-ICU: 10.8 and
13.6, and Hvh-ICU: 5.8 and 9.1, in 2006 and 2007, respectively.
The mean number of days between episodes was: Bbh-ICU: 20.3, 18.3,
27.4 and Hvh-ICU: 30.4, 24.3, 27.4, in 2006, 2007, 2008 (2008; three
quarters), respectively.
Using the programme CHARTrunner® (PQ Systems, Miamisburg, OH,
USA) data was analysed statistically. It was possible to recognize both
statistically signiﬁcant clusters of nosocomial episodes in the ICU’s, but
also a signiﬁcantly decrease in nosocomial infections (p< 0.01) after
change in recommendations for antimicrobial use in abdominal surgery.
Conclusion: Control charts showing days between episodes are
effectively used for surveillance of nosocomial bacteraemia in intensive
care units. Deviations in occurrence can be identiﬁed as clusters of
episodes and thereby makes it possible to quickly intervene.
R2226 Effect of shorter antimicrobial prophylaxis+using intestinal
cleaning+using single use sterile gels on infections
developing after transrectal prostate biopsies
B. Arda °, E. Kismali, S. Aydemir, A. Simsir, O. Sipahi, S. Tamsel,
S. Ulusoy, C. Ozyurt, M.A. Ozinel (Izmir, TR)
Background: The aim of this study was to evaluate the effects of
shotrter antimicrobial prophylaxis+using intestinal cleaning+using single
use sterile gels on infections developing after transrectal prostate biopsies
in a tertiary-care educational hospital.
Methods: After observing an increase in infections developing after
transrectal prostate biopsies at the end of 2007, biopsies were stopped
and procedures before and during the biopsies were evaluated. Infections
developed in the last six months were retrospectively evaluated by
using records of mictobiology, radioogy and urology. Sterilisation &
disinfection, antimicrobial prophylaxis regimens, intestinal decontam-
ination procedures and routine biopsy procedures were reevaluated
in cooperation with with the corresponding clinics. Afterwards we
implemented three main changes: (i) Five day lasting antimicrobial
prophylaxis was changed to one day lasting prophylaxis (ciproﬂoxacin
500mgx2+ornidazole: 2×1 gr starting two days before the biopsy and
lasting until the third day of it + amikacin 500mg !×1 during the
biopsy, to the ciproﬂoxacin 500mg×2 + ornidazole given 2 h before
the biopsy.) (ii) we started to implement intestinal cleaning one day
before the intervention by using enema [Fleet enema adult lavman,
Kozmed, Turkey, implemented twice on the day (8 h apart) before the
biopsy]. (iii) we started to consume single use sterile gels during biopsy
(instead of multiple use gels). Patients were diagnosed as clinical or
microbiologically conﬁrmed infection according to CDC criteria.
Results: Infection rate during the preintervention six months period
was 24/294 (8.1%, 17/294 microbiologically conﬁrmed infection, 7/294
clinically diagnosed infection)and it was 7/186 (3.7%, 5/186 microbi-
ologically conﬁrmed infection, 2/186 clinically diagnosed infection) in
the postintervention four months period (p: 0.056 with Chi-square test).
Conclusion: When we compared the two periods, there was a prominent
(more than 50% but p> 0.05) decrease in the post-biopsy infection rates.
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Our ﬁndings suggest that shorter antimicrobial prophylaxis regimens,
sterile gel consumption and intestinal cleaning may be useful in the
control of infections developing after transrectal prostate biopsies.
R2227 The hand hygiene compliance of healthcare workers
and detection of MRSA hand colonisation by using
CHROMagar MRSA
Z. Kocak Tufan °, H. Irmak, C. Bulut, S. Cesur, S. Kinikli, A. Demiroz
(Ankara, TR)
Aim: In this study, we aimed to investigate the hand hygiene compliance
of the health care personnel (HCPs) during their routine patient care,
determine the MRSA hand colonisation of the HCPs, investigate the
effect of different hand hygiene products on MRSA colonisation, and to
compare the chromogenic agar results with conventional methods.
Methods: The study was held with health care workers (HCWs),
who usually work in the departments like ICUs, infectious diseases
department and surgical departments. HCWs were investigated during
their routine patient care and hand cultures were taken before and
after hand wash/hygiene. Soap, alcohol based and chlorheksidin based
hand antiseptics were used for hand hygiene. Fingertip and inoculation
to plates with swab techniques were used for each individual when
getting the cultures. Both media were containing CHROMagar MRSA.
Suspected MRSA colonies in these media were conﬁrmed with
convantional methods.
Results: Thirty nine (39%) male and 61 (61%) female, totally 100
HCWs were included in the study. Mean age was 32.7±5.2. Of the
study group 33% was physicians, 38% was nurses and 29% was other
HCWs. Fifteen percent of them used alcohol based hand rubs while
35% used clorheksidin and 50% preferred soap and water for hand
wash. Clorheksidin was the main choice in operation rooms while soap
was for other departments. Among HCWs there was no difference
regarding antiseptic preferences. Mean hand hygiene duration time
was 44.6±29.9 seconds. Sex, occupation and working durations were
not statistically signiﬁcant for hand hygiene duration. However, in the
intensive care unit hand washing time was signiﬁcantly lesser than the
other departments (p< 0.5). Of all staff, MRSA was detected in 39%
and 13% with ﬁngertip method and in 11% and 6% with plate media,
before and after hand hygiene respectively. Log reductions of the MRSA
colonisation with alcohol based hand rub, soap and clorheksidin were
an average of 4.1 log10, 2.2 log10 and 2.7 log10 respectively. Effect of
the duration of the hand hygiene on log reduction of the MRSA was not
found to be statistically signiﬁcant.
Conclusion: We found a high ratio (39%) of hand colonisation with
MRSA among our hospital staff. It is also showed that the colonisation
can be reduced up to 66% with hand hygiene. The ﬁngertip technique
is found to be superior to inoculation to plate media. The study is also
among the ﬁrst studies which use chromojenic media for hand cultures.
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R2228 Neurosurgery-related bacterial meningitis – a 10-year review
C.M. Luca, A. Vata, D. Leca °, M. Hurmuzache, E. Miftode,
O. Dorneanu, L. Vata, V. Luca, C. Dorobat (Iasi, RO)
Objectives: Bacterial meningitis is an uncommon complication of
neurosurgical procedures associated with relevant morbidity and
mortality. Thus epidemiology, aetiology and prognosis of this infection
were studied.
Material and Method: we retrospectively studied 148 patients treated
for neurosurgery related bacterial meningitis (NSBM) in the Infectious
Diseases Hospital from Iasi, Romania, between 1998 and 2007.
Results: 16.9% of all bacterial meningitis treated in our hospital during
the period of the study were NSBM. An increase of the annual number
of NSBM and a decrease of community acquired bacterial meningitis
was also noted. Males were more frequently involved (62.1%); 41.4% of
patients were children (12.1% under one year old). The aetiology of the
NSBM could be established in only 49% of the patients; staphylococci
were involved in 16.2% of cases ((S. aureus − 11.7%, coagulase-negative
staphylococci − 4.5%). Most of the staphylococcal isolates were MRSA
(55.6%). Gram negative bacilli were involved in 6.2% of cases. The
mortality rate of NSBM was 8.43% and did not decrease during the
study period.
Conclusion: the annual number of neurosurgery related bacterial
meningitis is increasing, the most common pathogens were staphylococci
and the mortality rate was lower than in community acquired bacterial
meningitis
R2229 The evaluation of catheter-related bloodstream infections
in neurology and neurosurgery intensive care units
C. Ataman Hatipoglu °, K. Ipekkan, B. Oral, G. Tuncer Ertem,
M.A. Yetkin, F.S. Erdinc, C. Kilic, L. Inan, C. Bulut, A.P. Demiroz
(Ankara, TR)
Objectives: Catheter related bloodstream infections (CR-BSIs) are
considered the most common serious complication associated with the
use of central venous catheters (CVCs). We aimed in this study to
determine the rate, epidemiological and microbiological characteristics,
risk factors and outcomes of the CR-BSIs in patients hospitalised in
Neurology and Neurosurgery Intensive Care Units (ICUs).
Methods: This prospective study was carried out between January
2007 and January 2008. All the patients hospitalised in Neurology and
Neurosurgery ICUs with newly inserted central venous catheter were
enrolled into the study. CR-BSI rate, risk factors for CR-BSIs and for
mortality were studied.
Results: During the study period, 199 CVCs in 148 patients were
followed. Eighty-two patients were female (55.4%), mean age was
58.7±21.8 years. Sixty-seven patients (45.3%) hospitalised in Neurology
ICU and 81 (54.7%) in Neurosurgery ICU. Mean hospital stay in ICU
was 15.6±15.3 days. Eighty-nine (60.1%) patients were died. Mean
duration of catheterisation was 8.5±5.2 days. There were 32 episodes
of CR-BSI in 29 patients. Total catheter days were 1703 days. CR-BSI
rate was 20.3 per 1000 catheter days. In univariate analyses comparing
patients with CR-BSI and without CR-BSI, we found that prior antibiotic
therapy rate was higher (p = 0.02) and mean hospital stay in ICU was
longer (p< 0.001) in patients with CR-BSI. In patients hospitalised in
Neurology ICU, CR-BSI risk was 2.4 times higher than Neurosurgery
ICU patients (p = 0.004). Catheters which kept in place for more than
7 days were increased the risk of CR-BSI 6.3 times (p< 0.001). In
multivariate analyses, catheterisation day and hospital stay in ICU were
found independent risk factors (p< 0.001). The mortality rate was higher
in patients with CR-BSI (79.3%) than the patients without CR-BSI
(55.5%) (p = 0.019). In univariate analyses comparing fatal patients with
CR-BSI and non-fatal patients with CR-BSI for mortality risk factors,
we found that mortality rate was higher in patients aged greater than 60
(p = 0.017), in patients hospitalised in Neurology ICU (p = 0.006) and in
patients receiving TPN (p = 0.03). In multivariate analyses, being aged
greater than 60 was found independant risk factor for mortality (p=
0.037).
Conclusion: Catheterisation day and hospital stay were found indepen-
dent risk factors for catheter-associated blood-stream infections, and age
greater than 60 years was found independent risk factor for mortality.
R2230 Surveillance of vascular catheter and total parenteral
nutrition-related infections
P. Lanzafame °, P. Dallape`, L. Scartezzini, M. Monterosso, I. Caola,
E. Baldantoni (Trento, IT)
Objectives: Two vital components of critical care are the use of central
venous catheters (CVC) and total parenteral nutrition (TPN). In the
intensive care unit and surgical ward the patients often need for survival
and recovery. The use of CVC for the administration of TPN is a
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risk factor of catheter-related infections (CRIs) that are associated
with increased morbidity and mortality, prolonged hospitalisation,
and increased medical costs. We analysed the results of an active
surveillance system of nosocomial infections associated with CVC for
the administration of TPN in patients hospitalised in intensive care units
(ICU) and surgical wards (SW) of a country hospital (720 beds). We
evaluated the incidence rate of CVC/TPN related infections and the
microorganisms involved.
Methods: The surveillance was based on CDC’s Guideline of
Intravascular Catheter-related Infections. The study comprised patients
hospitalised between January 2006 and March 2008 in two surgical wards
(SW1, SW2) and in an intensive care unit (ICU). All CVCs associated
to TPN were prospectively followed until CVC removal. Standard
clinical and microbiological criteria were used to deﬁne colonisation
and infection.
Results: 348 patients receiving TPN, comprising 6559 central venous
catheter-days, were observed. The infections recorded were 37and the
incidence rate/1000 catheter-days was 5.64‰. The data of each unit
were analysed until March 2007. In this period in the ICU 5 cases of
CVC/TPN related infections were recorded; they correspond to a lower
incidence rate/1000 catheter-days (4.57‰) in comparison to the surgical
wards, where the highest incidence rate/1000 catheter-days was recorded,
especially in the wards with a high activity of abdominal surgery
(12.71‰ in SW1 and 7.76‰ in SW2). The average catheterisation
was higher in the patients with infections than in the patients
without infections (57.88 vs. 56.78) but not really signiﬁcant. The
microorganisms more frequently isolated in microbiological cultures was
Staphylococcus coagulase-negative, but also Candida spp., S. aureus,
S. maltophilia and Enterobacter spp. were detected.
Conclusions: The results show that the highest frequency of CVC/TPN
related infections was in the surgical ward of gastrointestinal surgery,
conﬁrming that gastrointestinal dysfunction and abdominal surgery are
associated with a high risk of CRIs, but this can also underline a need
to improve the infection control procedures in the ward.
R2231 Device-associated nosocomial infection rates in three
different intensive care units in a training and research
hospital, Ankara
M.A. Yetkin, C. Bulut, C.A. Hatipoglu °, F.S. Erdinc¸, G. Ertem, A. O¨zisik,
E. Karakoc¸, H. Basar, L. Inan, C. Kilic, A.P. Demiro¨z (Ankara, TR)
Objectives: Patients admitted to intensive care units (ICUs) have a
high risk of infection associated with their underlying conditions and
the invasive medical procedures that they undergo. In this study device
associated infection (DAI) rates of three different ICUs in our hospital
were calculated and compared with both Turkish National Nosocomial
Infection Surveillance Reports (TNNISR) and National Healthcare
Safety Network (NHSN) Report.
Methods: The study was conducted in our hospital, from August 2007
to December 2008. A prospective surveillance of DAIs in Neurology
ICU (NR-ICU), Neurosurgery ICU (NRS-ICU) and a Medical/surgical
ICU (MS-ICU) was conducted. Nosocomial infections were identiﬁed
according to CDC criteria. DAI rates were calculated as the number of
infections per 100 ICU patients and per 1,000 device-days.
Results: Data on 1841 patients who were hospitalised in NR-ICU, NRS-
ICU and MS-ICU with a total of 11959 patient-days were analyzed. The
mean overall infection rate per 100 patients was 29.1 infections, and the
mean infection rate per 1,000 patient-days was 44.7 infections. Devices
utilisation ratios and the rates of ventilator-associated pneumonia (VAP),
catheter-associated urinary tract infection (CA-UTI), and catheter-
associated bloodstream infections (CA-BSI) of three different ICU were
shown in Table 1.
The most common cause of VAP in all three ICUs was Acinetobacter
baumannii, whereas Candida spp. was mostly isolated microorganism
that caused urinary tract infections in those ICUs. A. baumannii, Candida
spp. and Enterococcus spp. were the most frequently isolated organisms
from CA-BSI from the patients hospitalised in MS-ICU, NRS-ICU and
NR-ICU, respectively.
When compared with TNNISR device associated infection rates were as
follows: CA-UTI rates of all the ICUs were between 75%-90%. CA-BSI
rates detected from MS-ICU and NRS-ICU were between 25%-50%,
whereas the same rate detected from NR-ICU was between 75%-90%.
VAP rates were as between 25%-50%, 75%, and 75%-90% for NRS-
ICU, MS-ICU and NR-ICU, respectively. We found DAI rates in our
ICUs higher than those reported by the NHSN system.
Conclusion: These results suggest that, DAI rates in our three ICUs
were higher than NHSN data and equal/higher than TNNISR data.
These data alerted us that we must improve education program for all
healthcare workers, rationalise device utilisation, and establish more-
effective infection control practices and policies in our ICUs.
Table 1. DAI and device utilisation ratio of ICUs
ICU Ventilator
utilisation
ratio
VAP
rate
Urinary
catheter
utilisation
ratio
CA-UTI
rate
SVK
utilisation
ratio
CA-BSI
rate
Medical/surgical 0.49 32.94 0.88 14.32 0.62 11.56
Neurosurgery 0.18 21.74 0.90 13.80 0.63 5.29
Neurology 0.15 53.16 0.98 21.00 0.31 19.27
VAP: ventilator-associated pneumonia; CA-UTI: catheter-associated urinary tract
infection; CA-BSI: catheter-associated bloodstream infection.
R2232 Vertebral osteomyelitis post-vertebral surgery. A descriptive
and comparative study of 100 cases
M.E. Jimenez-Mejias °, A. Plata, E. Garcı´a-Cabrera, J.D. Ruiz-Mesa,
J. Valencia, M. Delgado, J. Marquez-Rivas, J.D. Colmenero on behalf
of the Spanish Network for Research in Infectious Disease
Objectives: To study the epidemiology, clinical and diagnostic features,
treatment and outcome in patients with postvertebral surgery vertebral
osteomyelitis (PSVO), and to compare with other pyogenic vertebral
osteomyelitis (PVO).
Methods: Study of 514 patients diagnosed of vertebral osteomyelitis
between January 1983 and November 2008. Inclusion criteria: 1) spinal
inﬂammatory pain or fever and spinal pain on physical examination,
2) imaging ﬁndings compatible with VO, 3) aetiologic diagnosis. We
analyse epidemiology factors, clinical features, radiologic and analytic
parameters, microbiology isolates, treatment and outcome. Patients were
followed since 12 months. Statistical analysis: chi-square and Fisher’s
tests.
Results: PVO was diagnosed in 267 patients (52%); and of them 100
patients (37%) were PSVO. Underlying disease: 1) diabetes mellitus: 10
patients PSVO (10%) vs 44 PVO (26%)(p = 0.001); 2) immunosupresion:
7 patients PSVO vs 43 PVO (p< 0.001). Previous bacteraemia: 3 patients
PSVO vs 53 (32%) with PVO (p< 0.001). Duration symptoms: median
22 days (35 d. POV, p = 0.004). Clinical features: Inﬂammatory back pain
88 PSVO vs 157 (95%) PVO (p = ns), fever 54 PSVO vs 120 (72%) PVO
(p = 0.002), neurological symptoms and signs 78 patients (78%) PSVO vs
88 (53%) PVO (p = 0.001). Blood culture positive: 21/46 (46%) PSVO
and 79/129 (61%) PVO (p = ns). Bone biopsy culture positive: 37/41
(90%) PSVO and 71/91 of PVO (78%) (p = ns). Culture of other samples:
74/75 (99%) PSVO vs 59/68 (87%) of PVO (p = ns). Aetiological agents:
Gram-positive cocci 75 (64%) (coagulase negative Staphylococcus spp.
36, S. aureus 31, other Gram-positive cocci 8), Gram-negative bacilli 23
(20%)(Pseudomonas aeruginosa 7, Escherichia coli 6, Proteus mirabilis
5, others 5), anaerobic bacteria 18 (15%)(Propionibacterium spp. 7,
Bacteroides fragilis 3, others 8), and other 1. Polymicrobial isolates:
17 cases. For 64 patients with PSVO surgical treatment was needed vs
74 (44%) with PVO (p = 0.003). Severe functional sequelae: 41 patients
with PSVO vs 59 (35%) (p = ns). Relapse: 1 patient. No deaths.
Conclusions: 1) PSVO is an important segment of the PVO.
2) Underlying diseases and previous bacteraemia are less frequent than
others PVO. 3) The duration symptoms is smaller, and the neurological
symptoms and signs are more frequent than PVO. 4) PSVO is caused by a
variety of organisms. 5) Diagnostic yield of microbiological techniques
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is very high. 5) Patients with PSVO need of surgical treatment more
frequent.
R2233 High prevalence of colonisation of vancomycin-resistant
enterococci in adult haematology unit patients
M. Bronk °, A. Sledzinska, M. Kochowska-Bronk, A. Samet, L. Naumiuk
(Gdansk, PL)
Objective: Vancomycin-resistant enterococci (VRE) are widespread
worldwide. Colonisation and infection with VRE are problems in
hospitals worldwide. Despite growing concern about VRE as nosocomial
pathogens, they are rarely isolated in Polish hospitals. To determine the
prevalence of VRE colonisation in adult haematology unit patients during
a 5-year period at the Medical University Hospital, Gdansk, Poland.
Methods: Anal swab culture were collected from patients in adult
haematology unit between October 2003 and October 2008. Samples
were collected from patients whit more than 2 days of admission in these
units, and repeated every 6 days until discharge. Samples were cultured
on a bile esculine agar with vancomycin (6mg/L) for VRE. Strains
were then reincubated in a blood agar medium and identiﬁed by Vitek
(bioMerieux). Minimal inhibition concentration against vancomycin,
teicoplanin and linezolide was determined by an E-test.
Results: In adult haematology unit there were 5896 samples from 593
patients. VRE were isolated from 234 (37%) patients. Among total 234
non-repetitive VRE isolates, 223 were identiﬁed as E. faecium, 6 as
E. casseliﬂavus, 4 as E. gallinarum and 3 as E. faecalis. All isolates
E. faecium expressed a VanA phenotype. Only 3 isolates were resistante
to linezolide.
Conclusion: Vancomycin-resistant enterococci are a major concern
in our adult haematology unit. VRE colonisation must be monitored
and risk factors should be determined. They are useful for screening
hospitalised patients for VRE colonisation in order to establish
prevention and control measures.
R2234 Healthcare-associated infections in a medical-surgical
intensive care unit, in a research and training hospital
C. Bulut, C. Hatipoglu °, M.A. Yetkin, F.S. Erdinc¸, E. Karakoc¸,
H. Basar, A.P. Demiro¨z (Ankara, TR)
Objectives: Healthcare associated infection is a common problem in
intensive care medicine. Some factors such as severity of underlying
disease, altered consciousness, impaired protective reﬂexes, concomitant
immunsupression and exposure to invasive devices increases the risk of
healthcare associated infections.
In this study, we aimed to assess data on the epidemiology of healthcare
associated infections (HAI) among patients in a medical/surgical
intensive care unit (MS-ICU).
Methods: The study was conducted in Ankara Training and Research
Hospital, between September 2007 and December 2008. The patients,
treated for more than 48 hours in 10-bed MS-ICU were enrolled into the
study. The patients were followed until death or three days after discharge
by prospective daily surveillance. HAI were identiﬁed according to CDC
criterias. Identiﬁcation and antimicrobial susceptibility testing of isolated
microorganisms were performed by a Vitec-II system (Biomerio France).
Results: During the study period, 682 patients were hospitalised in MS-
ICU with a total 3446 patients days. Among these patients, 127 HAI were
detected. HAI rate was 18.6% and hospital infection incidence density
was 36.9 per 1000 patient’s days.
Ventilation associated pneumonia (40.9%), urinary catheter related
urinary tract infection (31.5%), catheter related bloodstream infection
(17.3%), pneumonia (7.9%) and surgical site infection (2.4%) were the
frequently detected infections. Ventilator associated pneumonia, urinary
catheter associated urinary tract infection and central line associated
bloodstream infection rates were 31.38, 12.89, 10.39 per 1000 devices
days respectively. Utilisation ratios of ventilator, urinary catheter and
central lines were as follows 0.48, 0.88 and 0.61, respectively. All of
these results were higher than NNIS results.
The most common isolated microorganisms were A. baumannii (35.2%),
E. coli (17.2%) and Candida spp. (16.4%). The frequency of resistance
of Staphylococcus aureus isolates to methicillin (MRSA) was 80%.
Extended spectrum b-lactamase production was detected in 43% of Gram
negative enteric bacteria isolates. Carbapenem resistance was 86% in
A. baumannii isolates.
Conclusion: In this study, ICU-acquired infection rates were found
higher when compared with NNIS results. These high rates alerted us to
take immediate precautions for decreasing device utilisation and device-
associated infection rates in our MS-ICU.
R2235 Neonatal sepsis at a neonatal care unit in the Black Sea
region of Turkey: a two-year analysis
G. Karatekin, M. Kilinc¸ °, O¨. Korkmaz, M. Gu¨naydin (Samsun, TR)
Objective: The pathogens of neonatal sepsis vary with geographic area,
time, and individual neonatal intensive care units. Therefore, knowledge
of related factors and the pattern of bloodstream infection can help
to determine the antibiotic prescribing policy and infection control
procedures. This study aimed to determine the prevalence, microbial
epidemiology of neonatal sepsis, and related factors in our centre.
Method: The retrospective study reviewed records of patients with
culture-proven sepsis from January 2007 to December 2008 at neonatal
intensive care unit (NICU) in Samsun Maternity and Children’s
hospital in Black Sea Region, Turkey. Blood cultures were done
using BacT/ALERT 3D system. Isolated pathogens were identiﬁed and
included in the study.
Results: During the study period 3173 neonates were admitted to
the NICU. From 1996 taken blood cultures, 161 bacteria strains were
isolated. Of these, 43 (29.8%) were evaluated as contaminated and
118 episodes culture proven septicaemia were identiﬁed. Gram-positive
organisms accounted for 57.6% (68/118) of the positive culture results,
Gram-negative organisms accounted for 40.7% (48/118), and yeast for
1.7% (2/118). Pseudomonas and Klebsiella spp. weren’t observed at
patients with neonatal sepsis.
The rate of neonatal septicaemia was 3.7% (118/3173) and the mortality
rate of these 19.5% (23/118). Neonatal sepsis mortality in 73.9% was
caused by Gram-negative organisms, which were found resistant to
commonly used antibiotics. The risk of death from neonatal sepsis was
7.24‰ (23/3173) for admitted patients. Sixty nine percent of the cases
were inborn patients. During the study period total number of live births
in the hospital was 15504, resulting in a hospital-based neonatal sepsis
incidence of 5.3‰ for in-born patients. The total number of live births
with low birth weight (LBW) (under 2500 g) during the study period
was 7.3%, however 51% of sepsis cases were LBW. The male to female
ratio was 1.53.
Conclusions: Male babies and babies with LBW had greater neonatal
sepsis rate, suggesting a greater care to be given to them. Since
death cases were caused by Gram-negative bacteria, antibiotic that is
effective for these help the mortality rate to decrease. Understanding the
local epidemiology of neonatal sepsis can lead to the development of
better medical practices, especially more appropriate choices for empiric
antibiotic therapy, and may contribute to improvement of infection
control practices.
R2236 The effect of transfusion on the rate of sepsis in patients
undergoing cardiac and vascular surgery at a tertiary care
centre in India
A. Kothari °, B. Panigrahi, V. Sagar, A. Bhan, N. Selot (New Delhi, IN)
Objectives: It has been reported that perioperative transfusion of
leukocyte-containing blood components is a risk factor for the
development of postoperative bacterial infections. The purpose of this
study is to analyze the rate of sepsis in patients undergoing cardiac
and vascular surgery and to study the correlation of blood transfusion,
duration of surgery and length of stay in the ICU with the rate of sepsis.
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Methods: We analyzed data from 516 consecutive adult patients
undergoing cardiac surgery at our hospital between 1st January 2005
to 30th April 2006. The patients underwent coronary bypass grafting,
valvular surgery or aneurysm surgery. Sepsis was deﬁned as positive
blood cultures along with features of systemic inﬂammatory response
syndrome. The rate of sepsis was analyzed in patients receiving 4 units
of blood vs >4 units of blood. The correlation of duration of surgery
(5 hours vs >5 hours) and the length of stay in the ICU (4 days vs
>4 days) with the rate of sepsis was also studied.
Results: 2.33% of the 516 patients developed postoperative sepsis
associated with positive blood cultures. 40% of the sepsis episodes were
associated with Gram negative organisms, 26.7% with Gram positive
organisms and 33.3% with candida. Mean blood products used for 516
patients was 5.08 units. The rate of sepsis in patients who received fewer
transfusions was 1.27% and those who received 5 or more transfusions
was 3.98%, p = 0.0690. Mean duration of surgery of 516 patients was
4.90 hours. 0.98% patients with the shorter duration of surgery developed
sepsis compared to 6.60% patients with the longer duration, p = 0.0041.
Mean duration of ICU stay of 516 patients was 4.64 days. 0.82% patients
who stayed in the ICU for 4 days or fewer developed sepsis compared to
5.92% patients who stayed in the ICU for more than 4 days, p = 0.0013.
Conclusion: In our study, the incidence of postoperative sepsis was
higher in patients receiving 5 or more blood units for transfusion, but this
was not statistically signiﬁcant. We also found that that longer duration
of surgery and length of stay in ICU has a highly signiﬁcant positive
correlation with incidence of postoperative septicaemia. Studies with
larger patient populations need to be done before a positive correlation
between blood product transfusion & postoperative septicaemia can be
established.
Travel medicine, tropical & parasitic diseases
R2237 A multi-centre retrospective study on intestinal parasitosis
in Italy, 2005–2007
A. Raglio °, M. Arosio, D. Crotti, S. Gatti, G. Bargiggia, F. Bernieri on
behalf of AMCLI-COSP Study Group (F. Lanzini, L. Vettorato, E. Sala,
S. Piccoli, I. Patamia, R. Grande, D. De Conno, V. Cutrupi, M. De Paola)
Objectives: Many data on the epidemiology of intestinal parasitosis are
available for developing area, not so for industrialised countries. Our
aim was to describe the epidemiology of parasitic intestinal infections in
Italy, through a multicentre study coordinated by Association of Italian
Clinical Microbiologists − Committee of Parasitology.
Methods: We asked twelve laboratories throughout the country to ﬁll
a questionnaire about their diagnostic methods and local epidemiology
related to the period of 1 January 2005−31 December 2007. The attention
was pointed to evaluate the results of standard stool parasitological
examination (O&P), cellophane-tape test, Baermann/larvae culture
methods and permanent stain (acid fast stain, Giemsa or trichrome stain)
for intestinal helminths and protozoa.
Results: All the laboratories performed O&P and cellophane-tape
test. 33524 samples were tested by O&P, 337 (1.0%) were positive
for helminths and 851 (2.54%) for pathogen Protozoa. Helminths
were: Taenia spp. 0.35%, Hymenolepis spp. 0.18%, A. lumbricoides
0.13%, T. trichiuria 0.12, Ancylostoma spp. 0.08%, S. mansoni 0.05%,
D. latum 0.04% and 851/33524 (2.54%); Protozoa were: G. lamblia
2.15%, E. histolytica/dispar 0.36% and I. belli 0.02%. 2313 samples
were examined by cellophane-tape test, 252 (10.89%) were positive
for E. vermicularis. 7/12 labs used Baermann or larves culture
methods for isolation of S. stercoralis: 196/14170 were positive
(1.38%). 6/12 labs performed Giemsa and 2/12 labs trichrome stain
for D. fragilis: 378/16357 (2.31%). All laboratories used acid fast stain
for Cryptosporidium spp.: 44/2647 (1.66%). 4/12 labs used antigen
detection for E. histolytica/dispar. Only 1 lab cultured suspected cases
for E. histolytica by Robinson medium: 83/403 (20.6%).
Conclusions: Not all the labs are still organised for good faecal diag-
nostics and are available to performe adequate data collection. Anyway,
faecal parasites and particularly helminths, excluding E. vermicularis
and S. stercoralis, are very rare in Italy. Moreover, more labs should
investigate for D. fragilis using at least Giemsa stain, and research
speciﬁcally S. stercoralis when risk factors are present. For E. histolytica
the antigen detection is useful but the gold standard remains the culture
that is still available in few labs.
R2238 Increase of imported leishmaniasis in the Netherlands?
A 12-year overview (1996–2007)
T. Herremans °, E. Pinelli, M. Casparie, N. Nozari, J. Roelfsema,
T. Kortbeek (Bilthoven, Utrecht, NL)
Objectives: Surveillance data indicates that the number of cutaneous
(CL), mucocutaneous (ML) and visceral leishmaniasis (VL) cases has
increased globally during the past decades. Leishmaniasis is not endemic
in the Netherlands and is only seen as an imported disease.
Methods: To investigate the trend of the occurrence we analysed all CL,
ML and VL patient samples sent to the laboratory at the CIb between
1996 and 2007. We then compared these results to cases reported to
the PALGA foundation, a nationwide network and registry of histo- and
cytopathology data.
Results: The majority of diagnosed leishmaniasis patients in the
Netherlands suffer from CL, and a weak, non-signiﬁcant increase over
the years can be observed. A CL outbreak among Dutch military
personnel stationed in endemic regions in 2005 was also noted. ML
is rarely found in the Netherlands − we detected only one to three cases
a year. However, the occurrence of VL has increased signiﬁcantly during
the last decade in the Netherlands, mainly among patients under 20 years
of age.
Conclusion: Physicians in the Netherlands should be aware that
leishmaniasis is close to home and can be contracted as close as Southern
Europe and that it is not limited to tropical and subtropical regions only.
R2239 Visceral leishmaniasis: report of 6 cases
N. Charalambaki °, P. Giannopoulou, I. Grafakos, A. Kyratsa,
K. Saﬁoleas, M. Antoniou, E. Trikka-Graphakos (Athens, Heraklion, GR)
Visceral leishmaniasis is considered important zoonotic infection,
endemic in Mediterranean countries, caused by the intracellular parasite
Leishmania spp.
Objective: Analysis of the epidemiological, clinical and laboratory
parameters of the disease at the region of responsibility of our hospital,
during the last 3 years.
Methods: 4 adults (mean age: 58.7 years) and 2 children (mean age:
1.7 years) were admitted with visceral leishmaniasis. On admission,
haematological, biochemical tests and abdominal ultrasound were
performed. The parasites were detected by direct microscopy of
bone marrow smears. Parasite culture performed in specialised media
(NNN and RPMI). Speciﬁc IgG antibodies detection by Indirect
Immunoﬂuorescence (Vircell microbiologist, Spain), Electrosyneresis,
(for detection of active form of the disease) and PCR were also
performed.
Results: All adults were in close contact with sray dogs, while one
referred recent trip to Pakistan. The incidence of the disease was higher
during warm months of the year. Most important clinical features were:
fever (100%), hepatosplenomegaly (100%), malaise (50%), ﬂue like
syndrome (10%). CRP and liver enzymes were elevated (100%). The
most frequent haematologic ﬁndings were anaemia (100%), leucopenia–
thrombocytopenia (90%) and eosinophilia (10%). The diagnosis was
established by detection of amastigotes forms of parasites in bone
marrow smears (80%), detection of elevated IgG (>1/400) titers by
IFA (90%) and Electrosyneresis (90%). Blood cultures were positive
(80%), while PCR was positive in all cases. All patients were treated
with liposomial amphotericine B.
Conclusions: 1. Increased incidence in our country is observed during
the last years, due to environmental changes and limitation of protective
measures against stray dogs. 2. The most common diagnostic approach
is the presence of parasites in bone marrow smears and serological
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tests. 3. Electrosyneresis and PCR are important for rapid and accurate
diagnosis of the disease.
R2240 Therapeutical approach in hydatic cyst disease with
multiple location
R. Stoicescu °, C.M. Mihai, D. Catrinoiu, A. Balasa, L. Mihai, V. Cuzic,
R. Sirbu, T. Negreanu, M. Arcus (Constanta, RO)
Background: Hydatid liver, pulmonary, cerebral and peritoneal disease
in children is a serious problem, mainly in areas where the parasite is
endemic.
Echinococcosis is a severe disease in childhood inaccessible to an initial
radical surgical treatment, medical therapy being an alternative with
controversial curative efﬁcacy.
Objective: to evaluate the efﬁcacy of albendazole and to discuss the role
of surgery in multiple hidatid cyst disease diagnosed in 29 patients.
Material and Method: The group of study was represented by 14
children aged 2−16 years and 15 adults, mean age 35.4 years, treated in
two county hospitals in Constanta between 2000 and 2008.
All patients had multiple hepatic cysts and 12 had coexisting cysts in
the lung.
One patient had a peritoneal cyst, 2 had cerebral cysts and 1 had multiple
located cysts (liver, brain, lungs and heart).
In 19 cases, medication with albendazole was used as the initial therapy,
given as 10mg/kg daily continuously, for several months (3−9 months).
Results: The overall success (deﬁned as progressive shrinkage and
solidiﬁcation of the cyst) of medical therapy was very low, 1 patient
with 2 pulmonary cysts was cured. Age, sex, and the size, location, and
number of cysts did not show any relationship to the response to medical
therapy. A total of 28 patients (10 primarily, 18 after unsuccessful
medical therapy) were treated surgically. During the follow-up period, 3
surgical patients(2 untreated and 1 treated with albendazole), developed
recurrent disease.
Conclusion: Medical treatment with albendazole resulted in fewer
curative successes than expected; probably a longer period of medical
treatment may increase the success rate, coupled with surgery.
R2241 European cluster of imported falciparum malaria from
Gambia
T. Jelinek °, C.S. Larsen, H. Siikama¨ki, B. Myrvang, P. Chiodini,
J. Gascon, L. Visser, A. Kapaun, G. Just-Nu¨bling, A. Bjo¨rkmann,
J. Cuadros on behalf of TropNetEurop
During the comparatively short time period of three months between
September and December 2008, TropNetEurop member sites reported
63 patients returning from Gambia with falciparum malaria. The series
impressed with a particularly high rate of disease complications and
deaths of patients. While the reasons for travel were quite diverse, a
striking lack of effective prophylactic measures was apparent in all.
Fifty-one patients had not used any malaria chemoprophylaxis. All
travellers who indicated that they had taken prophylactic drugs used
inadequate or downright wrong ones: two took homeopathic prophylaxis,
three used chloroquine only, one used paludrine only, and the remaining
stopped taking effective chemoprophylaxis too early. Thus, despite
the documented risk of complicated falciparum malaria from Gambia,
virtually all patients chose to use no or inadequate prophylaxis. Several
were counselled to take this decision by their travel agency, but in
a few cases even by their family doctor. The cluster underlines the
necessity of competent pre-travel information and adequate protection in
travellers, in particular at times when malaria appears to be decreasing
but still remains a high risk for non-immune travellers. Although there
probably is an overuse of chemoprophylaxis against malaria among
tourists travelling to Asia and Latin America, chemoprophylaxis is a
must for most travellers to African destinations, and in particular to
west Africa.
R2242 The campaign for malaria eradication in Romania,
1923–1963
R. Neghina °, A.-M. Neghina, C. Merkler, I. Marincu, R. Moldovan,
I. Iacobiciu (Timisoara, RO)
Objectives: The present study aims to analyze extensively the history
of the eradication campaign against malaria in Romania.
Methods: Retrospective analysis of the Romanian ofﬁcial documents
available on malaria epidemiology and eradication campaign.
Results: The median incidence of malaria cases before 1924 was
considered to be of about 5,000–6,000 per 100,000 inhabitants. During
the period 1925–1940, the median incidence was 879.6 cases per
100,000 inhabitants per year. During the Second World War period
(1941–1944) the malaria endemy registered a peak in 1942 with an
incidence of 1,218 cases per 100,000 inhabitants. In the following years
the incidence increased from 421.5 cases per 100,000 inhabitants in
1944 to 735.1 cases per 100,000 inhabitants in 1946. The Ministry
of Health formed a Malaria Commission in February 1947 with the
mission to reorganise the ﬁght against malaria based on international
guidelines. The efﬁciency of the complex methods used during the
antimalarial campaign begun in 1947, was proved by: 1. the reduction
by 99.4% of the new cases and 98.4% of the relapses in the whole
country, at the end of 1953, compared with malaria incidence in 1948;
2. 66% decrease of the incidence at the end of 1954 (compared with
the year 1953); 3. maintenance of the endemic index at 0 in the zones
cleared of malaria and protected against reinfestation by insecticide
barriers; 4. haematological control in 86,937 blood samples indicated
351 parasite carriers, out of whom 96.2% P. vivax, 3.3% P. falciparum
and 0.6% P. malariae; these results conﬁrmed the efﬁciency of the
methods and the absence of any deﬁciencies when pulverisation with
insecticides was performed in good conditions; 5. no reappearance of
epidemic foci among collectivities which continuously and periodically
were subjected to “imagocide” protection − with residual insecticides,
associated with chemotherapy and, eventually, chemoprophylaxis with
synthetic products − during a period of 6 years; there was no sign
of acquired resistance in vectors. In 1963, the Romanian authorities
informed World Health Organisation about the malaria eradication on
its territory.
Conclusion: Malaria was common in Romania until the largely
successful campaigns of the twentieth century. Through a combination
of vector control strategies and chemotherapy, the disease was gradually
brought under control, so that today malaria is not a signiﬁcant health
hazard in Romania.
Resistance and mechanisms of action of
antifungals
R2243 Comparative proteomic analysis of ﬂuconazole-resistant
and ﬂuconazole-sensitive Candida glabrata isolates
Y. Shen °, L. Zhang, H. Lu, Y. Zhang (Shanghai, CN)
Objectives: The known molecular mechanisms of ﬂuconazole resisitance
in C. glabrata are not sufﬁcient to explain the resistance in clinical
isolates of C. glabrata, new resistance-associated genes and other
possible underlying resistance mechanisms deserve a great deal of
concern and investigation.
Methods:We used proteomics-associated techniques to identify changes
in the proteome of ﬂuconazole-resistant isolates of C. glabrata compared
with ﬂuconazole-sensitive ones in order to identify proteins that are
differentially expressed in associated with ﬂuconazole resistance.
Results: Eight proteins were found to be more abundantly represented,
and four proteins were found to be less abundantly represented, in
ﬂuconazole-resistant strains compared with ﬂuconazole-sensitive ones.
These differentially expressed proteins involved in energy metabolism,
stress response and macromolecule synthesis.
Conclusion: These results indicate that proteins involved in energy
metabolism, stress response and macromolecule synthesis may play a
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role in the development of ﬂuconazole resistance in clinical isolates of
C. glabrata. The study provides further evidence that many different
mechanisms are involved in the development of ﬂuconazole resistance
in C. glabrata. These ﬁndings provide scientiﬁc basis for discovering
new genes and mechanisms associated with ﬂuconazole resistance in
C. glabrata.
R2244 Susceptibility to ﬂuconazole and voriconazole of aetiologic
agents of candidaemia in Saint Petersburg, Russia
N. Vasilyeva °, I. Vybornova, T. Bogomolova, L. Pestova, N. Klimko
(St. Petersburg, RU)
Objective: To study species distribution and prevalence of susceptibility
to ﬂuconazole and voriconazole among Candida spp., isolated from
blood of hospitalised patients in Saint Petersburg.
Methods: Susceptibility testing was performed according to CLSI M44A
document.
Results: During years 2003–2008 145 Candida spp. strains have
been cultured from blood of patients in several tertiary hospitals
in Saint Petersburg, Russia and transferred for species identiﬁcation
and susceptibility testing to reference mycological laboratory (Kashkin
Research Institute of Medical Mycology).
Species distribution was as follows: C. albicans – 36 strains (24.8%),
C. parapsilosis – 34 (23.4%), C. guilliermondii – 28 (19.3%),
C. glabrata – 14 (9.7%), C. tropicalis – 9 (6.2%), C. krusei – 5 (3.4%),
C. lusitaniae – 4 (2.8%), C. famata – 2 (1.4%), C. lipolytica – 1 (0.7%),
C. dubliniensis – 1 (0.7%), C. pelliculosa – 1 (0.7%), Candida sp. – 10
(6.9%).
All isolates were tested for susceptibility to ﬂuconazole. On the whole,
33 (22.8%) strains were resistant (R) or susceptible dose-dependent
(SDD) to this drug. All C. albicans and all except one C. parapsilosis
strains were susceptible to ﬂuconazole. All C. krusei isolates were R.
Low susceptibility (R, SDD) was found in 13 (46.4%) C. guilliermondii
strains and 12 (85.7%) C. glabrata isolates.
Susceptibility to voriconazole was tested in 56 Candida spp. strains,
isolated from blood during 2006–2008. On the whole, 8 (14.3%) isolates
were R or showed intermediate (I) susceptibility to this antifungal.
Among strains with low susceptibility (R, I) to voriconazole species
distribution was as follows: C. guilliermondii – 3 strains, C. krusei – 2,
C. glabrata – 2, C. parapsilosis − 1.
Conclusions: 1. Candida non-albicans species caused 75.2% of cases
of candidaemia in Saint Petersburg. 2 Among aetiologic agents of
candidaemia prevalence of susceptibility to ﬂuconazole was 77.2% and
to voriconazole − 85.7%.
R2245 Virulence factors and susceptibility patterns of Candida
species isolated from patients with obstructive uropathy
and bladder cancer
M. Omar, N. Fam °, T. El-Leithy, M. El-Said, I. El-Seidy, T. El-Etreby
(Cairo, EG)
Objectives: to study the distribution of virulence factors among candida
species isolated from patients with candiduria and their association with
resistance to antifungal agents.
Methods: urine specimens from 250 patients divided into 3 groups were
examined: group1 (n = 50) cancer bladder, group2 (n = 100) obstructive
uropathy and group 3 (n = 100) simple recurrent urinary tract infection
(UTI). Candida isolates were identiﬁed by CHROM-agar and by
Candifast Es Twin test. Resistance to antifungal agents was tested by
disc diffusion test for ﬂuconazole (FCZ 25Ug; Mast, UK) and E test
strips for ﬂuconazole, voriconazole and amphotericin B (AB Biodisk
Solna, Sweden) using Sabaroud dextrose agar. Bioﬁlm formation (BF)
was detected by tube and spectrophotometric plate adherence methods
and quantitated by crystal violet staining and XTT reduction assays.
Phospholipase activity (PLA) was screened using Sabouraud egg yolk
agar and proteinase (SAP) was detected using bovine serum albumin
agar.
Results: candiduria was detected in 24% of patients with highest
incidence among obstructive uropathy patients (67.2%). Candida non-
albicans species (tropicalis, krusei and glabrata) were signiﬁcantly higher
than C. albicans (73.1% versus 26.8%; p< 0.001) in this group. BF,
SAP and PLA were detected in 39.3%, 44.3% and 72.1% of isolates
respectively with signiﬁcant production among group 2 patients. The
tube adherence and crystal violet staining methods were simple sensitive
methods for detection and quantitation of BF. C. krusei and C. tropicalis
were the highest bioﬁlm-producing species (81.8% and 63.6%). FCZ
showed poor activity against all isolated candida species (24%-32.8%)
with high MIC values (>256 ug/ml). Voriconazole was active against all
isolated candida species with low MIC values (0.064–1 ug/ml) except in
C. glabrata (22%). All isolated candida species were more sensitive to
VCZ compared to FCZ; particularly C. krusei isolates (90% versus 9%).
AMB remained to be an effective drug with absolute sensitivity and low
MIC in C. glabrata isolates.
Conclusion: BF, PLA and SAP production are important virulence traits
in candiduria causing UTI. BF is common in non-albicans species
particularly C. krusei and C. tropicalis in patients with obstructive
uropathies. Resisance to FCZ is highly associated with virulence traits
so it may no longer be the drug of choice for treatment of candiduria.
AMB or VCZ are better alternatives while C. glabrata is best treated by
AMB.
Fungal infections
R2246 Rapid identiﬁcation of Candida species from clinical
specimens by RFLP-PCR method
T. Shokohi, Z. Saltanatpour, M. Hashemi, S. Maiahi, M.T. Hedayati,
A. Saltanatpour ° (Sari, IR)
Nowadays, opportunistic infections have been increasing as a result of
Candida species and non-albicans. Indeed traditional methods were used
for identiﬁcation clinical isolates of Candida spp are time-consuming and
also they are not appropriate for rapid and accurate reliable identiﬁcation.
Objective: Using universal, ITSI and ITS4, in this study, we could
amplify ITSI-5.8S-ITSII regions at both 80 clinical sample and 3
standard isolates. Clinical strains were isolated from urine, lip, throat
and cheek of patients of oncological ward of Imam hospital of Sari in
Iran.
Method: Chromagar was used for preliminary detection of candida
species. DNA from the selected specimens was extracted by Glass-Bead
strategy, and PCR-RFLP methods were done on the extracted genomes.
Result: Furthermore, we successfully identiﬁed all isolated species using
tow restriction enzyme, C. albicans (77.5%) was the most common
species among them. Consequently, C. glabrata (15%), C. tropicalis
(5%), C. krusei (2.5%) respectively. Although applied primers and
enzyme were able to identiﬁed C. parapsilosis, C. guilliermondi,
C. dubliniensis, there were no such isolates among all identiﬁed isolates.
Conclusion: RFLP-PCR using ITSI and ITS4 primers and restriction
enzyme is rapid, easy, reliable and also applicable method in clinical
laboratory for identiﬁcation of medically important Candida species.
R2247 Fungal strains isolated from liver transplant recipients
E. Swoboda-Kopec °, I. Netsvyetayeva, M. Sikora, S. Blachnio,
G. Mlynarczyk (Warsaw, PL)
Introduction: Fungal infections in liver transplant recipients constitute
constantly increase therapeutic problems. Candida genus is the leading
fungal pathogen in transplant medicine combine with high risk of
morbidity and mortality in liver transplant patients.
Aim of study: The aim of our study was to analyze of fungal strains
isolated from samples taken from clinical materials of liver transplant
recipients hospitalised in Department of General and Liver Surgery
Central Clinical Hospital in Warsaw in 2007.
Material and Methods: The total number of 50 positive clinical
samples from liver recipients were examinated, which constituted 39%
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of positive materials from the Transplant Department: clinical samples
were taken from respiratory tract − 30 (59%), wound swabs − 6 (12%),
urine samples − 5 (10%), drain tips − 5 (10%), other materials −
5 (10%). The specimens were inoculated into Sabouraud’s medium
with chloramphenicol and gentamicin (bioMerieux). The isolation and
identiﬁcation of the isolates was performed with the use of CHROMAgar
(Becton Dickinson) and biochemical test API ID32C (bioMerieux).
Results: The collection of fungal isolates included 62 strains, yeastlike
fungi 58 strains (94%) and moulds 4 strains (6%). The most often
isolated strains from Candida genus were: C. albicans − 31 (50%),
C. glabrata − 9 (15%), C. inconspicua − 8 (13%), C. parapsilosis −
5 (8%). Other yeastlike fungi constituted 8% − 5 strains. In total 4
strains of Aspergillus fumigatus (6%) were identiﬁed. Clinical samples
taken from respiratory tracts were positive in 60%, 37 fungal strais were
isolated from this material (C. albicans n = 19 (51%)).
Conclusions:
1. The most common fungal pathogens isolated from liver transplant
recipients was C. albicans − 31 strains (50%).
2. 17 isolates (28%) were natural resistance to ﬂuconazole − primary
regimens for yeast infections.
3. Aspergillus fumigatus isolates were cultured in 6% of the total number
of fungal strains.
R2248 Fatal cutaneous zygomycosis from Saksenaea vasiformis in a
young patient after a car accident. First isolation in Greece
P. Giannopoulou, N. Charalambaki, I. Grafakos, A. Kyratsa,
A. Chondrothanasi, F. Klouva-Molybda, E. Trikka-Grapgakos ° (Athens,
GR)
Introduction: Saksenaea vasiformis is a rare human pathogen with a
world-wide distribution associated with soil and invasive lesions after
traumatic implantation. We report a fatal case of cutaneous zygomycosis
caused by S. vasiformis in a previously healthy man suffered soil
contaminated wounds in a car accident.
Case report: A 30-year old patient was admitted to our hospital
due to mild cranial contusion. Three days after the accident at
the left posterior thoracic and lumbar region a rapidly progressive
necrotising lesion appeared. The patient became febrile (38.5–39ºC),
while was heamodynamical stable. He underwent extensively surgical
debridment and 2 specimens were taken for culture and histopathologic
examination. Exudates and necrotic tissue crude preparations were
examined by microscopy. On Gram staining, Gram(+) andGram(−) rods
were observed, while on direct microscopy, wide, non-septate, hyaline,
typical for Zygomycetes hyphae were present. Conventional culture
revealed mixed bacterial ﬂora. Minimally manipulated tissue samples
were cultured in Sabouraud dextrose agar at 25, 30 and 37ºC.At all
temperatures, woolly, rapidly growing, zygomycotic colonies appeared
in 24 hs and covered the entire Petri dish in 48 hs. Because the isolate
didn’t sporulate in malt extract and potato dextrose agars, it was cultured
in Czapek’s, 1% water and in saline agar at 25, 30 and 37ºC but remained
sterile for over 2 months. The isolate was identiﬁed by sequencing the
Internal Transcribed Spacer region (ITS) after DNA extraction from pure
culture and ITS PCR ampliﬁcation using the primers ITS1and ITS4.
The derived sequence was compared to published fungal sequences and
showed more than 99% homology with those published for S. vasiformis.
In vitro susceptibility testing to antifungals (CLSI, Etest methods) was
not possible to perform, probably due to the very fragile nature of
the non-sporulating isolates’ hyphae. Despite of the combination of the
aggressive surgical debridement of the infected tissues and the systemic
treatment with amphotericin B and posaconasole, the patient developed
extensively destructive necrotising local invasion and died from septic
shock on the 13th day of his hospitalisation.
Conclusion: S. vasiformis is an emerging human pathogen, that is most
often associated with cutaneous lesions after trauma that could lead to
a fatal outcome. Laboratory identiﬁcation may be difﬁcult or delayed
because of the mould’s failure to sporulate on the primary isolation
media.
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R2249 A signiﬁcantly different dysmetabolic proﬁle of the two
available non-nucleoside reverse transcriptase inhibitors:
nevirapine versus efavirenz
R. Manfredi °, L. Calza (Bologna, IT)
Introduction: Altered metabolism represents an emerging feature of
HIV-infected patients (p) treated with combined antiretroviral therapy
(cART), but a different proﬁle seems to regard the two available non-
nucleoside reverse transcriptase inhibitors (NNRTI): efavirenz (E) and
nevirapine (N).
Methods: Among over 1,100 p treated with cART for >12 months, the
metabolic pattern of NNRTI was assessed according to three different
backgrounds. The ﬁrst one included antiretroviral-naive p starting a
NNRTI-based regimen; the second included a large spectrum of p
experienced with 2 to 10 therapeutic lines (but still NNRTI-naive); the
third group included p who added for the ﬁrst time a NNRTI only on late
rescue therapies with at least 4 drugs (and including protease inhibitors).
Results: 441 p treated with E were compared with 378 p taking N
in our prospective observational survey lasting 12 to 44 months,
by a multivariate analysis of serum lipid-glucose levels, and other
metabolic abnormalities. Among the 241 p naive to antiretrovirals,
an altered triglyceridaemia was more common (p< 0.001) in the
E versus the N group. Considering the 386 antiretroviral-experienced
p who introduced a NNRTI for the ﬁrst time, the frequency of
hypertriglyceridaemia appeared greater in the E group (p< 0.0001), with
earlier development of this feature in p on E versus N (p< 0.0001). Also
in the 192 p receiving salvage HAART, the rate of hypertriglyceridaemia-
hypercholesterolaemia-hyperglycaemia tested greater among p treated
with E versus N (p< 0.03 to p< 0.001), and the time to peak alterations
was more rapid in the E group (p< 0.03). Comparing the 441 p
receiving E with the 378 p on N, the frequency of elevated triglyceride,
cholesterol, and glucose levels was greater in E-treated p (p< 0.0001 to
<0.005). Some grade of lipodystrophy was present in 311 pre-treated p,
but an appreciable ameliorement occurred after NNRTI introduction in
21 p of the E group, versus with 63 p on N (p< 0.002).
Conclusions: A sufﬁciently prolonged follow-up shows that E may not
resolve dysmetabolism, but might also prompt metabolic abnormalities
with more frequency and intensity compared with N. The two available
NNRTI have a signiﬁcantly different dysmetabolic proﬁle, which leads
to an increased interest in prospective pathogenetic and preventive
investigations.
R2250 Switch from lopinavir-ritonavir towards atazanavir-based
combinations in patients with sustained virological-
immunological control, and predominant dysmetabolic
abnormalities
R. Manfredi °, L. Calza (Bologna, IT)
Introduction: Among the long-term untoward effects of antiretroviral
therapy, metabolic abnormalities are the most frequent, and are burdened
by relevant risks to prompt major vascular events. The metabolic syn-
drome, and especially hypertriglyceridaemia and hypercholesterolaemia
are a major concern during protease inhibitor (PI)-based regimens, where
lopinavir/ritonavir (L/r) represents a standard of care for its potency-
durability, whereas the more recent PI atazanavir (A) is expected to
show a reduced metabolic toxicity, although literature reports are to date
scarce.
Patients and Methods: In an observational, prospective, case-control
(1:2) study involving our cohort of >1000 patients (p), among 162
p treated with 2 NRTI and L/r since >12mo and with undetectable
viraemia since >6mo, who developed hypertrigyceridaemia and/or
hypercholesterolaemia, 54 p (33.3%) switched to A/r (39 p) or unboosted
A (15 p), and were compared with the remaining 108 p who continued
L/r. For this interim analysis, p who completed >12mo of follow-up
were evaluable.
S664 19th ECCMID, Abstracts accepted for publication only
Results: Although the mean initial levels of triglyceridaemia and
cholesterolaemia were signiﬁcantly greater in the p group switched
to A (p< 0.01 and p< 0.04, respectively), just these p experienced
a signiﬁcantly higher drop of serum lipid levels during the 12-
mo follow-up: −91.2±53.8mg/dL for triglyceridaemia (p< 0.003), and
−33.6±26.9mg/dL for cholesterolaemia (p< 0.01), versus the L/r control
group. Even more favourable ﬁgures were recognised among the
15 p treated with unboosted A (−143.2mg/dL for triglyceridaemia,
−56.7mg/dL for cholesterolaemia), but statistical assessment was not
feasible. During the 12-mo follow-up, no virological-immunological
failure occurred. The substitution of L/r with A/r or A contributed to
maintain the stable virological-immunological response already reached
under L/r-based HAART, while signiﬁcant metabolic advantages were
observed in p switched to A/r and A alone, when considering total
triglyceridaemia and cholesterolaemia, from the 6th to the 12th mo of
follow-up. No signiﬁcant beneﬁts were observed with regard to the HDL-
LDL cholesterol fractions.
Conclusions: Further studies are needed to assess the role of A/r and A
also in PI-naive p, taking into consideration the role of the different
nucleos(t)idic backbone, and examining extensive p samples followed
for a longer time, with in-depth laboratory and instrumental monitoring.
R2251 HIV disease and management and pancreatic damage.
Epidemiology, clinical issues, pathogenetic correlates, and
therapeutic indications
R. Manfredi °, L. Calza (Bologna, IT)
Introduction: The frequency, risk factors, and clinical-therapeutic
features of pancreatic anomalies were assessed in a prospective case-
control study.
Methods: 1081 HIV-infected patients (p) followed for >12 months were
evaluated.
Results: The 435 p (40.2%) who experienced >1 episode of pancreatic
laboratory abnormality had a longer duration of seropositivity, exposure
to protease inhibitors, a more frequent CD4 count <200 cells/mL, AIDS,
chronic liver-biliary disease, and hypertriglyceridaemia, while no relation
was found with antiretroviral administration, and the duration or type
of administered NNRTI, when compared with the 646 controls, who
never developed pancreatic anomalies. Among the above-mentioned 435
p, elevated-prolonged laboratory alterations eventually associated with
signs of organ involvement occurred in 166 p (38.2%), and were related
to the administration of ddI, d4T, 3TC, pentamidine, cotrimoxazole, or
anti-TB/anti-mycobacterial therapy, cytotoxic chemotherapy, substance-
alcohol abuse, opportunistic infections, chronic liver-biliary disease, a
protease inhibitor-based HAART, and hypertriglyceridaemia. However,
no difference was noticed between the 46 p with clinical-imaging
evidence of pancreatic involvement and the remaining 120 asymptomatic
p, when assessed according to the same risk factors. Although
recurrences of enzyme alterations involved 69.6% of overall p, in
only 30.1% of cases a change of the antiretroviral-antimicrobial
therapy became necessary. An acute but uncomplicated pancreatitis
occurred in 9/46 symptomatic p (19.6%). A 2−4-week gabexate and/or
octreotide administration (performed in 79/166 cases: 47.6%), achieved
a signiﬁcant laboratory, clinical, and imaging cure-improvement in
82.3% of cases, with a better success rate of combined (gabexate
mesilate+octreotide) versus single (gabexate mesilate or ocreotide)
therapy. A signiﬁcantly reduced tendency to disease recurrences, and
a better tolerability of antiretrovirals, were also noticed.
Conclusions: Epidemiological and pathogenetic studies are strongly
needed to assess the evolution of pancreatic abnormalities during
the HAART era. The indications to gabexate mesilate-octreotide
administration deserve further investigation in the HIV disease setting.
R2252 The phenomenon of “AIDS Presenters”. Opportunistic
infections associated to a late, ﬁrst diagnosis of AIDS, after
a decade of HAART availability
R. Manfredi °, L. Calza (Bologna, IT)
Introduction: Notwithstanding the availability of HAART, AIDS
notiﬁcations continue to occur, with increasing prevalence for patients
(p) who missed-neglected their condition.
Patients and Methods: All cases of AIDS notiﬁed since the year
2001 were compared with those found in the decade preceding HAART
availability (1986–1995).
Results: Compared with the pre-HAART era, a signiﬁcant drop of
frequency of overall AIDS cases occurred: from a mean 58.3±11.2
patients-year observed in the decade 1986–1995, to 14.9±6.2 patients-
year during years 2001–2006 (p< 0.001), together with an increased
mean age (p< 0.002), female gender (p< 0.01), sexual vs i.v. transmis-
sion (p< 0.001), and proportion of immigrant vs resident p (p< 0.03).
In the HAART era, the most evident drop of frequency interested
opportunistic diseases linked to a CD4 count below 50–100 cells/mL,
while a proportional rise of tuberculosis, pneumonia, lymphomas,
and other neoplasms was observed. The frequency of both Candida
oesophagitis and Pneumocystis carinii pneumonia remained stable, as
the ﬁrst 2 AIDS-related conditions. After HAART availability, the
following diagnoses were neurotoxoplasmosis, wasting syndrome, AIDS-
dementia complex, and non-Hodgkin’s lymphomas. P with multiple
AIDS-deﬁning diseases, and also AIDS diagnoses made at death,
even showed a paradoxically increased frequency and absolute number
during the HAART era vs the prior decade (p< 0.001 and p< 0.02),
while no difference was found as to HIV-associated immunodeﬁciency.
Surprisingly, an underlying anti-HIV therapy was a more common event
until 1995, vs p observed in the HAART era (p< 0.001), since during
recent years AIDS notiﬁcation tends to be increasingly associated with
the ﬁrst diagnosis of HIV infection.
Discussion:When facing p with opportunism, clinicians should maintain
an elevated suspect for an advanced (but missed-untreated) HIV disease.
A continued attention will help a more rapid recognition and an
appropriate management of p who could not take beneﬁt from HAART,
since they remained unaware of their disease, or refused controls and
treatment.
R2253 HIV infection, HAART, and gynaecomastia.
Epidemiological, clinical, and pathogenetic relationship
R. Manfredi °, L. Calza (Bologna, IT)
Introduction: Gynaecomastia (G) is an emerging untoward event in
patients treated with HAART.
Patients and Methods: Through a cross-sectional study performed on
around 1000 HIV-infected patients (p) treated with antiretrovirals at our
reference centre in Bologna (Italy), we identiﬁed all cases of G related
to the administration of at least 12 consecutive months of HAART, to
assess possible correlations of G with a spectrum of clinical, laboratory,
and therapeutic variables (and including all adverse effects of HAART
itself). All p with true G (as distinguished from lipomastia by an
ultrasonography assay) were considered evaluable, while p with other
predisposing conditions (endocrine disease, alcohol abuse, liver cirrhosis,
and use of drug possibly predisposing to G), were carefully excluded.
Results: Twenty-one out of 616 evaluable HIV-infected male p (3.4%
of our p population), developed a true G when aged 12−58 years.
Seven p out of 21 never received protease inhibitor (PI)-containing
therapies, while efavirenz-based regimens apparently prompted G in
7 p who were naive for PI, and worsened this disturbance in three
further p who abandoned PI for efavirenz. Considering nucleoside
analogues (NA), two p developed G during treatment conducted with
dual isolated NA.Comparing the different administered NA, stavudine
seemed to be the most commonly used compound, also taken for the
longest time (p< 0.01). A complete hormonal workup did not detect
signiﬁcant abnormalities, save in one p, who had slight serum FHS,
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LH, and testosteron abnormalities (with normal prolactin levels). When
considering the eventual correlation with the most common HAART-
induced disturbances, some forms of lipodystrophy was concurrent in
all the 21 p with G, while hypertriglyceridaemia, hypercholesterolaemia,
and hyperglycaemia were found in 15, 9,and 3 p, respectively. During the
subsequent 12−36-month follow-up, a spontaneous ameliorement of G
was never observed, notwithstanding eventual HAART modiﬁcations.
Due to local hypersthesia, tenderness, and discomfort, two p resorted to
surgery.
Conclusions: G is probably an underestimated problem in the setting
of HAART. The frequent association of G with other HAART-related
dysmetabolism suggests possible common pathogenetic causes.
R2254 A novel, reliable laboratory technique to assess
hypersensitivity to all available antiretroviral compounds:
the cellular antigen stimulation test
R. Manfredi °, S. Sabbatani (Bologna, IT)
Introduction: Recently, novel allergometric techniques allow to test
inhalants, food, and also drugs by speciﬁc in vitro assays. A ﬂow
cytometry technique based on the search of sulphidoleukotrienes LCT4,
LTD4 and LTE4 released by basophils stimulated in vitro by IL-3 in
presence of the examined antigens (cellular antigen stimulation test,
or CAST), has a 80−90% sensitivity-speciﬁcity rate, and becomes
particularly useful when prick tests are not applicable, and allergic
reactions are not mediated by allergen-speciﬁc IgE immunoglobulins.
Methods and Results: During the past three years, 18 HIV-infected
subjects (11 females and 7 males, aged 32−52 years), underwent a
standardised, speciﬁc CAST assay, due to serious cutaneous (8 cases),
systemic (4 patients), and combined cutaneous-systemic hypersensitivity
reactions (6 subjects), apparently not elicited by the introduction of
abacavir and nevirapine (which are the antiretroviral agents burdened
by the greatest frequency of expected early allergic reactions, mediated
by already recognized pathogenetic mechanisms). Based on the results
of CAST testing, an allergic intolerance to ritonavir (6 cases), lopinavir,
nelﬁnavir, and didanosine (three cases each), saquinavir and lamivudine
(two cases), and fosamprenavir, zidovudine, zalcitabine, stavudine, and
efavirenz (one case each), was documented: in 15 cases out of 18
(83.3%) multiple intolerances were detected. A perfect relationship
was documented between the results of CAST testing and the panel
of combined antiretroviral compounds recently experienced by each
allergic patient, and a CAST-based elimination of in vitro allergenic
molecules allowed a rapid introduction of another effective antiretroviral
combination.
Conclusions: Adverse events to antiretroviral drugs are quite frequent
among HIV-infected patients, compared with the general population.
Further, controlled studies are strongly needed to implement in
vitro allergometric testing in patients treated for HIV infection, who
are exposed to unpredictable drug intolerance reactions. In fact,
HIV-infected subjects may suffer from frequent allergic drug reactions
which may be difﬁcult to be systematically recognized (due to the
frequent, multiple concurrent pharmacotherapy, and the combined
antiretroviral therapy itself).
R2255 Increasing survival in HIV patients with HLA-B57 allele:
report and analysis of a Spanish series
A. Salinas °, J. Ontan˜o´n, E. Martı´nez, F. Mateos, J.J. Blanch (Albacete,
ES)
Objectives: Different evolution of the human immunodeﬁciency virus
(HIV) in different patients has suggested the inﬂuence of an immunologic
factor that explains such differences. In the last few years HIV-1 infected
long-term non-progressors patients have been broadly studied. Among
this special group a high prevalence of haplotype HLA-B57 has been
detected and its inﬂuence in the HIV-1 replication capacity still remains
unclear.
Methods: All patients on HIV infection who carried the HLA-B57 allele
were selected for this study. Epidemiological, clinical, immunological
and therapeutic ﬁndings were analysed. The survival was measured in
years free of disease.
Results: 8 HIV-1 patients were studied. All of them had heterocigotic
haplotype HLA class I with the HLA-B57 allele. Patients were 6 women
and 2 men with a mean age at the time of diagnosis of 26.5 years
(19−36 y). All of them were spanish except one rumanian. 50% of
cases had heterosexual transmission. The mean CD4 at the time of
diagnosis was 466 cell/micrl. The mean HIV-RNA viral load at the time
of diagnosis was 6,882 copies/mL. High Active Antiretroviral Therapy
(HAART) was started only in 2 patients. 75% of patients did not need
start HAART having a mean survival of 11.5 years (7−18 y) free of
disease.
Conclusion: The HLA-B57 allele in HIV-1 infected patients is
associated with a long-term survival measured in years free of disease.
The reason that this allele produces a slower progression of the infection
remains unclear. Future research focused on the inﬂuence of this allele
in the HIV infection may lead to a better understanding of the disease
and a design of future therapeutic targets.
Hepatitis
R2256 The cytokine proﬁle in peripheral blood cells from chronic
hepatitis C virus (HCV)-infected patients: effects of
pegylated interferon and ribavirin
B. Bucholc °, U. Czajka, A. Wiatrzyk, W. Janaszek-Seydlitz, M. Dudziak
(Warsaw, PL)
Objectives: Hepatitis C virus (HCV) is a major cause of chronic liver
disease that leads to cirrhosis. Natural immune responses, both cellular
and humoral, are not capable of terminating HCV infection in most
patients. Host immunity involves effector mechanisms networked by its
elaborated cytokines.
The study was design to assess serum level and supernatant in peripheral
blood mononuclear cells (PBMC) in patients with chronic hepatitis C
(CHC) infection on the background histopathologic changes.
Methods: The study included 14 cases CHC with cirrhosis. All patients
were treatment of pegylated interferon and ribavirin. Blood samples were
collected from all subjects at 0, 2, 4 and 12 weeks at the treatment.
Serum pro- and anti-inﬂammatory cytokines levels were assayed by
ﬂow cytometer using BDTMCytometric Bead Array (CBA) Human
Inﬂammation Kit.
The cytokines in supernatant from PBMC were detected by ELISA using
the BD Biosciences kit.
Moreover in serum were assayed sFas by ELISA method.
The activity of chronic hepatitis C was scored according to the degree
of hepatic process inﬂammation and determined 1, 2 or 3.
HCV genotyping was performed by commercial test Inno-Lipa HCV. The
Level of HCV RNA in sera was evaluated by Real Time PCR method.
Results:
1. The decrease of viraemia after 12 week’s therapy in all patients was
observed.
2. In 8 cases virus HCV RNA was not detected. The decrease of
viraemia correlated with decrease ALT.
3. The level of sFas was many times higher in CHC patients in
comparison with healthy persons.
4. There was observed higher level all measuring cytokines pro-
inﬂammatory before treatment only in this patients who were
elimination HCV.
5. HCV RNA concentration in sera were between 2.32×104–3.45×106
copies.
6. Amongst the 14 patients HCV genotype 1a was found in one patient
and genotype 1b in 13 patients.
Conclusions:
1. The results suggest that higher level of pro-inﬂammatory cytokines
is connected with elimination HCV.
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2. The higher sFas expression in CHC patients than healthy, may suggest
mechanism of liver injury caused by disorder apoptosis.
R2257 Recognition of hepatitis C virus in a type of drug that is
abused by intravenous drug users in Iran
K. Tayeri °, R. Radfar, B. Ataei, N. Kasaeiyan, M. Yaran (Isfahan, IR)
Introduction: Hepatitis C virus (HCV) has now been recognized as
a major health problem worldwide and estimated number of infected
people is over 170 million people worldwide. Many studies in Iran are
reported the intravenous drug users (IDUs) had HCV infection at least
between 38% and 47% and in recent several studies higher percentages
were reported. HCV can be easily transmitted through blood products and
infected syringes, and infection rates are typically high among injecting
drug users (IDUs). NORJIZAC (Also known as “handmade temgizac”,
“Ab Crack (Crack solution”) is a slang name of a drug that abused by
numbers of Injecting drug users in Iran since 5 years ego. Main Route
of using NORJIZAC is via intravenous. In spite of high prevalence of
HCV among IDUs, specially NORJIZAC users, many of them haven’t
given any history of sharing in needles and syringes during injections.
Material and Methods:In a cross sectional study, 14 NORJIZAC
vials that were bought from smugglers in different times and different
locations within a period of 4 months, were tested for hepatitis C virus.
RNA extraction and then C-DNA synthesis by using reverse-transcriptase
enzyme and after that Real time PCR with speciﬁc primer and probe with
tagman probe method, were made on norgizac. All laboratory staff were
unaware about the nature of the drug.
Results: 2 of 14 vials were positive for hepatitis C virus with acceptable
viral load more than 10000/ml.
Discussion: HCV is estimated to be about 10 times more infectious than
HIV per unit of blood required, and therefore, requires less exposure than
HIV to reach high prevalence.
Although signiﬁcant advances have been made in preventing HIV
infection among IDUs with harm reduction programs, both prevalence
and incidence of hepatitis C remains high among IDUs. One of the most
important point about the environmental survival of HCV is prolonged
staying of virus in the environment.
Conclusion: Formerly we thought HCV was transmitted during needles
and syringes sharing among the injecting drug users, but we had several
patients without history of sharing. Results of this study show that
NORJIZAC itself could be infected with hepatitis C virus and avoiding of
sharing in injections couldn’t be enough against accepting HCV during
drug using, maybe this event could be occurred in another country.
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R2258 Seoul hantavirus infection in the far east of Russia
G. Kompanets °, T. Kushnareva, L. Yashina, I. Maxyoma, V. Ivanis,
R. Slonova (Vladivostok, Koltsovo, RU)
It is generally known that Rattus norvegicus (brown rat), widely
distributed around the world, is the natural reservoir of hantavirus Seoul
(SEOV). In Russia ﬁrst cases of HFRS related to SEOV were recorded in
1989 in far-eastern city Vladivostok (Primorsky region) with morbidity
0.3 cases per 100 000. Annual number of HFRS cases caused by SEOV
in far-eastern Russia has increased during the past decade: from 1.6
cases per 100,000 in 1992 to 6.0 per 100,000 in 2000.
Objective: Investigation of SEOV infection and the cause of increased
morbidity in the south of far-eastern Russia.
Methods: serology, virology and genetic study.
Results: Overall 344 cases of SEOV infection were ofﬁcially registered
during last decade. Average prevalence of hantavirus infection in
population of R. norvegicus in seaport Vladivostok varied from 4.3%
(1992) to 33.8% (2001). The considerable increase of HFRS morbidity
with seasonal peak in spring was related to acute phase of epizootic
process of SEOV infection in R. norvegicus and prevalence of infected
rodents with speciﬁc antigen and low avidity antibodies. Clinical course
of HFRS associated with SEOV was characterised by dominance of mild,
moderate and atypical forms of infections (87%). During past ten years
we observed the increase of severe forms of SEOV infection from 5.9%
to 22.0% including three fatalities. Genetic analysis showed that different
forms of HFRS were associated with strain Vladivostok (VDV) of SEOV
circulating in Vladivostok city. Strain VDV is closely related to SEOV
strains from Cambodia. The primary cause of SEOV infection activity
in urban foci is the increase of R. norvegicus population. Decrease of
measures of disinfestations in large seaport resulted in stable active
circulation of VDV strains in different urban facilities.
Conclusion: There is active urban focus of hantavirus infection
associated with circulation of SEOV in R. norvegicus population in
the south of far-eastern Russia. For effective prevention of hantavirus
infection we propose annual large-scale complex of disinfestations and
disinfections measures.
R2259 Evaluation of measles-speciﬁc immunity among healthcare
workers in a northern Greek hospital
F. Markou °, A. Poulou, G. Triantafyllou, P. Rozi (Serres, GR)
Objectives:Measles is an acute, highly contagious viral disease affecting
people of all ages. While it is primarily a disease affecting children,
it may also affect adults, among whom several complications such as
pneumonia and encephalitis are common. Hospital staff incurs a high risk
of infection and CDC guidelines recommend that non-immune persons
should be vaccinated. Since November 2005 an increase in adult cases
of measles has been reported in Greece and this rise was mostly detected
in northern Greece. Our objective was to evaluate immune status against
measles virus among healthcare workers of a northern Greek hospital
and the subsequent vaccination of non-immune hospital staff.
Methods: Serum samples were taken from 144 healthcare workers,
including physicians and nurses, who work in different hospital
departments. 44 of the employees were male and 100 female and their
ages ranged between 28 and 50 years. Samples were tested for the
detection of speciﬁc measles IgG antibodies by using an indirect ELISA
assay. All subjects were asked if they had had measles or been vaccinated
against it in the past.
Results: 141 of the 144 subjects (97.9%) had detectable immunity
against measles. 120 of the immune subjects (83%) had high titers
of protective antibodies, while 21 subjects (17%) had low titers. The
majority of those with high immune titers (85/120) reported measles
infection in the past history, whereas the majority of those with low
immune titers (16/21) reported past vaccination.
Conclusions: High rates of immunity to measles virus were detected
among our hospital personnel, either due to natural immunity or
due to vaccination. The highest titers of protective antibodies were
observed among those infected by measles in the past. Vaccination was
recommended for the three non-immune healthcare employees. Despite
the high immunity rates that were observed, continual alertness as well as
vaccination of non-immune personnel are regarded as essential due to the
rising adult cases of measles and the consequential severe complications.
R2260 Comparison of CMV IgG avidity assay on IMMULITE
2000 versus VIDAS on clinically derived serum samples
F. Vlaspolder °, P. Singer (Alkmaar, NL)
Objectives: The avidity index (AI) of CMV IgG antibodies can be used
to differentiate between primary CMV infection and past infections as a
complementary test besides the CMV IgM antibody assay. The presence
of CMV IgM antibodies is sometimes very difﬁcult to interpret, because
it can still be detected a long time after the primary infection.
The present study shows the results obtained with the IMMULITE 2000
compared with the well established VIDAS CMV IgG avidity assay.
Methods: The IMMULITE 2000 CMV IgG avidity assay is a three-
cycle immunoassay utilising a CMV antigen-coated 1/4-inch bead as
the solid phase for the capture of human anti-CMV antibodies and an
alkaline phosphatase-conjugated anti human IgG monoclonal antibody
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for detection. A dissociation reagent is then added to elute the weakly
bound IgG while Tris-based buffer is added as the baseline. Following
the addition of an enzyme antibody conjugate for signal detection, paired
results obtained on each sample are used to calculate the avidity index.
Samples used for evaluating assay performance are 167 patient serum
specimens procured from our hospital and from general practitioners.
Results: A method comparison between the IMMULITE 2000 and the
bioMe´rieux VIDAS CMV IgG avidity assays using 167 clinical samples
yielded an overall agreement of 74.3% (124/167) between IMMULITE
2000 and VIDAS results for high- and low avidity. AI > 0.8 was deﬁned
as high avidity and AI< 0.2 as low avidity for the VIDAS assay per its
package insert. For IMMULITE 2000, AI> 0.8 was categorised as high
avidity an AI< 0.4 as low avidity. The IMMULITE 2000 CMV IgG
avidity assay demonstrated a relative sensitivity of 96% (66/69) and a
relative speciﬁcity of 95% (18/19). Among these 167 clinical samples
50 sera were IgM positive. In table 1 the CMV IgG avidity results are
shown.
CMV-IgG avidity testing in 50 CMV-IgM positive sera
Immulite 2000 VIDAS
High Gray zone Low Total
High 13 3 0 16
Gray zone 1 14 0 15
Low 0 7 12 19
Total 14 24 12 50
In 16 CMV IgM dubious positive serum samples in both systems no
low avidity IgG was found. In 94% of the 101 IgG positive and IgM
negative serum samples no low avidity IgG could be detected in both
systems.
Conclusion: The IMMULITE 2000 gave in 70% a clear result in AI as
support of the CMV IgM interpretation, while the VIDAS system scored
only 52 percent.
The advantage of the IMMULITE 2000 system above the VIDAS system
is a fully automated high-throughput immunoanalyzer.
R2261 Comparison of the diagnostic value of ZEBRA IgM assays
versus VCA IgM assays in determining the infection status
of EBV-infection
P. Singer °, F. Vlaspolder (Alkmaar, NL)
Objectives: In general IgM antibodies are predominantly produced in the
acute phase of infectious diseases. Detection of IgM antibodies against
EBV VCA-antigen is widely used. VCA IgM antibodies can also be
detected in (long) past EBV-infections. ZEBRA IgM antibody detection
is a new commercial available assay used in EBV-serology
This study was undertaken for a general evaluation of two ZEBRA IgM
assays to get more information about their usefulness in determining the
status of EBV-infection, especially in the acute phase of the infection.
Methods: Twelve consecutive sera were gathered from 4 patients
in different stages of the EBV-infection. From these 4 patients the
haematological picture was also known
Forty-eight patient sera were collected from our routine serum bank,
representing all proﬁles of EBV-results based on DiaSorin’s EBNA-IgG,
EA-IgG and VCA-IgM ETI-assays.
The clinical status related to all sera was further determined with
Mikrogen EBV recomLine IgG (including IgG-avidity). The VCA IgM
results were also obtained by performing Mikrogen EBV recomLine
IgM blots. The ZEBRA IgM results were obtained using Mikrogen EBV
recomLine IgM blots and the Clindia EBV ZEBRA IgM Elisa test.
Results: The results of the 12 consecutive sera from the 4 patients were
showing that VCA IgM-antibodies are persisting longer then ZEBRA
IgM. These ﬁndings were conﬁrmed with another 48 sera. The positive
rate of the ZEBRA IgM assays (Mikrogen 19/25 – Clindia 21/25) in the
active stages of the infection was almost as high as the DiaSorin VCA
IgM assay (23/25), but more negative results were obtained in stages
with no active EBV-infection. In relation to the Clindia EBV ZEBRA
IgM test (21), the Mikrogen IgM blot (19) was less sensitive for detecting
ZEBRA IgM antibodies, but more speciﬁc. In relation to the DiaSorin
VCA IgM assay (41), the Mikrogen IgM blot (7) showed a very low
sensitivity in detecting VCA IgM-antibodies, but showed an excellent
speciﬁcity.
Conclusion: Both ZEBRA IgM assays showed more reliable results in
detecting active stages of EBV-infection then the DiaSorin VCA IgM
assay. The predictive values for an active EBV infection using both
ZEBRA IgM assays are comparable with the DiaSorin VCA IgM assay.
The predictive values of both ZEBRA IgM assays in non-active stages
of infection however, are much higher then the DiaSorin VCA IgM
assay. The Mikrogen EBV IgM blot showed a high speciﬁcity but a poor
sensitivity for detecting VCA IgM antibodies.
Categories Conclusions VCA IgM Zebra IgM
Dia Sorin Mikrogen Clindia EBV Mikrogen
EIA pos blot pos EIA pos blot pos
Never been infected 5 1 0 1 dub 0
Very early infection 5 5 0 4 3
Early infection 4 4 0 3 3
Active infection 14 12 7 12 + 1 dub 12
Reconvalescent stadium 2 2 0 2 1
Past infection 30 17 0 5 + 2 dub 3
Total 60 41 7 26 + 4 dub 22
R2262 Atypical appearance and course of progressive multifocal
leukoencephalopathy as the ﬁrst clue of a missed HIV
infection. Advanced MRI-spectroscopy functional-metabolic
imaging
R. Manfredi ° (Bologna, IT)
Introduction: Progressive multifocal leukoencephalopathy (PML) is still
an underinvestigated HIV-associated CNS opportunism. An exceptional
case report characterised by motor involvement, occurred as the 1st
AIDS-deﬁning event in the absence of appreciable immunodeﬁciency in
a patient (p) with a missed HIV infection, and was assessed by associated
functional-metabolic MRI techniques (spectroscopy-MRI).
Case report: A 45-y-old p had HIV infection detected after the
appearance-worsening of predominantly motor abnormalities (dysarthria,
coordination anomalies, ophthalmoparesis), in absence of other signs-
symptoms. HIV infection was found in absence of an appreciable
immunodeﬁciency (as expressed by a CD4 count of 564 cells/mL), and
viral load was limited to 24000 HIV-RNA copies/mL. An extremely
potent combination antiretroviral therapy was immediately started with
3TC, abacavir, and lopinavir/R, with subsequent adjunct of efavirenz and
enfuvirtide. Virological studies of cerebrospinal ﬂuid (CSF) disclosed
elevated levels of JC virus (11668 copies/mL) so that a diagnosis
of PML was conﬁrmed, after observing consistent neuroradiological
ﬁndings at CT-MRI scans. Despite the aggressive therapy approach,
which achieved undetectable HIV viraemia, a CD4 count >700 cells/mL,
and disappearance of JCV after 1mo, the neurological picture rapidly
deteriorated from a predominantly motor level (severe dysphagia,
trunk-limbs paresis, sphincter anomalies), while cognitive impairments
never occurred. The unfavourable clinical evolution paralleled the
neuroradiological worsening, and our p rapidly deceased 5 months
after the diagnosis, due to respiratory insufﬁciency. A combined MRI-
spectroscopy study performed 1mo before death included a proton
(1H) spectroscopy, and a MRI study-calculation of water diffusion
and anisotropy:through this novel technique combining morphological-
metabolic ﬁndings, multiple abnormalities involving the subtentorial
white substance were detected (the encephalic trunk and ponto-bulbar
structures), which usually are not part of PML course.
Discussion: A JCV-associated PML may occur as the ﬁrst AIDS-deﬁning
event in p unaware of HIV infection, and may rapidly evolve with
atypical clinical features (motor deﬁcits largely prevailing over cognitive
ones), even with an initial CD4 count >500 cells/mL, and a quick decay
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of both HIV-JCV viral loads. The neuroradiological features of our
p were implemented by ultraspecialistic spectroscopy-MRI techniques,
which have no reported equivalents until now in the available literature
R2263 Neurophysiciatric changes in associated with human
parvovirus B 19 meningoencephalitis
O. Coskun °, H. Erdem, C. Gul, B. Besirbellioglu, K. Sener, C.P. Eyigun
(Ankara, TR)
Human parvovirus B 19 (B19) is a common infectious pathogen
in humans. Infection with B19 has been associated with various
neurological syndromes including encephalitis, seizures, disturbance of
consciousness, meningitis, cerebellar ataxia, transverse myelitis, optic
neuropathy, neurologic amytrophy, Guillain–Barre´ Syndrome, paraesthe-
sia and carpal tunnel syndrome. In two retrospective studies, B19 virus
was detected in 4.6% and 4.3% of undiagnosed meningoencephalitis
cases.
Since its discovery, B19 has been linked with a broad spectrum of
clinical syndromes. An aetiological role for the virus has been conﬁrmed
in erythema infectiosum, transient aplastic crisis, persistent infection
manifesting as pure red cell aplasia in immunocompromised persons,
non-immune hydrops fetalis and arthritis. Less commonly recognized,
but receiving increasing attention, are the neurological manifestations, a
variety of which have been described in patients with either clinically
diagnosed or laboratory conﬁrmed B19 infection.
A 75-year-old, previously healthy and an intellectual retired doctor was
admitted to hospital due to abrupt beginning of headache, confusion,
agitation, dysarthria and fever. Physical examination revealed abnormal
mentation, cognitive disorders, dysarthria and apparent neck stiffness.
The initial fever was around 38ºC and resolved in two days.
Patients with viral meningoencephalitis usually have signs and symptoms
of meningeal inﬂammation, but, in addition to headache, fever, and
nuchal rigidity, it is characterised by alterations of consciousness.
Our patient was diagnosed as B19 meningoencephalitis with the
inﬂammatory CNS proﬁle, abnormal mentation, cognitive disorders,
dysarthria and apparent neck stiffness combined with the microbiological
data. Generally, the neurophysiciatric changes were seen in childhood
B19 meningoencephalitis. To the author’s knowledge, our case differs
from other adult cases reported in the literature due to dominant
presenting pattern of cerebral involvement with cognitive disorders,
personality changes and dysarthria. Moreover, the level of Parvoviru¨s
B19 DNA was relatively low, which resemble to offer a subacute or
chronic character
The patient we present is a rare case of B19-associated with
neurophysiciatric disorders in which mortality seems to be high and
that B19 might be the responsible agent for CNS infections particularly
in those without speciﬁc diagnosis.
Mycobacterial infections (including
diagnosis)
R2264 Frequency of tuberculosis in Qeshm, the biggest island in
the Persian Gulf
A. Shoae Hassani °, R. Nazari, E. Moradi, S. Zare Matanagh,
K. Hamdi (Lahijan, Tehran, Qeshm, IR)
Objectives: Despite availability antituberculosis drugs for almost
50 years, tuberculosis (TB) continues to exert an enormous toll on
world health. The incidence of TB is increasing all over the world.
Qeshm represents a region in south of Iran that is the biggest island
in the Persian gulf with 23 thousands inhabitants with a long tradition in
TB control, including a centralisation of the bacteriological diagnostic
facility. The present study was intended to analyze the transmission
of Mycobacterium tuberculosis by a combination of conventional
epidemiological approaches.
Methods: Mycobacterium tuberculosis analyzed in this study were
collected at the Health Care Center in Qeshm, Iran. A total of 81
new, bacteriologically veriﬁed TB cases were registered in Qeshm
Island between 2003 and 2008. All the isolates were examined for
their susceptibility to ethambutol, isoniazid, streptomycin, rifampin, and
pyrazinamide by using a radiometric culture system (BACTEC). The
data obtained from the cultures analyses were interpreted by using
demographic data, such as age, sex, ethnicity, and residence, for the
patients. The risk factors among the patients for being part of an
active chain of transmission, as opposed to demonstrating reactivation
of a previously acquired latent infection, were estimated by statistical
analyses (SPSS).
Results: A total of 81 clinical isolates belonging to patients having
pulmonary and extra pulmonary tuberculosis were collected during
Jan 2003 to Nov 2008. The incidence of tuberculosis in female
was 25.9% and in male was 74.1%. This survey observed 47.1%
of immigrated Afghans and 39.1% of Pakistanis were infected with
tuberculosis. Regarding the literacy 57% were unlettered. 91.7% of
people referring to health centre were new patients. 68.8% people
were infected with pulmonary tuberculosis. The peoples over 60 year
were highest group infected to pulmonary tuberculosis (30.4%) and
age groups 30−44 were highest the cases infection external pulmonary
tuberculosis. The major chains of recent transmission were localised to
distinct geographical regions in the area.
Conclusion: TB is frequent among immigrants, especially from
Afghanistan and Pakistan, but it is apparently readily suspected,
diagnosed, and treated by the health care system. Indigenous patients
with pulmonary symptoms are not primarily suspected to have TB and,
therefore, play an important role in recent TB transmission in Qeshm.
R2265 Extensively drug-resistant tuberculosis in patients
immigrated from Eastern Europe. Microbiological,
therapeutic, and public health issues
R. Manfredi °, L. Calza (Bologna, IT)
Introduction: Extensively Drug Resistant (XDR) tuberculosis (TB) is a
worldwide emergency. The increased number of patients (p) immigrating
from countries where the health care assistance could not ensure adequate
drug delivery-monitoring is a major concern in Europe.
Methods-Results: During the 2nd half of y 2006 and the 1st half
of y 2007 a 30-y-old male from Moldova and a 24-y-old female
from Ukraine underwent very prolonged hospitalisations due to XDR
TB. The ﬁrst p, with TB known since 6 y developed XDR due
to frequent treatment discontinuations. On the ground of in vitro
supplementary sensitivity assays, cycloserine, para-aminosalycilic acid,
capreomycin, ethionamide, and linezolid were added, obtaining clinical-
microbiological cure after 9mo of hospitalisation. Three mo after
discharge, our p maintained an effective 6-drug regimen on Day-
Hospital basis, but 3mo later another 5-mo admission was needed after
retrieval of a positive sputum. An outpatient treatment was conducted
on Day-Hospital basis for 3mo, but positive sputum prompted a 3rd
admission lasting since 3mo. Our 2nd p who came to Italy with a
XDR TB, had an unfavourable course, and was tested in vitro for
2nd-choice drugs, which suggested a cycloserine, para-aminosalycilic
acid, capreomycin, ethionamide, and moxiﬂoxacin adjunct, and achieved
clinical-bacteriological cure and hospital discharge after 5mo, despite a
concurrent chronic hepatitis C which hampered liver tolerability. During
the subsequent 3-mo Day-Hospital follow-up, a 5-drug association
ensured a temporary cure, but 4mo later another 3-mo admission was
needed due to repeated positive sputum searches.
Conclusions: The management of the emerging XDR TB encompasses
elevated clinical suspicion, diagnostic accuracy, availability of suscep-
tibility assays of 2nd-3rd line drugs, adequate isolation, and public
health issues, when prolonged hospitalisations or protected discharges
are needed. The frequent involvement of foreign immigrants is burdened
by further social-economic, cultural, and administrative problems. The
easy development of life-threatening and contagious XDR TB in health
care contexts where low-cost anti-TB drugs are not always available,
is in contrast with the huge danger and the incredibly elevated costs
of these episodes which need prolonged hospitalisation-isolation, and
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enormous technologic and health care efforts. A systematic planning
of the most adequate management-prophylactic measures aimed at
containing-preventing XDR TB in the next future, is strongly needed.
R2266 First-line anti-tuberculosis drug susceptibility rates of My-
cobacterium tuberculosis clinical isolates over a 6-year period
M.A. Ntrivala °, K. Paulou, E. Papaefstathiou, D. Basoulis, E. Mpriola,
E. Papafrangas, E.M. Fakiri (Marousi, GR)
Pathogens of the Mycobacterium tuberculosis complex, remain one of
the leading killers worldwide. In Europe, a large number of multidrug-
resistant (MDR) and more recently, extremely drug-resistant (XDR)
tuberculosis cases have been reported.
Aim: The assessment of resistance to ﬁrst line anti TB drugs of
M. tuberculosis isolates in a TB Unit of a tertiary General Hospital
Methods: During the last 6 years period (2002–2007), 23,709 clinical
samples have been cultured in solid (Lowenstein-Jensen) and liquid
(MGIT 960 Becton Dickinson) growth media. 317 of these samples,
one for each of the involved patients, revealed M. tuberculosis complex
mycobacteria. The identiﬁcation has been made by molecular methods −
GenoType Mycobacterium MTBC/CM/AS (Hain Lifescience) − and the
susceptibility testing has performed in the non-radiometric system MGIT
960 (bioMerieux). Drugs used were: Streptomycin (STR 1.0mg/ml),
Isoniazid (INH 0.1mg/ml), Rifampicin (RIF 1.0mg/ml), Ethambutol
(EMB 5.0mg/ml) and Pyrazinamide (PYZ 100mg/ml). The turn-around
time found to be 9−12 days. Among the 317 involved patients 259 were
Greeks and 60 immigrants, 220 men and 99 women.
Results: Antimycobacterial susceptibilities of the 317 M. tuberculosis
complex isolates, showed that 75.07% of these isolates were susceptible
to all ﬁve ﬁrst line anti-TB-drugs, whereas 24.93% were resistant at least
to one drug. More speciﬁcally the resistance rate to streptomycin was
16.09%, to isoniazid 16.40%, to rifampicin 2.84%, to ethambutol 2.84%
and to pyrazinamide 1.58%, while 5.04% of isolates were multidrug-
resistant (MDR).
Conclusions: 1. In our study, Resistant tuberculosis seems to be in an
acceptable level, with the resistance to ﬁrst line anti TB drugs in a
descending trend, comparing to former results of ours. 2. The use of
MGIT 960 for testing ﬁrst-line drugs streamlines the drug susceptibility
testing process. 3. Delay in recognition of drug resistant cases, inﬂuences
negatively the initiation of effective therapy and the co sequencing
control of Tuberculosis.
R2267 Clinical and epidemiological features of tuberculous
meningo-encephalitis paediatric cases over 10 years at a
teaching clinical hospital in Romania
Z. Barcsay °, I. Ebetiuc, E. Nicoara, J. John, S. Al Hanini, M. Cerbu,
A. Crisan (Timisoara, RO)
Objective:Meningo-encephalitis caused by Mycobacterium tuberculosis
still holds an important place among the central nervous system
infections and represents a relevant part of the extrapulmonary
localisation of this infection, by its diagnostic and therapeutic challenges.
Method: The patients were recorded by the personal data concerning
age, sex, geographic provenance, epidemiological data regarding
heredocollateral and their personal history regarding mycobacterial
infection, clinical stage at presentation, time interval until the diagnosis
and until starting tuberculostatic therapy. Cerebrospinal ﬂuid samples
were examined in dynamic before and during the therapy, using
direct light microscopy with Ziehl-Nielsen coloration and solid cultures
with Loewenstein-Jensen culture media. The imagistic evaluation (CT,
MRI) was also applied. We have evaluated the clinical evolution,
complication implying central nervous system and those associated with
the tuberculostatic therapy. We overviewed the antituberculous therapy,
and the resistance proﬁle.
Results: The group was formed by 35 non HIV-infected paediatric
patients aged from 18 months to 17 years, admitted during a period
of 10 years in a teaching Clinical Hospital (1997 october-2008 october).
54.2% were boys and 45.8% were girls, originated from four districts
in the western side of the country, 40% from the urban and 60% from
the rural area. The range of the symptoms at presentation was very
wide, from headache and fever, associated meningeal irritation signs to
coma, cranial nerve paresis. The average time span until establishing the
diagnosis and the begin of the correct treatment was 15 days. 88.5% of
the patients were previously treated with different classes of antibiotics.
25.7% of the cases were complicated with hydrocephalia and we have
confronted with toxic hepatitis related to the therapy in 14.2% of the
patients. In 3 of the cases the strains were resistant to one or two of the
major therapeutic agents. 74.3% of the patients fully recovered, while
25.7% remained with sequelae like hydrocephalia, blindness or paresis.
Conclusion: The physician should mantain a high degree of suspicion
regarding this disease because any delay in commencing the right
treatment is associated with a signiﬁcantly more reserved outcome and
important sequelae.
R2268 Whole-blood and cerebrospinal ﬂuid interferon-gamma
release assay for diagnosis of tuberculous meningitis
C.M. Luca, A. Vata, M.C. Petrovici, A. Teodor, D. Leca °, E. Nastase,
A. Luca, V. Luca, C. Dorobat (Iasi, RO)
Objectives: The interferon-gamma enzyme-linked immunosorbent assay
QuantiFERON-TB Gold (QTFG) has been designed for use with
whole blood and has been studied mainly for diagnosing active or
latent pulmonary tuberculosis. We aimed to assess the accuracy of the
commercially available QTFG in blood and adapted variants of the
assay using cerebrospinal ﬂuid (CSF) for the diagnosis of tuberculous
meningitis and compare it with the results of conventional diagnostic
tools.
Material and Method: We prospectively studied 33 patients with
tuberculous meningitis diagnosed and treated in the Infectious Diseases
Hospital from Iasi, Romania during the last 2 years. A lot of 33 patients
with bacterial or viral meningitis and without known BK exposure were
used as negative controls.
Results: A bacteriological conﬁrmation (direct exam from the CSF
or Lowenstein-Jensen culture) of the diagnosis was possible in only
21.2%. The accuracy of the QTFG assay from the CSF was higher than
from blood (65.6% vs 60.6% sensitivity, 96.7% vs 91.2% speciﬁcity)
or compared with the tuberculin skin test (sensitivity 54.5%, speciﬁcity
71.4%). The positive predictive value of a positive QTFG test from the
CSF was 95.2%. The test’s performance was not signiﬁcantly inﬂuenced
by patient’s age (5 to 76 years), immune status (6 patients with AIDS)
or prior anti-tuberculous treatment.
Conclusion: Despite its low sensitivity (in whole blood or CSF), due
to its high speciﬁcity, the QuantiFERON-TB Gold test could be an
important tool for the early diagnosis of tuberculous meningitis.
R2269 QuantiFERON TB Gold assay in tuberculosis diagnosis in
patients from areas with high and low TB incidence
S. Karabela °, S. Nikolaou, A. Sainti, E. Konstantinidou, D. Papaventsis,
P. Ioannidis, S. Kanavaki (Athens, GR)
Objective: Evaluation of Quantiferon TB Gold in Tube method (QFT)
for the latent TB diagnosis in patients originated from countries with
high (group A) and low (group B) incidence of TB.
Material: 948 whole blood samples from 153 (16.1%) individuals
belonging to group A and 795 (83.9%) to group B.
Method: Performance of Quantiferon TB Gold in Tube (Cellestis,
Australia) method according to the manufacturers’ instructions.
Results: QFT positive results was detected in 93/153 (60.8%) individuals
of group A and 273/795 (29.35) of group B (p< 0.0001). Clinical
information for previous BCG vaccination was available in 351 cases:
65 of group A and 286 of group B, where QFT conﬁrmed latent TB in
36/65 (50.8%) and 46/286 (16.1%) of group B (p< 0.0001). As it was
expected, Tuberculin Skin Test (TST) was positive in all 351 cases with
previous BCG vaccination.
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Conclusion: QFT is a highly diagnostic and useful method, especially
in patients originated from areas with high incidence of TB. In contrast
to widely used TST, it reduces over diagnosis of latent TB in previously
BCG vaccinated.
R2270 Increasing the sensitivity of acid-fast bacilli detection by
using concentration technique: an Indian study
S. Desai °, M. Sinha, A. Kiran, S. Mantri, R. Moger (Bangalore, IN)
Objectives: To increase the sensitivity of reporting of Acid fast Bacillus
(AFB) in the given specimen by using concentration technique besides
direct method of smear examination, for all the specimens received for
AFB screening, in a tertiary care hospital in India.
Methods: All specimens with a request for Acid fast bacillus (AFB)
stain were subjected to both direct Zeiehl-Neelson (ZN) technique and
concentration technique (National tuberculosis guidelines).
Direct smear method: smears made from the sputum/specimen samples
were heat ﬁxed and stained using the ZN technique for AFB staining.
Concentration method for AFB staining of sputum (National Tuberculo-
sis Institute guidelines)
For 4−5ml of sputum/specimen, double the volume of 4% of NaOH is
added aseptically and mixed well. The bottle is placed on a shaker and
kept in 37ºC incubator for 20 minutes. Then, sterile distilled water added
approximately 20 to 30ml, mixed well and centrifuged. The sediment is
used to make smears; heat ﬁxed and stained using the ZN technique for
AFB staining.
Results: Total number of specimens received between Jan 2007 and
Dec 2008 were about 1600. Sterile ﬂuids included Pericardial. Pleural,
peritoneal, ascitic, vertebral, synovial, cerebrospinal ﬂuids and blood.
Tissue specimens included endometrial, synovial, visceral pleura and
lymph nodes. All patients tested positive by concentration method were
treated with standard anti tubercular treatment. Table 1 explains the AFB
positivity in direct and concentration methods.
Table 1. AFB positive smears by direct and concentration techniques of various
specimens
SNo Specimens Total AFB positives Percentage of
numbers Total by direct
method
by
concentration
false negative
reporting
1 Sputum/BAL 1058 158 85 73 46
3 Sterile ﬂuids 143 8 5 3 37.7
4 Urine 142 14 8 6 42.5
5 Pus 69 7 6 1 14.3
6 Tissue 46 4 3 1 25
Conclusion: In India, two people become sputum-positive for tu-
berculosis every minute. One sputum-positive patient can infect
10.15 individuals a year. The Revised National Tuberculosis Control
Programme (RNTCP) aims to stop the spread of disease. Failure to
detect persons with infectious TB will continue to spread infection in the
community. By adapting direct method alone, nearly 50% of the samples
would have been missed, thereby missing out on patients who needed
treatment. Hence, increasing the sensitivity of AFB smear detection by
concentration technique should be an additional method besides direct
smear examination.
R2271 AIDS-associated atypical mycobacteriosis other than
Mycobacterium avium-intracellulare: a 14-year survey of
Mycobacterium xenopi and Mycobacterium kansasii
R. Manfredi °, L. Calza (Bologna, IT)
Introduction: A prompt and effective diagnosis and a timely treatment
of atypical mycobacteriosis and especially Mycobacterium kansasii and
Mycobacterium xenopi disease, remains a serious challenge for clinicians
engaged in the management of the immunocompromised host, including
HIV disease.
Patients and Methods: Sixteen and eleven HIV-infected patients with
a microbiologically-conﬁrmed M. kansasii and M. xenopi respiratory
infection respectively, have been observed in a 14-year period, out of over
4,100 hospitalisations performed because of HIV-associated disorders.
These episodes were carefully evaluated from an epidemiological,
bacteriological, clinical, and therapeutic point of view.
Results: In 12 out of 27 cases (44.4%) a bacteraemia was also retrieved.
The proportionally reduced crude frequency of atypical mycobacte-
riosis as HIV-related complication, which virtually disappeared after
introduction of potent antiretroviral combinations (HAART) in 1996, is
underlined. In early nineties, the lack of effective antiretroviral regimens
made frequent the association of this opportunism with full-blown
AIDS, a mean CD4+ lymphocyte count of around 20 cells/mL, and
an extremely variable chest X-ray features. The recent detection of
two further episodes was due to a late recognition of a far advanced
HIV disease (so-called AIDS presenters), complicated by multiple
opportunistic disorders.
Discussion: M. kansasii and M. xenopi respiratory and/or disseminated
infection continues to occur, and pose relevant diagnostic problems,
including late or missed identiﬁcation due to slow culture and frequently
concurrent opportunistic disease. Serious therapeutic difﬁculties, due to
the unpredictable in vitro antimicrobial susceptibility proﬁle of these
organisms, and the need to start as soon as possible an effective
combination therapy which should not interfere with other medications
(especially HAART), are also discussed.
Infection in the immunocompromised host
and transplant recipients
R2272 Lower respiratory infection in cancer patients
E. Chinou °, E. Dalla, Z. Chiolou, M. Georgouli, P. Giannakakos,
E. Skouteli (Athens, GR)
Objectives: The epidemiology of infections in cancer patients undergoes
changes which impact empiric therapy. The aim of this study was to
describe the type and the microbiology of lower respiratory infection
occurring in hospitalised cancer patients.
Methods: Retrospective review of medical records over a two years
period (2007–8). Classic culture methods, Api system for microbial
identiﬁcation and CLSI breakpoints for antimicrobial susceptibility were
used.
Results: During this period 558 sputum specimens were sent from
389 patients and 36 microbiological documented infections were
recorded. The 36 patients were febrile (>38ºC) immunosuppressed,
under chemotherapy. 25/36 patients had an underlying solid organ
cancer (18 with lung cancer) whereas 11/36 had a haematologic
malignancy. The mean time of hospitalisation until the infection has been
occurred was 9 days. 30/36 patients had monomicrobial infection (83%).
Bacteriological analysis revealed: 13 strains of MRSA, 12 P. aeruginosa,
7 K. pneumoniae, 4 Candida sp, 3 E. cloacae and 3 A. baumannii. 11/36
patients (38%) occurred bacteraemia due to the same phenotypic strain
and 4 of these patients died.
Conclusion: The predominant site of lower respiratory infection in
our patients was microbiologically documented pneumonia (9.2%). The
principal pathogens were Gram negative bacteria with high rate of
resistance. Thus in cancer patients the empiric therapy should be based
on local microbiologic and susceptibility data.
R2273 Cytomegalovirus infections in liver transplant recipients
V. Avkan-Oguz °, T. Unek, M. Hancer, H. Astarcioglu, S. Karademir
(Izmir, TR)
Background and Objective: Cytomegalovirus (CMV) infections
are the single most common viral infection since successful liver
transplantation. The incidence of cytomegalovirus infections ranges
8−19% in seropositive liver transplant recipients (CMV R+). However it
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is vital that the centres have their own infection data proﬁle. We aimed
to ﬁnd out viral infection incidence in liver transplant patients in DEU
Hospital (Izmir/Turkey) in order to make a decision strategy for antiviral
prophylaxis or preemptive therapy.
Methods: Between January 2003 and December 2007, 212 cases of
liver transplantation were performed at our centre. Records of case were
examined for risk factors of CMV infection retrospectively. Age, gender,
MELD score, renal insufﬁciency, cold ischaemia time, bacterial and
fungal infection, immunosuppressive therapy, massive blood transfusion,
vascular and hepatic artery thrombosis, rejection were accepted as
independent risk factors. None of the patients have received prophylaxis
or preemptive treatment for CMV.
Results: In this study 99 (46, 7%) out of 212 patients were consulted to
infectious disease and clinical microbiology specialists because of post-
transplant infections and 20 (9, 4%) patients required antiviral treatment.
Of 212 recipient, only 10 (4, 7%) were CMV seronegative. Of 20
patients used antiviral treatment, 12 (5, 7%) had Herpes simplex virus I/
Varicella zoster virus infection and 8 (3, 7%) had CMV infection. Even
there was no microbiological evidence, clinical response was determined
with antiviral therapy in two cases with CMV infection. The details of
six cases proven as CMV diseases are presented in table. All of these
CMV cases had CMV R+ and were followed up by CMV antigenaemia
assay. In the absence of effective antiviral prophylaxis or preemptive
therapy, CMV infections usually occurred three months to six month
following transplant surgery.
Conclusion: Upon analysis of viral infections our centre, the incidence
of viral infections in liver transplant patients was found to be lower than
expected and CMV diseases usually were the type of delayed-onset.
According to these ﬁndings antiviral prophylaxis after transplantation is
not recommended for the recipients in Dokuz Eylul University Hospital.
However preemptive therapy should be used for those liver transplant
recipient having high risk factors for CMV disease.
Table: The details of six cases proven CMV diseases
Case I Case II Case III Case IV Case V Case VI
Primary diseases Hepatitis B Alcoholism Hepatitis C Hepatitis B Hepatitis B +
minimal
change disease
Hepatitis C
Age/gender 66/M 59/M 58/F 53/M 41/F 58/M
MELD score 15 19 14 16 20 18
Transplant type Cadaveric Living Living Cadaveric Living Living
Renal insufﬁciency − − − − Renal
transplantation
−
Cold ischaemia time (min) 370 120 90 330 120 90
Bacterial and fungal
infection
+ + − − − −
Immunosuppression Tacrolimus Tacrolimus Ciclosporin Tacrolimus Tacrolimus Ciclosporin
Prednisolone Prednisolone Prednisolone Prednisolone Prednisolone Prednisolone
MMF MMF MMF MMF MMF MMF
Massive blood transfusion 16 6 4 4 7 20
Vascular and hepatic
artery thrombosis
− + − − − −
Rejection − − − − − −
Date of CMV infection
determined
Sixth month Third month Third month First month Fourth month Third month
Prognosis Exitus Alive Alive
HCV nuks
Alive Alive Alive
HCV nuks
R2274 Asymptomatic Toxoplasma gondii infection in liver
transplant patients
C. Contini °, S. Seraceni, R. Cultrera, S. Scivales, B. Castagna,
F. Bruschi (Ferrara, Pisa, IT)
Objectives: Toxoplasma gondii infection in transplant recipients can lead
to toxoplasmosis, which in some cases may have a rapid disease course
or to be fatal. Serological tests do not often contribute to the diagnosis.
Although PCR may early identify the infection, this technique is not
well standardised and there is no consensus on the optimal protocol to
be used in laboratories. We homogenised our PCR data with those of a
Real-time PCR targeting different T. gondii genes.
Methods: T. gondii genes were explored before and after liver
transplantation (LT) with PCR and Real-time PCR (LightCycler, Roche)
targeting bradyzoite (BAG-1) matrix (MAG-1), cyst surface (SAG-4) and
dense granule (GRA-6) speciﬁc genes other than B1 gene. These have
been developed by us and retrospectively evaluated in PBMC specimens
from 7 LT patients in whom serological status (anti T. gondii IgG) before
transplantation was known in 4 patients only.
Results: We found 4 PCR positive specimens of which 2 with B1 gene
(after LT) and 2 with GRA-6 and BAG-1 (before LT). With LightCycler
(expressed as T. gondii genome equivalents/ml) the overall positivity
rates were 12 before and 17 after LT. In particular, in marked contrast
with PCR results, the number of positive specimens before LT were 4
(B1), 2 (SAG-1), 3 (SAG-4 and MAG-1, respectively). After LT we
did detect 7 (B1), 3 (SAG-1), 5 (SAG-4) 3 (MAG-1). Two patients
were found to have elevated DNA copy number of SAG-4 in post-LT
specimens only.
Conclusions: Transmission of toxoplasna infection via LT is extremely
uncommon with only few conﬁrmed cases previously reported.
LightCycler based method can identify a relatively high incidence of
potential new infections compared with PCR excluding most of the
false-negative PCR results associated with contamination with previously
ampliﬁed products. This is of greater use for monitoring LT recipients
with negative serological tests at risk of developing toxoplasmosis and
managing therapy. LT patients did not receive TMP/SMX as post-
transplant infection prophylaxis. Improvement and standardisation of
diagnostic tests, especially real-time PCR targeting markers expressed
on bradyzoites or matrix is also important in order to prevent relapses
and symptomatic disease.
R2275 Comparative evaluation of daptomycin and
pharmakocinetically-guided vancomycin therapy in patients
with prolonged neutropenia or haematopoietic stem cell
transplantation
M. Vergoulidou °, A. Koch, E. Thiel, L. Uharek, S. Schwartz (Berlin, DE)
Objectives: Limited data on the use of daptomycin, which exhibits ex-
tended activity against Gram-positive bacteria, in immunocompromised
patients (pts) are available.
Methods: We retrospectively studied pts treated with daptomycin during
prolonged neutropenia or after haematopoietic stem cell transplantation
(HSCT). Results were compared to a control group of pts with
pharmakocinetically-guided vancomycin therapy (target trough level
<15mg/l).
Results: Overall, we identiﬁed 15 pts with daptomycin and 18 pts with
vancomycin therapy (median age 53 and 58 y). Both agents were always
added to a broad-spectrum antibacterial regime, including antifungal
therapy in 11 pts. Underlying conditions were HSCT in 10 and 11 pts,
haematological malignancies in 4 and 7 pts and solid tumour in 1 and
none pt with daptomycin and vancomycin therapy, respectively. Eighteen
pts had neutropenia, 15 pts had immunosuppressive comedications
(steroids, cyclosporine, mycophenolate mofetil) and 9 pts had graft-
versus-host disease. Pts had fever of unknown origin (28), urinary tract
infections (3), soft tissue infection (1) or pneumonia (1). Six pts with
daptomycin therapy have had vancomycin pretreatment.
With start of daptomycin and vancomycin the concurrent antibiotic
regime was modiﬁed in 6/15 and 8/18 pts, respectively (p = 1). The
median daily doses were 4mg/kg (range 2−9) for daptomycin and
22mg/kg (range: 13−36) for vancomycin. The median durations of
daptomycin and vancomycin therapy were 8 (range 1−20) and 10 (range
3−21) days, respectively.
Defervescence was achieved in 9/15 and 13/18 pts treated with
daptomycin and vancomycin, respectively (p = 0.49). The median ratios
of the serum creatinine at the end of therapy compared to baseline
were 1.15 and 1.12 for daptomycin and vancomycin (p = 0.5). Except
for nausea (2) and skin rash (1) in 3 vancomycin treated pts, no other
toxicicities attributable to either drug were observed.
Conclusion: Daptomycin showed similar efﬁcacy and tolerability
compared to pharmacokinetically-guided vancomycin therapy in this
series of immunocompromised pts. Further studies are needed to explore
the role of daptomycin in this particular group of pts.
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Community-acquired infections including
CAP, sepsis, STD, . . .
R2276 Survivin: any potential implication in early sepsis?
S. Mera °, D. Tatulescu, C. Cismaru, A. Slavcovici, V. Zanc, M. Flonta,
D. Carstina (Cluj-Napoca, RO)
Objectives: Sepsis is initiated by leukocyte and endothelial activation,
followed by massive cytokine surge, activation of inﬂammation and
coagulation. Survivin, a protein initially described as an inhibitor of
apoptosis is intensely expressed in tumour cells while in normal adult,
differentiated tissues its expression is absent. Previous in vitro studies
indicated that extracellular survivin up-regulates adhesion molecules on
the surface of leukocytes changing their reactivity pattern, suggesting
immunoregulatory properties for extracellular survivin. Given our
previous observations, we aimed to study the potential involvement of
circulating survivin in the pathogenesis of sepsis.
Methods: In 31 septic patients we analyzed serum levels of survivin
over the ﬁrst 7 days upon admission. Fourteen healthy volunteers served
as controls.
Results: Patients (24 males/7 females) had the median age of 60. The
primary infection had urinary (12), respiratory (14), abdominal (3),
dental (1) and cutaneous (1) origin. Five patients had concomitant known
malignancies. Five patients (16%) died during the ﬁrst week. Survivin
was detected in nine (29%) patients, ranging between 13.5–812 pg/ml.
There was no correlation between survivin levels, severity of sepsis or
outcome. Circulating survivin was undetectable in volunteers while all
cancer patients had high survivin levels.
Conclusion: Sepsis does not lead to circulating survivin. However,
detectable survivin may reveal concomitant comorbidities that may
indirectly aggravate the prognosis.
R2277 Inﬂammatory systemic response and aetiology in
community-acquired pneumonia
J.M. Sahuquillo-Arce °, R. Menendez, S. Reyes, R. Martinez,
M.A. Marcos, X. Filella, E. Polverino, A. Torres, M. Gobernado
(Valencia, Barcelona, ES)
Objectives: The aim of this study was to evaluate the systemic cytokine
proﬁle (tumour necrosis factor alpha (TNF), interleukin (IL) 1, IL6,
IL8 and IL10), C reactive protein (CRP) and procalcitonin (PCT) in
patients with community acquired pneumonia (CAP), according to their
aetiological agent.
Methods: A prospective study was performed in 685 hospitalised
patients with CAP from two tertiary hospitals. Cytokines, PCT and CRP
measurements were obtained on day 1. Data were analyzed with the
SPSS 15.0 software package.
Results: Data are presented as median and interquartile range in Table 1.
Statistically signiﬁcant differences are marked with an asterisk.
Table 1. Inﬂammatory cytokines and markers in the most important CAP aetiological agents
Day 1 Virus Entb Strpn Pseae Myc/Chla Legionella
(n = 12) (n = 13) (n = 118) (n = 18) (n = 22) (n = 24)
RCP* mg/dl 12
(8.9−16.8)
20.1
(12.55−31.45)
19.85
(10.3−28.4)
10
(7.4−13.8)
11.3
(7.5−24.3)
24.9
(21.3−33.5)
PCT* ng/ml 0.24
(0.16−0.47)
1.585
(0.56−8.965)
1.71
(0.48−7.37)
0.44
(0.14−0.62)
0.19
(0.09−0.48)
0.71
(0.5−3.15)
TNF-a* pg/ml 14
(10−27)
14.5
(11.5−68)
27
(16−47)
23
(15−42)
25
(21−40)
49
(40−72)
IL-1 pg/ml 13
(4−14)
20
(8.5−41)
16
(4−30)
16
(4−29)
24
(5−35)
19
(5−35)
IL-6* pg/ml 66
(30−192)
168.5
(58−339.5)
144
(38−305)
105
(22−223)
40
(21−79)
202
(69−1548)
IL-10 pg/ml 22
(1−27)
6
(0−25.5)
7
(0−21)
6
(3−12)
9
(0−15)
3
(0−12)
IL-8* pg/ml 4
(3−9)
54.5
(13.5−79.5)
6
(2−19)
12
(8−20)
12
(5−22)
16
(11−35)
Entb, Enterobacteriaceae; Strpn, Streptococcus pneumoniae; Pseae, Pseudomonas aeruginosa; Myc/Chla, Myco-
plasma/Chlamydia. *p< 0.05.
Conclusions: Viruses had a higher IL-10 median while Enterobacte-
riaceae, Legionella, and S. pneumoniae showed higher levels of IL 6.
PCT is lower in CAP caused by viruses, Mycoplasma or Chlamydia
pneumoniae. Legionella displayed the highest levels of RCP, TNF and
IL-6, while Enterobacteriaceae had the highest level of IL-8.
R2278 Accuracy of clinical presentation in predicting the aetiology
of acute bacterial meningitis
J. Modol °, M. Gimenez, E. Mesalles, S. Molinos, B. Catalan,
L. Pedro-Botet, P. Tudela, F. Armestar (Badalona, ES)
Objective: To determine whether acute bacterial meningitis (ABM)
aetiologies can be differentiated based on clinical and biological data
available on admission.
Methods: prospective observational study of adults hospitalised with
ABM at a university hospital in Spain over a 10-year period (1997–2006).
Among the 78 cases we included 71, corresponding to the most common
microorganisms causing ABM: S. pneumoniae (33), N. meningitidis (19)
and L. monocytogenes (19). We analyzed demographic data, predisposing
factors, clinical features and laboratory data on hospital admission.
Results: Clinical and biological data are shown on Table 1. In
the univariate analysis, the following variables were associated with
pneumococcal meningitis: history of head trauma or cerebrospinal ﬂuid
(CSF) leakage (sensitivity “S” 30.3%, speciﬁcity “Sp” 100%, positive
predictive value “PPV” 100%, negative predictive value “NPV” 61%),
previous meningitis episode (S 18.2%, Sp 100%, PPV 100%, NPV
57.1%). The presence of petechiae was associated with meningococcal
ABM (S 44.4%, Sp 95.9%, PPV 80%, NPV 82.5%). Age >60 (S 77.8,
Sp 67.3, PPV 45.2, NPV 89.7), clear CSF (S 61.5, Sp 89.1, PPV 61.5,
NPV 89.1), lymphocyte predominance in CSF (S 36.4%, Sp 95.7%,
PPV 66.7%, NPV 80%), CSF protein <5 g/L (S 87.5%, Sp 48.9%, PPV
37.8%, NPV 91.7%), and CSF Gram’s stain without microorganisms
(S 57.9%, Sp 82.7%, PPV 55%, NPV 84.3%) were associated with
Listeria. In the multivariate analysis, Listeria ABM was associated with
clear CSF, lymphocyte predominance, and CSF Gram’s stain without
microogranisms; S. pneumoniae with history of head trauma or CSF
leakage and N. meningitidis with the presence of petechiae.
Table 1. Clinical and biological data by aetiologies
S. pneumoniae N. meningitidis L. monocytogenes p
N (%) N (%) N (%)
Data available on admission
Underlying diseases
Head trauma/CSF leakage 10/33 (30.2) 0/18 (0) 0/18 (0) 0.002**
Previous meningitis 6/33 (18.2) 0/18 (0) 0/18 (0) 0.028*
Immunocompromised 7/33 (21.2) 3/18 (16.7) 11/18 (61.1) 0.004
Age >60 years 10/33 (30.3) 7/19 (36.8) 14/18 (77.8) 0.04*
Clinical manifestations
Petechial rash 1/30 (3.3) 8/18 (44.4) 1/18 (5.6) <0.001**
CSF
Clear 4/25 (16) 1/17 (5.9) 8/13 (61.6) <0.001**
Lymphocytic 2/30 (6.7) 0/16 (0) 4/15 (26.7) 0.03**
Protein <5 g/L 16/28 (57.1) 7/17 (41.2) 14/16 (87.5) 0.02**
Gram’s stain 25/33 (75.8) 18/19 (94.7) 8/19 (42.1) 0.001**
Other microbiological test
CSF culture 27/33 (81.8) 12/19 (63.2) 18/19 (94.7)
CSF PCR 11/11 (100) 7/7 (100) 1/4 (25)
Blood cultures 27/33 (81.8) 6/19 (31.6) 15/18 (83.3)
Blood PCR 4/11 (36.4) 5/7 (71.4) 0/2 (0)
**p< 0.05 in multivariate analysis; *p = 0.05−0.1 in multivariate analysis.
Conclusions: A history of head trauma or CSF leakage and a previous
meningitis episode are highly predictive of pneumococcal meningitis.
The presence of petechiae is suggestive of meningococcal origin. A CSF
with lymphocyte predominance is highly predictive of Listeria ABM.
However, globally the clinical features lack of sensitivity for establishing
the aetiology of acute bacterial meningitis. CSF Gram’s stain is the best
tool available on admission for the diagnose of ABM, and when it doesn’t
show microorganisms it’s suggestive of Listeria ABM.
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R2279 The CURB-65 criteria in bacteraemic community-acquired
pneumonia patients
A. Marin, V. Ursic °, R. Erzen, V. Tomic, E. Music (Golnik, SI)
Objectives: CURB-65 is the key procedure in evaluation of patient
condition at admittance. In this retrospective study we aimed to evaluate
the usefulness of CURB-65 criteria in admitted patients with positive
hemoculture. We analyzed the predictive value of CURB-65 criteria in
average duration of hospital stay and mortality.
Methods: We collected data regarding age, sex, bacteria isolated from
blood, presence of confusion, blood urea, respiratory rate, blood pressure,
serum creatinine (SC), C-reactive protein (CRP), white cell count
(WCB), length of hospital stay (DH) and outcome of therapy.
Results: The total number of patient screened was 30, 21 males and 9
females. Median age was 69.1 years (range 42−92 years, 21 patients
>65 years). Average duration of hospital stay was 16.8 days with
23.3% mortality. Positive CURB-65 criteria were: acute confusion, blood
urea >8.3mmol/l, respiratory rate >30/min, diastolic BP 60mmHg or
systolic BP 90mmHg and age >65 years. Bacteria most often isolated
from blood were: S. pneumoniae in 10 patients, E. coli in 4 patients,
K. pneumoniae in 3 patients and Methicillin-sensitive S. aureus (MSSA)
in 3 patients and H. parainﬂuenzae in 2 patients.
Conclusion: According to results CURB-65 is a good indicator of
prognosis and outcome, but not of the length of hospital stay in
bacteraemic CAP patients. Bacteraemic CAP in elderly could be
presented even with mild clinical course and good prognosis. We found
higher levels of serum creatinine a predictor of higher mortality.
Table 1: Correlation between CURB-65 criteria, age, serum creatinine, CRP, WBC and average duration of hospital
stay and mortality in bacteraemic patients admitted due to CAP
No. of positive
CURB criteria
No. of
patients
Median SC
(umol/L)
Median CRP
(mg/L)
Median WBC
(×109/L)
Median DH
(days)
Mortality
(%)
0 1 60.0 143.9 12.8 36.0 0
1 4 49.8 34.1 16.0 12.0 0
2 14 93.7 181.5 11.7 21.3 14
3 8 122.9 213.2 13.8 12.0 13
4 2 157.0 342.0 11.8 19.0 50
5 1 355.0 434.9 5.2 1 100
R2280 Changes in the detection of C. trachomatis in a female
population in Greece during the last 4 years
O. Kakisi, C. Avdeliodi, M. Simou, H. Kada °, M. Falagas (Athens, GR)
Background: Our purpose was to measure and compare the annual
incidence of Chlamydia trachomatis infection in an urban population
of women of reproductive age during the last 4 years in Athens Greece
and report the relevant ﬁndings.
Material and Methods: In total, 6554 endocervical samples of unique
women that attended our hospital outpatients’ gynaecological department
during the last 4 years (1/1/2005–31/12/2008) were included in the study.
The molecular method used for the detection of C. trachomatis was SDA
(strand displacement ampliﬁcation) BD PROBE TEC TM. Patients were
also stratiﬁed by age, pregnancy, previous miscarriages, symptoms and
nationality.
Results: The ﬁgure shows the respective incidences of C. trachomatis
in our study population during 2005–2008. The observed decrease is
in the magnitude of >50% between 2005 and 2008 (P< 0.05). To our
knowledge there exists no known factor for the signiﬁcant decrease in
the measured incidence of C. trachomatis infection of women in Athens,
Greece.
Conclusion: In light of the recent discovery of new plasmid mutants of
C. trachomatis that evade detection by standard molecular methods in
Sweden, we believe that attention is warranted for the observed decrease
in our own study population. Although the BD PROBE TEC assay is
believed not to be affected by the presence of mutant strains, there is an
evident need for the investigation of factors that have attributed to this
change.
R2281 Invasive pneumococcal disease in adults: clinical forms and
spectrum of serotypes
Z. Blechova, O. Dzupova °, M. Trojanek, B. Sykorova, J. Motlova,
V. Maresova (Prague, CZ)
Objectives: Invasive pneumococcal disease (IPD), mainly pneumonia
and purulent meningitis, occur in all age groups with the highest
frequency in elderly and children. Despite being less common than
pneumococcal upper respiratory tract infections, they may be severe and
even lethal. The aim of our study was to ﬁnd out the frequency of clinical
forms, clinical outcome and spectrum of Streptococcus pneumoniae
serotypes causing invasive infections.
Methods: A retrospective epidemiological study of adult patients
with IPD was carried out at four departments (Infectious Diseases,
Pneumology, Internal Medicine, Surgery) of the University Hospital
Bulovka in Prague, Czech Republic, in years 2000–2007. Patients older
than 18 years with symptoms of acute infection were included if
S. pneumoniae was isolated in blood or CSF culture. All strains were
subsequently serotyped.
Results: Ninety-four patients with IPD were included in the study, 40
females and 54 males with the age range 19−87 years and median age
of 57 years. The highest frequency of IPD (32 pts, 34%) was recorded in
the age group of 50−64 years. The clinical forms were pneumonia (54
pts, 57%), meningitis (37 pts, 40%), bacteraemia (1 patient), primary
peritonitis (1 patient), and septic arthritis (1 patient). IPD had lethal
outcome in 23 cases (25%) with the highest case fatality ratio 50% in
the age group of 65 years and older. Case fatality ratio was 20% in
pneumonia (11/54) and 30% in meningitis (11/37). The most frequent
serotypes were 3 (12 pts), 4 (11 pts), 8 (10 pts), 1 (7 pts), 7F (7 pts),
14 (6 pts), 6A (6 pts). Only 17% of isolated S. pneumoniae serotypes
would not be covered with the 23-valent polysacharide vaccine.
Conclusion: IPD may have severe course with even lethal outcome
mainly in elderly. The results support the importance of active
surveillance of IPD with regard to both the spectrum of available
vaccines and detection of population at risk.
Acknowledgement: The study was partially supported by the grant IGA
MZ CR NR/8770−3.
R2282 Incidence of Ureaplasma urealyticum in women with
chronic urinary symptoms
S. Baka °, A. Liapis, S. Antonopoulou, D. Sioutis, E. Logothetis,
E. Kouskouni (Athens, GR)
Objective: The aim of the present study was to evaluate the incidence
of U. urealyticum in women presenting with chronic urinary symptoms
at our hospital.
Methods: We studied 153 consecutive women referred to our academic
hospital for chronic voiding symptoms who underwent urologic
evaluation between January 2007 and March 2008. Patients with UTI
were excluded from the study. Only women with no prior cultures
or assays for the identiﬁcation of mycoplasmas were enrolled in the
study while subjects receiving antibiotics within the previous month
were not included. Samples from the urethra, vagina and cervix were
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obtained from all women. In order to identify aerobic microorganisms
samples were inoculated on blood agar, MacConkey agar, Chapman and
Sabouraud agar followed by incubation at 37ºC for 24 hours, whereas
anaerobic cultures were carried out on Wilkins-Chalgren agar at 37ºC
for 48 hours. The automated system VITEK 2 (BioMerieux, France) was
used for the identiﬁcation of isolated strains while for the identiﬁcation
of U. urealyticum, the Mycoplasma IST 2 (BioMerieux, Marcy l’Etoile,
France).
Results: The median age of the women studied was 51.7 years (range
24−70). U. urealyticum was detected from at least one site in 81 (52.9%)
women. In particular, 26 (32.1%) women had positive cultures for
U. urealyticum from one site (12 from urethra, 5 from vagina and 9
from cervix) while in 55 (67.9%) women, positive cultures were obtained
from all 3 sites. In 27 (17.7%) cases, U. urealyticum was the only
pathogen isolated, in 10 (6.5%) patients U. urealyticum was associated
with Streptococcus agalactiae, in 10 (6.5%) with Enterococcus faecalis,
in 9 (5.9%) with Staphylococcus aureus, in 6 (3.9%) with Pseudomonas
aeruginosa, in 3 (2.0%) with Klebsiella pneumoniae, in 10 (6.5%) with
Gardnerella vaginalis and 6 (3.9%) with Candida spp. Twenty four
(15.7%) women had positive cultures only for Enterococcus faecalis
(17) or S. agalactiae (7) while 16 (10.4%) had Gram-negative rods and
5 G. vaginalis. Finally, in 27 (17.7%) patients no pathogens could be
isolated.
Conclusions: A high incidence of U. urealyticum was observed in our
study group. Therefore, it is important to test all patients with chronic
urinary symptoms for the presence of this microorganism.
R2283 Asymptomatic bacteriuria may assist urinary tract
infections?
A. Sener °, N. Yapar, N. Cakir, A. Yuce (Canakkale, Izmir, TR)
Objectives: Urinary tract infections (UTI) have a great mortality and
morbidity rate at geriatric patients. Asymptomatic bacteriuria (ASB) is
frequent in elderly and even more prevalent in residents of long-term
care facilities. Relation between ASB and UTI is not clear yet. Resistant
bacteria can frequently cause persistant ASB.
Methods: Study group was consist of residents of three big nursery
homes in Izmir. Patient selection criteria were; being over 65 years old
who had not urinary symptoms but had not urinary catheterisation at
least for ﬁfteen days and not had given any antibacterial thearpy in
one week. Two urine samples were taken with interval of 24−48 hours
by clean catch technique. The patients who has ASB, were observed for
UTI for six months. New urinary cultures were made for asympthomatic
bacteriuric patients at thirth month. All isolates were investigated for
resistance of ampicilline, aztreonam, amoxicilline-kalvulonate, ceftriax-
one, cefotaxime, ceftazidime, amicasine, norﬂoxacine, ciproﬂoxacine,
trimethoprime-sulfamethoxazole.
Results: Prevalence of ASB was 24.1% (146/606). Escherichia coli
(87/146, 59.5%), Klebsiella pneumonia (23/146, 15.7%), Klebsiella
oxytoca (18/146, 12.3%) were the ﬁrst three pathogens of ASB. Proteus
mirabilis (15/146, 10.4%) and Proteus vulgaris (3/146, 2.1%) were the
other agents. 117 of all 146 ASB have trimethoprim-sulfamethoxazole
resistance (80.1%). Ciproﬂoxacine resistant E. coli (21, 24.1%) and
K. pneumonia (3, 13%) were persistant at thirth and sixth month. All
patients were followed up for six months and UTI was not observed.
Conclusion: Four types of infections occur most often among geriatrics:
urinary tract, respiratory tract, skin and soft tissue, and gastrointestinal
tract. UTI is the most important clinical stiuation among these, because
identifying symptoms and underlying conditions that physicians use to
determine treatment for a UTI may assist the long-term care facility
(LTCF) nurse in optimal use of time and resources. ASB is one of the
critical points and must determine UTI correlation.
R2284 Comparison of bacterial isolates in acute post-traumatic
tibial fracture infection and chronic posttraumatic tibial
osteomyelitis
V. Dzupa, O. Dzupova °, A. Nejedly, J. Zahorka (Prague, CZ)
Objectives: Acute posttraumatic infection of opened tibial fracture
and chronic posttraumatic tibial osteomyelitis are serious illnesses
compromising limb function and their treatment usually constitutes
a difﬁcult medical problem. The aim of the study is to present the
microbiological ﬁndings in patients of both groups and ﬁnd out if the
bacterial isolates signiﬁcantly differ.
Methods: All patients were treated by radical debridement and muscle
ﬂap transfer. Perioperatively sampled tissue was routinely cultured.
The study included patients with positive culture as well as negative
culture but clinically apparent purulency. The c2 test of independence
contingency table was used to compare categorial data. The level of
signiﬁcance for the test was set at 5%.
Results: Between January 1, 2002 and September 30, 2007, 52 patients
were included in the study group. There were 10 women and 42 men
with a mean age of 44 years (range, 10 to 67 years). In 36 patients
with acute posttraumatic tibial fracture infection Gram-positive bacteria,
Gram-negative bacteria and mixed ﬂora was isolated in 19, 9 and 7
patients, respectively. Two patients had got negative cultures. In 16
patients with chronic posttraumatic tibial osteomyelitis Gram-positive
bacteria, Gram-negative bacteria and mixed ﬂora was isolated in 6, 4
and 3 patients, respectively. Three patients had got negative cultures.
The differencies between groups did not prove statistical signiﬁcance.
Conclusion: Nonsigniﬁcant differencies between groups of bacterial iso-
lates in both diagnoses, even though they cannot exclude haematogenous
seeding as a cause of chronic posttraumatic tibial osteomyelitis, rather
support the theory of reactivated long-persisting bacterial infection in
the site of injury.
R2285 Real practice of antimicrobials use in the treatment of
sexually transmitted diseases in Russia
Y.A. Belkova °, O.Y. Aleksandrova, B.V. Berezhanskiy, E.N. Bochanova,
V.V. Chebotarev, I.L. Chechula, A.V. Dekhnich, E.V. Eliseeva,
E.A. Ortenberg, A.M. Savicheva, I.A. Toropova, R.S. Kozlov
(Smolensk, Ekaterinburg, Moscow, Krasnoyarsk, Stavropol, Krasnodar,
Vladivostok, Tyumen, St. Petersburg, Yakutsk, RU)
Objectives: Prompt treatment of sexually transmitted diseases (STDs)
is an essential component of their control. So, we aimed to reveal real
practice of treatment of bacterial STDs throughout Russia.
Methods: A multicentre retrospective study was conducted in 10
different cities of Russia. Clinical records of adult patients treated for
bacterial STDs during Jan 2007–Dec 2007 were collected.
Results: The data on 1250 patients (61% male, 39% female,
mean age 28.8±9.2) with: early syphilis (n = 341), uncomplicated
gonococcal (n = 309), chlamydial (n = 310), mycoplasmic (n = 137) and
ureaplasmic (n = 153) infection were analyzed. Overall 1567 disease
orientated prescriptions were registered. Antimicrobials accounted
for 1352 (86.3%) and were represented by six groups: macrolides
(30%), cephalosporins I-III (22%), penicillins (19.5%), tetracyclines
(15.1%), ﬂuoroquinolones (9.5%), aminoglycosides (4%). Early syphilis
was commonly treated by benzathine penicillin (38.4%), procaine
penicillin (28.3%), ceftriaxone (26.9%) and penicillin G (5.5%);
gonococcal infection − by ceftriaxone (57.5%), spectinomycin (9.3%),
doxycycline (7.2%), azithromycin (5.1%); chlamydial infection − by
azithromycin (28.2%), doxycycline (22.2%), claritromycin (14.9%),
josamycin (11.1%), oﬂoxacin (7.9%); mycoplasmic and ureaplasmic
infection − by doxycycline (31.8%), josamycin (21.3%), azithromycin
(13.1%), claritromycin (12.8%), levoﬂoxacin (5.6%). Other agents
accounted for less than 5% each. Administered therapy went in conﬂict
with modern national guidelines in 28.2% of patients, international
guidelines − in 24.2%. Among correctly chosen agents only 24% and
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11%, respectively, were used in recommended course doses (higher
dose − 69.1% and 83.7%, lower − 6.9% and 5.3%).
Conclusion: Relatively low compliance to national and international
guidelines as well as existing tendency to use antibiotics in higher then
recommended course doses require administrative actions to change this
situation throughout our country.
Lyme borreliosis, toxoplasmosis
R2286 Lyme borreliosis: descriptive study of 151 patients followed
up in a university hospital, Lyon (France)
K. Barrial °, C. Roure-Sobas, A. Carricajo, S. Tigaud (Lyon,
Saint-Etienne, FR)
Objectives: To describe epidemiological, clinical and serological
features of patients with a positive screening test for Lyme borreliosis
(LB), followed in the Hospital University of Lyon.
Methods: A descriptive study taking place among patients with positive
or equivocal test Enzygmost® (Dade-Berhing) for IgM and/or IgG
antibodies against Borrelia, between May and December 2007. All
the sera were tested with immunoblot (IB) Euroline® (EuroImmun,
BioAdvance) daily used in the laboratory. In each case, we studied the
all patient clinical ﬁle.
Results: 151 patients were included. 33 (22%) of them were diagnosed
as LB, 10 (6.6%) were likely LB and 101 (67%) were non conﬁrmed. 7
ﬁles were not avalaible.
The median age was 54 years, range (4; 91). The sex ratio M/F was 1.2.
Tick bite was reported in 27% (n = 41) and 48% (n = 16) patients
among the population studied and positive LB patients respectively.
Previous LB occurred in 12% (n = 18) and 18% (n = 6). Neurological
complications, especially facial paralysis and meningoradiculitis, were
the most frequent reported in 45% (n = 68) and 48% (n = 16) of cases.
Speciﬁc antibiotherapy was prescribed in 19% (n = 19) of negative LB
patients.
Among conﬁrmed LB patients, 83% and 61% were IB positive to IgG
and IgM antibodies against Borrelia, respectively. IB were positive in
38% (n = 38) among negative LB patients.
Conclusion: Epidemiological criteria of population studied was similar
to french population LB. Borrelia garinii predominates in the western
part of Europe which might explain the high frequency of neurological
complications. LB diagnosis remained difﬁcult and serological test
results might always be interpreted in relation to the clinical ﬁndings.
R2287 Evaluation of two line immunoassays for the detection of
Borrelia antibodies
I. Verstreken, T. Appeltans, J. Verhaegen °, K. Lagrou (Leuven, BE)
Objectives: Lyme borreliosis is a multisystemic disease with diverse
clinical manifestations transmitted to humans by ticks. Clinical diagnosis
is difﬁcult. In routine practice a two step test strategy is recommended
for the diagnosis of the disease. Several conﬁrmation tests are available.
We evaluated the performance characteristics of two different line
immunoassays.
Methods: 62 sera submitted to the Laboratory Medicine unit of the
University Hospitals Leuven were analyzed for the presence of Borrelia
IgM and IgG antibodies with two line immunoassays: recomLine
Borrelia (Mikrogen) and Borrelia Europe LINE (VIROTECH) and
with an immunoblot assay recomBlot Borrelia (Mikrogen) as reference
method. All tests were performed on the auto LIA II instrument
(Innogenetics). Sensitivity was evaluated on 33 preselected sera from
patients with Lyme borreliosis based on clinical symptoms and the
presence of Borrelia IgM and/or IgG with recomBlot Borrelia assay
(8 erythema migrans, 10 arthritis, 15 neuroborreliosis). Speciﬁcity was
evaluated on 29 sera (10 Epstein Barr virus IgM positive sera, 9
rheumatoid factor positive sera and 10 sera positive for rapid plasma
reagin antibodies).
Results: Speciﬁcity of both IgM line assays was 89.7%. 2/29 false
positive IgM results were from patients with a primary EBV infection.
Cross reaction due to EBV infection can be detected by the Europe
LINE assay due to the presence of the EBV-VCA gp125 antigen on the
strip. One IgG positive result was obtained with both line assays. This
was probably due to a previous Borrelia infection in a rheumatoid factor
positive patient. Sensitivity for both line assays was 97% if we combine
IgM and IgG test results. IgG were present in 7/8 (87.5%) of erythema
migrans sera with both line assay compared to 1/8 (12.5%) sera that was
IgG positive with the recomBlot assay.
Conclusion: The performance characteristics of the two Borrelia
antibody conﬁrmation line immunoassays, recomLine Borrelia and
Borrelia Europe LINE, were very good and similar in this evaluation.
From early stage sera it seems that the sensitivity of both IgG line assays
is higher compared to the Mikrogen IgG recomBlot assay.
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R2288 In vitro susceptibility and pathogen prevalence data in
complicated skin and skin-structure infections: results of
the RELIEF study
I.C. Gyssens °, M. Dryden, P. Kujath, D. Nathwani, N. Schaper, P. Arvis,
P. Reimnitz, J. Alder, B. Hampel (Nijmegen, Maastricht, NL; Winchester,
Dundee, UK; Lubeck, Wuppertal, Berlin, DE; Lille, FR; Montville, US)
Objectives: The choice of antimicrobial therapy in complicated skin
and skin structure infections (cSSSIs) is complex due to the potential
diversity of the pathogens present. In particular, cSSSIs are characterised
by a high prevalence of Staphylococcus aureus, including methicillin
(oxacillin [OXA])-resistant S. aureus (MRSA) both in hospital and
community settings. Furthermore, in recent years, serious cSSSIs caused
by multi-drug resistant pathogens − including non-fermentive Gram-
negative bacilli and Enterobacteriaceae − have become more common.
This has created the need for additional therapeutic agents such as
broad spectrum ﬂuoroquinolones. In the present study, we evaluated
the antimicrobial activity of moxiﬂoxacin (MXF) and commonly used
antimicrobial agents against recent clinical bacterial isolates collected in
the RELIEF study.
Table: MIC50/MIC90 (mg/L) for pathogens obtained from patients with cSSSIs
Organism N MXF PIP/TAZ AMC OXA CRO CFZ GEN ERT MET
Gram-positive bacteria
MSSA 368 0.03/
0.06
1/
2
0.5/
1
0.25/
0.5
4/
4
8/
8
0.5/
1
0.12/
0.25
−
MRSA 48 2/
4
16/
>128
8/
>32
>8/
>8
64/
>64
64/
>64
>32/
>32
2/
>32
−
S. pyogenes 73 0.12/
0.25
0.25/
0.25
0.06/
0.06
− 0.06/
0.06
0.12/
0.25
8/
8
0.015/
0.015
−
S. agalactiae 50 0.12/
0.25
0.5/
0.5
0.12/
0.12
− 0.12/
0.12
0.5/
1
32/
32
0.06/
0.06
−
S. equisimilis 31 0.12/
0.25
0.25/
0.25
0.06/
0.06
− 0.06/
0.06
0.25/
0.25
8/
>32
0.03/
0.03
−
E. faecalis 135 0.25/
16
4/
8
1/
1
− >64/
>64
>64/
>64
16/
>32
8/
8
−
Gram-negative bacteria
E. coli 126 0.06/
16
2/
4
4/
16
− 0.06/
0.12
0.12/
0.25
0.5/
2
0.015/
0.015
−
Non-ESBL 119 0.06/
2
2/
4
4/
16
− 0.06/
0.06
0.12/
0.25
0.5/
2
0.015/
0.015
−
ESBL 7 16/
>32
2/
16
8/
16
− >64/
>64
1/
16
16/
>32
0.03/
0.06
−
P. aeruginosa 21 8/
>32
16/
>128
>32/
>32
− >64/
>64
8/
64
8/
>32
8/
>32
−
A. baumannii 23 2/
8
64/
>128
>32/
>32
− >64/
>64
32/
>64
>32/
>32
4/
16
−
Anaerobes
B. fragilis 51 0.5/
2
0.25/
1
− − − − − − 1/
1
− denotes not tested.
Methods: RELIEF was a double-dummy, double-blind, randomised
controlled trial conducted from 2007 to 2008 in 15 countries, most in
Europe. Acceptable culture specimens included skin biopsy, curettage of
the wound base after debridement, tissue or bone biopsy, aspiration of
purulent secretions including leading-edge needle aspiration. Clinically
signiﬁcant isolates (n = 1120) were recovered for processing from
603/803 patients in the ITT population who had at least one organism
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at isolated at baseline. Minimum inhibitory concentrations (MIC) values
for MXF and amoxicillin/clavulanic acid (AMC), ceftazidime (CFZ),
ceftriaxone (CRO), ertapenem (ERT), gentamicin (GEN), metronidazole
(MET), OXA and piperacillin/tazobactam (PIP/TAZ) were determined
using validated reference broth microdilution panels. Testing, incubation
and MIC interpretation were performed according to CLSI guidelines.
Results: The most frequently isolated pathogens (found in 20 patients)
were S. aureus (416/1120, 37.1%) of which 12% were methicillin
resistant, Enterococcus faecalis (135/1120, 12.1%), E. coli (126/1120,
11.3%), Streptococcus pyogenes (73/1120, 6.5%), Bacteroides fragilis
(50/1120, 4.5%), Streptococcus agalactiae (50/1120, 4.4%), Streptococ-
cus equisimilis (31/1120, 2.8%), Acinetobacter baumannii (23/1120,
2.1%) and Pseudomonas aeruginosa (21/1120, 1.9%). MICs for the
pathogens vs antimicrobial agents are shown in the Table.
Conclusion: MXF demonstrated good in vitro activity against most
cSSSI pathogens. MXF MIC values were comparable with those of
antimicrobial agents commonly used for the treatment of cSSSIs.
R2289 Clinical outcomes with daptomycin used as ﬁrst-line
therapy and after administration of other antibiotics for
Staphylococcus aureus infection
G. Sakoulas, J. Brown, K. Lamp °, L. Friedrich, K. Lindﬁeld (San
Diego, Buffalo, Lexington, US)
Objectives: Daptomycin exhibits in vitro concentration-dependent
bactericidal activity against most clinically relevant Gram-positive
pathogens. The primary objective of this study was to compare clinical
outcomes of patients treated with daptomycin as ﬁrst-line therapy versus
after prior antibiotic therapy, and secondarily to identify potential risk
factors of poor outcome of daptomycin therapy.
Methods: This was a retrospective cohort study using data from
the Cubicin Outcomes Registry and Experience database (2005–
2007). Clinical outcomes of patients treated for Staphylococcus aureus
infections with daptomycin were evaluated (cure, improvement, failure).
The effects of relevant patient characteristics on clinical outcome were
examined using univariate and multivariate statistical analyses.
Results: Of 1227 clinically evaluable patients, 250 (20%) received
daptomycin as ﬁrst-line therapy and 977 (80%) after other prior
antibiotics. Clinical success was reported for 1140 (93%) of 1227
patients. Univariate analysis identiﬁed 10 patient factors associated with
outcome: 7 with clinical failure (ICU, reduced renal function, diabetes,
concomitant antibiotics, bacteraemia, endocarditis, and prior vancomycin
failure) and 3 with clinical success, cure or improvement (outpatient
daptomycin and complicated and uncomplicated skin and skin structure
infections). Only the presence of infective endocarditis (OR 2.56),
bacteraemia (OR 1.77), reduced renal function (OR 1.78), and diabetes
(OR 1.79) were identiﬁed by stepwise multivariate analysis as risk factors
independently associated with clinical failure of daptomycin therapy.
Conclusion: Daptomycin is equally effective as ﬁrst-line therapy and
subsequent therapy following other antibiotics, including vancomycin,
in the treatment of S. aureus infections. Further prospective and
pharmacoeconomic studies to evaluate daptomycin as salvage or ﬁrst-
line therapy are needed.
Paediatric infections
R2290 The role of Staphylococcus aureus in atopic dermatitis
G. Prignano °, B. Capitanio, M.T. Gallo, C. Pascolini, L. Cilli, A. De
Santis, F. Anastasia, M. Vespaziani, E. Greco, F. Ensoli (Rome, IT)
Objectives: Atopic dermatitis is a chronic inﬂammatory skin disease
associated with colonisation of the skin with Staphylococcus aureus
known to produce toxins with superantigen activity. A correlation
between the severity of the eczema and colonisation with S. aureus has
been demonstrated and it has been determined that bacterial colonisation
is an important factor aggravating skin lesions. Recent studies revealed
that nasal carriage of S. aureus (NCSA) could be an important risk
factor for subsequent infection including MRSA (methicillin-resistant
S. aureus). The aim of this study was to determine the prevalence of
S. aureus and MRSA in the lesional and nonlesional skin, and in the
anterior vestibule of the nose in patients affected by atopic dermatitis.
In addition we also examined the relationship between S. aureus skin
lesion and nasal colonisation, the production of toxins and the presence
of nasal colonisation in patient’s cohabitants.
Methods: Nasal and skin (lesional and nonlesional) swabs cultures
for bacterial isolation were obtained from 94 children affected by
atopic dermatitis. Nasal swabs were taken from 15 patients’ cohabitants.
S. aureus strains were tested for emo-agglutination passive reverse
(Oxoid, UK) for detecting the toxins SEA, SEB, SEC, SED and TSST-1.
Results: S. aureus colonisation prevalence estimates were 36% in the
lesional skin of atopic dermatitis patients, in the same group of patients
the percentage of S. aureus in the anterior vestibule of the nose
was 94.4%. In the group of study we found the presence of MRSA
with a prevalence of 7.9% in the lesional skin and 3% in the nose.
65% of S. aureus strains isolated from patients releases staphylococcal
enterotoxins type A, B, C, D (SEA-SEB-SEC-SED) and/or TSST-1. We
observed that all positive patients to S. aureus had at least one positive
cohabitant and that the presence and the kind of enterotoxins in strains
isolated from cohabitants coincide to 100% with those of the patients.
Conclusion: This data focus the importance of the nasal carriage as risk
factor for the development of skin lesions in atopic dermatitis patients.
It’s important to redeﬁne the exact pathogenetic role of S. aureus for a
better therapeutic strategy as S. aureus, in particular strains producing
toxins, could be considered a trigger or aggravating atopic dermatitis. In
the current diagnostic practice is appropriate to include the research of
S. aureus in the patients’ family cohabitants.
R2291 Procalcitonin as prognostic marker of infection complicated
in newborn with congenital heart disease
E. Chernevskaya °, N. Beloborodova, D. Popov, M. Tumanyan,
S. Efremov (Moscow, RU)
Objectives: Recent data indicate that prenatal latent infections in
newborns with congenital heart disease (CHD) may increase risk of
postoperative infectious complications. Early recognitions of this process
can improve the results of surgery. The aim of our study was to estimate
the diagnostic value of procalcitonin (PCT) as a predictor of infectious
complications in newborn with CHD.
Methods: Blood plasma samples from 37 newborns with CHD on the
ﬁrst week of life (mean age 4 (1−6) days, median weight 3.23 (1.98–
4.24) kg) were taken before surgery. PCT concentrations were measured
by immunoluminometric method (PCT sensitive LIA, B.R.A.H.M.S
Aktiengesellschaft GmbH, Germany). The data were compared by Mann-
Whitney U-test and Wilcoxon matched pairs test, p-value of <0.05 was
considered statistically signiﬁcant. The data are expressed as median and
25th and 75th percentiles.
Table 1
PCT, ng/ml
Vaginal delivery Operative delivery
preterm at term 40−42 weeks at term
(n = 3) (n = 26) (n = 3) (n = 5)
Median 0.6 0.33 0.05 0.85
Percentiles 0.25–1.21 0.21–1.0 0.05–0.39 0.34–0.89
Results: All newborns were without clinical signs of infections, but
twenty-ﬁve of 37 patients (68%) had evidence of higher levels of PCT
before surgery.
There was no correlation between newborns age and levels of PCT
(r = −0.31, p = 0.7). The PCT levels were higher in newborns of
12−48 hours of life in comparison with newborns aged after 48 hours
of life but the data weren’t statistically signiﬁcant (0.8 (0.3–1.4, n = 10)
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vs. 0.31 (0.15–0.9, n = 27, respectively). The PCT levels didn’t depends
statistically signiﬁcant from the gestation and type of delivery (table 1).
The type of congenital heart disease, antibiotic prophylaxis in ﬁrst hours
of life, prescription of prostaglandin E weren’t impacted on PCT level
also.
Meanwhile, retrospective study have shown statistically signiﬁcant
difference between PCT level before surgery in group of newborn with
postoperative infection complicated and without it (0.66 (0.38–2.03) vs
0.3 (0.24–0.89) ng/ml, respectively, p = 0.03). Predictor point of infection
complications were 0.345 ng/ml cut-off PCT value before surgery with
sensitivity and speciﬁcity 83% and 62% respectively.
Conclusions: Our data suggest that 68% of newborns with congenital
heart disease have latent microbial process. The plasma concentration
of PCT may serve as a prognostic marker in newborn before repair of
congenital cardiac disease. Cut-off value of PCT 0.345 ng/ml may be
used as “look-out level” of infetion before cardiac surgery in newborns.
R2292 Murine typhus in a paediatric hospital in Greece
G. Antonaki, P. Tsialta, Z. Sergiou, T. Ganouri, K. Kallergi ° (Athens, GR)
Objectives: The aim of this study is to present the clinical and
epidemiological characteristics of Rickettsia typhi infection in children,
during the last ﬁve years.
Methods: Between October 2003 and October 2008, 496 children under
15 years of age, admitted to our hospital with fever, were tested for
Rickettsia typhi infection. For the serological diagnosis an indirect
immunoﬂorescence assay was used.
Results: Serological diagnosis of acute Rickettsia typhi infection
(IgM antibody titers of 64 or higher and IgG antibody titers of
256 or higher to typhus group antigen) was found in 17 children
(9 boys and 8 girls, median age 11 years). The most frequent
manifestations of rickettsial disease were fever (100%) and rash (41%).
Rash appeared as maculopapular or erythematous. Splenomegaly (29%)
and lymphadenopathy (18%) were noted less frequently. Abnormal
laboratory ﬁndings included mild elevation of liver enzymes, anaemia,
leukopenia and thrombocytopenia. Most of the cases presented at fall
(88%). The residence of the majority of the children was in the provinve
or in the suburban area of Attica (76%).
Conclusion: Murine typhus is rare in children, usually presented in fall
months with fever and rash. Serological tests in symptomatic children
from endemic areas should be performed.
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R2293 Evaluating the user experience of the Sealife Semantic Web
browsers
H. Oliver °, S. Jupp, E. de Quincey, D. Alexopoulou, B. Habermann,
K. Khelif, P. Kostkova, G. Jawaheer, R. Stevens, G. Ferguson,
V. Surendranath, S. Wiseman, J. Mani-Saada, G. Diallo, H. Dietze,
G. Madle, J. Weinberg, M. Schroeder (London, Manchester, UK;
Dresden, DE; Sophia Antipolis, FR; Edinburgh, UK)
Objectives: The purpose of the Sealife project, launched in 2006,
is to create browsers that use the Semantic Web to create a faster,
better focussed, and richer search experience for infectious disease
professionals, whose time is at a premium.[1] From December 2008
to March 2009, a user-centric evaluation of the Sealife browsers was
undertaken.
The evaluation required each user to carry out speciﬁc search tasks
using either the National Electronic Library of Infection (NeLI,
http://www.neli.org.uk) or PubMed, to determine whether the Sealife
browsers enhanced their search experience compared with those
websites’ search engines alone. For example, some users were asked
to ﬁnd the answer to the question “What percentage of viral encephalitis
and meningitis cases in the UK are of undetermined aetiology?” This
project will demonstrate how Semantic Web browsers can help users to
ﬁnd answers to their questions more quickly and more efﬁciently.
Methods: The evaluation was carried out online, in a workshop, and
through focus groups. Participants were recruited through the NeLI and
National Resource for Infection Control (NRIC, http://www.nric.org.uk/)
mailing lists, and the NeLI Advisory Board.
The methods used were as follows:
– Pre- and post-evaluation questionnaires
– Questionnaires following each evaluation task
– Web server log analysis
– Interviews
The scenarios were assigned to each user according to browser
compatibility and/or at random. Each user worked through half of the
tasks using a Sealife browser, and half without. The tasks were always
presented in the same order, but were counterbalanced such that some
users began with a Sealife browser and ended without, and other users
vice versa.
Results: This ongoing study thus far has 24 users, a majority of whom
have reported that the Sealife browsers increased the usability, ease,
and speed of their search experience, and increased the relevance and
ﬁndability of information.
Full results will be analyzed in February and March and will be presented
at the conference.
Conclusions: Preliminary results from our survey demonstrated that
Semantic Web browsers can enhance the speed, relevance, and richness
of the existing Web search experience for the life scientist.
Reference(s)
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